Document and Entity Information
Document and Entity Information - USD ($) | 12 Months Ended | ||
Dec. 31, 2023 | Feb. 29, 2024 | Jun. 30, 2023 | |
Cover [Abstract] | |||
Document Type | 10-K | ||
Amendment Flag | false | ||
Document Annual Report | true | ||
Document Transition Report | false | ||
Document Period End Date | Dec. 31, 2023 | ||
Document Fiscal Year Focus | 2023 | ||
Document Fiscal Period Focus | FY | ||
Entity File Number | 033-03094 | ||
Entity Central Index Key | 0000733076 | ||
Entity Registrant Name | Brighthouse Life Insurance Company | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Tax Identification Number | 06-0566090 | ||
Entity Address, Address Line One | 11225 North Community House Road | ||
Entity Address, State or Province | NC | ||
Entity Address, City or Town | Charlotte | ||
Entity Address, Postal Zip Code | 28277 | ||
City Area Code | (980) | ||
Local Phone Number | 365-7100 | ||
Current Fiscal Year End Date | --12-31 | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Small Business | false | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | false | ||
Document Financial Statement Error Correction | false | ||
Entity Shell Company | false | ||
Entity Public Float | $ 0 | ||
Entity Common Stock, Shares Outstanding | 3,000 |
Audit Information
Audit Information | 12 Months Ended |
Dec. 31, 2023 | |
Audit Information [Abstract] | |
Auditor Name | Deloitte & Touche LLP |
Auditor Firm ID | 34 |
Auditor Location | Charlotte, North Carolina |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Investments: | ||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $86,129 and $83,395, respectively; allowance for credit losses of $21 and $6, respectively) | $ 80,085 | $ 74,757 |
Equity securities, at estimated fair value | 66 | 66 |
Mortgage loans (net of allowance for credit losses of $137 and $119, respectively) | 22,475 | 22,877 |
Policy loans | 938 | 898 |
Limited partnerships and limited liability companies | 4,946 | 4,774 |
Short-term investments, principally at estimated fair value | 574 | 299 |
Other invested assets, principally at estimated fair value (net of allowance for credit losses of $13 and $13, respectively) | 4,411 | 2,984 |
Total investments | 113,495 | 106,655 |
Cash and cash equivalents | 3,165 | 3,752 |
Accrued investment income | 1,163 | 868 |
Premiums, reinsurance and other receivables (net of allowance for credit losses of $3 and $10, respectively) | 19,389 | 18,145 |
Deferred policy acquisition costs and value of business acquired | 4,487 | 4,642 |
Current income tax recoverable | 24 | 18 |
Deferred income tax asset | 1,833 | 1,673 |
Market risk benefit assets | 656 | 483 |
Other assets | 302 | 322 |
Separate account assets | 81,690 | 78,880 |
Total assets | 226,204 | 215,438 |
Liabilities | ||
Future policy benefits | 32,149 | 31,146 |
Policyholder account balances | 80,193 | 72,602 |
Market risk benefit liabilities | 10,344 | 10,411 |
Other policy-related balances | 3,619 | 3,860 |
Payables for collateral under securities loaned and other transactions | 3,660 | 4,547 |
Long-term and short-term debt | 836 | 963 |
Other liabilities | 7,772 | 6,515 |
Separate account liabilities | 81,690 | 78,880 |
Total liabilities | 220,263 | 208,924 |
Contingencies, Commitments and Guarantees (Note 16) | ||
Brighthouse Life Insurance Company’s stockholder’s equity: | ||
Common stock, par value $25,000 per share; 4,000 shares authorized; 3,000 shares issued and outstanding | 75 | 75 |
Additional paid-in capital | 17,507 | 17,773 |
Retained earnings (deficit) | (6,542) | (5,418) |
Accumulated other comprehensive income (loss) | (5,114) | (5,931) |
Total Brighthouse Life Insurance Company’s stockholder’s equity | 5,926 | 6,499 |
Noncontrolling interests | 15 | 15 |
Total equity | 5,941 | 6,514 |
Total liabilities and equity | $ 226,204 | $ 215,438 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 |
Assets | |||
Amortized cost of fixed maturity securities available-for-sale | $ 86,129 | $ 83,395 | |
Fixed maturity securities, allowance for credit losses | 21 | 6 | $ 11 |
Mortgage loans valuation allowances | 137 | 119 | |
Leveraged leases, allowance for credit losses | 13 | 13 | |
Premiums, reinsurance and other, allowance for credit losses | $ 3 | $ 10 | |
Brighthouse Life Insurance Company’s stockholder’s equity: | |||
Common stock, par value | $ 25,000 | $ 25,000 | |
Common stock, shares authorized | 4,000 | 4,000 | |
Common stock, shares, issued | 3,000 | 3,000 | |
Common stock, shares, outstanding | 3,000 | 3,000 |
Consolidated Statements of Oper
Consolidated Statements of Operations - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Revenues | |||
Premiums | $ 811 | $ 641 | $ 687 |
Universal life and investment-type product policy fees | 1,778 | 1,876 | 2,320 |
Net investment income | 4,560 | 4,064 | 4,815 |
Other revenues | 418 | 406 | 337 |
Net investment gains (losses) | (242) | (240) | (63) |
Net derivative gains (losses) | (3,920) | (585) | (3,986) |
Total revenues | 3,405 | 6,162 | 4,110 |
Expenses | |||
Policyholder benefits and claims (including liability remeasurement gains (losses) of ($233), $137, ($51), respectively) | 2,418 | 2,186 | 2,485 |
Interest credited to policyholder account balances | 1,801 | 1,313 | 1,243 |
Amortization of deferred policy acquisition costs and value of business acquired | 564 | 568 | 558 |
Change in market risk benefits | (1,497) | (4,105) | (4,142) |
Other expenses | 1,625 | 1,694 | 1,824 |
Total expenses | 4,911 | 1,656 | 1,968 |
Income (loss) before provision for income tax | (1,506) | 4,506 | 2,142 |
Provision for income tax expense (benefit) | (383) | 795 | 379 |
Net income (loss) | (1,123) | 3,711 | 1,763 |
Less: Net income (loss) attributable to noncontrolling interests | 1 | 1 | 1 |
Net income (loss) attributable to Brighthouse Life Insurance Company | $ (1,124) | $ 3,710 | $ 1,762 |
Consolidated Statements of Op_2
Consolidated Statements of Operations (Parenthetical) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Statement [Abstract] | |||
Liability for Future Policy Benefit, Remeasurement Gain (Loss) | $ (233) | $ 137 | $ (51) |
Consolidated Statements Of Comp
Consolidated Statements Of Comprehensive Income (Loss) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Statement of Comprehensive Income [Abstract] | |||
Net income (loss) | $ (1,123) | $ 3,711 | $ 1,763 |
Other comprehensive income (loss): | |||
Unrealized investment gains (losses), net of related offsets | 2,313 | (13,946) | (2,891) |
Unrealized gains (losses) on derivatives | (284) | 308 | 158 |
Changes in instrument-specific credit risk on market risk benefits | (637) | 2,344 | (636) |
Changes in discount rates on the liability for future policy benefits | (376) | 4,060 | 1,234 |
Foreign currency translation adjustments | 18 | (22) | 1 |
Other comprehensive income (loss), before income tax | 1,034 | (7,256) | (2,134) |
Income tax (expense) benefit related to items of other comprehensive income (loss) | (217) | 1,524 | 449 |
Other Comprehensive Income (Loss), Net of Tax, Total | 817 | (5,732) | (1,685) |
Comprehensive income (loss) | (306) | (2,021) | 78 |
Less: Comprehensive income (loss) attributable to noncontrolling interests, net of income tax | 1 | 1 | 1 |
Comprehensive income (loss), net of tax, Attributable to Parent | $ (307) | $ (2,022) | $ 77 |
Consolidated Statements of Equi
Consolidated Statements of Equity - USD ($) $ in Millions | Total | Cumulative effect of change in accounting principle, net of income tax | Cumulative Effect, Period of Adoption, Adjusted Balance | Common Stock | Common Stock Cumulative Effect, Period of Adoption, Adjusted Balance | Additional Paid-in Capital | Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjusted Balance | Retained Earnings (Deficit) | Retained Earnings (Deficit) Cumulative effect of change in accounting principle, net of income tax | Retained Earnings (Deficit) Cumulative Effect, Period of Adoption, Adjusted Balance | Accumulated Other Comprehensive Income (Loss) | Accumulated Other Comprehensive Income (Loss) Cumulative effect of change in accounting principle, net of income tax | Accumulated Other Comprehensive Income (Loss) Cumulative Effect, Period of Adoption, Adjusted Balance | Brighthouse Life Insurance Company’s Stockholder’s Equity | Brighthouse Life Insurance Company’s Stockholder’s Equity Cumulative effect of change in accounting principle, net of income tax | Brighthouse Life Insurance Company’s Stockholder’s Equity Cumulative Effect, Period of Adoption, Adjusted Balance | Noncontrolling Interests | Noncontrolling Interests Cumulative Effect, Period of Adoption, Adjusted Balance |
Beginning Balance at Dec. 31, 2020 | $ 18,115 | $ (9,106) | $ 9,009 | $ 75 | $ 75 | $ 18,323 | $ 18,323 | $ (5,719) | $ (5,171) | $ (10,890) | $ 5,421 | $ (3,935) | $ 1,486 | $ 18,100 | $ (9,106) | $ 8,994 | $ 15 | $ 15 |
Dividends paid to parent | (550) | (550) | (550) | |||||||||||||||
Change in noncontrolling interests | (1) | 0 | (1) | |||||||||||||||
Net income (loss) attributable to Brighthouse Life Insurance Company | 1,762 | 1,762 | 1,762 | 1 | ||||||||||||||
Net income (loss) | 1,763 | |||||||||||||||||
Other comprehensive income (loss), net of income tax | (1,685) | (1,685) | (1,685) | |||||||||||||||
Ending Balance at Dec. 31, 2021 | 8,536 | 75 | 17,773 | (9,128) | (199) | 8,521 | 15 | |||||||||||
Change in noncontrolling interests | (1) | 0 | (1) | |||||||||||||||
Net income (loss) attributable to Brighthouse Life Insurance Company | 3,710 | 3,710 | 3,710 | 1 | ||||||||||||||
Net income (loss) | 3,711 | |||||||||||||||||
Other comprehensive income (loss), net of income tax | (5,732) | (5,732) | (5,732) | |||||||||||||||
Ending Balance at Dec. 31, 2022 | 6,514 | 75 | 17,773 | (5,418) | (5,931) | 6,499 | 15 | |||||||||||
Dividends paid to parent | (266) | (266) | (266) | |||||||||||||||
Change in noncontrolling interests | (1) | 0 | (1) | |||||||||||||||
Net income (loss) attributable to Brighthouse Life Insurance Company | (1,124) | (1,124) | (1,124) | 1 | ||||||||||||||
Net income (loss) | (1,123) | |||||||||||||||||
Other comprehensive income (loss), net of income tax | 817 | 817 | 817 | |||||||||||||||
Ending Balance at Dec. 31, 2023 | $ 5,941 | $ 75 | $ 17,507 | $ (6,542) | $ (5,114) | $ 5,926 | $ 15 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Cash flows from operating activities | |||
Net income (loss) | $ (1,123) | $ 3,711 | $ 1,763 |
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||
Amortization of premiums and accretion of discounts associated with investments, net | (258) | (225) | (253) |
(Gains) losses on investments, net | 227 | 240 | 63 |
(Gains) losses on derivatives, net | 2,632 | 162 | 3,088 |
(Income) loss from equity method investments, net of dividends and distributions | 76 | 109 | (987) |
Interest credited to policyholder account balances | 1,801 | 1,313 | 1,243 |
Universal life and investment-type product policy fees | (1,778) | (1,876) | (2,320) |
Change in market risk benefits, net | (888) | (3,353) | (3,298) |
Change in accrued investment income | (212) | (115) | (45) |
Change in premiums, reinsurance and other receivables | (1,279) | (1,388) | 538 |
Change in deferred policy acquisition costs and value of business acquired, net | 155 | 144 | 64 |
Change in income tax | (380) | 804 | 322 |
Change in other assets | 1,100 | 1,220 | 1,521 |
Change in future policy benefits and other policy-related balances | (62) | (1,814) | (436) |
Change in other liabilities | (18) | 286 | (14) |
Net cash provided by (used in) operating activities | (7) | (782) | 1,249 |
Cash flows from investing activities | |||
Sales, maturities and repayments of fixed maturity securities | 5,922 | 10,647 | 12,406 |
Sales, maturities and repayments of equity securities | 30 | 50 | 128 |
Sales, maturities and repayments of mortgage loans | 1,206 | 2,075 | 2,891 |
Sales, maturities and repayments of limited partnerships and limited liability companies | 205 | 252 | 271 |
Purchases of fixed maturity securities | (8,699) | (15,720) | (21,036) |
Purchases of equity securities | (4) | (14) | (18) |
Purchases of mortgage loans | (813) | (5,321) | (6,929) |
Purchases of limited partnerships and limited liability companies | (453) | (814) | (837) |
Cash received in connection with freestanding derivatives | 5,048 | 4,439 | 3,956 |
Cash paid in connection with freestanding derivatives | (5,422) | (4,270) | (4,590) |
Receipts on loans to affiliate | 125 | 0 | 0 |
Issuances of loans to affiliate | 0 | (125) | (1) |
Net change in policy loans | (40) | (29) | 15 |
Net change in short-term investments | (259) | 365 | 1,223 |
Net change in other invested assets | (109) | (372) | (24) |
Net cash provided by (used in) investing activities | (3,263) | (8,837) | (12,545) |
Cash flows from financing activities | |||
Policyholder account balances: Deposits | 21,514 | 31,190 | 15,520 |
Policyholder account balances: Withdrawals | (17,641) | (19,960) | (4,100) |
Net change in payables for collateral under securities loaned and other transactions | (887) | (1,706) | 1,016 |
Long-term and short-term debt issued | 0 | 125 | 0 |
Long-term and short-term debt repaid | (127) | (3) | (1) |
Dividends paid to parent | (266) | 0 | (550) |
Financing element on certain derivative instruments and other derivative related transactions, net | 91 | (178) | (368) |
Other, net | (1) | (1) | (1) |
Net cash provided by (used in) financing activities | 2,683 | 9,467 | 11,516 |
Change in cash, cash equivalents and restricted cash | (587) | (152) | 220 |
Cash, cash equivalents and restricted cash, beginning of year | 3,752 | 3,904 | 3,684 |
Cash, cash equivalents and restricted cash, end of year | 3,165 | 3,752 | 3,904 |
Supplemental disclosures of cash flow information | |||
Net cash paid (received) for interest | 71 | 69 | 67 |
Net cash paid (received) for income tax | 0 | (12) | 53 |
Non-cash transactions: | |||
Transfer of mortgage loans to affiliates | 0 | 95 | 0 |
Transfer of limited partnerships and limited liability companies from affiliates | $ 0 | $ 99 | $ 0 |
Business, Basis of Presentation
Business, Basis of Presentation and Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Business, Basis of Presentation and Summary of Significant Accounting Policies | 1. Business, Basis of Presentation and Summary of Significant Accounting Policies Business “BLIC” and the “Company” refer to Brighthouse Life Insurance Company, a Delaware corporation originally incorporated in Connecticut in 1863, and its subsidiaries. Brighthouse Life Insurance Company is a wholly-owned subsidiary of Brighthouse Holdings, LLC (“BH Holdings”) and an indirect wholly-owned subsidiary of Brighthouse Financial, Inc. (“BHF” and together with its subsidiaries, “Brighthouse Financial”). BLIC offers a range of annuity and life insurance products to individuals. The Company is organized into three segments: Annuities; Life; and Run-off. In addition, the Company reports certain of its results of operations in Corporate & Other. Basis of Presentation The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported on the consolidated financial statements. In applying these policies and estimates, management makes subjective and complex judgments that frequently require assumptions about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries; others are specific to the Company’s business and operations. Actual results could differ from these estimates. Consolidation The accompanying consolidated financial statements include the accounts of Brighthouse Life Insurance Company and its subsidiaries, as well as partnerships and limited liability companies (“LLC”) that the Company controls. Intercompany accounts and transactions have been eliminated. The Company uses the equity method of accounting for investments in limited partnerships and LLCs when it has more than a minor ownership interest or more than a minor influence over the investee’s operations. The Company generally recognizes its share of the investee’s earnings on a three-month lag in instances where the investee’s financial information is not sufficiently timely or when the investee’s reporting period differs from the Company’s reporting period. When the Company has virtually no influence over the investee’s operations, the investment is carried at fair value. Reclassifications Certain amounts in the prior years’ consolidated financial statements and related footnotes thereto have been reclassified to conform with the 2023 presentation as discussed throughout the Notes to the Consolidated Financial Statements. See “— Adoption of New Accounting Pronouncements” for discussion of the adoption of new guidance on long-duration contracts as of January 1, 2023, parts of which were retrospectively applied to prior periods presented in the consolidated financial statements. Summary of Significant Accounting Policies Insurance Contract Obligations The Company has obligations under insurance contracts to pay benefits over an extended period of time. The Company establishes liabilities for future obligations under long-duration insurance contracts based on the accounting model appropriate for each type of contract or contract feature. Liabilities for insurance contract benefits are generally accrued over time as revenue is recognized, or established based on the balance that accrues to the contract holder. In addition, certain insurance contracts may contain features that are required to be measured at fair value separately from the base contracts, either as a market risk benefit (“MRB”) or embedded derivative. The discussion below provides an overview of the different accounting models for insurance contract obligations and the applicability of such models to the Company’s insurance products. Liability for Future Policy Benefits The Company establishes a liability for future policy benefits (“LFPB”) for non-participating term and whole life insurance and income annuities. LFPBs are accrued over time as revenue is recognized based on a net premium ratio. The net premium ratio is the portion of gross premiums required to provide for all future benefits. LFPBs are established using the Company’s current assumptions of future cash flows, discounted at a rate that approximates a single A corporate bond curve. The Company generally aggregates insurance contracts into groupings by issue year, product and segment for determining the net premium ratio and related LFPBs. The Company reviews cash flow assumptions regularly, and if they change significantly, LFPBs are adjusted by determining a revised net premium ratio. The revised net premium ratio is calculated as of contract inception using both actual historical experience and updated future cash flow assumptions. The recalculated net premium ratio is applied to derive a remeasurement gain or loss recognized in the current period net income. For insurance policies in-force as of December 31, 2020, January 1, 2021 is considered the contract inception date. The net premium ratio is also updated quarterly for the difference between actual and expected experience. The net premium ratio is not updated for changes in discount rate assumptions, as changes in the discount rate are updated quarterly and the impacts are reflected in other comprehensive income (loss) (“OCI”). The discount rate assumption is determined by developing a yield curve based on market observable yields for upper-medium grade fixed income instruments derived from an external index. The yield curve is applied to the expected future cash flows used in the measurement of LFPBs based on the duration characteristics of those liabilities. The most significant cash flow assumptions used in the establishment of LFPBs are mortality, policy lapses and market interest rates. See Note 4 for more information on the effect of changes in assumptions on the measurement of LFPBs. The Company also establishes an LFPB for participating term and whole life insurance using a net premium ratio and the Company’s current assumptions of future cash flows. Assumptions are determined at issuance of the policy and are not updated unless a premium deficiency exists. A premium deficiency exists when the LFPB plus the present value of expected future gross premiums are less than expected future benefits and expenses (based on current assumptions). When a premium deficiency exists, the Company will reduce any deferred acquisition costs and may also establish an additional liability to eliminate the deficiency. See Note 4 for more information on assumptions used in establishing LFPBs related to participating term and whole life insurance. Policyholder Account Balances The Company establishes a policyholder account balance liability for customer deposits on universal life insurance, universal life insurance with secondary guarantees (“ULSG”) and deferred annuity contracts. The policyholder account balance liability is equal to the sum of deposits, plus interest credited, less charges and withdrawals, excluding the impact of any applicable charge that may be incurred upon surrender. The Company also holds additional liabilities for certain product features including secondary guarantees on universal life insurance contracts and the crediting rates associated with index-linked annuities. Additional Liabilities for ULSG The Company establishes a liability in addition to the account balance for ULSG. These liabilities are determined by estimating the expected value of death benefits payable when the account balance is projected to be zero and recognizing those benefits ratably over the contract period based on total expected assessments. The benefits used in calculating the liabilities are based on the average benefits payable over a range of scenarios. The Company also maintains a liability for profits followed by losses on ULSG determined by projecting future earnings and establishing a liability to offset losses that are expected to occur in later years. Both ULSG liabilities are adjusted for the effects of unrealized investment gains and losses. The Company reviews cash flow assumptions regularly, and, if they change significantly, the liability for secondary guarantees is adjusted by a cumulative charge or credit to net income. Liabilities for secondary guarantees are presented within future policy benefits with changes in the liabilities reported in policyholder benefits and claims, except for the effects of unrealized investment gains and losses, which are reported in OCI. The most significant assumptions used in estimating liabilities for secondary guarantees are the general account rate of return, premium persistency, mortality and lapses. See Note 4 for more information on the effect of changes in assumptions on the measurement of liabilities for secondary guarantees. Market Risk Benefits on Annuity Guarantees MRBs are contracts or contract features that provide protection to the policyholder from capital markets risks by transferring such risks to the Company. MRBs are required to be separated from the deferred annuity host contract and measured at fair value. The Company establishes MRB assets and liabilities for guaranteed minimum benefits on variable annuity contracts including guaranteed minimum death benefits (“GMDB”), guaranteed minimum income benefits (“GMIB”), guaranteed minimum accumulation benefits (“GMAB”) and guaranteed minimum withdrawal benefits (“GMWB”). MRB assets are also established for reinsured benefits related to these guarantees. Certain index-linked annuity products may also have guaranteed minimum benefits classified as MRBs. The measurement of fair value includes an adjustment for the risk that the Company fails to satisfy its obligations, which is referred to as nonperformance risk, as well as risk margin to capture the non-capital markets risks of the instrument, which represents the additional compensation a market participant would require to assume the risks related to the uncertainties in certain actuarial assumptions. MRBs are measured at estimated fair value, with changes reported in change in MRBs on the consolidated statements of operations, except for the change due to nonperformance risk, which is reported in OCI. See Note 5 for more information on the effect of changes in inputs and assumptions on the measurement of MRBs and Note 11 for more information on the determination of fair value of MRBs. Embedded Derivatives on Index-Linked Annuities The Company issues, and assumes through reinsurance, index-linked annuities which allow the policyholder to participate in returns from certain specified equity indices. The crediting rates associated with these features are classified as embedded derivatives and measured at estimated fair value, with changes in estimated fair value reported in net derivative gains (losses). These embedded derivatives are classified within policyholder account balances on the consolidated balance sheets. Embedded derivative liabilities are required to be separated from the deferred annuity host contract and measured at fair value. The estimated fair value is determined using a combination of an option pricing model and an option-budget approach. Under this approach, the Company estimates the cost of funding the crediting rate using option pricing and establishes that cost on the balance sheet as a reduction to the initial deposit amount. The estimate of fair value includes an adjustment for nonperformance risk, as well as a risk margin. Actuarial assumptions are reviewed at least annually, and if they change significantly, the estimated fair value is adjusted through net income. Capital market inputs used in the measurement of index-linked crediting rate embedded derivatives are updated quarterly through net income. The reduction to the initial deposit is accreted back up to the initial deposit over the estimated life of the contract. Embedded derivatives related to index-linked annuities are presented within policyholder account balances while changes in the estimated fair value are reported in net derivative gains (losses). For more information on the determination of estimated fair value of embedded derivatives, see Note 11. Recognition of Revenues and Deposits on Insurance Contracts Premiums related to traditional long-duration contracts are recognized as revenues when due from policyholders. When premiums for income annuities are due over a significantly shorter period than the period over which policyholder benefits are incurred, the Company establishes a deferred profit liability (“DPL”) for the excess of the gross premium over the net premium. DPLs are amortized into net income in proportion to the amount of expected future benefit payments. Assumptions used in the measurement of the DPL are updated at the same time as the related LFPBs, with the updated estimates used to recalculate the DPL as of contract inception. The remeasurement gain or loss from updating DPLs is recognized in current period net income along with the related change in LFPBs. Deposits related to universal life insurance, deferred annuity contracts and investment contracts are credited to policyholder account balances. Revenues from such contracts consist of asset-based investment management fees, cost of insurance charges, risk charges, policy administration fees and surrender charges. These fees, which are included in universal life and investment-type product policy fees, are recognized when assessed to the contract holder, except for non-level insurance charges which are deferred by the establishment of an unearned revenue liability and amortized over the expected life of the contracts. Premiums and policy fees are presented net of reinsurance. Deferred Policy Acquisition Costs, Value of Business Acquired and Other Intangibles The Company incurs significant costs in connection with acquiring new and renewal insurance business. Costs that are directly related to the successful acquisition or renewal of insurance contracts are capitalized as deferred policy acquisition costs (“DAC”). These costs mainly consist of commissions and include the portion of employees’ compensation and benefits related to time spent selling, underwriting or processing the issuance of new insurance contracts. All other acquisition-related costs are expensed as incurred. Value of business acquired (“VOBA”) is an intangible asset resulting from a business combination that represents the excess of book value over the estimated fair value of acquired insurance, annuity and investment-type contracts in-force as of the acquisition date. The Company amortizes DAC and VOBA in a manner that approximates a straight-line basis over the expected life of the related contracts. For life insurance contracts, amortization is based on projections of amounts of insurance in-force, while projections of policy counts are used for deferred annuity contracts and expected future benefits payments for income annuities. These assumptions are reviewed at least annually, and if they change significantly, updates are recognized through changes to future amortization. VOBA balances are tested annually to determine if the balance is deemed unrecoverable from expected future profits. All changes in DAC and VOBA balances are recorded to net income. Periodically, the Company modifies product benefits, features, rights or coverages that occur by the exchange of an existing contract for a new contract, or by amendment, endorsement, or rider to a contract, or by election or coverage within a contract. If a modification is considered to have substantially changed the contract, the associated DAC or VOBA is written off immediately through net income and any new acquisition costs associated with the replacement contract are deferred. If the modification does not substantially change the contract, the DAC or VOBA amortization on the original contract will continue and any acquisition costs associated with the related modification are expensed. The Company also has intangible assets representing deferred sales inducements (“DSI”), which are included in other assets, and unearned revenue liabilities, which are included in other policy-related balances. The Company defers sales inducements and unearned revenue and amortizes the balances using the same methodology and assumptions used to amortize DAC and VOBA. Reinsurance The Company enters into reinsurance arrangements pursuant to which it cedes certain insurance risks to unaffiliated and former related party reinsurers. Cessions under reinsurance agreements do not discharge the Company’s obligations as the primary insurer. The accounting for reinsurance arrangements depends on whether the arrangement provides indemnification against loss or liability relating to insurance risk in accordance with GAAP. For ceded reinsurance of existing in-force blocks of insurance contracts that transfer significant insurance risk, premiums, benefits and the amortization of DAC are reported net of reinsurance ceded. Amounts recoverable from reinsurers related to incurred claims and ceded reserves are included in premiums, reinsurance and other receivables and amounts payable to reinsurers included in other liabilities. If the Company determines that a reinsurance agreement does not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk, the Company records the agreement using the deposit method of accounting. Deposits received are included in other liabilities and deposits made are included in premiums, reinsurance and other receivables. As amounts are paid or received, consistent with the underlying contracts, the deposit assets or liabilities are adjusted. Interest on such deposits is recorded as other revenues or other expenses, as appropriate. The funds withheld liability represents amounts withheld by the Company in accordance with the terms of the reinsurance agreements. Under certain reinsurance agreements, the Company withholds the funds rather than transferring the underlying investments and, as a result, records a funds withheld liability in other liabilities. The Company recognizes interest on funds withheld, included in other expenses, at rates defined by the terms of the agreement which may be contractually specified or directly related to the investment portfolio. Certain funds withheld arrangements may also contain embedded derivatives measured at fair value that are related to the investment return on the assets withheld. Embedded derivatives related to funds withheld arrangements are presented within policyholder account balances on the consolidated balance sheets, with changes in the estimated fair value reported in net derivative gains (losses). Reinsurance arrangements may also contain features classified as MRBs, including reinsurance of guaranteed minimum benefits associated with variable annuity contracts. The Company accounts for assumed reinsurance similar to directly written business. Investments Net Investment Income and Net Investment Gains (Losses) Income from investments is reported in net investment income, unless otherwise stated herein. Gains and losses on sales of investments, impairment losses and changes in valuation allowances are reported in net investment gains (losses), unless otherwise stated herein. Fixed Maturity Securities Available-For-Sale The Company’s fixed maturity securities are classified as available-for-sale and are reported at their estimated fair value. Unrealized investment gains and losses on these securities are recorded as a separate component of OCI, net of policy-related amounts and deferred income taxes. Publicly-traded security transactions are recorded on a trade date basis, while privately-placed and bank loan security transactions are recorded on a settlement date basis. Investment gains and losses on sales are determined on a specific identification basis. Interest income and prepayment fees are recognized when earned. Interest income is recognized using an effective yield method giving effect to amortization of premiums and accretion of discounts and is based on the estimated economic life of the securities, which for residential mortgage-backed securities (“RMBS”), commercial mortgage-backed securities (“CMBS”) and asset-backed securities (“ABS”) (collectively, “Structured Securities”) considers the estimated timing and amount of prepayments of the underlying loans. The amortization of premium and accretion of discount of fixed maturity securities also takes into consideration call and maturity dates. Amortization of premium and accretion of discount on Structured Securities considers the estimated timing and amount of prepayments of the underlying loans. Actual prepayment experience is periodically reviewed, and effective yields are recalculated when differences arise between the originally anticipated and the actual prepayments received and currently anticipated. Prepayment assumptions for Structured Securities are estimated using inputs obtained from third-party specialists and based on management’s knowledge of the current market. For credit-sensitive Structured Securities and certain prepayment-sensitive securities, the effective yield is recalculated on a prospective basis. For all other Structured Securities, the effective yield is recalculated on a retrospective basis. The Company regularly evaluates fixed maturity securities for declines in fair value to determine if a credit loss exists. This evaluation is based on management’s case-by-case evaluation of the underlying reasons for the decline in fair value including, but not limited to an analysis of the gross unrealized losses by severity and financial condition of the issuer. For fixed maturity securities in an unrealized loss position, when the Company has the intent to sell the security, or it is more likely than not that the Company will be required to sell the security before recovery, the amortized cost basis of the security is written down to fair value through net investment gains (losses). For fixed maturity securities that do not meet the aforementioned criteria, management evaluates whether the decline in estimated fair value has resulted from credit losses or other factors. If the Company determines the decline in estimated fair value is due to credit losses, the difference between the amortized cost of the security and the present value of projected future cash flows expected to be collected is recognized as an allowance through net investment gains (losses). If the estimated fair value is less than the present value of projected future cash flows expected to be collected, this portion of the allowance related to other-than-credit factors is recorded in OCI. Once a security specific allowance for credit losses is established, the present value of cash flows expected to be collected from the security continues to be reassessed. Any changes in the security specific allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in net investment gains (losses). Fixed maturity securities are also evaluated to determine whether any amounts have become uncollectible. When all, or a portion, of a security is deemed uncollectible, the uncollectible portion is written-off with an adjustment to amortized cost and a corresponding reduction to the allowance for credit losses. Mortgage Loans Mortgage loans are stated at unpaid principal balance, adjusted for any unamortized premium or discount, and any deferred fees or expenses, and net of an allowance for credit losses. Interest income and prepayment fees are recognized when earned. Interest income is recognized using an effective yield method giving effect to amortization of premiums and accretion of discounts. The allowance for credit losses for mortgage loans represents the Company’s best estimate of expected credit losses over the remaining life of the loans and is determined using relevant available information from internal and external sources, relating to past events, current conditions, and a reasonable and supportable forecast. Policy Loans Policy loans are stated at unpaid principal balances. Interest income is recorded as earned using the contractual interest rate. Generally, accrued interest is capitalized on the policy’s anniversary date. Any unpaid principal and accrued interest is deducted from the cash surrender value or the death benefit prior to settlement of the insurance policy . Limited Partnerships and LLCs The Company uses the equity method of accounting for investments when it has more than a minor ownership interest or more than a minor influence over the investee’s operations; when the Company has virtually no influence over the investee’s operations the investment is carried at estimated fair value. The Company generally recognizes its share of the equity method investee’s earnings on a three-month lag in instances where the investee’s financial information is not sufficiently timely or when the investee’s reporting period differs from the Company’s reporting period; while distributions on investments carried at estimated fair value are recognized as earned or received. Short-term Investments Short-term investments include securities and other investments with remaining maturities of one year or less, but greater than three months, at the time of purchase and are stated at estimated fair value or amortized cost, which approximates estimated fair value. The Company’s short-term investments generally involve large dollar amounts that turn over quickly and have short maturities. For the years ended December 31, 2023, 2022 and 2021, cash proceeds from sales, maturities and repayments of short-term investments were $1.1 billion, $976 million and $3.6 billion, respectively. For the years ended December 31, 2023, 2022 and 2021, cash payments on purchases of short-term investments were $1.4 billion, $611 million and $2.4 billion, respectively. Other Invested Assets Other invested assets consist principally of freestanding derivatives with positive estimated fair values which are described in “— Derivatives” below. Securities Lending Program Securities lending transactions whereby blocks of securities are loaned to third parties, primarily brokerage firms and commercial banks, are treated as financing arrangements and the associated liability is recorded at the amount of cash received. Income and expenses associated with securities lending transactions are reported as investment income and investment expense, respectively, in net investment income. The Company obtains collateral at the inception of the loan, usually cash, in an amount generally equal to 102% of the estimated fair value of the securities loaned and maintains it at a level greater than or equal to 100% for the duration of the loan. The Company monitors the estimated fair value of the securities loaned on a daily basis and additional collateral is obtained as necessary throughout the duration of the loan. Securities loaned under such transactions may be sold or re-pledged by the transferee. The Company is liable to return to the counterparties the cash collateral received. Funding Agreements The Company established liabilities for funding agreements associated with the Company’s institutional spread margin business, which are equal to the unpaid principal balance, adjusted for any unamortized premium or discount. Liabilities related to funding agreements are reported in policyholder account balances. Derivatives Freestanding Derivatives Freestanding derivatives are carried at estimated fair value on the Company’s balance sheet either as assets in other invested assets or as liabilities in other liabilities. The Company does not offset the estimated fair value amounts recognized for derivatives executed with the same counterparty under the same master netting agreement. If a derivative is not designated or did not qualify as an accounting hedge, changes in the estimated fair value of the derivative are reported in net derivative gains (losses). The Company generally reports cash received or paid for a derivative in the investing activity section of the statement of cash flows except for cash flows of certain derivative options with deferred premiums, which are reported in the financing activity section of the statement of cash flows. Hedge Accounting The Company primarily designates derivatives as a hedge of a forecasted transaction or a variability of cash flows to be received or paid related to a recognized asset or liability (cash flow hedge). When a derivative is designated as a cash flow hedge and is determined to be highly effective, changes in fair value are recorded in OCI and subsequently reclassified into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item. To qualify for hedge accounting, at the inception of the hedging relationship, the Company formally documents its risk management objective and strategy for undertaking the hedging transaction, as well as its designation of the hedge. In its hedge documentation, the Company sets forth how the hedging instrument is expected to hedge the designated risks related to the hedged item and sets forth the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness is formally assessed at inception and at least quarterly throughout the life of the designated hedging relationship. The Company discontinues hedge accounting prospectively when: (i) it is determined that the derivative is no longer highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item; (ii) the derivative or hedged item expires, is sold, terminated, or exercised; (iii) it is no longer probable that the hedged forecasted transaction will occur; or (iv) the derivative is de-designated as a hedging instrument. When hedge accounting is discontinued the derivative is carried at its estimated fair value on the balance sheet, with changes in its estimated fair value recognized in the current period as net derivative gains (losses). The changes in estimated fair value of derivatives previously recorded in OCI related to discontinued cash flow hedges are released into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item. When the hedged item matures or is sold, or the forecasted transaction is not probable of occurring, the Company immediately reclassifies any remaining balances in OCI to net derivative gains (losses). Embedded Derivatives The Company has index-linked annuities that are directly written or assumed through reinsurance contracts that contain embedded derivatives which are required to be separated from their host contracts and reported as derivatives. Certain funds withheld arrangements associated with reinsurance may also contain embedded derivatives. See “— Insurance Contract Obligations” and “— Reinsurance” for additional information on the accounting policies for embedded derivatives. Fair Value Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. In most cases, the exit price and the transaction (or entry) price will be the same at initial recognition. In determining the estimated fair value of the Company’s investments, fair values are based on unadjusted quoted prices for identical investments in active markets that are readily and regularly obtainable. When such quoted prices are not available, fair values are based on quoted prices in markets that are not active, quoted prices for similar but not identical investments, or other observable inputs. If these inputs are not available, or observable inputs are not determinable, unobservable inputs and/or adjustments to observable inputs requiring management judgment are used to determine the estimated fair value of investments. Separate Accounts Separate accounts underlying the Company’s variable life and annuity contracts are reported at fair value. Assets in separate accounts supporting the contract liabilities are legally insulated from the Company’s general account liabilities. Investments in these separate accounts are directed by the contract holder and all investment performance, net of co |
Financial Services, Insurance,
Financial Services, Insurance, ASU 2018-12 Transition | 12 Months Ended |
Dec. 31, 2023 | |
ASU 2018-12 Transition [Abstract] | |
ASU 2018-12 Transition | 2. ASU 2018-12 Transition The Company adopted ASU 2018-12 for LFPBs, DAC and other balances amortized on a basis consistent with DAC by applying the guidance to contracts in-force on the basis of their existing carrying amounts at the transition date. The Company adopted ASU 2018-12 for MRBs on a fully retrospective basis. The effect of transition adjustments on stockholder’s equity at January 1, 2021 due to the adoption of ASU 2018-12 was as follows: Retained Earnings (Deficit) AOCI (In millions) Liability for future policy benefits $ (434) $ (2,053) Market risk benefits and related adjustments (5,971) (3,452) DAC and VOBA — 494 Reinsurance recoverables (141) 30 Deferred income tax asset 1,375 1,046 Total $ (5,171) $ (3,935) For LFPBs, the transition adjustment to retained earnings relates to instances where net premiums exceed gross premiums resulting in LFPBs being increased to eliminate the premium deficiency. The premium deficiency primarily relates to structured settlement annuities. The transition adjustment related to AOCI represents the effect of the requirement to discount LFPBs based on an upper-medium grade fixed income rate as well as the removal of amounts previously recorded in AOCI for the effects of unrealized investment gains and losses. For MRBs, the transition adjustment to AOCI relates to the cumulative effect of changes in the nonperformance risk between contract issue date and transition date. In aggregate, the additional spread applied to the risk-free rate decreased from contract inception to the transition date, which had a negative impact on equity. The remaining difference between the estimated fair value and carrying amount of MRBs at transition, excluding the amounts recorded in AOCI, was recorded as an adjustment to retained earnings as of the transition date. For DAC and VOBA, the Company removed amounts previously recorded in AOCI for the effect of unrealized investment gains and losses. For reinsurance, the adjustments to both retained earnings and AOCI were made to align the measurement of reinsurance recoverables with the related LFPBs. The balances of and changes in LFPBs at January 1, 2021 due to the adoption of ASU 2018-12 were as follows: Term and Whole Life Insurance Income Annuities Structured Settlement and Pension Risk Transfer Annuities (In millions) Balance at December 31, 2020 $ 2,797 $ 4,260 $ 10,115 Removal of related balances in AOCI — (203) (1,784) Change in cash flow assumptions 13 (168) 200 Initial recognition of deferred profit liabilities — 172 217 Change in discount rate assumptions 522 748 2,770 Adjusted balance at January 1, 2021 3,332 4,809 11,518 Less: Reinsurance recoverable 59 29 102 Adjusted balance at January 1, 2021, net of reinsurance $ 3,273 $ 4,780 $ 11,416 The balance of and changes in liabilities classified as MRBs at January 1, 2021 due to the adoption of ASU 2018-12 were as follows: Variable Annuities (In millions) Balance at December 31, 2020 $ 8,622 Adjustment for the difference between carrying amount and estimated fair value, except for the difference due to nonperformance risk 6,347 Adjustment for cumulative effect of changes in nonperformance risk since issuance 3,452 Adjusted balance at January 1, 2021 18,421 Less: Reinsurance recoverable 169 Adjusted balance at January 1, 2021, net of reinsurance $ 18,252 The balances of and changes in DAC and VOBA on January 1, 2021 due to the adoption of ASU 2018-12 were as follows: Variable Annuities Fixed Rate Annuities Index-Linked Annuities Term and Whole Life Insurance Universal Life Insurance (In millions) DAC: Balance at December 31, 2020 $ 2,326 $ 64 $ 886 $ 451 $ 144 Removal of related amounts in AOCI 460 — — — (37) Adjusted balance at January 1, 2021 $ 2,786 $ 64 $ 886 $ 451 $ 107 VOBA: Balance at December 31, 2020 $ 363 $ 76 $ — $ 8 $ 38 Removal of related amounts in AOCI 65 — — — 6 Adjusted balance at January 1, 2021 $ 428 $ 76 $ — $ 8 $ 44 The following tables present amounts previously reported in 2022 and 2021, the effect on those amounts of the change due to the adoption of ASU 2018-12 as described in Note 1, and the currently reported amounts in the Consolidated Balance Sheets and Consolidated Statements of Operations. See Notes 4, 5, 6 and 7 for more information. December 31, 2022 December 31, 2021 As Previously Effect of As Currently As Previously Effect of As Currently (In millions) Total assets $ 216,151 $ (713) $ 215,438 $ 247,255 $ 2,476 $ 249,731 Future policy benefits $ 41,105 $ (9,959) $ 31,146 $ 43,589 $ (3,759) $ 39,830 Policyholder account balances $ 74,112 $ (1,510) $ 72,602 $ 66,195 $ (1,905) $ 64,290 Market risk benefit liabilities $ — $ 10,411 $ 10,411 $ — $ 16,062 $ 16,062 Total liabilities $ 209,287 $ (363) $ 208,924 $ 231,144 $ 10,051 $ 241,195 Retained earnings (deficit) $ (5,717) $ 299 $ (5,418) $ (5,653) $ (3,475) $ (9,128) Accumulated other comprehensive income (loss) $ (5,282) $ (649) $ (5,931) $ 3,901 $ (4,100) $ (199) Total equity $ 6,864 $ (350) $ 6,514 $ 16,111 $ (7,575) $ 8,536 Total liabilities and equity $ 216,151 $ (713) $ 215,438 $ 247,255 $ 2,476 $ 249,731 Year Ended December 31, 2022 Year Ended December 31, 2021 As Previously Effect of As Currently As Previously Effect of As Currently (In millions) Universal life and investment-type product policy fees $ 2,562 $ (686) $ 1,876 $ 2,986 $ (666) $ 2,320 Net derivative gains (losses) $ 402 $ (987) $ (585) $ (2,359) $ (1,627) $ (3,986) Total revenues $ 7,832 $ (1,670) $ 6,162 $ 6,400 $ (2,290) $ 4,110 Policyholder benefits and claims $ 4,143 $ (1,957) $ 2,186 $ 3,213 $ (728) $ 2,485 Change in market risk benefits $ — $ (4,105) $ (4,105) $ — $ (4,142) $ (4,142) Total expenses $ 8,103 $ (6,447) $ 1,656 $ 6,404 $ (4,436) $ 1,968 Net income (loss) $ (63) $ 3,774 $ 3,711 $ 67 $ 1,696 $ 1,763 |
Segment Information
Segment Information | 12 Months Ended |
Dec. 31, 2023 | |
Segment Reporting [Abstract] | |
Segment Information | 3. Segment Information The Company is organized into three segments: Annuities; Life; and Run-off. In addition, the Company reports certain of its results of operations in Corporate & Other. Annuities The Annuities segment consists of a variety of variable, fixed, index-linked and income annuities designed to address contract holders’ needs for protected wealth accumulation on a tax-deferred basis, wealth transfer and income security. Life The Life segment consists of insurance products, including term, universal, whole and variable life products designed to address policyholders’ needs for financial security and protected wealth transfer, which may be on a tax-advantaged basis. Run-off The Run-off segment consists of products that are no longer actively sold and are separately managed, including ULSG, structured settlements, pension risk transfer contracts, certain company-owned life insurance policies and certain funding agreements. Corporate & Other Corporate & Other contains the excess capital not allocated to the segments and interest expense related to the Company’s outstanding debt, as well as expenses associated with certain legal proceedings and income tax audit issues. Corporate & Other also includes long-term care business reinsured through 100% quota share reinsurance agreements and activities related to funding agreements associated with the Company’s institutional spread margin business. In connection with the adoption of ASU 2018-12, the Company reclassified direct-to-consumer life insurance that is no longer sold from Corporate & Other to the Life segment. The segment information below reflects the direct-to-consumer life insurance in the Life segment for all periods presented. Financial Measures and Segment Accounting Policies Adjusted earnings is a financial measure used by management to evaluate performance and facilitate comparisons to industry results. Consistent with GAAP guidance for segment reporting, adjusted earnings is also used to measure segment performance. The Company believes the presentation of adjusted earnings, as the Company measures it for management purposes, enhances the understanding of its performance by the investor community by highlighting the results of operations and the underlying profitability drivers of the business. Adjusted earnings, which may be positive or negative, focuses on the Company’s primary businesses by excluding the impact of market volatility, which could distort trends. The following are significant items excluded from total revenues in calculating adjusted earnings: • Net investment gains (losses); and • Net derivative gains (losses), excluding earned income and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments, but do not qualify for hedge accounting treatment (“Investment Hedge Adjustments”). The following are significant items excluded from total expenses in calculating adjusted earnings: • Change in MRBs; and • Change in fair value of the crediting rate on experience-rated contracts (“Market Value Adjustments”). The provision for income tax related to adjusted earnings is calculated using the statutory tax rate of 21%, net of impacts related to the dividends received deduction, tax credits and current period non-recurring items. The Company’s adjusted earnings definition and presentation has been updated for all periods presented to reflect the adoption of ASU 2018-12. The segment accounting policies are the same as those used to prepare the Company’s consolidated financial statements, except for the adjustments to calculate adjusted earnings described above. In addition, segment accounting policies include the methods of capital allocation described below. Segment investment and capitalization targets are based on statutory oriented risk principles and metrics. Segment invested assets backing liabilities are based on net statutory liabilities plus excess capital. For the variable annuity business, the excess capital held is based on the target statutory total asset requirement consistent with the Company’s variable annuity risk management strategy. For insurance businesses other than variable annuities, excess capital held is based on a percentage of required statutory risk-based capital (“RBC”). Assets in excess of those allocated to the segments, if any, are held in Corporate & Other. Segment net investment income reflects the performance of each segment’s respective invested assets. Operating results by segment, as well as Corporate & Other, were as follows: Year Ended December 31, 2023 Annuities Life Run-off Corporate Total (In millions) Pre-tax adjusted earnings $ 1,380 $ 86 $ (99) $ (91) $ 1,276 Provision for income tax expense (benefit) 257 17 (22) (50) 202 Post-tax adjusted earnings 1,123 69 (77) (41) 1,074 Less: Net income (loss) attributable to noncontrolling interests — — — 1 1 Adjusted earnings $ 1,123 $ 69 $ (77) $ (42) 1,073 Adjustments for: Net investment gains (losses) (242) Net derivative gains (losses), excluding investment hedge adjustments of $105 (4,025) Change in market risk benefits 1,497 Market value adjustments (12) Provision for income tax (expense) benefit 585 Net income (loss) attributable to Brighthouse Life Insurance Company $ (1,124) Interest revenue $ 2,558 $ 391 $ 1,141 $ 575 Interest expense $ — $ — $ — $ 70 Year Ended December 31, 2022 Annuities Life Run-off Corporate Total (In millions) Pre-tax adjusted earnings $ 1,291 $ (32) $ 108 $ (156) $ 1,211 Provision for income tax expense (benefit) 244 (8) 21 (154) 103 Post-tax adjusted earnings 1,047 (24) 87 (2) 1,108 Less: Net income (loss) attributable to noncontrolling interests — — — 1 1 Adjusted earnings $ 1,047 $ (24) $ 87 $ (3) 1,107 Adjustments for: Net investment gains (losses) (240) Net derivative gains (losses), excluding investment hedge adjustments of $71 (656) Change in market risk benefits 4,105 Market value adjustments 86 Provision for income tax (expense) benefit (692) Net income (loss) attributable to Brighthouse Life Insurance Company $ 3,710 Interest revenue $ 2,254 $ 396 $ 1,166 $ 319 Interest expense $ — $ — $ — $ 70 Year Ended December 31, 2021 Annuities Life Run-off Corporate Total (In millions) Pre-tax adjusted earnings $ 1,550 $ 532 $ 264 $ (293) $ 2,053 Provision for income tax expense (benefit) 296 112 58 (108) 358 Post-tax adjusted earnings 1,254 420 206 (185) 1,695 Less: Net income (loss) attributable to noncontrolling interests — — — 1 1 Adjusted earnings $ 1,254 $ 420 $ 206 $ (186) 1,694 Adjustments for: Net investment gains (losses) (63) Net derivative gains (losses), excluding investment hedge adjustments of $21 (4,007) Change in market risk benefits 4,142 Market value adjustments 17 Provision for income tax (expense) benefit (21) Net income (loss) attributable to Brighthouse Life Insurance Company $ 1,762 Interest revenue $ 2,207 $ 643 $ 1,910 $ 76 Interest expense $ — $ — $ — $ 67 Total revenues by segment, as well as Corporate & Other, were as follows: Years Ended December 31, 2023 2022 2021 (In millions) Annuities $ 4,440 $ 4,048 $ 4,297 Life 1,013 988 1,382 Run-off 1,643 1,703 2,425 Corporate & Other 576 319 76 Adjustments (4,267) (896) (4,070) Total $ 3,405 $ 6,162 $ 4,110 Total assets by segment, as well as Corporate & Other, were as follows at: December 31, 2023 2022 (In millions) Annuities $ 157,614 $ 148,228 Life 20,363 17,214 Run-off 26,849 28,466 Corporate & Other 21,378 21,530 Total $ 226,204 $ 215,438 Total premiums, universal life and investment-type product policy fees and other revenues by major product group were as follows: Years Ended December 31, 2023 2022 2021 (In millions) Annuity products $ 1,890 $ 1,796 $ 2,093 Life insurance products 1,110 1,119 1,243 Other products 7 8 8 Total $ 3,007 $ 2,923 $ 3,344 Substantially all of the Company’s premiums, universal life and investment-type product policy fees and other revenues originated in the U.S. Revenues derived from any individual customer did not exceed 10% of premiums, universal life and investment-type product policy fees and other revenues for the years ended December 31, 2023, 2022 and 2021. |
Insurance Liabilities
Insurance Liabilities | 12 Months Ended |
Dec. 31, 2023 | |
Insurance [Abstract] | |
Insurance Liabilities | 4. Insurance Liabilities Liability for Future Policy Benefits Information regarding LFPBs for non-participating traditional and limited-payment contracts was as follows: Years Ended December 31, 2023 2022 2021 Term and Whole Life Insurance Income Annuities Structured Settlement and Pension Risk Transfer Annuities Term and Whole Life Insurance Income Annuities Structured Settlement and Pension Risk Transfer Annuities Term and Whole Life Insurance Income Annuities Structured Settlement and Pension Risk Transfer Annuities (Dollars in millions) Present value of expected net premiums: Balance, beginning of year $ 2,804 $ — $ — $ 3,212 $ — $ — $ 3,274 $ — $ — Beginning balance at original discount rate 3,146 — — 2,964 — — 2,868 — — Effect of model refinements — — — 121 — — — — — Effect of changes in cash flow assumptions 206 — — 159 — — 100 — — Effect of actual variances from expected experience (17) — — 114 — — 158 — — Adjusted beginning of year balance 3,335 — — 3,358 — — 3,126 — — Issuances 93 — — 93 — — 112 — — Interest accrual 108 — — 112 — — 107 — — Net premiums collected (374) — — (417) — — (381) — — Ending balance at original discount rate 3,162 — — 3,146 — — 2,964 — — Effect of changes in discount rate assumptions (263) — — (342) — — 248 — — Balance, end of year $ 2,899 $ — $ — $ 2,804 $ — $ — $ 3,212 $ — $ — Present value of expected future policy benefits: Balance, beginning of year $ 5,172 $ 3,469 $ 6,793 $ 6,253 $ 4,283 $ 10,171 $ 6,606 $ 4,636 $ 11,301 Beginning balance at original discount rate 5,816 3,848 7,410 5,682 3,817 8,165 5,678 3,889 8,531 Effect of model refinements — — — 134 — (278) — — — Effect of changes in cash flow assumptions 296 — — 179 55 (157) 100 (40) (41) Effect of actual variances from expected experience (15) (21) (47) 150 (21) (23) 158 (6) (16) Adjusted beginning of year balance 6,097 3,827 7,363 6,145 3,851 7,707 5,936 3,843 8,474 Issuances 99 369 — 101 220 — 128 193 — Interest accrual 211 139 314 216 144 327 214 149 359 Benefit payments (502) (342) (592) (646) (367) (624) (596) (368) (668) Ending balance at original discount rate 5,905 3,993 7,085 5,816 3,848 7,410 5,682 3,817 8,165 Effect of changes in discount rate assumptions (520) (274) (388) (644) (379) (617) 571 466 2,006 Balance, end of year $ 5,385 $ 3,719 $ 6,697 $ 5,172 $ 3,469 $ 6,793 $ 6,253 $ 4,283 $ 10,171 Net liability for future policy benefits, end of year $ 2,486 $ 3,719 $ 6,697 $ 2,368 $ 3,469 $ 6,793 $ 3,041 $ 4,283 $ 10,171 Less: Reinsurance recoverable, end of year 24 30 65 32 25 68 42 28 93 Net liability for future policy benefits, after reinsurance recoverable $ 2,462 $ 3,689 $ 6,632 $ 2,336 $ 3,444 $ 6,725 $ 2,999 $ 4,255 $ 10,078 Weighted-average duration of liability 8.8 years 8.2 years 11.6 years 8.5 years 8.5 years 11.6 years 8.5 years 8.5 years 12.7 years Weighted-average interest accretion rate 3.91 % 3.99 % 4.46 % 3.94 % 3.89 % 4.45 % 3.94 % 3.98 % 4.45 % Current discount rate 4.94 % 4.95 % 5.03 % 5.26 % 5.27 % 5.32 % 2.53 % 2.55 % 2.81 % Gross premiums or assessments recognized during period $ 595 $ 472 $ — $ 625 $ 243 $ — $ 648 $ 240 $ — Expected future gross premiums, undiscounted $ 5,999 $ — $ — $ 6,535 $ — $ — $ 6,736 $ — $ — Expected future gross premiums, discounted $ 4,535 $ — $ — $ 4,875 $ — $ — $ 5,014 $ — $ — Expected future benefit payments, undiscounted $ 8,148 $ 5,616 $ 13,767 $ 8,015 $ 5,434 $ 14,418 $ 7,877 $ 5,446 $ 17,241 Expected future benefit payments, discounted $ 5,905 $ 3,993 $ 7,085 $ 5,816 $ 3,848 $ 7,410 $ 5,682 $ 3,817 $ 8,165 The measurement of LFPBs can be significantly impacted by changes in assumptions for policyholder behavior. As part of the 2023 and 2022 annual actuarial review (“AAR”), the Company updated assumptions regarding mortality and lapses for term and non-participating whole life insurance. The impact from changes in assumptions is presented in effect of changes in cash flow assumptions in the table above. Information regarding the additional insurance liabilities for universal life-type contracts with secondary guarantees was as follows: Years Ended December 31, 2023 2022 2021 (Dollars in millions) Balance, beginning of year $ 6,935 $ 7,168 $ 6,743 Beginning balance before the effect of unrealized gains and losses 7,175 6,731 6,203 Effect of changes in cash flow assumptions 52 (37) 153 Effect of actual variances from expected experience 145 179 (124) Adjusted beginning of year balance 7,372 6,873 6,232 Interest accrual 357 333 308 Net assessments collected 414 416 475 Benefit payments (359) (447) (286) Effect of realized capital gains (losses) — — 2 Ending balance before the effect of unrealized gains and losses 7,784 7,175 6,731 Effect of unrealized gains and losses (177) (240) 437 Balance, end of year 7,607 6,935 7,168 Less: Reinsurance recoverable, end of year 1,438 1,384 1,294 Net additional liability, after reinsurance recoverable $ 6,169 $ 5,551 $ 5,874 Weighted-average duration of liability 6.7 years 6.7 years 6.7 years Weighted-average interest accretion rate 4.92 % 4.90 % 4.90 % Gross assessments recognized during period $ 1,064 $ 1,070 $ 1,255 The measurement of liabilities for secondary guarantees can be significantly impacted by changes in the expected general account rate of return, which is driven by the Company’s assumption for long-term treasury yields. The Company’s practice of projecting treasury yields uses a mean reversion approach that assumes that long-term interest rates are less influenced by short-term fluctuations and are only changed when sustained interim deviations are expected. As part of the 2023 AAR, the Company increased the long-term general account earned rate, driven by an increase in the mean reversion rate from 3.50% to 3.75%. The Company also updated assumptions regarding policyholder behavior, including mortality, premium persistency, lapses, withdrawals and maintenance expenses. As part of the 2022 AAR, the Company increased the long-term general account earned rate, driven by an increase in the mean reversion rate from 3.00% to 3.50%. Both period assumption updates are reflected in the table above. A reconciliation of the net LFPBs for nonparticipating traditional and limited-payment contracts and the additional insurance liabilities for universal life-type contracts with secondary guarantees reported in the preceding rollforward tables to LFPBs on the consolidated balance sheets was as follows at: December 31, 2023 2022 (In millions) Liabilities reported in the preceding rollforward tables $ 20,509 $ 19,565 Long-term care insurance (1) 5,581 5,686 ULSG liabilities, including liability for profits followed by losses 2,427 2,449 Participating whole life insurance (2) 2,849 2,689 Deferred profit liabilities 475 369 Other 308 388 Total liability for future policy benefits $ 32,149 $ 31,146 _______________ (1) Includes liabilities related to fully reinsured individual long-term care insurance. See Note 8. (2) Participating whole life insurance uses an interest assumption based on the non-forfeiture interest rate, ranging from 3.5% to 4.0%, and mortality rates guaranteed in calculating the cash surrender values described in such contracts, and also includes a liability for terminal dividends. Participating whole life insurance represented 3% of the Company’s life insurance in-force at both December 31, 2023 and 2022, and 40% and 41% of gross traditional life insurance premiums for the years ended December 31, 2023 and 2022, respectively. Policyholder Account Balances Information regarding policyholder account balances was as follows: Universal Life Insurance Variable Annuities (1) Index-linked Annuities Fixed Rate Annuities ULSG Company-Owned Life Insurance (1) (Dollars in millions) Year Ended December 31, 2023 Balance, beginning of year $ 2,100 $ 4,664 $ 33,897 $ 14,274 $ 5,307 $ 641 Premiums and deposits 210 75 7,183 2,694 660 — Surrenders and withdrawals (129) (647) (3,732) (2,405) (23) — Benefit payments (59) (101) (240) (377) (85) (8) Net transfers from (to) separate account 18 14 — — — 1 Interest credited 40 129 445 486 208 28 Policy charges (200) (23) (11) — (1,015) (9) Changes related to embedded derivatives — — 4,085 — — — Balance, end of year $ 1,980 $ 4,111 $ 41,627 $ 14,672 $ 5,052 $ 653 Weighted-average crediting rate (2) 2.03 % 2.91 % 1.47 % 3.31 % 4.02 % 4.33 % Year Ended December 31, 2022 Balance, beginning of year $ 2,134 $ 4,475 $ 32,000 $ 11,849 $ 5,569 $ 646 Premiums and deposits 199 145 6,632 3,676 697 — Surrenders and withdrawals (49) (453) (2,220) (904) (32) — Benefit payments (59) (104) (180) (345) (84) (8) Net transfers from (to) separate account 21 131 — — — (13) Interest credited 56 493 392 (2) 197 23 Policy charges (202) (23) (8) — (1,040) (7) Changes related to embedded derivatives — — (2,719) — — — Balance, end of year $ 2,100 $ 4,664 $ 33,897 $ 14,274 $ 5,307 $ 641 Weighted-average crediting rate (2) 2.65 % 10.91 % 1.16 % (0.02) % 3.62 % 3.41 % Year Ended December 31, 2021 Balance, beginning of year $ 2,110 $ 4,605 $ 23,274 $ 12,349 $ 5,823 $ 679 Premiums and deposits 290 194 7,054 114 687 — Surrenders and withdrawals (48) (566) (1,419) (610) (46) — Benefit payments (55) (95) (151) (342) (77) (10) Net transfers from (to) separate account 17 238 — — — (35) Interest credited 84 140 365 338 186 24 Policy charges (264) (41) (6) — (1,004) (12) Changes related to embedded derivatives — — 2,883 — — — Balance, end of year $ 2,134 $ 4,475 $ 32,000 $ 11,849 $ 5,569 $ 646 Weighted-average crediting rate 3.97 % 3.07 % 1.12 % 2.79 % 3.27 % 3.66 % _______________ (1) Includes liabilities related to separate account products where the contract holder elected a general account investment option. (2) Excludes the effects of embedded derivatives related to index-linked crediting rates. A reconciliation of policyholder account balances reported in the preceding rollforward table to the liability for policyholder account balances on the consolidated balance sheets was as follows at: December 31, 2023 2022 (In millions) Policyholder account balances reported in the preceding rollforward table $ 68,095 $ 60,883 Funding agreements classified as investment contracts 11,115 10,689 Other investment contract liabilities 983 1,030 Total policyholder account balances $ 80,193 $ 72,602 The balance of account values by range of guaranteed minimum crediting rates and the related range of difference, in basis points, between rates being credited to policyholders and the respective guaranteed minimums was as follows at: Range of Guaranteed Minimum Crediting Rate At Guaranteed Minimum 1 to 50 Basis Points Above 51 to 150 Basis Points Above Greater than 150 Basis Points Above Total (In millions) December 31, 2023 Annuities (1): Less than 2.00% $ 645 $ 204 $ 301 $ 7,632 $ 8,782 2.00% to 3.99% 8,125 233 201 307 8,866 Greater than 3.99% 872 — — — 872 Total $ 9,642 $ 437 $ 502 $ 7,939 $ 18,520 Life insurance (2) (3): Less than 2.00% $ — $ — $ — $ 236 $ 236 2.00% to 3.99% — 441 49 132 622 Greater than 3.99% 1,077 — — — 1,077 Total $ 1,077 $ 441 $ 49 $ 368 $ 1,935 ULSG (3): Less than 2.00% $ — $ — $ — $ — $ — 2.00% to 3.99% 1,134 1,485 1,663 254 4,536 Greater than 3.99% 506 — — — 506 Total $ 1,640 $ 1,485 $ 1,663 $ 254 $ 5,042 December 31, 2022 Annuities (1): Less than 2.00% $ 805 $ 293 $ 356 $ 5,805 $ 7,259 2.00% to 3.99% 5,224 4,871 594 8 10,697 Greater than 3.99% 470 — — — 470 Total $ 6,499 $ 5,164 $ 950 $ 5,813 $ 18,426 Life insurance (2) (3): Less than 2.00% $ — $ — $ — $ 172 $ 172 2.00% to 3.99% — 462 87 150 699 Greater than 3.99% 1,148 — — — 1,148 Total $ 1,148 $ 462 $ 87 $ 322 $ 2,019 ULSG (3): Less than 2.00% $ — $ — $ — $ — $ — 2.00% to 3.99% 1,224 1,581 1,729 266 4,800 Greater than 3.99% 527 — — — 527 Total $ 1,751 $ 1,581 $ 1,729 $ 266 $ 5,327 _______________ (1) Includes policyholder account balances for fixed rate annuities and the fixed account portion of variable annuities. (2) Includes policyholder account balances for retained asset accounts, universal life policies and the fixed account portion of universal variable life insurance policies. (3) Amounts are gross of policy loans. See Note 6 for information regarding net amount at risk and cash surrender values. Obligations Under Funding Agreements Institutional Spread Margin Business Brighthouse Life Insurance Company has issued unsecured fixed and floating rate funding agreements to certain special purpose entities that have issued either debt securities or commercial paper for which payment of interest and principal is secured by such funding agreements. The Company had obligations outstanding under these funding agreements of $5.5 billion at both December 31, 2023 and 2022. Brighthouse Life Insurance Company has a secured funding agreement program with the Federal Home Loan Bank (“FHLB”) of Atlanta. The Company had obligations outstanding under this program of $4.4 billion and $3.9 billion at December 31, 2023 and 2022, respectively. Funding agreements are issued to FHLBs in exchange for cash, for which the FHLBs have been granted liens on certain assets, some of which are in their custody to collateralize the Company’s obligations under the funding agreements. The Company is permitted to withdraw any portion of the collateral in the custody of the FHLBs as long as there is no event of default and the remaining qualified collateral is sufficient to satisfy the collateral maintenance level. Upon any event of default by the Company, the FHLBs’ recovery on the collateral is limited to the amount of the Company’s liabilities to the FHLBs. See Note 9 for information on invested assets pledged as collateral in connection with funding agreements. Brighthouse Life Insurance Company has a secured funding agreement program with the Federal Agricultural Mortgage Corporation and its affiliate Farmer Mac Mortgage Securities Corporation (“Farmer Mac”). The Company had obligations outstanding under this program of $700 million at both December 31, 2023 and 2022. Funding agreements are issued to Farmer Mac in exchange for cash, for which Farmer Mac have been granted liens on certain assets to collateralize the Company’s obligations under the funding agreements. Upon any event of default by the Company, Farmer Mac’s recovery on the collateral is limited to the amount of the Company’s liabilities to Farmer Mac. See Note 9 for information on invested assets pledged as collateral in connection with funding agreements. Inactive Funding Agreement Programs Brighthouse Life Insurance Company has obligations outstanding under inactive funding agreement programs of $525 million at both December 31, 2023 and 2022. |
Market Risk Benefits
Market Risk Benefits | 12 Months Ended |
Dec. 31, 2023 | |
Insurance [Abstract] | |
Market Risk Benefits | 5. Market Risk Benefits Information regarding MRB assets and liabilities associated with variable annuities was as follows: Years Ended December 31, 2023 2022 2021 (Dollars in millions) Balance, beginning of year $ 9,997 $ 15,726 $ 18,421 Balance, beginning of year, before effect of changes in nonperformance risk 8,253 11,639 14,969 Decrements (176) 16 (70) Effect of changes in future expected assumptions 260 212 41 Effect of actual different from expected experience 186 (48) (86) Effect of changes in interest rates (427) (8,397) (1,831) Effect of changes in fund returns (2,203) 3,806 (2,578) Issuances (7) (47) (96) Effect of changes in risk margin (34) (152) (128) Aging of the block and other 1,496 1,224 1,418 Balance, end of year, before effect of changes in nonperformance risk 7,348 8,253 11,639 Effect of changes in nonperformance risk 2,374 1,744 4,087 Balance, end of year 9,722 9,997 15,726 Less: Reinsurance recoverable, end of year 43 71 118 Balance, end of year, net of reinsurance (1) $ 9,679 $ 9,926 $ 15,608 Weighted-average attained age of contract holder 73.0 years 71.8 years 71.1 years _______________ (1) Amounts represent the sum of MRB assets and MRB liabilities presented on the consolidated balance sheets at December 31, 2023, 2022 and 2021, with the exception of $9 million, $2 million and $5 million, respectively, of index-linked annuities not included in this table. Market conditions, including, but not limited to, changes in interest rates, equity indices, market volatility and variations in actuarial assumptions, including policyholder behavior, mortality and risk margins related to non-capital markets inputs, as well as changes in nonperformance risk, may result in significant fluctuations in the estimated fair value of the guarantees. As part of the AAR in 2023 and 2022, the Company updated assumptions regarding policyholder behavior, mortality, separate account fund allocations and volatility, which are reflected in the table above. |
Separate Accounts
Separate Accounts | 12 Months Ended |
Dec. 31, 2023 | |
Insurance [Abstract] | |
Separate Accounts | 6. Separate Accounts Separate Accounts Information regarding separate account liabilities was as follows: Years Ended December 31, 2023 2022 2021 Variable Annuities Universal Life Insurance Company-Owned Life Insurance Variable Annuities Universal Life Insurance Company-Owned Life Insurance Variable Annuities Universal Life Insurance Company-Owned Life Insurance (In millions) Balance, beginning of year $ 74,845 $ 1,970 $ 1,919 $ 101,108 $ 2,576 $ 2,367 $ 99,257 $ 2,339 $ 2,253 Premiums and deposits 762 84 — 1,199 91 — 2,081 97 3 Surrenders and withdrawals (6,073) (68) (20) (5,965) (55) (16) (7,971) (69) (68) Benefit payments (1,391) (18) (28) (1,298) (24) (33) (1,575) (24) (38) Investment performance 11,071 405 327 (17,878) (519) (356) 12,054 336 234 Policy charges (2,098) (78) (58) (2,227) (78) (61) (2,481) (85) (47) Net transfers from (to) general account (14) (18) (1) (131) (21) 13 (238) (17) 35 Other (16) (1) 9 37 — 5 (19) (1) (5) Balance, end of year $ 77,086 $ 2,276 $ 2,148 $ 74,845 $ 1,970 $ 1,919 $ 101,108 $ 2,576 $ 2,367 A reconciliation of separate account liabilities reported in the preceding rollforward table to the separate account liabilities balance on the consolidated balance sheets was as follows at: December 31, 2023 2022 (In millions) Separate account liabilities reported in the preceding rollforward table $ 81,510 $ 78,734 Variable income annuities 161 130 Pension risk transfer annuities 19 16 Total separate account liabilities $ 81,690 $ 78,880 The aggregate estimated fair value of assets, by major investment asset category, supporting separate accounts was as follows at: December 31, 2023 2022 (In millions) Equity securities $ 81,417 $ 78,583 Fixed maturity securities 259 277 Cash and cash equivalents 7 9 Other assets 7 11 Total aggregate estimated fair value of assets $ 81,690 $ 78,880 Net Amount at Risk and Cash Surrender Values Information regarding the net amount at risk and cash surrender value for insurance products was as follows at: Universal Life Insurance Variable Annuities Index-linked Annuities Fixed Rate Annuities ULSG Company-Owned Life Insurance (In millions) December 31, 2023 Account balances reported in the preceding rollforward tables: Policyholder account balances $ 1,980 $ 4,111 $ 41,627 $ 14,672 $ 5,052 $ 653 Separate account liabilities 2,276 77,086 — — — 2,148 Total account balances $ 4,256 $ 81,197 $ 41,627 $ 14,672 $ 5,052 $ 2,801 Net amount at risk $ 22,214 $ 13,156 N/A N/A $ 65,299 $ 2,644 Cash surrender value $ 4,049 $ 80,756 $ 39,270 $ 14,068 $ 4,498 $ 2,579 December 31, 2022 Account balances reported in the preceding rollforward tables: Policyholder account balances $ 2,100 $ 4,664 $ 33,897 $ 14,274 $ 5,307 $ 641 Separate account liabilities 1,970 74,845 — — — 1,919 Total account balances $ 4,070 $ 79,509 $ 33,897 $ 14,274 $ 5,307 $ 2,560 Net amount at risk $ 23,818 $ 16,334 N/A N/A $ 66,926 $ 3,368 Cash surrender value $ 3,789 $ 79,222 $ 31,293 $ 13,723 $ 4,671 $ 2,344 December 31, 2021 Account balances reported in the preceding rollforward tables: Policyholder account balances $ 2,134 $ 4,475 $ 32,000 $ 11,849 $ 5,569 $ 646 Separate account liabilities 2,576 101,108 — — — 2,367 Total account balances $ 4,710 $ 105,583 $ 32,000 $ 11,849 $ 5,569 $ 3,013 Net amount at risk $ 24,995 $ 6,316 N/A N/A $ 68,905 $ 3,665 Cash surrender value $ 4,407 $ 105,574 $ 29,848 $ 11,112 $ 4,821 $ 2,794 Products may contain both separate account and general account fund options; accordingly, net amount at risk and cash surrender value reported in the table above relate to the total account balance for each respective product grouping. |
Deferred Policy Acquisition Cos
Deferred Policy Acquisition Costs, Value of Business Acquired and Other Intangibles | 12 Months Ended |
Dec. 31, 2023 | |
Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Net [Abstract] | |
Deferred Policy Acquisition Costs, Value of Business Acquired and Other Intangibles | 7. Deferred Policy Acquisition Costs, Value of Business Acquired and Other Intangibles Deferred Policy Acquisition Costs and Value of Business Acquired See Note 1 for a description of capitalized acquisition costs. Information regarding DAC and VOBA was as follows: Variable Annuities Fixed Rate Annuities Index-linked Annuities Term and Whole Life Insurance Universal Life Insurance (In millions) DAC: Adjusted balance at January 1, 2021 (1) $ 2,786 $ 64 $ 886 $ 451 $ 107 Capitalization 90 36 355 (3) 16 Amortization (262) (12) (160) (51) (9) Balance at December 31, 2021 2,614 88 1,081 397 114 Capitalization 54 31 330 (1) 10 Amortization (254) (12) (198) (49) (9) Balance at December 31, 2022 2,414 107 1,213 347 115 Capitalization 36 14 344 2 13 Amortization (233) (11) (225) (43) (9) Balance at December 31, 2023 $ 2,217 $ 110 $ 1,332 $ 306 $ 119 VOBA: Adjusted balance at January 1, 2021 (1) $ 428 $ 76 $ — $ 8 $ 44 Amortization (51) (6) — (2) (5) Balance at December 31, 2021 377 70 — 6 39 Amortization (36) (5) — (1) (4) Balance at December 31, 2022 341 65 — 5 35 Amortization (32) (6) — (1) (4) Balance at December 31, 2023 $ 309 $ 59 $ — $ 4 $ 31 Total DAC and VOBA: Balance at December 31, 2023 $ 2,526 $ 169 $ 1,332 $ 310 $ 150 Balance at December 31, 2022 $ 2,755 $ 172 $ 1,213 $ 352 $ 150 Balance at December 31, 2021 $ 2,991 $ 158 $ 1,081 $ 403 $ 153 _______________ (1) Includes an adjustment to eliminate balances included in AOCI related to the adoption of ASU 2018-12 (see Note 2). Deferred Sales Inducements Information regarding DSI, included in other assets, was as follows: December 31, 2023 2022 2021 Variable Annuities Fixed Rate Annuities Variable Annuities Fixed Rate Annuities Variable Annuities Fixed Rate Annuities (In millions) Balance, beginning of year $ 233 $ 9 $ 259 $ 10 $ 283 $ 12 Capitalization 1 — 1 — 1 — Amortization (25) (1) (27) (1) (25) (2) Balance, end of year $ 209 $ 8 $ 233 $ 9 $ 259 $ 10 Unearned Revenue Information regarding unearned revenue, included in other policy-related balances, was as follows: December 31, 2023 2022 2021 Universal Life Insurance ULSG Variable Annuities Universal Life Insurance ULSG Variable Annuities Universal Life Insurance ULSG Variable Annuities (In millions) Balance, beginning of year $ 143 $ 488 $ 73 $ 118 $ 344 $ 79 $ 80 $ 184 $ 84 Capitalization 35 174 — 35 181 2 46 185 2 Amortization (11) (50) (7) (10) (37) (8) (8) (25) (7) Balance, end of year $ 167 $ 612 $ 66 $ 143 $ 488 $ 73 $ 118 $ 344 $ 79 |
Reinsurance
Reinsurance | 12 Months Ended |
Dec. 31, 2023 | |
Reinsurance Disclosures [Abstract] | |
Reinsurance | 8. Reinsurance The Company enters into reinsurance agreements primarily as a purchaser of reinsurance for its various insurance products and also as a provider of reinsurance for some insurance products issued by NELICO, as well as former affiliated and unaffiliated companies. The Company participates in reinsurance activities in order to limit losses, minimize exposure to significant risks and provide additional capacity for future growth. Accounting for reinsurance requires extensive use of assumptions and estimates, particularly related to the future performance of the underlying business and the potential impact of counterparty credit risks. The Company periodically reviews actual and anticipated experience compared to the aforementioned assumptions used to establish assets and liabilities relating to ceded and assumed reinsurance and evaluates the financial strength of counterparties to its reinsurance agreements using criteria similar to that evaluated in the security impairment process discussed in Note 9. Annuities and Life For annuities, the Company reinsures portions of the living and death benefit guarantees issued in connection with certain variable annuities to unaffiliated reinsurers. Under these reinsurance agreements, the Company pays a reinsurance premium generally based on fees associated with the guarantees collected from policyholders and receives reimbursement for benefits paid or accrued in excess of account values, subject to certain limitations. The value of MRBs on the ceded risk is determined using a methodology consistent with the guarantees directly written by the Company with the exception of the input for nonperformance risk that reflects the credit of the reinsurer. The Company also assumes 100% of the living and death benefit guarantees issued in connection with certain variable annuities issued by NELICO. The Company cedes certain fixed rate annuities to unaffiliated third-party reinsurers and assumes certain index-linked annuities from an unaffiliated third-party insurer. These reinsurance arrangements are structured on a coinsurance basis and are reported as deposit accounting. For its life products, the Company has historically reinsured the mortality risk primarily on an excess of retention basis or on a quota share basis. In addition to reinsuring mortality risk as described above, the Company reinsures other risks, as well as specific coverages. Placement of reinsurance is done primarily on an automatic basis and also on a facultative basis for risks with specified characteristics. On a case-by-case basis, the Company may retain up to $20 million per life and reinsure 100% of amounts in excess of the amount the Company retains. The Company also reinsures 90% of the risk associated with participating whole life policies to a former affiliate and assumes certain term life policies and universal life policies with secondary death benefit guarantees issued by a former affiliate. The Company evaluates its reinsurance programs routinely and may increase or decrease its retention at any time. Corporate & Other The Company reinsures, through 100% quota share reinsurance agreements, certain run-off long-term care and workers’ compensation business written by the Company. At December 31, 2023, the Company had $5.8 billion of reinsurance recoverables associated with its reinsured long-term care business. The reinsurer has established trust accounts for the Company’s benefit to secure their obligations under the reinsurance agreements. Additionally, the Company is indemnified for losses and certain other payment obligations it might incur with respect to such reinsured long-term care insurance business. Catastrophe Coverage The Company has exposure to catastrophes which could contribute to significant fluctuations in the Company’s results of operations. The Company uses excess of retention and quota share reinsurance agreements to provide greater diversification of risk and minimize exposure to larger risks. Reinsurance Recoverables The Company reinsures its business through a diversified group of primarily highly rated reinsurers. The Company analyzes recent trends in arbitration and litigation outcomes in disputes, if any, with its reinsurers and monitors ratings and the financial strength of its reinsurers. In addition, the reinsurance recoverable balance due from each reinsurer and the recoverability of such balance is evaluated as part of this overall monitoring process. The Company generally secures large reinsurance recoverable balances with various forms of collateral, including secured trusts, funds withheld accounts and irrevocable letters of credit. These reinsurance recoverable balances are stated net of allowances for uncollectible reinsurance, which at both December 31, 2023 and 2022 were not significant. The Company had $6.0 billion of unsecured reinsurance recoverable balances with third-party reinsurers at both December 31, 2023 and 2022. The Company records an allowance for credit losses which is a valuation account that reduces reinsurance recoverable balances to present the net amount expected to be collected from reinsurers. When assessing the creditworthiness of the Company’s reinsurance recoverable balances, beyond the analysis of individual claims disputes, the Company considers the financial strength of its reinsurers using public ratings and ratings reports, current existing credit enhancements to reinsurance agreements and the statutory and GAAP financial statements of the reinsurers. Impairments are then determined based on probable and estimable defaults. The Company had an allowance for credit losses of $3 million and $10 million on its reinsurance recoverable balances at December 31, 2023 and 2022, respectively. In 2023, the Company had $3 million of additions to the allowance and $10 million of impairments charged against the allowance. At December 31, 2023, the Company had $18.7 billion of net ceded reinsurance recoverables with third-party reinsurers. Of this total, $16.7 billion, or 89%, were with the Company’s five largest ceded reinsurers, including $4.2 billion of net ceded reinsurance recoverables which were unsecured. At December 31, 2022, the Company had $17.3 billion of net ceded reinsurance recoverables with third-party reinsurers. Of this total, $15.3 billion, or 88%, were with the Company’s five largest ceded reinsurers, including $4.1 billion of net ceded reinsurance recoverables which were unsecured. The amounts on the consolidated statements of operations include the impact of reinsurance. Information regarding the significant effects of reinsurance was as follows: Years Ended December 31, 2023 2022 2021 (In millions) Premiums Direct premiums $ 1,458 $ 1,321 $ 1,398 Reinsurance assumed 20 8 (10) Reinsurance ceded (667) (688) (701) Net premiums $ 811 $ 641 $ 687 Universal life and investment-type product policy fees Direct universal life and investment-type product policy fees $ 2,402 $ 2,525 $ 2,871 Reinsurance assumed 48 44 41 Reinsurance ceded (672) (693) (592) Net universal life and investment-type product policy fees $ 1,778 $ 1,876 $ 2,320 Other revenues Direct other revenues $ 202 $ 220 $ 262 Reinsurance assumed 3 3 6 Reinsurance ceded 213 183 69 Net other revenues $ 418 $ 406 $ 337 Policyholder benefits and claims Direct policyholder benefits and claims $ 3,608 $ 3,788 $ 3,867 Reinsurance assumed 123 134 101 Reinsurance ceded (1,313) (1,736) (1,483) Net policyholder benefits and claims $ 2,418 $ 2,186 $ 2,485 Change in market risk benefits Direct change in market risk benefits $ (1,436) $ (3,942) $ (3,956) Reinsurance assumed (92) (214) (243) Reinsurance ceded 31 51 57 Net change in market risk benefits $ (1,497) $ (4,105) $ (4,142) Other expenses Direct other expenses $ 1,625 $ 1,758 $ 1,815 Reinsurance assumed 25 — 20 Reinsurance ceded (25) (64) (11) Net other expenses $ 1,625 $ 1,694 $ 1,824 The amounts on the consolidated balance sheets include the impact of reinsurance. Information regarding the significant effects of reinsurance was as follows at: December 31, 2023 2022 Direct Assumed Ceded Total Direct Assumed Ceded Total (In millions) Assets Premiums, reinsurance and other receivables (net of allowance for credit losses) $ 289 $ 33 $ 19,067 $ 19,389 $ 245 $ 30 $ 17,870 $ 18,145 Market risk benefit assets $ 613 $ — $ 43 $ 656 $ 412 $ — $ 71 $ 483 Liabilities Future policy benefits $ 31,989 $ 160 $ — $ 32,149 $ 31,020 $ 126 $ — $ 31,146 Policyholder account balances $ 75,893 $ 4,300 $ — $ 80,193 $ 68,409 $ 4,193 $ — $ 72,602 Market risk benefit liabilities $ 9,972 $ 372 $ — $ 10,344 $ 9,980 $ 431 $ — $ 10,411 Other policy-related balances $ 2,023 $ 1,596 $ — $ 3,619 $ 2,228 $ 1,632 $ — $ 3,860 Other liabilities $ 6,526 $ 11 $ 1,235 $ 7,772 $ 5,059 $ 22 $ 1,434 $ 6,515 Reinsurance agreements that do not expose the Company to a reasonable possibility of a significant loss from insurance risk are recorded using the deposit method of accounting. The deposit assets on reinsurance were $7.4 billion and $5.8 billion at December 31, 2023 and 2022, respectively. The deposit liabilities on reinsurance were $4.0 billion at both December 31, 2023 and 2022. Related Party Reinsurance Transactions Information regarding the significant effects of assumed reinsurance with NELICO included on the consolidated statements of operations was as follows: Years Ended December 31, 2023 2022 2021 (In millions) Premiums $ 6 $ 2 $ 2 Universal life and investment-type product policy fees $ (1) $ (1) $ 1 Other revenues $ 1 $ 2 $ 2 Policyholder benefits and claims $ 39 $ 22 $ 16 Change in market risk benefits $ (92) $ (214) $ (243) Other expenses $ — $ (6) $ (3) Information regarding the significant effects of assumed reinsurance with NELICO included on the consolidated balance sheets was as follows at: December 31, 2023 2022 (In millions) Assets Premiums, reinsurance and other receivables (net of allowance for credit losses) $ 28 $ 29 Liabilities Future policy benefits $ 47 $ 31 Market risk benefit liabilities $ 367 $ 428 Other policy-related balances $ 13 $ 11 Other liabilities $ (4) $ 11 Related party reinsurance agreements that do not expose the Company to a reasonable possibility of a significant loss from insurance risk are recorded using the deposit method of accounting. There were no deposit assets on related party reinsurance at both December 31, 2023 and 2022. The deposit liabilities on related party reinsurance were $112 million and $142 million at December 31, 2023 and 2022, respectively. |
Investments
Investments | 12 Months Ended |
Dec. 31, 2023 | |
Investments, Debt and Equity Securities [Abstract] | |
Investments | 9. Investments See Notes 1 and 11 for a description of the Company’s accounting policies for investments and the fair value hierarchy for investments and the related valuation methodologies. Fixed Maturity Securities Available-for-sale Fixed Maturity Securities by Sector Fixed maturity securities by sector were as follows at: December 31, 2023 December 31, 2022 Amortized Allowance for Credit Losses Gross Unrealized Estimated Amortized Allowance for Credit Losses Gross Unrealized Estimated Gains Losses Gains Losses (In millions) U.S. corporate $ 38,303 $ 15 $ 383 $ 3,332 $ 35,339 $ 36,399 $ 1 $ 200 $ 4,436 $ 32,162 Foreign corporate 12,769 — 89 1,276 11,582 12,368 1 37 1,912 10,492 U.S. government and agency 8,446 — 285 517 8,214 8,195 — 299 596 7,898 RMBS 8,127 4 48 805 7,366 8,384 1 44 936 7,491 ABS 6,509 — 23 131 6,401 5,647 — 3 295 5,355 CMBS 6,940 2 2 601 6,339 7,239 3 — 699 6,537 State and political subdivision 3,958 — 153 298 3,813 4,015 — 120 394 3,741 Foreign government 1,077 — 41 87 1,031 1,148 — 39 106 1,081 Total fixed maturity securities $ 86,129 $ 21 $ 1,024 $ 7,047 $ 80,085 $ 83,395 $ 6 $ 742 $ 9,374 $ 74,757 The Company held non-income producing fixed maturity securities with an estimated fair value of $52 million at December 31, 2023. The Company did not hold non-income producing fixed maturity securities at December 31, 2022. Maturities of Fixed Maturity Securities The amortized cost and estimated fair value of fixed maturity securities, by contractual maturity date, were as follows at December 31, 2023: Due in One Due After One Due After Five Due After Ten Structured Total Fixed (In millions) Amortized cost $ 2,725 $ 17,064 $ 15,000 $ 29,764 $ 21,576 $ 86,129 Estimated fair value $ 2,691 $ 16,611 $ 13,764 $ 26,913 $ 20,106 $ 80,085 Actual maturities may differ from contractual maturities due to the exercise of call or prepayment options. Fixed maturity securities not due at a single maturity date have been presented in the year of final contractual maturity. Structured Securities are shown separately, as they are not due at a single maturity. Continuous Gross Unrealized Losses for Fixed Maturity Securities by Sector The estimated fair value and gross unrealized losses of fixed maturity securities in an unrealized loss position, by sector and by length of time that the securities have been in a continuous unrealized loss position, were as follows at: December 31, 2023 December 31, 2022 Less than 12 Months 12 Months or Greater Less than 12 Months 12 Months or Greater Estimated Gross Estimated Gross Estimated Gross Estimated Gross (Dollars in millions) U.S. corporate $ 4,549 $ 409 $ 22,435 $ 2,923 $ 24,163 $ 3,279 $ 3,915 $ 1,157 Foreign corporate 1,010 74 8,229 1,202 8,219 1,407 1,560 505 U.S. government and agency 445 8 3,453 509 3,037 259 1,146 337 RMBS 413 21 5,749 784 4,693 489 2,245 447 ABS 572 3 3,355 128 3,347 159 1,728 136 CMBS 411 33 5,713 568 5,524 534 961 165 State and political subdivision 460 31 1,636 267 2,026 313 239 81 Foreign government 113 6 620 81 779 98 21 8 Total fixed maturity securities $ 7,973 $ 585 $ 51,190 $ 6,462 $ 51,788 $ 6,538 $ 11,815 $ 2,836 Total number of securities in an unrealized loss position 1,339 6,958 7,261 2,018 Allowance for Credit Losses for Fixed Maturity Securities Evaluation and Measurement Methodologies For fixed maturity securities in an unrealized loss position, management first assesses whether the Company intends to sell, or whether it is more likely than not it will be required to sell the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security’s amortized cost basis is written down to estimated fair value through net investment gains (losses). For fixed maturity securities that do not meet the aforementioned criteria, management evaluates whether the decline in estimated fair value has resulted from credit losses or other factors. Inherent in management’s evaluation of the security are assumptions and estimates about the operations of the issuer and its future earnings potential. Considerations used in the allowance for credit loss evaluation process include, but are not limited to: (i) the extent to which estimated fair value is less than amortized cost; (ii) any changes to the rating of the security by a rating agency; (iii) adverse conditions specifically related to the security, industry or geographic area; and (iv) payment structure of the fixed maturity security and the likelihood of the issuer being able to make payments in the future or the issuer’s failure to make scheduled interest and principal payments. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security are compared to the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis, a credit loss is deemed to exist and an allowance for credit losses is recorded, limited by the amount that the estimated fair value is less than the amortized cost basis, with a corresponding charge to net investment gains (losses). Any unrealized losses that have not been recorded through an allowance for credit losses are recognized in OCI. Once a security specific allowance for credit losses is established, the present value of cash flows expected to be collected from the security continues to be reassessed. Any changes in the security specific allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in net investment gains (losses). Fixed maturity securities are also evaluated to determine whether any amounts have become uncollectible. When all, or a portion, of a security is deemed uncollectible, the uncollectible portion is written-off with an adjustment to amortized cost and a corresponding reduction to the allowance for credit losses. Accrued interest receivables are presented separate from the amortized cost basis of fixed maturity securities. An allowance for credit losses is not estimated on an accrued interest receivable, rather receivable balances 90-days past due are deemed uncollectible and are written off with a corresponding reduction to net investment income. The accrued interest receivable on fixed maturity securities totaled $648 million and $595 million at December 31, 2023 and 2022, respectively, and is included in accrued investment income. Fixed maturity securities are also evaluated to determine if they qualify as purchased financial assets with credit deterioration (“PCD”). To determine if the credit deterioration experienced since origination is more than insignificant, both (i) the extent of the credit deterioration and (ii) any rating agency downgrades are evaluated. For securities categorized as PCD assets, the present value of cash flows expected to be collected from the security are compared to the par value of the security. If the present value of cash flows expected to be collected is less than the par value, credit losses are embedded in the purchase price of the PCD asset. In this situation, both an allowance for credit losses and amortized cost gross-up is recorded, limited by the amount that the estimated fair value is less than the grossed-up amortized cost basis. Any difference between the purchase price and the present value of cash flows is amortized or accreted into net investment income over the life of the PCD asset. Any subsequent PCD asset allowance for credit losses is evaluated in a manner similar to the process described above for fixed maturity securities. Current Period Evaluation Rollforward of the Allowance for Credit Losses for Fixed Maturity Securities by Sector The changes in the allowance for credit losses by sector were as follows: U.S. Corporate RMBS CMBS Foreign Corporate Total (In millions) Balance at December 31, 2021 $ 2 $ — $ 2 $ 7 $ 11 Allowance on securities where credit losses were not previously recorded — 1 — — 1 Reductions for securities sold (1) — — — (1) Change in allowance on securities with an allowance recorded in a previous period — — 1 — 1 Write-offs charged against allowance (1) — — — (6) (6) Balance at December 31, 2022 1 1 3 1 6 Allowance on securities where credit losses were not previously recorded 15 3 — — 18 Reductions for securities sold (1) — — — (1) Change in allowance on securities with an allowance recorded in a previous period — — (1) — (1) Write-offs charged against allowance (1) — — — (1) (1) Balance at December 31, 2023 $ 15 $ 4 $ 2 $ — $ 21 _______________ (1) The Company recorded total write-offs of $8 million and $10 million for the years ended December 31, 2023 and 2022, respectively. Mortgage Loans Mortgage Loans by Portfolio Segment Mortgage loans are summarized as follows at: December 31, 2023 2022 Carrying % of Carrying % of (Dollars in millions) Commercial $ 13,189 58.7 % $ 13,547 59.2 % Agricultural 4,416 19.6 4,333 18.9 Residential 5,007 22.3 5,116 22.4 Total mortgage loans (1) 22,612 100.6 22,996 100.5 Allowance for credit losses (137) (0.6) (119) (0.5) Total mortgage loans, net $ 22,475 100.0 % $ 22,877 100.0 % _______________ (1) Purchases of mortgage loans from third parties were $311 million and $2.2 billion for the years ended December 31, 2023 and 2022, respectively, and were primarily comprised of residential mortgage loans. Allowance for Credit Losses for Mortgage Loans Evaluation and Measurement Methodologies The allowance for credit losses is a valuation account that is deducted from the mortgage loan’s amortized cost basis to present the net amount expected to be collected on the mortgage loan. The loan balance, or a portion of the loan balance, is written-off against the allowance when management believes this amount is uncollectible. Accrued interest receivables are presented separate from the amortized cost basis of mortgage loans. An allowance for credit losses is generally not estimated on an accrued interest receivable, rather when a loan is placed in nonaccrual status the associated accrued interest receivable balance is written off with a corresponding reduction to net investment income. The accrued interest receivable on mortgage loans is included in accrued investment income and totaled $122 million and $115 million at December 31, 2023 and 2022, respectively. The allowance for credit losses is estimated using relevant available information, from internal and external sources, relating to past events, current conditions, and a reasonable and supportable forecast. Historical credit loss experience provides the basis for estimating expected credit losses. Adjustments to historical loss information are made for differences in current loan-specific risk characteristics and environmental conditions. A reasonable and supportable forecast period of two-years is used with an input reversion period of one-year. Mortgage loans are evaluated in each of the three portfolio segments to determine the allowance for credit losses. The loan-level loss rates are determined using individual loan terms and characteristics, risk pools/internal ratings, national economic forecasts, prepayment speeds, and estimated default and loss severity. The resulting loss rates are applied to the mortgage loan’s amortized cost to generate an allowance for credit losses. In certain situations, the allowance for credit losses is measured as the difference between the loan’s amortized cost and liquidation value of the collateral. These situations include collateral dependent loans, modifications, foreclosure probable loans, and loans with dissimilar risk characteristics. Mortgage loans are also evaluated to determine if they qualify as PCD assets. To determine if the credit deterioration experienced since origination is more than insignificant, the extent of credit deterioration is evaluated. All re-performing/modified loan (“RPL”) pools purchased after December 31, 2019 are determined to have been acquired with evidence of more than insignificant credit deterioration since origination and are classified as PCD assets. RPLs are pools of residential mortgage loans acquired at a discount or premium which have both credit and non-credit components. For PCD mortgage loans, the allowance for credit losses is determined using a similar methodology described above, except the loss-rate is determined at the pool level instead of the individual loan level. The initial allowance for credit losses, determined on a collective basis, is then allocated to the individual loans. The initial amortized cost of the loan is grossed-up to reflect the sum of the loan’s purchase price and allowance for credit losses. The difference between the grossed-up amortized cost basis and the par value of the loan is a non-credit discount or premium, which is accreted or amortized into net investment income over the remaining life of the loan. Any subsequent PCD mortgage loan allowance for credit losses is evaluated in a manner similar to the process described above for each of the three portfolio segments. Rollforward of the Allowance for Credit Losses for Mortgage Loans by Portfolio Segment The changes in the allowance for credit losses by portfolio segment were as follows: Commercial Agricultural Residential Total (In millions) Balance at December 31, 2021 $ 67 $ 12 $ 44 $ 123 Current period provision 5 3 11 19 Charge-offs, net of recoveries (23) — — (23) Balance at December 31, 2022 49 15 55 119 Current period provision 24 5 (6) 23 Charge-offs, net of recoveries (4) (1) — (5) Balance at December 31, 2023 $ 69 $ 19 $ 49 $ 137 PCD Mortgage Loans There were no new purchases of PCD mortgage loans during the year ended December 31, 2023. Purchases of PCD mortgage loans were $69 million at December 31, 2022. Credit Quality of Mortgage Loans by Portfolio Segment The amortized cost of mortgage loans by year of origination and credit quality indicator was as follows at: 2023 2022 2021 2020 2019 Prior Total (In millions) December 31, 2023 Commercial mortgage loans Loan-to-value ratios: Less than 65% $ 206 $ 655 $ 1,823 $ 177 $ 1,239 $ 2,628 $ 6,728 65% to 75% — 935 1,079 222 261 1,157 3,654 76% to 80% — 427 76 39 209 563 1,314 Greater than 80% — 400 227 — 150 716 1,493 Total commercial mortgage loans 206 2,417 3,205 438 1,859 5,064 13,189 Agricultural mortgage loans Loan-to-value ratios: Less than 65% 202 571 1,132 452 505 1,265 4,127 65% to 75% 1 127 108 6 30 17 289 Total agricultural mortgage loans 203 698 1,240 458 535 1,282 4,416 Residential mortgage loans Performing 105 1,286 1,669 145 204 1,508 4,917 Nonperforming — 22 22 1 2 43 90 Total residential mortgage loans 105 1,308 1,691 146 206 1,551 5,007 Total $ 514 $ 4,423 $ 6,136 $ 1,042 $ 2,600 $ 7,897 $ 22,612 2022 2021 2020 2019 2018 Prior Total (In millions) December 31, 2022 Commercial mortgage loans Loan-to-value ratios: Less than 65% $ 1,916 $ 2,819 $ 405 $ 1,493 $ 888 $ 3,624 $ 11,145 65% to 75% 503 354 — 271 367 402 1,897 76% to 80% — 18 40 90 65 48 261 Greater than 80% — — — 25 57 162 244 Total commercial mortgage loans 2,419 3,191 445 1,879 1,377 4,236 13,547 Agricultural mortgage loans Loan-to-value ratios: Less than 65% 532 1,163 418 496 643 710 3,962 65% to 75% 148 90 59 56 1 16 370 Greater than 80% — — — — 1 — 1 Total agricultural mortgage loans 680 1,253 477 552 645 726 4,333 Residential mortgage loans Performing 1,266 1,745 167 215 168 1,491 5,052 Nonperforming 4 8 — 2 1 49 64 Total residential mortgage loans 1,270 1,753 167 217 169 1,540 5,116 Total $ 4,369 $ 6,197 $ 1,089 $ 2,648 $ 2,191 $ 6,502 $ 22,996 The loan-to-value ratio is a measure commonly used to assess the quality of commercial and agricultural mortgage loans. The loan-to-value ratio compares the amount of the loan to the estimated fair value of the underlying property collateralizing the loan and is commonly expressed as a percentage. A loan-to-value ratio less than 100% indicates an excess of collateral value over the loan amount. Loan-to-value ratios greater than 100% indicate that the loan amount exceeds the collateral value. Performing status is a measure commonly used to assess the quality of residential mortgage loans. A loan is considered performing when the borrower makes consistent and timely payments. The amortized cost of commercial mortgage loans by debt-service coverage ratio was as follows at: December 31, 2023 2022 Amortized Cost % of Amortized Cost % of (Dollars in millions) Debt-service coverage ratios: Greater than 1.20x $ 12,082 91.6 % $ 12,132 89.6 % 1.00x - 1.20x 702 5.3 589 4.3 Less than 1.00x 405 3.1 826 6.1 Total $ 13,189 100.0 % $ 13,547 100.0 % The debt-service coverage ratio compares a property’s net operating income to its debt-service payments. Debt-service coverage ratios less than 1.00 times indicate that property operations do not generate enough income to cover the loan’s current debt payments. A debt-service coverage ratio greater than 1.00 times indicates an excess of net operating income over the debt-service payments. Past Due Mortgage Loans by Portfolio Segment The Company has a high-quality, well-performing mortgage loan portfolio, with over 99% of all mortgage loans classified as performing at both December 31, 2023 and 2022. Delinquency is defined consistent with industry practice, when mortgage loans are past due as follows: commercial and residential mortgage loans — 60 days and agricultural mortgage loans — 90 days. The aging of the amortized cost of past due mortgage loans by portfolio segment was as follows at: December 31, 2023 2022 Commercial Agricultural Residential Total Commercial Agricultural Residential Total (In millions) Current $ 13,172 $ 4,400 $ 4,915 $ 22,487 $ 13,547 $ 4,314 $ 5,041 $ 22,902 30-59 days past due — — 2 2 — — 11 11 60-89 days past due — — 30 30 — — 16 16 90-179 days past due — — 23 23 — 3 31 34 180+ days past due 17 16 37 70 — 16 17 33 Total $ 13,189 $ 4,416 $ 5,007 $ 22,612 $ 13,547 $ 4,333 $ 5,116 $ 22,996 Mortgage Loans in Nonaccrual Status by Portfolio Segment Mortgage loans are placed in a nonaccrual status if there are concerns regarding collectability of future payments or the loan is past due, unless the past due loan is well collateralized. The amortized cost of mortgage loans in a nonaccrual status by portfolio segment was as follows at: Commercial Agricultural Residential (1) Total (In millions) December 31, 2023 $ 17 $ — $ 90 $ 107 December 31, 2022 $ 11 $ 3 $ 64 $ 78 _______________ (1) The Company had no mortgage loans in nonaccrual status for which there was no related allowance for credit losses at both December 31, 2023 and 2022. Modified Mortgage Loans by Portfolio Segment Under certain circumstances, modifications are granted to nonperforming mortgage loans. Generally, the types of concessions may include interest rate reduction, term extension, principal forgiveness, or a combination of all three. The Company did not have a significant amount of mortgage loans modified during both years ended December 31, 2023 and 2022. Other Invested Assets Over 75% of other invested assets is comprised of freestanding derivatives with positive estimated fair values. See Note 10 for information about freestanding derivatives with positive estimated fair values. Other invested assets also includes the Company’s investment in company-owned life insurance, FHLB stock, leveraged leases, tax credit and renewable energy partnerships and the intercompany lending facility. Leveraged Leases The carrying value of leveraged leases was $47 million and $48 million at December 31, 2023 and 2022, respectively. The allowance for credit losses was $13 million at both December 31, 2023 and 2022. Rental receivables are generally due in periodic installments. The payment periods for leveraged leases generally range from one to nine years. For rental receivables, the primary credit quality indicator is whether the rental receivable is performing or nonperforming, which is assessed monthly. Nonperforming rental receivables are generally defined as those that are 90 days or more past due. At both December 31, 2023 and 2022, all leveraged leases were performing. Net Unrealized Investment Gains (Losses) Unrealized investment gains (losses) on fixed maturity securities and the effect on future policy benefits, that would result from the realization of the unrealized gains (losses), are included in net unrealized investment gains (losses) in AOCI. The components of net unrealized investment gains (losses), included in AOCI, were as follows: Years Ended December 31, 2023 2022 2021 (In millions) Fixed maturity securities $ (6,023) $ (8,632) $ 8,251 Derivatives 344 628 320 Other (7) (7) (27) Subtotal (5,686) (8,011) 8,544 Amounts allocated from: Future policy benefits 696 992 (1,925) Deferred income tax benefit (expense) 1,048 1,474 (1,390) Net unrealized investment gains (losses) $ (3,942) $ (5,545) $ 5,229 The changes in net unrealized investment gains (losses) were as follows: Years Ended December 31, 2023 2022 2021 (In millions) Balance at December 31, $ (5,545) $ 5,229 $ 5,429 Unrealized investment gains (losses) change due to cumulative effect, net of income tax — — 1,959 Balance at January 1, $ (5,545) $ 5,229 $ 7,388 Unrealized investment gains (losses) during the year 2,325 (16,555) (3,420) Unrealized investment gains (losses) relating to: Future policy benefits (296) 2,917 687 Deferred income tax benefit (expense) (426) 2,864 574 Balance at December 31, $ (3,942) $ (5,545) $ 5,229 Change in net unrealized investment gains (losses) $ 1,603 $ (10,774) $ (2,159) Concentrations of Credit Risk There were no investments in any counterparty that were greater than 10% of the Company’s equity, other than the U.S. government and its agencies, at both December 31, 2023 and 2022. Securities Lending Elements of the securities lending program are presented below at: December 31, 2023 2022 (In millions) Securities on loan: (1) Amortized cost $ 3,420 $ 3,995 Estimated fair value $ 3,194 $ 3,638 Cash collateral received from counterparties (2) $ 3,277 $ 3,731 Reinvestment portfolio — estimated fair value $ 3,246 $ 3,603 _______________ (1) Included in fixed maturity securities. (2) Included in payables for collateral under securities loaned and other transactions. The cash collateral liability by loaned security type and remaining tenor of the agreements were as follows at: December 31, 2023 December 31, 2022 Open (1) 1 Month 1 to 6 Total Open (1) 1 Month 1 to 6 Total (In millions) U.S. government and agency $ 647 $ 655 $ 1,584 $ 2,886 $ 640 $ 1,527 $ 984 $ 3,151 U.S. corporate — 252 — 252 2 410 — 412 Foreign corporate — 130 — 130 — 152 — 152 Foreign government — 9 — 9 — 16 — 16 Total $ 647 $ 1,046 $ 1,584 $ 3,277 $ 642 $ 2,105 $ 984 $ 3,731 _______________ (1) The related loaned security could be returned to the Company on the next business day which would require the Company to immediately return the cash collateral. If the Company is required to return significant amounts of cash collateral on short notice and is forced to sell securities to meet the return obligation, it may have difficulty selling such collateral that is invested in securities in a timely manner, be forced to sell securities in a volatile or illiquid market for less than what otherwise would have been realized in normal market conditions, or both. The estimated fair value of the securities on loan related to the cash collateral on open at December 31, 2023 was $631 million, primarily comprised of U.S. government and agency securities which, if put back to the Company, could be immediately sold to satisfy the cash requirement. The reinvestment portfolio acquired with the cash collateral consisted principally of fixed maturity securities (including agency RMBS, ABS, U.S. government and agency securities, U.S. and foreign corporate securities, non-agency RMBS and CMBS) with 56% invested in agency RMBS, U.S. government and agency securities and cash and cash equivalents at December 31, 2023. If the securities on loan or the reinvestment portfolio become less liquid, the Company has the liquidity resources of most of its general account available to meet any potential cash demands when securities on loan are put back to the Company. Invested Assets on Deposit, Held in Trust and Pledged as Collateral Invested assets on deposit, held in trust and pledged as collateral at estimated fair value were as follows at: December 31, 2023 2022 (In millions) Invested assets on deposit (regulatory deposits) (1) $ 8,590 $ 7,996 Invested assets held in trust (reinsurance agreements) (2) 7,103 5,592 Invested assets pledged as collateral (3) 13,979 13,920 Total invested assets on deposit, held in trust and pledged as collateral $ 29,672 $ 27,508 _______________ (1) The Company has assets, primarily fixed maturity securities, on deposit with governmental authorities relating to certain policyholder liabilities, of which $102 million and $21 million of the assets on deposit represents restricted cash and cash equivalents at December 31, 2023 and 2022, respectively. (2) The Company has assets, primarily fixed maturity securities, held in trust relating to certain reinsurance transactions, of which $117 million and $233 million of the assets held in trust balance represents restricted cash and cash equivalents at December 31, 2023 and 2022, respectively. (3) The Company has pledged invested assets in connection with various agreements and transactions, including funding agreements (see Note 4) and derivative transactions (see Note 10). See “— Securities Lending” for information regarding securities on loan. In addition, the Company’s investment in FHLB common stock, which is considered restricted until redeemed by the issuer, was $245 million and $201 million at redemption value at December 31, 2023 and 2022, respectively. Collectively Significant Equity Method Investments The Company holds investments in limited partnerships and LLCs consisting of leveraged buy-out funds, private equity funds, joint ventures and other funds. The portion of these investments accounted for under the equity method had a carrying value of $4.9 billion at December 31, 2023. The Company’s maximum exposure to loss related to these equity method investments is the carrying value of these investments plus unfunded commitments of $1.2 billion at December 31, 2023. The Company’s investments in limited partnerships and LLCs are generally of a passive nature in that the Company does not participate in the management of the entities. As described in Note 1, the Company generally records its share of earnings in its equity method investments using a three-month lag methodology and within net investment income. Aggregate net investment income from these equity method investments exceeded 10% of the Company’s consolidated pre-tax income (loss) for each of the years ended December 31, 2023, 2022 and 2021. This aggregated summarized financial data does not represent the Company’s proportionate share of the assets, liabilities or earnings of such entities. The aggregated summarized financial data presented below reflects the latest available financial information and is as of and for the years ended December 31, 2023, 2022 and 2021. Aggregate total assets of these entities totaled $799.0 billion and $879.8 billion at December 31, 2023 and 2022, respectively. Aggregate total liabilities of these entities totaled $56.7 billion and $109.2 billion at December 31, 2023 and 2022, respectively. Aggregate net income (loss) of these entities totaled $24.8 billion, ($12.8) billion and $22.6 billion for the years ended December 31, 2023, 2022 and 2021, respectively. Aggregate net income (loss) from the underlying entities in which the Company invests is primarily comprised of investment income, including recurring investment income and realized and unrealized investment gains (losses). Variable Interest Entities A variable interest entity (“VIE”) is a legal entity that does not have sufficient equity at risk to finance its activities or is structured such that equity investors lack the ability to make significant decisions relating to the entity’s operations through voting rights or do not substantively participate in the gains and losses of the entity. The Company enters into various arrangements with VIEs in the normal course of business and has invested in legal entities that are VIEs. VIEs are consolidated when it is determined that the Company is the primary beneficiary. A primary beneficiary is the variable interest holder in a VIE with both (i) the power to direct the activities of the VIE that most significantly impact the economic performance of the VIE and (ii) the obligation to absorb losses or the right to receive benefits that could potentially be significant to the VIE. In addition, the evaluation of whether a legal entity is a VIE and if the Company is a primary beneficiary includes a review of the capital structure of the VIE, the related contractual relationships and terms, the nature of the operations and purpose of the VIE, the nature of the VIE interests issued and the Company’s involvement with the entity. There were no material VIEs for which the Company has concluded that it is the primary beneficiary at either December 31, 2023 or 2022. The carrying amount and maximum exposure to loss related to the VIEs for which the Company has concluded that it holds a variable interest, but is not the primary beneficiary, were as follows at: December 31, 2023 2022 Carrying Maximum Carrying Maximum (In millions) Fixed maturity securities $ 15,386 $ 16,611 $ 15,781 $ 17,334 Limited partnerships and LLCs 4,220 5,242 4,123 5,478 Total $ 19,606 $ 21,853 $ 19,904 $ 22,812 The Company’s investments in unconsolidated VIEs are described below. Fixed Maturity Securities The Company invests in U.S. corporate bonds, foreign corporate bonds and Structured Securities issued by VIEs. The Company is not obligated to provide any financial or other support to these VIEs, other than the original investment. The Company’s involvement with these entities is limited to that of a passive investor. The Company has no unilateral right to appoint or remove the servicer, special servicer, or investment manager, which are generally viewed as having the power to direct the activities that most significantly impact the economic performance of the VIE, nor does the Company function in any of these roles. The Company does not have the obligation to absorb losses or the right to receive benefits from the entity that could potentially be significant to the entity; as a result, the Company has determined it is not the primary beneficiary, or consolidator, of the VIE. The Company’s maximum exposure to loss on these fixed maturity securities is limited to the amortized cost of these investments. See “— Fixed Maturity Securities Available-for-sale” for information on these securities. Limited Partnerships and LLCs The Company holds investments in certain limited partnerships and LLCs which are VIEs. These ventures include limited partnerships, LLCs, private equity funds, and, to a lesser extent, tax credit and renewable energy partnerships. The Company is not considered the primary beneficiary, or consolidator, when its involvement takes the form of a limited partner interest and is restricted to a role of a passive investor, as a limited partner’s interest does not provide the Company with any substantive kick-out or participating rights, nor does it provide the Company with the power to direct the activities of the fund. The Company’s maximum exposure to loss on these investments is limited to: (i) the amount invested in debt or equity of the VIE and (ii) commitments to the VIE, as described in Note 16. Net Investment Income The components of net investment income were as follows: Years Ended December 31, 2023 2022 2021 (In millions) Investment income: Fixed maturity securities $ 3,481 $ 3,044 $ 2,794 Equity securities 2 2 5 Mortgage loans 957 840 686 Policy loans 45 42 41 Limited partnerships and LLCs (1) 167 263 1,391 Cash, cash equivalents and short-term investments 181 56 3 Other 84 66 42 Total investment income 4,917 4,313 4,962 Less: Investment expenses 357 249 147 Net investment income $ 4,560 $ 4,064 $ 4,815 _______________ (1) Includes net investment income pertaining to other limited partnership interests of $186 million, $170 million and $1.3 billion for the years ended December 31, 2023, 2022 and 2021, respectively. Net Investment Gains (Losses) Components of Net Investment Gains (Losses) The components of net investment gains (losses) were as follows: Years Ended December 31, 2023 2022 2021 (In millions) Fixed maturity securities $ (2 |
Derivatives
Derivatives | 12 Months Ended |
Dec. 31, 2023 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivatives | 10. Derivatives Accounting for Derivatives See Note 1 for a description of the Company’s accounting policies for derivatives and Note 11 for information about the fair value hierarchy for derivatives. Derivative Strategies The Company maintains an overall risk management strategy that incorporates the use of derivative instruments to minimize its exposure to various market risks, including interest rate, foreign currency exchange rate, credit and equity market. Derivatives are financial instruments with values derived from interest rates, foreign currency exchange rates, credit spreads and/or other financial indices. Derivatives may be exchange-traded or contracted in the over-the-counter (“OTC”) market. Certain of the Company’s OTC derivatives are cleared and settled through central clearing counterparties (“OTC-cleared”), while others are bilateral contracts between two counterparties (“OTC-bilateral”). Interest Rate Derivatives Interest rate swaps: The Company uses interest rate swaps to manage the interest rate risks primarily in variable annuity products and ULSG. Interest rate swaps are used in non-qualifying hedging relationships. Interest rate caps: The Company uses interest rate caps to protect its floating rate liabilities against rises in interest rates above a specified level, and against interest rate exposure arising from mismatches between assets and liabilities. Interest rate caps are used in non-qualifying hedging relationships. Interest rate floors: The Company uses interest rate floors to protect against a decline in interest rates on floating rate assets in the Company’s institutional spread margin business. Interest rate floors are used in non-qualifying hedging relationships. Interest rate swaptions: The Company uses interest rate swaptions to manage the interest rate risks primarily in variable annuity products and ULSG. Interest rate swaptions are used in non-qualifying hedging relationships. Interest rate swaptions are included in interest rate options. Interest rate forwards: The Company uses interest rate forwards to manage the interest rate risks primarily in variable annuity products and ULSG. Interest rate forwards are used in cash flow and non-qualifying hedging relationships. Foreign Currency Exchange Rate Derivatives Foreign currency swaps: The Company uses foreign currency swaps to convert foreign currency denominated cash flows to U.S. dollars to reduce cash flow fluctuations due to changes in currency exchange rates. Foreign currency swaps are used in cash flow and non-qualifying hedging relationships. Foreign currency forwards: The Company uses foreign currency forwards to hedge currency exposure on its invested assets. Foreign currency forwards are used in non-qualifying hedging relationships. Credit Derivatives Credit default swaps: The Company uses credit default swaps to create synthetic credit investments to replicate credit exposure that is more economically attractive than what is available in the market or otherwise unavailable (written credit protection), or to reduce credit loss exposure on certain assets that the Company owns (purchased credit protection). Credit default swaps are used in non-qualifying hedging relationships. Credit default swaptions: The Company uses credit default swaptions to synthetically create investments that are either more expensive to acquire or otherwise unavailable in the cash markets. Swaptions are used to create callable bonds from replication synthetic asset transaction (“RSAT”) positions. This enhances the income of the RSAT program through earned premiums while not changing the credit profile of the RSATs. Credit default swaptions are used in non-qualifying hedging relationships. Equity Market Derivatives Equity index options: The Company uses equity index options primarily to hedge minimum guarantees embedded in certain variable annuity products against adverse changes in equity markets. Additionally, the Company uses equity index options to hedge index-linked annuity products and certain invested assets against adverse changes in equity markets. Certain of these contracts may also contain settlement provisions linked to interest rates (“hybrid options”). Equity index options are used in non-qualifying hedging relationships. Equity total return swaps: The Company uses equity total return swaps to hedge minimum guarantees embedded in certain variable annuity products against adverse changes in equity markets. Additionally, the Company uses equity total return swaps to hedge index-linked annuity products against adverse changes in equity markets. Equity total return swaps are used in non-qualifying hedging relationships. Equity variance swaps: The Company uses equity variance swaps to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. Equity variance swaps are used in non-qualifying hedging relationships. Primary Risks Managed by Derivatives The primary underlying risk exposure, gross notional amount and estimated fair value of derivatives, excluding embedded derivatives, held were as follows at: December 31, 2023 2022 Gross Notional Amount Estimated Fair Value Gross Notional Amount Estimated Fair Value Primary Underlying Risk Exposure Assets Liabilities Assets Liabilities (In millions) Derivatives Designated as Hedging Instruments: Cash flow hedges: Interest rate forwards Interest rate $ — $ — $ — $ 60 $ — $ 12 Foreign currency swaps Foreign currency exchange rate 3,895 339 45 3,981 584 8 Total qualifying hedges 3,895 339 45 4,041 584 20 Derivatives Not Designated or Not Qualifying as Hedging Instruments: Interest rate swaps Interest rate 31,252 140 103 3,145 98 46 Interest rate floors Interest rate 3,500 7 1 3,250 12 3 Interest rate caps Interest rate 7,050 19 1 6,350 137 43 Interest rate options Interest rate 33,680 47 167 28,688 22 232 Interest rate forwards Interest rate 17,017 32 1,937 18,168 35 2,466 Foreign currency swaps Foreign currency exchange rate 735 99 1 810 147 — Foreign currency forwards Foreign currency exchange rate 384 — 1 295 1 1 Credit default swaps — written Credit 1,405 27 — 1,757 18 2 Credit default swaptions Credit — — — 100 — — Equity index options Equity market 20,099 757 687 17,229 697 351 Equity total return swaps Equity market 53,742 2,236 2,137 32,909 520 747 Hybrid options Equity market 270 — — — — — Total non-designated or non-qualifying derivatives 169,134 3,364 5,035 112,701 1,687 3,891 Total $ 173,029 $ 3,703 $ 5,080 $ 116,742 $ 2,271 $ 3,911 Based on gross notional amounts, a substantial portion of the Company’s derivatives was not designated or did not qualify as part of a hedging relationship at both December 31, 2023 and 2022. The Company’s use of derivatives includes (i) derivatives that serve as hedges of the Company’s exposure to various risks and generally do not qualify for hedge accounting because they do not meet the criteria required under portfolio hedging rules; (ii) derivatives that economically hedge insurance liabilities and generally do not qualify for hedge accounting because they do not meet the criteria of being “highly effective” as outlined in Accounting Standards Codification 815 — Derivatives and Hedging; (iii) derivatives that economically hedge MRBs that do not qualify for hedge accounting because the changes in estimated fair value of the MRBs are already recorded in net income; and (iv) written credit default swaps that are used to create synthetic credit investments and that do not qualify for hedge accounting because they do not involve a hedging relationship. The amount and location of gains (losses), including earned income, recognized for derivatives and gains (losses) pertaining to hedged items reported in net derivative gains (losses) were as follows: Year Ended December 31, 2023 Net Net Net Amount of Gains (Losses) Deferred in AOCI (In millions) Derivatives Designated as Hedging Instruments: Cash flow hedges: Interest rate $ 1 $ — $ 3 $ (1) Foreign currency exchange rate 7 (8) 51 (272) Total cash flow hedges 8 (8) 54 (273) Derivatives Not Designated or Not Qualifying as Hedging Instruments: Interest rate (384) — — — Foreign currency exchange rate (40) 2 — — Credit 32 — — — Equity market 570 — — — Embedded (4,100) — — — Total non-qualifying hedges (3,922) 2 — — Total $ (3,914) $ (6) $ 54 $ (273) Year Ended December 31, 2022 Net Net Net Amount of Gains (Losses) Deferred in AOCI (In millions) Derivatives Designated as Hedging Instruments: Cash flow hedges: Interest rate $ 5 $ — $ 4 $ (50) Foreign currency exchange rate 12 (11) 52 379 Total cash flow hedges 17 (11) 56 329 Derivatives Not Designated or Not Qualifying as Hedging Instruments: Interest rate (4,001) — — — Foreign currency exchange rate 95 (16) — — Credit (2) — — — Equity market 590 — — — Embedded 2,743 — — — Total non-qualifying hedges (575) (16) — — Total $ (558) $ (27) $ 56 $ 329 Year Ended December 31, 2021 Net Net Net Amount of Gains (Losses) Deferred in AOCI (In millions) Derivatives Designated as Hedging Instruments: Cash flow hedges: Interest rate $ 2 $ — $ 3 $ (20) Foreign currency exchange rate 7 (3) 34 190 Total cash flow hedges 9 (3) 37 170 Derivatives Not Designated or Not Qualifying as Hedging Instruments: Interest rate (717) — — — Foreign currency exchange rate 48 2 — — Credit 17 — — — Equity market (486) — — — Embedded (2,856) — — — Total non-qualifying hedges (3,994) 2 — — Total $ (3,985) $ (1) $ 37 $ 170 At December 31, 2023, the Company held no qualified derivatives hedging exposure to future cash flows for forecasted asset purchases. At December 31, 2022, the maximum length of time over which the Company was hedging its exposure to variability in future cash flows for forecasted transactions was less than one year. At December 31, 2023 and 2022, the balance in AOCI associated with cash flow hedges was $344 million and $628 million, respectively. Credit Derivatives In connection with synthetically created credit investment transactions, the Company writes credit default swaps for which it receives a premium to insure credit risk. If a credit event occurs, as defined by the contract, the contract may be cash settled or it may be settled gross by the Company paying the counterparty the specified swap notional amount in exchange for the delivery of par quantities of the referenced credit obligation. The estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps were as follows at: December 31, 2023 2022 Rating Agency Designation of Referenced Estimated Fair Value of Credit Default Swaps Maximum Amount of Future Payments under Credit Default Swaps Weighted Average Years to Maturity (2) Estimated Fair Value of Credit Default Swaps Maximum Amount of Future Payments under Credit Default Swaps Weighted Average Years to Maturity (2) (Dollars in millions) Aaa/Aa/A $ 6 $ 419 1.6 $ 7 $ 544 2.2 Baa 19 958 4.9 8 1,185 5.0 Ba 2 24 3.0 2 24 4.0 Caa and Lower — 4 2.0 (1) 4 3.0 Total $ 27 $ 1,405 3.9 $ 16 $ 1,757 4.1 _______________ (1) The Company has written credit protection on both single name and index references. The rating agency designations are based on availability and the midpoint of the applicable ratings among Moody’s, S&P and Fitch. If no rating is available from a rating agency, then an internally developed rating is used. (2) The weighted average years to maturity of the credit default swaps is calculated based on weighted average gross notional amounts. Counterparty Credit Risk The Company may be exposed to credit-related losses in the event of counterparty nonperformance on derivative instruments. Generally, the credit exposure is the fair value at the reporting date less any collateral received from the counterparty. The Company manages its credit risk by: (i) entering into derivative transactions with creditworthy counterparties governed by master netting agreements; (ii) trading through regulated exchanges and central clearing counterparties; (iii) obtaining collateral, such as cash and securities, when appropriate; and (iv) setting limits on single party credit exposures which are subject to periodic management review. See Note 11 for a description of the impact of credit risk on the valuation of derivatives. The estimated fair values of net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at: Gross Amounts Not Offset on the Consolidated Balance Sheets Gross Amount Recognized Financial Instruments (1) Collateral Received/Pledged (2) Net Amount Securities Collateral Received/Pledged (3) Net Amount After Securities Collateral (In millions) December 31, 2023 Derivative assets $ 3,495 $ (3,112) $ (154) $ 229 $ (194) $ 35 Derivative liabilities $ 4,917 $ (3,112) $ — $ 1,805 $ (1,805) $ — December 31, 2022 Derivative assets $ 2,295 $ (1,659) $ (629) $ 7 $ (5) $ 2 Derivative liabilities $ 3,910 $ (1,659) $ — $ 2,251 $ (2,251) $ — _______________ (1) Represents amounts subject to an enforceable master netting agreement or similar agreement. (2) The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreement. (3) Securities collateral received from counterparties is not reported on the consolidated balance sheets and may not be sold or re-pledged unless the counterparty is in default. Amounts do not include excess of collateral pledged or received. The Company’s collateral arrangements generally require the counterparty in a net liability position, after considering the effect of netting agreements, to pledge collateral when the amount owed by that counterparty reaches a minimum transfer amount. Certain of these arrangements also include credit-contingent provisions which permit the party with positive fair value to terminate the derivative at the current fair value or demand immediate full collateralization from the party in a net liability position, in the event that the financial strength or credit rating of the party in a net liability position falls below a certain level. The aggregate estimated fair values of derivatives in a net liability position containing such credit-contingent provisions and the aggregate estimated fair value of assets posted as collateral for such instruments were as follows at: December 31, 2023 2022 (In millions) Estimated fair value of derivatives in a net liability position (1) $ 1,805 $ 2,251 Estimated fair value of collateral provided (2): Fixed maturity securities $ 4,811 $ 4,894 _______________ (1) After taking into consideration the existence of netting agreements. (2) Substantially all of the Company’s collateral arrangements provide for daily posting of collateral for the full value of the derivative contract. As a result, if the credit-contingent provisions of derivative contracts in a net liability position were triggered, minimal additional assets would be required to be posted as collateral or needed to settle the instruments immediately. Additionally, the Company is required to pledge initial margin for certain new OTC-bilateral derivative transactions to third-party custodians. |
Fair Value
Fair Value | 12 Months Ended |
Dec. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Fair Value | 11. Fair Value When developing estimated fair values, the Company considers three broad valuation techniques: (i) the market approach, (ii) the income approach, and (iii) the cost approach. The Company determines the most appropriate valuation technique to use, given what is being measured and the availability of sufficient inputs, giving priority to observable inputs. The Company categorizes its assets and liabilities measured at estimated fair value into a three-level hierarchy, based on the significant input with the lowest level in its valuation. The input levels are as follows: Level 1 Unadjusted quoted prices in active markets for identical assets or liabilities. The Company defines active markets based on average trading volume for equity securities. The size of the bid/ask spread is used as an indicator of market activity for fixed maturity securities. Level 2 Quoted prices in markets that are not active or inputs that are observable either directly or indirectly. These inputs can include quoted prices for similar assets or liabilities other than quoted prices in Level 1, quoted prices in markets that are not active, or other significant inputs that are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 Unobservable inputs that are supported by little or no market activity and are significant to the determination of estimated fair value of the assets or liabilities. Unobservable inputs reflect the reporting entity’s own assumptions about the assumptions that market participants would use in pricing the asset or liability. Recurring Fair Value Measurements The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy are presented in the tables below. Investments that do not have a readily determinable fair value and are measured at net asset value (or equivalent) as a practical expedient to estimated fair value are excluded from the fair value hierarchy. December 31, 2023 Fair Value Hierarchy Level 1 Level 2 Level 3 Total Estimated (In millions) Assets Fixed maturity securities: U.S. corporate $ — $ 34,344 $ 995 $ 35,339 Foreign corporate — 11,257 325 11,582 U.S. government and agency 3,680 4,534 — 8,214 RMBS — 7,351 15 7,366 ABS — 6,075 326 6,401 CMBS — 6,300 39 6,339 State and political subdivision — 3,813 — 3,813 Foreign government — 995 36 1,031 Total fixed maturity securities 3,680 74,669 1,736 80,085 Equity securities 18 23 25 66 Short-term investments 214 360 — 574 Derivative assets: (1) Interest rate — 245 — 245 Foreign currency exchange rate — 426 12 438 Credit — 21 6 27 Equity market — 2,993 — 2,993 Total derivative assets — 3,685 18 3,703 Market risk benefit assets — — 656 656 Separate account assets 20 81,670 — 81,690 Total assets $ 3,932 $ 160,407 $ 2,435 $ 166,774 Liabilities Market risk benefit liabilities $ — $ — $ 10,344 $ 10,344 Derivative liabilities: (1) Interest rate — 2,209 — 2,209 Foreign currency exchange rate — 47 — 47 Credit — — — — Equity market — 2,824 — 2,824 Total derivative liabilities — 5,080 — 5,080 Embedded derivatives on index-linked annuities (2) — — 8,186 8,186 Total liabilities $ — $ 5,080 $ 18,530 $ 23,610 December 31, 2022 Fair Value Hierarchy Level 1 Level 2 Level 3 Total Estimated (In millions) Assets Fixed maturity securities: U.S. corporate $ — $ 30,973 $ 1,189 $ 32,162 Foreign corporate — 9,894 598 10,492 U.S. government and agency 3,507 4,391 — 7,898 RMBS — 7,477 14 7,491 ABS — 5,037 318 5,355 CMBS — 6,504 33 6,537 State and political subdivision — 3,741 — 3,741 Foreign government — 1,043 38 1,081 Total fixed maturity securities 3,507 69,060 2,190 74,757 Equity securities 12 27 27 66 Short-term investments 206 93 — 299 Derivative assets: (1) Interest rate — 304 — 304 Foreign currency exchange rate — 703 29 732 Credit — 10 8 18 Equity market — 1,217 — 1,217 Total derivative assets — 2,234 37 2,271 Market risk benefit assets — — 483 483 Separate account assets 29 78,851 — 78,880 Total assets $ 3,754 $ 150,265 $ 2,737 $ 156,756 Liabilities Market risk benefit liabilities $ — $ — $ 10,411 $ 10,411 Derivative liabilities: (1) Interest rate — 2,802 — 2,802 Foreign currency exchange rate — 9 — 9 Credit — — 2 2 Equity market — 1,098 — 1,098 Total derivative liabilities — 3,909 2 3,911 Embedded derivatives on index-linked annuities (2) — — 3,932 3,932 Total liabilities $ — $ 3,909 $ 14,345 $ 18,254 _______________ (1) Derivative assets are reported in other invested assets and derivative liabilities are reported in other liabilities. The amounts are presented gross in the tables above to reflect the presentation on the consolidated balance sheets. (2) Embedded derivative liabilities on index-linked annuities are reported in policyholder account balances. Valuation Controls and Procedures The Company monitors and provides oversight of valuation controls and policies for securities, mortgage loans and derivatives, which are primarily executed by its valuation service providers. The valuation methodologies used to determine fair values prioritize the use of observable market prices and market-based parameters and determines that judgmental valuation adjustments, when applied, are based upon established policies and are applied consistently over time. The valuation methodologies for securities, mortgage loans and derivatives are reviewed on an ongoing basis and revised when necessary. In addition, the Chief Accounting Officer periodically reports to the Audit Committee of Brighthouse Financial’s Board of Directors regarding compliance with fair value accounting standards. The fair value of financial assets and financial liabilities is based on quoted market prices, where available. Prices received are assessed to determine if they represent a reasonable estimate of fair value. Several controls are performed, including certain monthly controls, which include, but are not limited to, analysis of portfolio returns to corresponding benchmark returns, comparing a sample of executed prices of securities sold to the fair value estimates, reviewing the bid/ask spreads to assess activity, comparing prices from multiple independent pricing services and ongoing due diligence to confirm that independent pricing services use market-based parameters. The process includes a determination of the observability of inputs used in estimated fair values received from independent pricing services or brokers by assessing whether these inputs can be corroborated by observable market data. Independent non-binding broker quotes, also referred to herein as “consensus pricing,” are used for a non-significant portion of the portfolio. Prices received from independent brokers are assessed to determine if they represent a reasonable estimate of fair value by considering such pricing relative to the current market dynamics and current pricing for similar financial instruments. A formal process is also applied to challenge any prices received from independent pricing services that are not considered representative of estimated fair value. If prices received from independent pricing services are not considered reflective of market activity or representative of estimated fair value, independent non-binding broker quotations are obtained. If obtaining an independent non-binding broker quotation is unsuccessful, the last available price will be used. Additional controls are performed, such as, balance sheet analytics to assess reasonableness of period-to-period pricing changes, including any price adjustments. Price adjustments are applied if prices or quotes received from independent pricing services or brokers are not considered reflective of market activity or representative of estimated fair value. The Company did not have significant price adjustments during the year ended December 31, 2023. Determination of Fair Value Fixed Maturity Securities The fair values for actively traded marketable bonds, primarily U.S. government and agency securities, are determined using the quoted market prices and are classified as Level 1 assets. For fixed maturity securities classified as Level 2 assets, fair values are determined using either a market or income approach and are valued based on a variety of observable inputs as described below. U.S. corporate and foreign corporate securities: Fair value is determined using third-party commercial pricing services, with the primary inputs being quoted prices in markets that are not active, benchmark yields, spreads off benchmark yields, new issuances, issuer rating, trades of identical or comparable securities, or duration. Privately-placed securities are valued using the additional key inputs: market yield curve, call provisions, observable prices and spreads for similar public or private securities that incorporate the credit quality and industry sector of the issuer, and delta spread adjustments to reflect specific credit-related issues. U.S. government and agency, state and political subdivision and foreign government securities: Fair value is determined using third-party commercial pricing services, with the primary inputs being quoted prices in markets that are not active, benchmark U.S. Treasury yield or other yields, spread off the U.S. Treasury yield curve for the identical security, issuer ratings and issuer spreads, broker-dealer quotes, and comparable securities that are actively traded. Structured Securities: Fair value is determined using third-party commercial pricing services, with the primary inputs being quoted prices in markets that are not active, spreads for actively traded securities, spreads off benchmark yields, expected prepayment speeds and volumes, current and forecasted loss severity, ratings, geographic region, weighted average coupon and weighted average maturity, average delinquency rates and debt-service coverage ratios. Other issuance-specific information is also used, including, but not limited to, collateral type, structure of the security, vintage of the loans, payment terms of the underlying asset, payment priority within tranche, and deal performance. Equity Securities and Short-term Investments The fair value for actively traded equity securities and short-term investments are determined using quoted market prices and are classified as Level 1 assets. For financial instruments classified as Level 2 assets, fair values are determined using a market approach and are valued based on a variety of observable inputs as described below. Equity securities and short-term investments: Fair value is determined using third-party commercial pricing services, with the primary input being quoted prices in markets that are not active. Derivatives The fair values for exchange-traded derivatives are determined using the quoted market prices and are classified as Level 1 assets. For OTC-bilateral derivatives and OTC-cleared derivatives classified as Level 2 assets or liabilities, fair values are determined using the income approach. Valuations of non-option-based derivatives utilize present value techniques, whereas valuations of option-based derivatives utilize option pricing models which are based on market standard valuation methodologies and a variety of observable inputs. The significant inputs to the pricing models for most OTC-bilateral and OTC-cleared derivatives are inputs that are observable in the market or can be derived principally from, or corroborated by, observable market data. Certain OTC-bilateral and OTC-cleared derivatives may rely on inputs that are significant to the estimated fair value that are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. These unobservable inputs may involve significant management judgment or estimation. Even though unobservable, these inputs are based on assumptions deemed appropriate given the circumstances and management believes they are consistent with what other market participants would use when pricing such instruments. Most inputs for OTC-bilateral and OTC-cleared derivatives are mid-market inputs but, in certain cases, liquidity adjustments are made when they are deemed more representative of exit value. Market liquidity, as well as the use of different methodologies, assumptions and inputs, may have a material effect on the estimated fair values of the Company’s derivatives and could materially affect net income. The credit risk of both the counterparty and the Company are considered in determining the estimated fair value for all OTC-bilateral and OTC-cleared derivatives, and any potential credit adjustment is based on the net exposure by counterparty after taking into account the effects of netting agreements and collateral arrangements. The Company values its OTC-bilateral and OTC-cleared derivatives using standard swap curves which may include a spread to the risk-free rate, depending upon specific collateral arrangements. This credit spread is appropriate for those parties that execute trades at pricing levels consistent with similar collateral arrangements. As the Company and its significant derivative counterparties generally execute trades at such pricing levels and hold sufficient collateral, additional credit risk adjustments are not currently required in the valuation process. The Company’s ability to consistently execute at such pricing levels is in part due to the netting agreements and collateral arrangements that are in place with all of its significant derivative counterparties. An evaluation of the requirement to make additional credit risk adjustments is performed by the Company each reporting period. Market Risk Benefits MRBs principally include guaranteed minimum benefits on variable annuity contracts including benefits reinsured related to these guarantees. The estimated fair value of variable annuity guarantees accounted for as MRBs is determined based on the present value of projected future benefits less the present value of projected future fees attributable to the guarantees. At policy inception, the Company determines an attributed fee ratio by solving for a percentage of projected future rider fees to be collected from the policyholder equal to the present value of projected future guaranteed benefits. To the extent the rider fees are insufficient, the Company may also include fees related to mortality and expense charges in the attributed fee ratio, provided the total fees included in the calculation do not exceed total contract fees and assessments collected from the contract holder. Any additional fees not included in the attributed fee ratio are considered revenue and reported in universal life and investment-type product policy fees. The attributed fee ratio is not updated in subsequent periods. The Company updates the estimated fair value of variable annuity guarantees in subsequent periods by projecting future benefits using capital markets inputs and actuarial assumptions including expectations of policyholder behavior. A risk neutral valuation methodology is used to project the cash flows from the guarantees under multiple capital markets scenarios. The reported estimated fair value is then determined by taking the present value of these cash flows using a discount rate that incorporates a spread over the risk-free rate to reflect the Company’s nonperformance risk and adding a risk margin. The valuation of MRBs includes an adjustment for the risk that the Company fails to satisfy its obligations, which is referred to as nonperformance risk. The nonperformance risk adjustment is captured as an additional spread applied to the risk-free rate in determining the rate to discount the cash flows of the liability. The spread over the risk-free rate is based on the Company’s creditworthiness taking into consideration publicly available information relating to spreads in the secondary market for Brighthouse Financial’s debt. These observable spreads are then adjusted, as necessary, to reflect the financial strength ratings of the issuing insurance subsidiaries as compared to the credit rating of Brighthouse Financial. Risk margins are established to capture the non-capital markets risks of the instrument which represent the additional compensation a market participant would require to assume the risks related to the uncertainties in certain actuarial assumptions. The establishment of risk margins requires the use of significant actuarial judgment, including assumptions of the amount needed to cover the guarantees. Actuarial assumptions are reviewed at least annually, and if they change significantly, the estimated fair value is adjusted through net income. Capital market inputs used in the measurement of variable annuity guarantees are updated quarterly through net income, except for the change attributable to the Company’s nonperformance risk, which is reported in OCI. Embedded Derivatives Embedded derivatives include crediting rates associated with index-linked annuity contracts. Embedded derivatives are recorded at estimated fair value with changes in estimated fair value reported in net income. The crediting rates associated with these features are embedded derivatives which are measured at estimated fair value separately from the host fixed annuity contract. These embedded derivatives are classified within policyholder account balances on the consolidated balance sheets. The estimated fair value of crediting rates associated with index-linked annuities is determined using a combination of an option-pricing model and an option-budget approach. The valuation of these embedded derivatives also includes the establishment of a risk margin, as well as changes in nonperformance risk. Actuarial assumptions including policyholder behavior and expectations for renewals at the end of the term period are reviewed at least annually, and if they change significantly, the estimated fair value is adjusted through net income. Capital market inputs used in the measurement of crediting rate embedded derivatives are updated quarterly through net income. Transfers Into or Out of Level 3: Assets and liabilities are transferred into Level 3 when a significant input cannot be corroborated with market observable data. This occurs when market activity decreases significantly and underlying inputs cannot be observed, current prices are not available, and/or when there are significant variances in quoted prices, thereby affecting transparency. Assets and liabilities are transferred out of Level 3 when circumstances change such that a significant input can be corroborated with market observable data. This may be due to a significant increase in market activity, a specific event, or one or more significant input(s) becoming observable. Assets and Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3) Certain quantitative information about the significant unobservable inputs used in the fair value measurement, and the sensitivity of the estimated fair value to changes in those inputs, for the more significant asset and liability classes measured at fair value on a recurring basis using significant unobservable inputs (Level 3) were as follows at: December 31, 2023 December 31, 2022 Impact of Valuation Techniques Significant Range Range Market Risk Benefits Variable annuity guaranteed minimum benefits Option pricing techniques • Mortality rates 0.04 % - 12.90 % 0.04 % - 12.90 % Decrease (1) • Lapse rates 1.00 % - 22.80 % 1.00 % - 24.11 % Decrease (2) • Utilization rates 0.00 % - 25.00 % 0.00 % - 25.00 % Increase (3) • Withdrawal rates 0.00 % - 10.00 % 0.00 % - 10.00 % (4) • Long-term equity volatilities 12.59 % - 22.50 % 19.99 % - 28.45 % Increase (5) • Nonperformance risk spread 0.76 % - 1.63 % (2.73) % - 4.52 % Decrease (6) Embedded Derivatives Index-linked annuity crediting rates • Option pricing techniques • Mortality rates 0.03 % - 9.24 % 0.03 % - 9.24 % Decrease (1) • Lapse rates 1.00 % - 62.30 % 1.00 % - 62.30 % Decrease (2) • Withdrawal rates 0.50 % - 9.00 % 0.50 % - 9.00 % (4) • Nonperformance risk spread 0.45 % - 1.74 % 0.00 % - 1.98 % Decrease (6) _______________ (1) Mortality rates vary by age and by demographic characteristics such as gender. The range shown reflects the mortality rate for policyholders between 35 and 90 years old. Mortality rate assumptions are set based on company experience and include an assumption for mortality improvement. (2) The lapse rate range reflects base lapse rates for major product categories for duration 1-20. Base lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, as well as other factors, such as the applicability of any surrender charges. For variable annuity guarantees, a dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in-the-money contracts are less likely to lapse. Lapse rates are also generally assumed to be lower in periods when a surrender charge applies. (3) The utilization rate assumption for variable annuity guarantees estimates the percentage of contract holders with a GMIB or lifetime withdrawal benefit who will elect to utilize the benefit upon becoming eligible in a given year. The range shown represents the floor and cap of the GMIB dynamic election rates across varying levels of in-the-money. For lifetime withdrawal guarantee riders, the assumption is that everyone will begin withdrawals once account value reaches zero which is equivalent to a 100% utilization rate. Utilization rates may vary by the type of guarantee, the amount by which the guaranteed amount is greater than the account value, the contract’s withdrawal history and by the age of the policyholder. (4) The withdrawal rate represents the percentage of account balance that any given policyholder will elect to withdraw from the contract each year. The withdrawal rate assumption varies by age and duration of the contract, and also by other factors such as benefit type. For any given contract, withdrawal rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. For variable annuity GMWBs, any increase (decrease) in withdrawal rates results in an increase (decrease) in the estimated fair value of the guarantees. For variable annuity GMABs and GMIBs, any increase (decrease) in withdrawal rates results in a decrease (increase) in the estimated fair value. (5) Long-term equity volatilities represent equity volatility beyond the period for which observable equity volatilities are available. For any given contract, long-term equity volatility rates vary throughout the period over which cash flows are projected for purposes of valuing MRBs. (6) Nonperformance risk spread varies by duration. For any given contract, multiple nonperformance risk spreads will apply, depending on the duration of the cash flow being discounted for purposes of valuing the MRB or embedded derivative. The Company does not develop unobservable inputs used in measuring fair value for all other assets and liabilities classified within Level 3; therefore, these are not included in the table above. The other Level 3 assets and liabilities primarily included fixed maturity securities and derivatives. For fixed maturity securities valued based on non-binding broker quotes, an increase (decrease) in credit spreads would result in a higher (lower) fair value. For derivatives valued based on third-party pricing models, an increase (decrease) in credit spreads would generally result in a higher (lower) fair value. The changes in assets and (liabilities) measured at estimated fair value on a recurring basis using significant unobservable inputs (excluding MRBs disclosed in Note 5) were summarized as follows: Fair Value Measurements Using Significant Unobservable Inputs (Level 3) Fixed Maturity Securities Corporate (1) Structured Securities Foreign Equity Short-term Net Embedded Derivatives on Index-Linked Annuities (In millions) Balance, January 1, 2022 $ 1,399 $ 220 $ 26 $ 13 $ 2 $ 36 $ (6,641) Total realized/unrealized gains (losses) included in net income (loss) (3) (4) (5) 1 — — — (9) 2,743 Total realized/unrealized gains (losses) included in AOCI (266) (23) (10) — — 17 — Purchases (5) 933 251 5 14 — 1 — Sales (5) (184) (16) (2) — (2) (9) — Issuances (5) — — — — — — — Settlements (5) — — — — — — (34) Transfers into Level 3 (6) 94 33 19 — — — — Transfers out of Level 3 (6) (184) (101) — — — (1) — Balance, December 31, 2022 1,787 365 38 27 — 35 (3,932) Total realized/unrealized gains (losses) included in net income (loss) (3) (4) (11) — — (3) — (6) (4,097) Total realized/unrealized gains (losses) included in AOCI 28 5 3 — — (3) — Purchases (5) 162 85 — 2 — 4 — Sales (5) (116) (22) (2) (1) — — — Issuances (5) — — — — — — — Settlements (5) — — — — — — (157) Transfers into Level 3 (6) 188 3 — — — — — Transfers out of Level 3 (6) (718) (56) (3) — — (12) — Balance, December 31, 2023 $ 1,320 $ 380 $ 36 $ 25 $ — $ 18 $ (8,186) Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at December 31, 2021 (7) $ (2) $ — $ — $ — $ — $ (11) $ (2,929) Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at December 31, 2022 (7) $ 3 $ — $ — $ 1 $ — $ (1) $ 2,485 Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at December 31, 2023 (7) $ (11) $ — $ — $ (2) $ — $ (5) $ (4,513) Changes in unrealized gains (losses) included in OCI for the instruments still held as of December 31, 2021 (7) $ (6) $ — $ — $ — $ — $ 12 $ — Changes in unrealized gains (losses) included in OCI for the instruments still held as of December 31, 2022 (7) $ (268) $ (23) $ (10) $ — $ — $ 17 $ — Changes in unrealized gains (losses) included in OCI for the instruments still held as of December 31, 2023 (7) $ 11 $ 4 $ 3 $ — $ — $ (3) $ — Gains (Losses) Data for the year ended December 31, 2021: Total realized/unrealized gains (losses) included in net income (loss) (3) (4) $ (1) $ — $ — $ — $ — $ 1 $ (2,856) Total realized/unrealized gains (losses) included in AOCI $ (7) $ — $ — $ — $ — $ 12 $ — _______________ (1) Comprised of U.S. and foreign corporate securities. (2) Freestanding derivative assets and liabilities are reported net for purposes of the rollforward. (3) Amortization of premium/accretion of discount is included in net investment income. Changes in the allowance for credit losses and direct write-offs are charged to net income (loss) on securities are included in net investment gains (losses). Lapses associated with net embedded derivatives are included in net derivative gains (losses). Substantially all realized/unrealized gains (losses) included in net income (loss) for net derivatives and net embedded derivatives are reported in net derivative gains (losses). (4) Interest and dividend accruals, as well as cash interest coupons and dividends received, are excluded from the rollforward. (5) Items purchased/issued and then sold/settled in the same period are excluded from the rollforward. Fees attributed to embedded derivatives are included in settlements. (6) Gains and losses, in net income (loss) and OCI, are calculated assuming transfers into and/or out of Level 3 occurred at the beginning of the period. Items transferred into and out of Level 3 in the same period are excluded from the rollforward. (7) Changes in unrealized gains (losses) included in net income (loss) for fixed maturities are reported in either net investment income or net investment gains (losses). Substantially all changes in unrealized gains (losses) included in net income (loss) for net derivatives and net embedded derivatives are reported in net derivative gains (losses). Fair Value of Financial Instruments Carried at Other Than Fair Value The following tables provide fair value information for financial instruments that are carried on the balance sheet at amounts other than fair value. These tables exclude the following financial instruments: cash and cash equivalents, accrued investment income and payables for collateral under securities loaned and other transactions. The estimated fair value of the excluded financial instruments, which are primarily classified in Level 2, approximates carrying value as they are short-term in nature such that the Company believes there is minimal risk of material changes in interest rates or credit quality. All remaining balance sheet amounts excluded from the tables below are not considered financial instruments subject to this disclosure. The carrying values and estimated fair values for such financial instruments, and their corresponding placement in the fair value hierarchy, are summarized as follows at: December 31, 2023 Fair Value Hierarchy Carrying Level 1 Level 2 Level 3 Total (In millions) Assets Mortgage loans $ 22,475 $ — $ — $ 20,578 $ 20,578 Policy loans $ 938 $ — $ 479 $ 494 $ 973 Other invested assets $ 260 $ — $ 245 $ 15 $ 260 Premiums, reinsurance and other receivables $ 7,431 $ — $ 80 $ 7,498 $ 7,578 Liabilities Policyholder account balances $ 31,362 $ — $ — $ 30,501 $ 30,501 Long-term debt $ 836 $ — $ 26 $ 755 $ 781 Other liabilities $ 1,191 $ — $ 438 $ 753 $ 1,191 Separate account liabilities $ 1,148 $ — $ 1,148 $ — $ 1,148 December 31, 2022 Fair Value Hierarchy Carrying Level 1 Level 2 Level 3 Total (In millions) Assets Mortgage loans $ 22,877 $ — $ — $ 20,760 $ 20,760 Policy loans $ 898 $ — $ 477 $ 453 $ 930 Other invested assets $ 341 $ — $ 201 $ 140 $ 341 Premiums, reinsurance and other receivables $ 5,915 $ — $ 77 $ 5,988 $ 6,065 Liabilities Policyholder account balances $ 31,223 $ — $ — $ 30,303 $ 30,303 Short-term debt $ 125 $ — $ — $ 125 $ 125 Long-term debt $ 838 $ — $ 28 $ 714 $ 742 Other liabilities $ 1,009 $ — $ 212 $ 797 $ 1,009 Separate account liabilities $ 1,022 $ — $ 1,022 $ — $ 1,022 |
Long-term and Short-term Debt
Long-term and Short-term Debt | 12 Months Ended |
Dec. 31, 2023 | |
Debt Disclosure [Abstract] | |
Long-term and Short-term Debt | 12. Long-term and Short-term Debt Long-term debt outstanding was as follows at: December 31, Stated Interest Rate Maturity 2023 2022 (In millions) Surplus note — affiliated (1) 8.070% 2059 $ 412 $ 412 Surplus note — affiliated (1) 8.150% 2058 200 200 Surplus note — affiliated (1) 7.800% 2058 200 200 Other long-term debt — unaffiliated (2) 7.028% 2030 24 26 Total long-term debt $ 836 $ 838 _______________ (1) Interest on affiliated surplus notes is payable annually. Payments of interest and principal may be made only with the prior approval of the Delaware Department of Insurance. (2) Represents non-recourse debt of a subsidiary for which creditors have no access, subject to customary exceptions, to the general assets of the Company other than recourse to certain investment companies. The aggregate maturities of long-term debt at December 31, 2023 were $2 million in 2024, $3 million in each of 2025, 2026, 2027 and 2028, and $822 million thereafter. Interest expense related to long-term and short-term debt of $70 million, $70 million and $67 million for the years ended December 31, 2023, 2022 and 2021, respectively, is included in other expenses, of which $68 million, $68 million and $65 million, respectively, was associated with affiliated debt. Intercompany Liquidity Facilities BHF has established an intercompany liquidity facility with certain of its insurance and non-insurance subsidiaries to provide short-term liquidity within and across the combined group of companies. Under the facility, which is comprised of a series of revolving loan agreements among BHF and its participating subsidiaries, each company may lend to or borrow from each other, subject to certain maximum limits for a term of up to 364 days, depending on the agreement. On May 16, 2022, BH Holdings issued a $125 million promissory note to Brighthouse Life Insurance Company and Brighthouse Life Insurance Company of NY (“BHNY”) issued a $125 million promissory note to BH Holdings (the “May 2022 Promissory Notes”), in which both notes bore interest at a fixed rate of 2.5363%. Upon maturity on August 16, 2022, the May 2022 Promissory Notes were replaced by two new promissory notes which bore interest at a fixed rate of 4.0466% (the “August 2022 Promissory Notes”). Upon maturity on November 16, 2022, the August 2022 Promissory Notes were replaced by two new promissory notes which bore interest at a fixed rate of 5.7689% and 5.4504%, respectively (the “November 2022 Promissory Notes”). Upon maturity on February 16, 2023, the November 2022 Promissory Notes were replaced by two new promissory notes which bore interest at a fixed rate of 5.9966% and 5.9937%, respectively (the “May 2023 Promissory Notes”). On March 28, 2023, BHNY repaid to BH Holdings, and BH Holdings repaid to Brighthouse Life Insurance Company, each $50 million of principal plus accrued interest in cash on the respective May 2023 Promissory Notes. Upon maturity on May 16, 2023, the May 2023 Promissory Notes were replaced by two new $75 million promissory notes that bear interest at a fixed rate of 6.4433% and 6.2918%, respectively, and were both repaid on June 30, 2023. Committed Facilities Reinsurance Financing Arrangement Brighthouse Reinsurance Company of Delaware (“BRCD”) maintains a $15.0 billion financing arrangement with a pool of highly rated third-party reinsurers consisting of credit-linked notes that each mature in 2039. At December 31, 2023, there were no borrowings and there was $15.0 billion of funding available under this financing arrangement. For the years ended December 31, 2023, 2022 and 2021, the Company recognized commitment fees of $21 million, $26 million and $34 million, respectively, in other expenses associated with this financing arrangement. Repurchase Facilities At December 31, 2023, Brighthouse Life Insurance Company maintains secured committed repurchase facilities (the “Repurchase Facilities”) with terms of up to three years under which Brighthouse Life Insurance Company may enter into repurchase transactions in an aggregate amount up to $2.5 billion. Under the Repurchase Facilities, Brighthouse Life Insurance Company may sell certain eligible securities at a purchase price based on the market value of the securities less an applicable margin based on the types of securities sold, with a concurrent agreement to repurchase such securities at a predetermined future date (up to three months) and at a price which represents the original purchase price plus interest. At December 31, 2023, there were no borrowings under the Repurchase Facilities. |
Equity
Equity | 12 Months Ended |
Dec. 31, 2023 | |
Equity [Abstract] | |
Equity | 13. Equity Statutory Financial Information The states of domicile of Brighthouse Life Insurance Company and BHNY impose RBC requirements that were developed by the National Association of Insurance Commissioners (“NAIC”). Such requirements are used by regulators to assess the minimum amount of statutory capital and surplus needed for an insurance company to support its operations, based on its size and risk profile (referred to as “company action level RBC”). RBC is based on statutory financial statements and is calculated in a manner prescribed by the NAIC. The RBC ratio, which is the basis for determining regulatory compliance, is equal to total adjusted capital (“TAC”) divided by the applicable company action level RBC. Companies below 100% of their company action level RBC are subject to corrective action. As of December 31, 2023, the annual RBC ratios for Brighthouse Life Insurance Company and BHNY were each in excess of 400%. Brighthouse Life Insurance Company and BHNY prepare statutory-basis financial statements in accordance with statutory accounting practices prescribed or permitted by the insurance department of the state of domicile. Statutory accounting principles differ from GAAP primarily by charging policy acquisition costs to expense as incurred, establishing future policy benefit liabilities using different actuarial assumptions, reporting of reinsurance agreements and valuing investments and deferred tax assets on a different basis. The tables below present amounts from Brighthouse Life Insurance Company and BHNY, which are derived from the statutory-basis financial statements as filed with the insurance regulators. Statutory net income (loss) was as follows: Years Ended December 31, Company State of Domicile 2023 2022 2021 (In millions) Brighthouse Life Insurance Company Delaware $ (3,131) $ 1,373 $ (156) Brighthouse Life Insurance Company of NY New York $ 539 $ (152) $ (52) Statutory capital and surplus was as follows at: December 31, Company 2023 2022 (In millions) Brighthouse Life Insurance Company $ 4,623 $ 6,349 Brighthouse Life Insurance Company of NY $ 819 $ 223 The Company has a reinsurance subsidiary, BRCD, which reinsures risks including level premium term life and ULSG assumed from other Brighthouse Financial life insurance subsidiaries. BRCD, with the explicit permission of the Delaware Insurance Commissioner (“Delaware Commissioner”), has included the value of credit-linked notes as admitted assets, which resulted in higher statutory capital and surplus of $11.0 billion and $10.7 billion for the years ended December 31, 2023 and 2022, respectively. The statutory net income (loss) of BRCD was ($300) million, ($208) million and $543 million for the years ended December 31, 2023, 2022 and 2021, respectively, and the combined statutory capital and surplus, including the aforementioned prescribed practices, were $661 million and $696 million at December 31, 2023 and 2022, respectively. Dividend Restrictions The table below sets forth the dividends permitted to be paid by certain of the Company’s insurance companies without insurance regulatory approval and dividends paid: 2024 2023 2022 2021 Company Permitted Without Approval (1) Paid (2) Paid (2) Paid (2) (In millions) Brighthouse Life Insurance Company (3) $ — $ 266 $ — $ 550 Brighthouse Life Insurance Company of NY $ 81 $ — $ — $ — _______________ (1) Reflects dividend amounts that may be paid during 2024 without prior regulatory approval. However, because dividend tests may be based on dividends previously paid over rolling 12-month periods, if paid before a specified date during 2024, some or all of such dividends may require regulatory approval to the extent dividends were paid in 2023. (2) Reflects all amounts paid, including those requiring regulatory approval. (3) Any payment of dividends in 2024 would be considered an extraordinary dividend subject to regulatory approval due to negative unassigned funds (surplus). Under the Delaware Insurance Law, Brighthouse Life Insurance Company is permitted, without prior insurance regulatory clearance, to pay a stockholder dividend as long as the amount of the dividend when aggregated with all other dividends in the preceding 12 months does not exceed the greater of: (i) 10% of its surplus to policyholders as of the end of the immediately preceding calendar year; or (ii) its net gain from operations for the immediately preceding calendar year (excluding realized capital gains), not including pro rata distributions of Brighthouse Life Insurance Company’s own securities. Brighthouse Life Insurance Company will be permitted to pay a stockholder dividend in excess of the greater of such two amounts only if it files notice of the declaration of such a dividend and the amount thereof with the Delaware Commissioner and the Delaware Commissioner either approves the distribution of the dividend or does not disapprove the distribution within 30 days of its filing. In addition, any dividend that exceeds earned surplus (defined as “unassigned funds (surplus)”) as of the immediately preceding calendar year requires insurance regulatory approval. Under the Delaware Insurance Law, the Delaware Commissioner has broad discretion in determining whether the financial condition of a stock life insurance company would support the payment of such dividends to its stockholders. Under New York insurance laws, BHNY is permitted, without prior insurance regulatory clearance, to pay stockholder dividends to its parent in any calendar year based on one of two standards. Under one standard, BHNY is permitted, without prior insurance regulatory clearance, to pay dividends out of earned surplus (defined as positive “unassigned funds (surplus),” excluding 85% of the change in net unrealized capital gains or losses (less capital gains tax), for the immediately preceding calendar year), in an amount up to the greater of: (i) 10% of its surplus to policyholders as of the end of the immediately preceding calendar year or (ii) its statutory net gain from operations for the immediately preceding calendar year (excluding realized capital gains), not to exceed 30% of surplus to policyholders as of the end of the immediately preceding calendar year. In addition, under this standard, BHNY may not, without prior insurance regulatory clearance, pay any dividends in any calendar year immediately following a calendar year for which its net gain from operations, excluding realized capital gains, was negative. Under the second standard, if dividends are paid from a source other than earned surplus, BHNY may, without prior insurance regulatory clearance, pay an amount up to the lesser of: (i) 10% of its surplus to policyholders as of the end of the immediately preceding calendar year or (ii) its statutory net gain from operations for the immediately preceding calendar year (excluding realized capital gains). In addition, BHNY will be permitted to pay a dividend to its parent in excess of the amounts allowed under both standards only if it files notice of its intention to declare such a dividend and the amount thereof with the New York Superintendent of Financial Services (the “NY Superintendent”), and the NY Superintendent either approves the distribution of the dividend or does not disapprove the dividend within 30 days of its filing. To the extent BHNY pays a stockholder dividend, such dividend will be paid to Brighthouse Life Insurance Company, its direct parent and sole stockholder. Accumulated Other Comprehensive Income (Loss) Information regarding changes in the balances of each component of AOCI was as follows: Unrealized Unrealized Gains (Losses) on Derivatives Changes in Nonperformance Risk on Market Risk Benefits Changes in Discount Rates on the Liability for Future Policy Benefits Foreign Currency Translation Adjustments Total (In millions) Balance at December 31, 2020 $ 5,321 $ 108 $ — $ — $ (8) $ 5,421 Cumulative effect to change in accounting principle, net of income tax (2) 1,959 — (2,727) (3,167) — (3,935) Balance at January 1, 2021 7,280 108 (2,727) (3,167) (8) 1,486 OCI before reclassifications (2,898) 170 (636) 1,234 1 (2,129) Deferred income tax benefit (expense) (3) 608 (36) 134 (259) — 447 AOCI before reclassifications, net of income tax 4,990 242 (3,229) (2,192) (7) (196) Amounts reclassified from AOCI 7 (12) — — — (5) Deferred income tax benefit (expense) (3) (1) 3 — — — 2 Amounts reclassified from AOCI, net of income tax 6 (9) — — — (3) Balance at December 31, 2021 4,996 233 (3,229) (2,192) (7) (199) OCI before reclassifications (14,148) 329 2,344 4,060 (22) (7,437) Deferred income tax benefit (expense) (3) 2,951 (50) (492) (852) 4 1,561 AOCI before reclassifications, net of income tax (6,201) 512 (1,377) 1,016 (25) (6,075) Amounts reclassified from AOCI 202 (21) — — — 181 Deferred income tax benefit (expense) (3) (42) 5 — — — (37) Amounts reclassified from AOCI, net of income tax 160 (16) — — — 144 Balance at December 31, 2022 (6,041) 496 (1,377) 1,016 (25) (5,931) OCI before reclassifications 2,109 (273) (637) (376) 18 841 Deferred income tax benefit (expense) (3) (443) 58 134 79 (4) (176) AOCI before reclassifications, net of income tax (4,375) 281 (1,880) 719 (11) (5,266) Amounts reclassified from AOCI 204 (11) — — — 193 Deferred income tax benefit (expense) (3) (43) 2 — — — (41) Amounts reclassified from AOCI, net of income tax 161 (9) — — — 152 Balance at December 31, 2023 $ (4,214) $ 272 $ (1,880) $ 719 $ (11) $ (5,114) _______________ (1) See Note 9 for information on offsets to investments related to future policy benefits. (2) See Notes 1 and 2 for information on the adoption of ASU 2018-12. (3) The effects of income taxes on amounts recorded to AOCI are also recognized in AOCI. These income tax effects are released from AOCI when the related activity is reclassified into results from operations. Information regarding amounts reclassified out of each component of AOCI was as follows: AOCI Components Amounts Reclassified from AOCI Consolidated Statements of Operations Locations Years Ended December 31, 2023 2022 2021 (In millions) Net unrealized investment gains (losses): Net unrealized investment gains(losses) $ (192) $ (182) $ (4) Net investment gains (losses) Net unrealized investment gains (losses) (12) (20) (3) Net derivative gains (losses) Net unrealized investment gains (losses), before income tax (204) (202) (7) Income tax (expense) benefit 43 42 1 Net unrealized investment gains (losses), net of income tax (161) (160) (6) Unrealized gains (losses) on derivatives - cash flow hedges: Interest rate swaps 1 5 2 Net derivative gains (losses) Interest rate swaps 3 4 3 Net investment income Foreign currency swaps 7 12 7 Net derivative gains (losses) Gains (losses) on cash flow hedges, before income tax 11 21 12 Income tax (expense) benefit (2) (5) (3) Gains (losses) on cash flow hedges, net of income tax 9 16 9 Total reclassifications, net of income tax $ (152) $ (144) $ 3 |
Other Revenues and Other Expens
Other Revenues and Other Expenses | 12 Months Ended |
Dec. 31, 2023 | |
Other Income and Expenses [Abstract] | |
Other Revenues and Other Expenses | 14. Other Revenues and Other Expenses Other Revenues The Company has entered into contracts with mutual funds, fund managers, and their affiliates (collectively, the “Funds”) whereby the Company is paid monthly or quarterly fees (“12b-1 fees”) for providing certain services to customers and distributors of the Funds. The 12b-1 fees are generally equal to a fixed percentage of the average daily balance of the customer’s investment in a fund. The percentage is specified in the contract between the Company and the Funds. Payments are generally collected when due and are neither refundable nor able to offset future fees. To earn these fees, the Company performs services such as responding to phone inquiries, maintaining records, providing information to distributors and shareholders about fund performance and providing training to account managers and sales agents. The passage of time reflects the satisfaction of the Company’s performance obligations to the Funds and is used to recognize revenue associated with 12b-1 fees. Other revenues consisted primarily of 12b-1 fees of $199 million, $217 million and $264 million for the years ended December 31, 2023, 2022 and 2021, respectively, of which substantially all were reported in the Annuities segment. Other Expenses Information on other expenses was as follows: Years Ended December 31, 2023 2022 2021 (In millions) Compensation $ 383 $ 336 $ 360 Contracted services and other labor costs 282 266 249 Transition services agreements 30 55 119 Establishment costs — 63 93 Premium and other taxes, licenses and fees 55 49 47 Volume related costs, excluding compensation, net of DAC capitalization 536 496 666 Interest expense on debt 70 70 67 Other 269 359 223 Total other expenses $ 1,625 $ 1,694 $ 1,824 Capitalization of DAC See Note 7 for additional information on the capitalization of DAC. Interest Expense on Debt See Note 12 for attribution of interest expense by debt issuance. Related Party Expenses See Note 17 for a discussion of related party expenses included in the table above. |
Income Tax
Income Tax | 12 Months Ended |
Dec. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Income Tax | 15. Income Tax The provision for income tax was as follows: Years Ended December 31, 2023 2022 2021 (In millions) Current: Federal $ (5) $ (88) $ 5 Deferred: Federal (378) 883 374 Provision for income tax expense (benefit) $ (383) $ 795 $ 379 The reconciliation of the income tax provision at the statutory tax rate to the provision for income tax as reported was as follows: Years Ended December 31, 2023 2022 2021 (Dollars in millions) Tax provision at statutory rate $ (316) $ 946 $ 449 Tax effect of: Resolution of prior years — (71) (3) Dividends received deduction (31) (32) (34) Change in uncertain tax benefits — (20) — Tax credits (8) (19) (15) Change in valuation allowance (18) — 18 Return to provision (5) (5) 12 Adjustments to deferred tax — (2) (48) Other, net (5) (2) — Provision for income tax expense (benefit) $ (383) $ 795 $ 379 Effective tax rate 25 % 18 % 18 % Deferred income tax represents the tax effect of the differences between the book and tax bases of assets and liabilities. Net deferred income tax assets and liabilities consisted of the following at: December 31, 2023 2022 (In millions) Deferred income tax assets: Net unrealized investment losses $ 1,048 $ 1,473 Net operating loss carryforwards 1,826 1,246 Investments, including derivatives 210 285 Tax credit carryforwards 189 183 Employee benefits 3 3 Intangibles 48 55 Other — 28 Total deferred income tax assets 3,324 3,273 Less: Valuation allowance — 18 Total net deferred income tax assets 3,324 3,255 Deferred income tax liabilities: Policyholder liabilities and receivables 910 985 DAC 580 597 Other 1 — Total deferred income tax liabilities 1,491 1,582 Net deferred income tax asset (liability) $ 1,833 $ 1,673 The following table sets forth the net operating loss carryforwards for tax purposes at December 31, 2023. Net Operating Loss Carryforwards (In millions) Expiration 2032 $ 2,006 Indefinite 6,691 $ 8,697 The following table sets forth the general business credits and foreign tax credits available for carryforward for tax purposes at December 31, 2023. Tax Credit Carryforwards General Business Credits Foreign Tax Credits (In millions) Expiration 2024-2028 $ — $ 44 2029-2033 — 120 2034-2038 20 — 2039-2043 5 — Indefinite — — $ 25 $ 164 The Company’s liability for unrecognized tax benefits may increase or decrease in the next 12 months. A reasonable estimate of the increase or decrease cannot be made at this time. However, the Company continues to believe that the ultimate resolution of the pending issues will not result in a material change to its consolidated financial statements, although the resolution of income tax matters could impact the Company’s effective tax rate in the future. A reconciliation of the beginning and ending amount of unrecognized tax benefits was as follows: Years Ended December 31, 2023 2022 2021 (In millions) Balance at January 1, $ 14 $ 34 $ 34 Additions for tax positions of prior years — — — Reductions for tax positions of prior years — — — Additions for tax positions of current year — — — Reductions for tax positions of current year — — — Settlements with tax authorities — — — Lapses of statutes of limitations — (20) — Balance at December 31, $ 14 $ 14 $ 34 Unrecognized tax benefits that, if recognized would impact the effective rate $ 14 $ 14 $ 34 The Company classifies interest accrued related to unrecognized tax benefits in interest expense, included in other expenses, while penalties are included in income tax expense. Interest related to unrecognized tax benefits was not significant. The Company had no penalties for each of the years ended December 31, 2023, 2022 and 2021. The Company is subject to examination by the Internal Revenue Service and other tax authorities in jurisdictions in which the Company has significant business operations. The income tax years under examination vary by jurisdiction and subsidiary. The Company is no longer subject to federal, state or local income tax examinations for years prior to 2017. Management believes it has established adequate tax liabilities, and final resolution of any audits for the years 2017 and forward is not expected to have a material impact on the Company’s consolidated financial statements. Tax Sharing Agreements For the periods prior to the Separation, the Company filed a consolidated federal income tax return with MetLife, Inc. and its insurance and non-insurance subsidiaries. Current taxes (and the benefits of tax attributes such as losses) are allocated to the Company, and its includable subsidiaries, under a tax sharing agreement with MetLife, Inc. This tax sharing agreement states that federal taxes are computed on a modified separate return basis with benefits for losses. For periods after the Separation through the year ended December 31, 2022, Brighthouse Life Insurance Company, BHNY and BRCD entered into a tax sharing agreement to join a consolidated federal income tax return. The tax sharing agreement states that federal taxes are computed on a modified separate return basis with benefit for losses. The non-insurance subsidiaries of the Company filed their own federal income tax returns. Brighthouse Life Insurance Company, BHNY and BRCD intend to file a consolidated federal income tax return with Brighthouse Financial, Inc. and certain of its subsidiaries for the year ended December 31, 2023 and future years. In furtherance thereof, such parties intend to join a single tax sharing agreement, pursuant to which federal taxes are computed on a modified separate return basis with benefits for losses. Income Tax Transactions with Former Parent The Company entered into a tax separation agreement with MetLife. Among other things, the tax separation agreement governs the allocation between MetLife and the Company of the responsibility for the taxes of the MetLife group. The tax separation agreement also allocates rights, obligations and responsibilities in connection with certain administrative matters relating to the preparation of tax returns and control of tax audits and other proceedings relating to taxes. For the years ended December 31, 2023 and 2022, MetLife, Inc. paid the Company $0 and $14 million, respectively, and for the year ended December 31, 2021, the Company paid MetLife, Inc $73 million, under the tax separation agreement. At December 31, 2023 and 2022, there was a current income tax receivable of $15 million and $14 million, respectively, related to this agreement. |
Contingencies, Commitments and
Contingencies, Commitments and Guarantees | 12 Months Ended |
Dec. 31, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Contingencies, Commitments and Guarantees | 16. Contingencies, Commitments and Guarantees Contingencies Litigation The Company is a defendant in a number of litigation matters. In some of the matters, large or indeterminate amounts, including punitive and treble damages, are sought. Modern pleading practice in the U.S. permits considerable variation in the assertion of monetary damages or other relief. Jurisdictions may permit claimants not to specify the monetary damages sought or may permit claimants to state only that the amount sought is sufficient to invoke the jurisdiction of the trial court. In addition, jurisdictions may permit plaintiffs to allege monetary damages in amounts well exceeding reasonably possible verdicts in the jurisdiction for similar matters. This variability in pleadings, together with the actual experience of the Company in litigating or resolving through settlement numerous claims over an extended period of time, demonstrates to management that the monetary relief which may be specified in a lawsuit or claim bears little relevance to its merits or disposition value. The Company also receives and responds to subpoenas or other inquiries seeking a broad range of information from various state and federal regulators, agencies and officials. The issues involved in information requests and regulatory matters vary widely, but can include inquiries or investigations concerning the Company’s compliance with applicable insurance and other laws and regulations. The Company cooperates in these inquiries. Due to the vagaries of litigation, the outcome of a litigation matter and the amount or range of potential loss at particular points in time may normally be difficult to ascertain. Uncertainties can include how fact finders will evaluate documentary evidence and the credibility and effectiveness of witness testimony, and how trial and appellate courts will apply the law in the context of the pleadings or evidence presented, whether by motion practice, or at trial or on appeal. Disposition valuations are also subject to the uncertainty of how opposing parties and their counsel will themselves view the relevant evidence and applicable law. The Company establishes liabilities for litigation and regulatory loss contingencies when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. It is possible that some matters could require the Company to pay damages or make other expenditures or establish accruals in amounts that could not be estimated at December 31, 2023. Matters as to Which an Estimate Can Be Made For some loss contingency matters, the Company is able to estimate a reasonably possible range of loss. For such matters where a loss is believed to be reasonably possible, but not probable, no accrual has been made. In addition to amounts accrued for probable and reasonably estimable losses, as of December 31, 2023, the Company estimates the aggregate range of reasonably possible losses to be up to approximately $10 million. Matters as to Which an Estimate Cannot Be Made For other matters, the Company is not currently able to estimate the reasonably possible loss or range of loss. The Company is often unable to estimate the possible loss or range of loss until developments in such matters have provided sufficient information to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from other parties and investigation of factual allegations, rulings by the court on motions or appeals, analysis by experts, and the progress of settlement negotiations. On a quarterly and annual basis, the Company reviews relevant information with respect to litigation contingencies and updates its accruals, disclosures and estimates of reasonably possible losses or ranges of loss based on such reviews. Sales Practices Claims Over the past several years, the Company has faced claims and regulatory inquiries and investigations, alleging improper marketing or sales of individual life insurance policies, annuities or other products. The Company continues to defend vigorously against the claims in these matters. The Company believes adequate provision has been made in its consolidated financial statements for all probable and reasonably estimable losses for sales practices matters. Cost of Insurance Class Actions Richard A. Newton v. Brighthouse Life Insurance Company (U.S. District Court, Northern District of Georgia, Atlanta Division, filed May 8, 2020). Plaintiff has filed a purported class action lawsuit against Brighthouse Life Insurance Company. Plaintiff was the owner of a universal life insurance policy issued by Travelers Insurance Company, a predecessor to Brighthouse Life Insurance Company. Plaintiff seeks to certify a class of all persons who own or owned life insurance policies issued where the terms of the life insurance policy provide or provided, among other things, a guarantee that the cost of insurance rates would not be increased by more than a specified percentage in any contract year. Plaintiff also alleges that cost of insurance charges were based on improper factors and should have decreased over time due to improving mortality but did not. Plaintiff alleges, among other things, causes of action for breach of contract, fraud, suppression and concealment, and violation of the Georgia Racketeer Influenced and Corrupt Organizations Act. Plaintiff seeks to recover damages, including punitive damages, interest and treble damages, attorneys’ fees, and injunctive and declaratory relief. Brighthouse Life Insurance Company filed a motion to dismiss in June 2020, which was granted in part and denied in part in March 2021. Plaintiff was granted leave to amend the complaint. On January 18, 2023, the plaintiff filed a motion on consent to amend the second amended class action complaint to narrow the scope of the class sought to those persons who own or owned life insurance policies issued in Georgia. The motion was granted on January 23, 2023, and the third amended class action complaint was filed on January 23, 2023. The Company intends to vigorously defend this matter. Lawrence Martin v. Brighthouse Life Insurance Company (U.S. District Court, Southern District of New York, filed April 6, 2021). Plaintiff has filed a purported class action lawsuit against Brighthouse Life Insurance Company. Plaintiff is the owner of a universal life insurance policy issued by Travelers Insurance Company, a predecessor to Brighthouse Life Insurance Company. Plaintiff seeks to certify a class of similarly situated owners of universal life insurance policies issued or administered by defendants and alleges that cost of insurance charges were based on improper factors and should have decreased over time due to improving mortality but did not. Plaintiff alleges, among other things, causes of action for breach of contract, breach of the covenant of good faith and fair dealing, and unjust enrichment. Plaintiff seeks to recover compensatory damages, attorney’s fees, interest, and equitable relief including a constructive trust. Brighthouse Life Insurance Company filed a motion to dismiss in June 2021, which was denied in February 2022. Brighthouse Life Insurance Company of NY was initially named as a defendant when the lawsuit was filed, but was dismissed as a defendant, without prejudice, in April 2022. The Company intends to vigorously defend this matter. MOVEit Data Security Incident Litigation Kennedy v. Progress Software Corporation, et al. (U.S. District Court, District of Massachusetts, filed October 3, 2023). BHF has been named as a defendant in a purported class action lawsuit. The action relates to a data security incident at an alleged third-party vendor, PBI Research Services (“PBI”), and allegedly involves the MOVEit file transfer system that PBI uses in its provision of services (“MOVEit Incident”). As it relates to BHF, plaintiff seeks to certify a subclass of persons whose private information was allegedly maintained by BHF and accessed or acquired in connection with the MOVEit Incident. Plaintiff alleges, among other things, that BHF negligently chose to utilize PBI to store and transfer plaintiff’s and purported class members’ private information despite PBI’s use of the MOVEit software which plaintiff contends contained security vulnerabilities. The complaint asserts claims against BHF for negligence, negligence per se, and unjust enrichment, and plaintiff seeks declaratory and injunctive relief, damages, attorneys’ fees and prejudgment interest. BHF intends to vigorously defend this matter. Summary Various litigations, claims and assessments against the Company, in addition to those discussed previously and those otherwise provided for in the Company’s consolidated financial statements, have arisen in the course of the Company’s business, including, but not limited to, in connection with its activities as an insurer, investor and taxpayer. Further, state insurance regulatory authorities and other federal and state authorities regularly make inquiries and conduct investigations concerning the Company’s compliance with applicable insurance and other laws and regulations. It is not possible to predict the ultimate outcome of all pending investigations and legal proceedings. In some of the matters referred to previously, large or indeterminate amounts, including punitive and treble damages, are sought. Although, in light of these considerations, it is possible that an adverse outcome in certain cases could have a material effect upon the Company’s financial position, based on information currently known by the Company’s management, in its opinion, the outcomes of such pending investigations and legal proceedings are not likely to have such an effect. However, given the large or indeterminate amounts sought in certain of these matters and the inherent unpredictability of litigation, it is possible that an adverse outcome in certain matters could, from time to time, have a material effect on the Company’s consolidated net income or cash flows in particular quarterly or annual periods. Other Loss Contingencies As with litigation and regulatory loss contingencies, the Company considers establishing liabilities for loss contingencies associated with disputes or other matters involving third parties, including counterparties to contractual arrangements entered into by the Company (e.g., third-party vendors and reinsurers), as well as with tax or other authorities (“other loss contingencies”). The Company establishes liabilities for such other loss contingencies when it is probable that a loss will be incurred and the amount of the loss can be reasonably estimated. In matters where it is not probable, but is reasonably possible that a loss will be incurred and the amount of loss can be reasonably estimated, such losses or range of losses are disclosed, and no accrual is made. In the absence of sufficient information to support an assessment of the reasonably possible loss or range of loss, no accrual is made and no loss or range of loss is disclosed. On a quarterly basis, the Company reviews relevant information with respect to other loss contingencies and, when applicable, updates its accruals, disclosures and estimates of reasonably possible losses or ranges of loss based on such reviews. In the matters where the Company’s subsidiaries are acting as the reinsured or the reinsurer, such matters have involved assertions by third parties primarily related to rates, fees or reinsured benefit calculations, and, in certain of such matters, the counterparty has made a request to arbitrate. For tax-related matters, this has involved disputes with taxing authorities, ongoing audits, evaluation of filing positions and any potential assessments related thereto. As of December 31, 2023, the Company estimates the range of reasonably possible losses in excess of the amounts accrued for certain other loss contingencies to be from zero up to approximately $125 million for the aforementioned matters. For certain other matters, the Company may not currently be able to estimate the reasonably possible loss or range of loss until developments in such matters have provided sufficient information to support an assessment of such loss. During the second quarter of 2022, the Company settled a reinsurance-related matter with a third party for $140 million, which is reported in other expenses. Commitments Mortgage Loan Commitments The Company commits to lend funds under mortgage loan commitments. The amounts of these mortgage loan commitments were $374 million and $247 million at December 31, 2023 and 2022, respectively. Commitments to Fund Partnership Investments, and Private Corporate Bond Investments The Company commits to fund partnership investments and to lend funds under private corporate bond investments. The amounts of these unfunded commitments were $1.4 billion and $1.9 billion at December 31, 2023 and 2022, respectively. Guarantees In the normal course of its business, the Company has provided certain indemnities, guarantees and commitments to third parties such that it may be required to make payments now or in the future. In the context of acquisition, disposition, investment and other transactions, the Company has provided indemnities and guarantees, including those related to tax, environmental and other specific liabilities and other indemnities and guarantees that are triggered by, among other things, breaches of representations, warranties or covenants provided by the Company. In addition, in the normal course of business, the Company provides indemnifications to counterparties in contracts with triggers similar to the foregoing, as well as for certain other liabilities, such as third-party lawsuits. These obligations are often subject to time limitations that vary in duration, including contractual limitations and those that arise by operation of law, such as applicable statutes of limitation. In some cases, the maximum potential obligation under the indemnities and guarantees is subject to a contractual limitation ranging from $6 million to $92 million, with a cumulative maximum of $98 million, while in other cases such limitations are not specified or applicable. Since certain of these obligations are not subject to limitations, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these guarantees in the future. Management believes that it is unlikely the Company will have to make any material payments under these indemnities, guarantees, or commitments. In addition, the Company indemnifies its directors and officers as provided in its charters and bylaws. Also, the Company indemnifies its agents for liabilities incurred as a result of their representation of the Company’s interests. Since these indemnities are generally not subject to limitation with respect to duration or amount, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these indemnities in the future. The Company’s recorded liabilities were $1 million at both December 31, 2023 and 2022 for indemnities, guarantees and commitments. |
Related Party Transactions
Related Party Transactions | 12 Months Ended |
Dec. 31, 2023 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | 17. Related Party Transactions The Company has various existing arrangements with its Brighthouse Financial affiliates including related party reinsurance, debt and equity transactions (see Notes 8, 12 and 13). Other material arrangements between the Company and its related parties not disclosed elsewhere are as follows: Shared Services and Overhead Allocations The Company has entered into various agreements with affiliates regarding the provision of certain services, which include, but are not limited to, treasury, financial planning and analysis, legal, human resources, tax planning, internal audit, financial reporting and information technology. When specific identification to a particular legal entity and/or product is not practicable, an allocation methodology based on various performance measures or activity-based costing, such as sales, new policies/contracts issued, reserves, and in-force policy counts is used. The bases for such charges are modified and adjusted by management when necessary or appropriate to reflect fairly and equitably the actual incidence of cost incurred by the Company and/or affiliate. Management believes that the methods used to allocate expenses under these arrangements are reasonable. Revenues received from an affiliate related to these agreements, recorded in universal life and investment-type product policy fees, were $175 million, $193 million and $235 million for the years ended December 31, 2023, 2022 and 2021, respectively. Costs incurred under these arrangements were $935 million, $946 million and $1.0 billion for the years ended December 31, 2023, 2022 and 2021, respectively, and were recorded in other expenses. The Company had net receivables from/(payables to) affiliates, related to the items discussed above, of ($110) million and ($188) million at December 31, 2023 and 2022, respectively. Broker-Dealer Transactions The related party expense for the Company was commissions paid on the sale of variable products and passed through to the broker-dealer affiliate. The related party revenue for the Company was fee income passed through the broker-dealer affiliate from trusts and mutual funds whose shares serve as investment options of policyholders of the Company. Fee income received related to these transactions and recorded in other revenues was $169 million, $186 million and $224 million for the years ended December 31, 2023, 2022 and 2021, respectively. Commission expenses incurred related to these transactions and recorded in other expenses was $887 million, $920 million and $1.0 billion for the years ended December 31, 2023, 2022 and 2021, respectively. The Company also had related party fee income receivables of $14 million at both December 31, 2023 and 2022. |
Consolidated Summary of Investm
Consolidated Summary of Investments - Other Than Investments in Related Parties | 12 Months Ended |
Dec. 31, 2023 | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Abstract] | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Text Block] | Brighthouse Life Insurance Company (An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.) Schedule I Consolidated Summary of Investments Other Than Investments in Related Parties December 31, 2023 (In millions) Types of Investments Cost or Estimated Fair Value Amount at Fixed maturity securities: Bonds: U.S. government and agency $ 8,446 $ 8,214 $ 8,214 State and political subdivision 3,958 3,813 3,813 Public utilities 3,745 3,430 3,430 Foreign government 1,077 1,031 1,031 All other corporate bonds 46,909 43,115 43,115 Total bonds 64,135 59,603 59,603 Mortgage-backed and asset-backed securities 21,576 20,106 20,106 Redeemable preferred stock 418 376 376 Total fixed maturity securities 86,129 80,085 80,085 Equity securities: Non-redeemable preferred stock 33 34 34 Common stock: Industrial, miscellaneous and all other 31 31 31 Public utilities — 1 1 Total equity securities 64 66 66 Mortgage loans 22,475 22,475 Policy loans 938 938 Limited partnerships and LLCs 4,946 4,946 Short-term investments 574 574 Other invested assets 4,411 4,411 Total investments $ 119,537 $ 113,495 _______________ (1) Cost or amortized cost for fixed maturity securities represents original cost reduced by impairments that are charged to earnings and adjusted for amortization of premiums or accretion of discounts; for mortgage loans, cost represents original cost reduced by repayments and valuation allowances and adjusted for amortization of premiums or accretion of discounts; for equity securities, cost represents original cost; for limited partnerships and LLCs, cost represents original cost adjusted for equity in earnings and distributions. |
Condensed Financial Information
Condensed Financial Information (Parent Company) | 12 Months Ended |
Dec. 31, 2023 | |
Condensed Financial Information Disclosure [Abstract] | |
Condensed Financial Information (Parent Company Only) | Brighthouse Life Insurance Company Schedule II Condensed Financial Information (Parent Company Only) December 31, 2023 and 2022 (In millions, except share and per share data) 2023 2022 Condensed Balance Sheets Assets Investments: Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) $ 68,317 $ 64,250 Equity securities, at estimated fair value 48 55 Mortgage loans (net of allowance for credit losses of $129 and $114, respectively) 21,249 21,658 Policy loans 938 898 Limited partnerships and limited liability companies 4,384 4,191 Short-term investments, principally at estimated fair value 574 299 Investment in subsidiaries 2,347 2,604 Other invested assets, principally at estimated fair value 8,697 2,600 Total investments 106,554 96,555 Cash and cash equivalents 2,682 3,102 Accrued investment income 1,049 765 Premiums, reinsurance and other receivables (net of allowance for credit losses of $3 and $10, respectively) 18,869 17,591 Receivable from subsidiaries 15,830 11,091 Deferred policy acquisition costs and value of business acquired 4,047 4,184 Current income tax recoverable 23 27 Deferred income tax receivable 3,380 3,321 Market risk benefits assets 588 438 Other assets 279 299 Separate account assets 77,563 74,958 Total assets $ 230,864 $ 212,331 Liabilities and Stockholder's Equity Liabilities Future policy benefits $ 32,066 $ 31,693 Policyholder account balances 79,017 67,753 Market risk benefits liabilities 10,183 10,303 Other policy-related balances 3,902 4,296 Payables for collateral under securities loaned and other transactions 3,616 4,353 Long-term debt 812 812 Other liabilities 17,779 11,664 Separate account liabilities 77,563 74,958 Total liabilities 224,938 205,832 Stockholder's Equity Common stock, par value $25,000 per share; 4,000 shares authorized; 3,000 shares issued and outstanding 75 75 Additional paid-in capital 17,507 17,773 Retained earnings (deficit) (6,542) (5,418) Accumulated other comprehensive income (loss) (5,114) (5,931) Total stockholder's equity 5,926 6,499 Total liabilities and stockholder's equity $ 230,864 $ 212,331 See accompanying notes to the condensed financial information. Brighthouse Life Insurance Company Schedule II Condensed Financial Information (continued) (Parent Company Only) For the Years Ended December 31, 2023, 2022 and 2021 (In millions) 2023 2022 2021 Condensed Statements of Operations Revenues Premiums $ 599 $ 423 $ 423 Universal life and investment-type product policy fees 1,527 1,607 2,025 Net investment income 3,992 3,620 4,340 Other revenues 519 480 394 Net investment gains (losses) (234) (233) 12 Net derivative gains (losses) (3,616) 1,800 (3,488) Total revenues 2,787 7,697 3,706 Expenses Policyholder benefits and claims (including remeasurement gains (losses) of ($137), $79, $47, respectively) 1,692 1,420 1,534 Interest credited to policyholder account balances 1,641 1,152 1,079 Amortization of deferred policy acquisition costs and value of business acquired 499 504 503 Change in market risk benefits (1,494) (4,107) (4,153) Other expenses 1,817 1,926 2,815 Total expenses 4,155 895 1,778 Income (loss) before provision for income tax and equity in earnings (losses) of subsidiaries (1,368) 6,802 1,928 Provision for income tax expense (benefit) (347) 1,292 340 Income (loss) before equity in earnings (losses) of subsidiaries (1,021) 5,510 1,588 Equity in earnings (losses) of subsidiaries (103) (1,800) 174 Net income (loss) attributable to Brighthouse Life Insurance Company $ (1,124) $ 3,710 $ 1,762 Comprehensive income (loss) $ (307) $ (2,022) $ 77 See accompanying notes to the condensed financial information. Brighthouse Life Insurance Company Schedule II Condensed Financial Information (continued) (Parent Company Only) For the Years Ended December 31, 2023, 2022 and 2021 (In millions) 2023 2022 2021 Condensed Statements of Cash Flows Net cash provided by (used in) operating activities $ 238 $ (938) $ 1,285 Cash flows from investing activities Sales, maturities and repayments of: Fixed maturity securities 5,561 9,701 11,647 Equity securities 18 48 107 Mortgage loans 1,180 2,036 2,814 Limited partnerships and limited liability companies 197 249 271 Purchases of: Fixed maturity securities (7,587) (14,364) (18,942) Equity securities (3) (14) (8) Mortgage loans (775) (4,864) (6,680) Limited partnerships and limited liability companies (449) (807) (837) Cash received in connection with freestanding derivatives 4,505 4,327 3,489 Cash paid in connection with freestanding derivatives (5,207) (3,833) (4,471) Receipts on loans to affiliate 125 — — Issuances of loans to affiliate — (125) — Returns of capital and dividends from subsidiaries 25 30 24 Capital contributions to subsidiaries — (100) — Net change in policy loans (40) (29) 15 Net change in short-term investments (261) 351 1,021 Net change in other invested assets (4,530) (381) (33) Net cash provided by (used in) investing activities (7,241) (7,775) (11,583) Cash flows from financing activities Policyholder account balances: Deposits 24,917 29,938 14,210 Withdrawals (17,305) (19,680) (3,890) Net change in payables for collateral under securities loaned and other transactions (737) (1,569) 821 Dividends paid to parent (266) — (550) Financing element on certain derivative instruments and other derivative related transactions, net (26) (183) (368) Net cash provided by (used in) financing activities 6,583 8,506 10,223 Change in cash, cash equivalents and restricted cash (420) (207) (75) Cash, cash equivalents and restricted cash, beginning of year 3,102 3,309 3,384 Cash, cash equivalents and restricted cash, end of year $ 2,682 $ 3,102 $ 3,309 Supplemental disclosures of cash flow information Net cash paid (received) for: Interest $ 65 $ 65 $ 65 Income tax $ (20) $ (56) $ 45 Non-cash transactions: Transfer of fixed maturity securities from affiliates $ 103 $ 589 $ 240 Transfer of limited partnerships and limited liability companies to affiliates $ — $ 587 $ — Transfer of fixed maturity securities to affiliates $ 234 $ 296 $ 722 Transfer of mortgage loans to affiliates $ — $ 89 $ — See accompanying notes to the condensed financial information. Brighthouse Life Insurance Company Schedule II Notes to the Condensed Financial Information (Parent Company Only) 1. Basis of Presentation The condensed financial information of Brighthouse Life Insurance Company (the “Parent Company”) should be read in conjunction with the consolidated financial statements of Brighthouse Life Insurance Company and its subsidiaries and the notes thereto (the “Consolidated Financial Statements”). These condensed unconsolidated financial statements reflect the results of operations, financial position and cash flows for the Parent Company. Investments in subsidiaries are accounted for using the equity method of accounting. Reclassifications Certain amounts in the prior years’ condensed financial statements of the Parent Company have been reclassified to conform with the 2023 presentation. See Note 1 of the Notes to the Consolidated Financial Statements for information regarding the adoption of new guidance on long-duration contracts as of January 1, 2023, parts of which were retrospectively applied to prior periods presented in the Parent Company financial statements. The preparation of these condensed unconsolidated financial statements in conformity with GAAP requires management to adopt accounting policies and make certain estimates and assumptions. The most important of these estimates and assumptions relate to the fair value measurements, identifiable intangible assets and the provision for potential losses that may arise from litigation and regulatory proceedings and tax audits, which may affect the amounts reported in the condensed unconsolidated financial statements and accompanying notes. Actual results could differ from these estimates. 2. Investment in Subsidiaries During the year ended December 31, 2023, Brighthouse Life Insurance Company paid a non-cash capital contribution of $100 million to BHNY. During the year ended December 31, 2022, Brighthouse Life Insurance Company paid a cash capital contribution of $100 million to BHNY. |
Consolidated Supplementary Insu
Consolidated Supplementary Insurance Information | 12 Months Ended |
Dec. 31, 2023 | |
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Abstract] | |
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Disclosure [Text Block] | Brighthouse Life Insurance Company (An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.) Schedule III Consolidated Supplementary Insurance Information December 31, 2023 and 2022 (In millions) Segment DAC Future Policy Benefits and Other Policy-Related Balances Policyholder Account Balances Unearned Premiums (1)(2) Unearned 2023 Annuities $ 4,027 $ 3,995 $ 60,723 $ — $ 65 Life 456 5,942 2,187 11 167 Run-off 4 19,420 6,694 — 612 Corporate & Other — 6,411 10,589 5 — Total $ 4,487 $ 35,768 $ 80,193 $ 16 $ 844 2022 Annuities $ 4,140 $ 3,742 $ 53,156 $ — $ 73 Life 498 5,714 2,349 10 143 Run-off 4 18,688 6,933 — 488 Corporate & Other — 6,862 10,164 5 — Total $ 4,642 $ 35,006 $ 72,602 $ 15 $ 704 _______________ (1) Amounts are included in the future policy benefits and other policy-related balances column. (2) Includes premiums received in advance. Brighthouse Life Insurance Company (An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.) Schedule III Consolidated Supplementary Insurance Information — (continued) December 31, 2023, 2022 and 2021 (In millions) Segment Premiums and Universal Life Net Investment Income (1) Policyholder Benefits and Claims and Interest Credited to Policyholder Account Balances Amortization of DAC and VOBA Other 2023 Annuities $ 1,499 $ 2,536 $ 1,556 $ 507 $ 997 Life 615 385 688 57 182 Run-off 475 1,115 1,587 — 167 Corporate & Other — 524 388 — 279 Total $ 2,589 $ 4,560 $ 4,219 $ 564 $ 1,625 2022 Annuities $ 1,418 $ 2,233 $ 1,271 $ 505 $ 980 Life 588 391 847 63 110 Run-off 511 1,146 1,216 — 292 Corporate & Other — 294 165 — 312 Total $ 2,517 $ 4,064 $ 3,499 $ 568 $ 1,694 2021 Annuities $ 1,785 $ 2,196 $ 1,144 $ 491 $ 1,112 Life 733 642 610 67 173 Run-off 489 1,900 1,953 — 191 Corporate & Other — 77 21 — 348 Total $ 3,007 $ 4,815 $ 3,728 $ 558 $ 1,824 _______________ (1) See Note 3 of the Notes to the Consolidated Financial Statements for the basis of allocation of net investment income. |
Consolidated Reinsurance
Consolidated Reinsurance | 12 Months Ended |
Dec. 31, 2023 | |
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Abstract] | |
Consolidated Reinsurance | Brighthouse Life Insurance Company (An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.) Schedule IV Consolidated Reinsurance December 31, 2023, 2022 and 2021 (Dollars in millions) Gross Amount Ceded Assumed Net Amount % Amount Assumed to Net 2023 Life insurance in-force $ 463,582 $ 129,016 $ 7,479 $ 342,045 2.2 % Insurance premium Life insurance (1) $ 1,257 $ 475 $ 20 $ 802 2.5 % Accident & health insurance 201 192 — 9 0.0 % Total insurance premium $ 1,458 $ 667 $ 20 $ 811 2.5 % 2022 Life insurance in-force $ 475,382 $ 138,063 $ 8,034 $ 345,353 2.3 % Insurance premium Life insurance (1) $ 1,123 $ 493 $ 8 $ 638 1.3 % Accident & health insurance 198 195 — 3 0.0 % Total insurance premium $ 1,321 $ 688 $ 8 $ 641 1.2 % 2021 Life insurance in-force $ 494,317 $ 145,618 $ 8,966 $ 357,665 2.5 % Insurance premium Life insurance (1) $ 1,193 $ 500 $ (10) $ 683 (1.5) % Accident & health insurance 205 201 — 4 0.0 % Total insurance premium $ 1,398 $ 701 $ (10) $ 687 (1.5) % _______________ (1) Includes annuities with life contingencies. For the years ended December 31, 2023, 2022 and 2021, reinsurance assumed included related party transactions for life insurance in-force of $1.4 billion, $1.5 billion and $1.6 billion, respectively, and life insurance premiums of $6 million, $2 million and $2 million, respectively. There were no related party transactions for ceded life insurance in-force and life insurance premiums for the years ended December 31, 2023, 2022 and 2021. |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Pay vs Performance Disclosure | |||
Net income (loss) | $ (1,124) | $ 3,710 | $ 1,762 |
Insider Trading Arrangements
Insider Trading Arrangements | 12 Months Ended |
Dec. 31, 2023 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
Business, Basis of Presentati_2
Business, Basis of Presentation and Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Use of Estimates, Policy [Policy Text Block] | Basis of Presentation The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported on the consolidated financial statements. In applying these policies and estimates, management makes subjective and complex judgments that frequently require assumptions about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries; others are specific to the Company’s business and operations. Actual results could differ from these estimates. |
Consolidation, Policy [Policy Text Block] | Consolidation The accompanying consolidated financial statements include the accounts of Brighthouse Life Insurance Company and its subsidiaries, as well as partnerships and limited liability companies (“LLC”) that the Company controls. Intercompany accounts and transactions have been eliminated. The Company uses the equity method of accounting for investments in limited partnerships and LLCs when it has more than a minor ownership interest or more than a minor influence over the investee’s operations. The Company generally recognizes its share of the investee’s earnings on a three-month lag in instances where the investee’s financial information is not sufficiently timely or when the investee’s reporting period differs from the Company’s reporting period. When the Company has virtually no influence over the investee’s operations, the investment is carried at fair value. Reclassifications Certain amounts in the prior years’ consolidated financial statements and related footnotes thereto have been reclassified to conform with the 2023 presentation as discussed throughout the Notes to the Consolidated Financial Statements. See “— Adoption of New Accounting Pronouncements” for discussion of the adoption of new guidance on long-duration contracts as of January 1, 2023, parts of which were retrospectively applied to prior periods presented in the consolidated financial statements. |
Insurance, Long-Duration Contract [Policy Text Block] | Insurance Contract Obligations The Company has obligations under insurance contracts to pay benefits over an extended period of time. The Company establishes liabilities for future obligations under long-duration insurance contracts based on the accounting model appropriate for each type of contract or contract feature. Liabilities for insurance contract benefits are generally accrued over time as revenue is recognized, or established based on the balance that accrues to the contract holder. In addition, certain insurance contracts may contain features that are required to be measured at fair value separately from the base contracts, either as a market risk benefit (“MRB”) or embedded derivative. The discussion below provides an overview of the different accounting models for insurance contract obligations and the applicability of such models to the Company’s insurance products. |
Liability for Future Policy Benefit [Policy Text Block] | Liability for Future Policy Benefits The Company establishes a liability for future policy benefits (“LFPB”) for non-participating term and whole life insurance and income annuities. LFPBs are accrued over time as revenue is recognized based on a net premium ratio. The net premium ratio is the portion of gross premiums required to provide for all future benefits. LFPBs are established using the Company’s current assumptions of future cash flows, discounted at a rate that approximates a single A corporate bond curve. The Company generally aggregates insurance contracts into groupings by issue year, product and segment for determining the net premium ratio and related LFPBs. The Company reviews cash flow assumptions regularly, and if they change significantly, LFPBs are adjusted by determining a revised net premium ratio. The revised net premium ratio is calculated as of contract inception using both actual historical experience and updated future cash flow assumptions. The recalculated net premium ratio is applied to derive a remeasurement gain or loss recognized in the current period net income. For insurance policies in-force as of December 31, 2020, January 1, 2021 is considered the contract inception date. The net premium ratio is also updated quarterly for the difference between actual and expected experience. The net premium ratio is not updated for changes in discount rate assumptions, as changes in the discount rate are updated quarterly and the impacts are reflected in other comprehensive income (loss) (“OCI”). The discount rate assumption is determined by developing a yield curve based on market observable yields for upper-medium grade fixed income instruments derived from an external index. The yield curve is applied to the expected future cash flows used in the measurement of LFPBs based on the duration characteristics of those liabilities. The most significant cash flow assumptions used in the establishment of LFPBs are mortality, policy lapses and market interest rates. See Note 4 for more information on the effect of changes in assumptions on the measurement of LFPBs. The Company also establishes an LFPB for participating term and whole life insurance using a net premium ratio and the Company’s current assumptions of future cash flows. Assumptions are determined at issuance of the policy and are not updated unless a premium deficiency exists. A premium deficiency exists when the LFPB plus the present value of expected future gross premiums are less than expected future benefits and expenses (based on current assumptions). When a premium deficiency exists, the Company will reduce any deferred acquisition costs and may also establish an additional liability to eliminate the deficiency. See Note 4 for more information on assumptions used in establishing LFPBs related to participating term and whole life insurance. |
Policyholder Accounts, Policy [Policy Text Block] | Policyholder Account Balances The Company establishes a policyholder account balance liability for customer deposits on universal life insurance, universal life insurance with secondary guarantees (“ULSG”) and deferred annuity contracts. The policyholder account balance liability is equal to the sum of deposits, plus interest credited, less charges and withdrawals, excluding the impact of any applicable charge that may be incurred upon surrender. The Company also holds additional liabilities for certain product features including secondary guarantees on universal life insurance contracts and the crediting rates associated with index-linked annuities. Additional Liabilities for ULSG The Company establishes a liability in addition to the account balance for ULSG. These liabilities are determined by estimating the expected value of death benefits payable when the account balance is projected to be zero and recognizing those benefits ratably over the contract period based on total expected assessments. The benefits used in calculating the liabilities are based on the average benefits payable over a range of scenarios. The Company also maintains a liability for profits followed by losses on ULSG determined by projecting future earnings and establishing a liability to offset losses that are expected to occur in later years. Both ULSG liabilities are adjusted for the effects of unrealized investment gains and losses. The Company reviews cash flow assumptions regularly, and, if they change significantly, the liability for secondary guarantees is adjusted by a cumulative charge or credit to net income. Liabilities for secondary guarantees are presented within future policy benefits with changes in the liabilities reported in policyholder benefits and claims, except for the effects of unrealized investment gains and losses, which are reported in OCI. The most significant assumptions used in estimating liabilities for secondary guarantees are the general account rate of return, premium persistency, mortality and lapses. See Note 4 for more information on the effect of changes in assumptions on the measurement of liabilities for secondary guarantees. Separate Accounts Separate accounts underlying the Company’s variable life and annuity contracts are reported at fair value. Assets in separate accounts supporting the contract liabilities are legally insulated from the Company’s general account liabilities. Investments in these separate accounts are directed by the contract holder and all investment performance, net of contract fees and assessments, is passed through to the contract holder. Investment performance and the corresponding amounts credited to contract holders of such separate accounts are offset in the same line on the statements of operations. Separate accounts that do not pass all investment performance to the contract holder, including those underlying certain index-linked annuities, are combined on a line-by-line basis with the Company’s general account assets, liabilities, revenues and expenses. The accounting for investments in these separate accounts is consistent with the methodologies described herein for similar financial instruments held in the general account. The Company receives asset-based distribution and service fees from mutual funds available to the variable life and annuity contract holders as investment options in its separate accounts. These fees are recognized in the period in which the related services are performed and are included in other revenues. |
Market Risk Benefit [Policy Text Block] | Market Risk Benefits on Annuity Guarantees MRBs are contracts or contract features that provide protection to the policyholder from capital markets risks by transferring such risks to the Company. MRBs are required to be separated from the deferred annuity host contract and measured at fair value. The Company establishes MRB assets and liabilities for guaranteed minimum benefits on variable annuity contracts including guaranteed minimum death benefits (“GMDB”), guaranteed minimum income benefits (“GMIB”), guaranteed minimum accumulation benefits (“GMAB”) and guaranteed minimum withdrawal benefits (“GMWB”). MRB assets are also established for reinsured benefits related to these guarantees. Certain index-linked annuity products may also have guaranteed minimum benefits classified as MRBs. The measurement of fair value includes an adjustment for the risk that the Company fails to satisfy its obligations, which is referred to as nonperformance risk, as well as risk margin to capture the non-capital markets risks of the instrument, which represents the additional compensation a market participant would require to assume the risks related to the uncertainties in certain actuarial assumptions. MRBs are measured at estimated fair value, with changes reported in change in MRBs on the consolidated statements of operations, except for the change due to nonperformance risk, which is reported in OCI. See Note 5 for more information on the effect of changes in inputs and assumptions on the measurement of MRBs and Note 11 for more information on the determination of fair value of MRBs. |
Derivatives, Embedded Derivatives [Policy Text Block] | Embedded Derivatives on Index-Linked Annuities The Company issues, and assumes through reinsurance, index-linked annuities which allow the policyholder to participate in returns from certain specified equity indices. The crediting rates associated with these features are classified as embedded derivatives and measured at estimated fair value, with changes in estimated fair value reported in net derivative gains (losses). These embedded derivatives are classified within policyholder account balances on the consolidated balance sheets. Embedded derivative liabilities are required to be separated from the deferred annuity host contract and measured at fair value. The estimated fair value is determined using a combination of an option pricing model and an option-budget approach. Under this approach, the Company estimates the cost of funding the crediting rate using option pricing and establishes that cost on the balance sheet as a reduction to the initial deposit amount. The estimate of fair value includes an adjustment for nonperformance risk, as well as a risk margin. Actuarial assumptions are reviewed at least annually, and if they change significantly, the estimated fair value is adjusted through net income. Capital market inputs used in the measurement of index-linked crediting rate embedded derivatives are updated quarterly through net income. The reduction to the initial deposit is accreted back up to the initial deposit over the estimated life of the contract. Embedded derivatives related to index-linked annuities are presented within policyholder account balances while changes in the estimated fair value are reported in net derivative gains (losses). For more information on the determination of estimated fair value of embedded derivatives, see Note 11. |
Insurance Premiums Revenue Recognition, Policy [Policy Text Block] | Recognition of Revenues and Deposits on Insurance Contracts Premiums related to traditional long-duration contracts are recognized as revenues when due from policyholders. When premiums for income annuities are due over a significantly shorter period than the period over which policyholder benefits are incurred, the Company establishes a deferred profit liability (“DPL”) for the excess of the gross premium over the net premium. DPLs are amortized into net income in proportion to the amount of expected future benefit payments. Assumptions used in the measurement of the DPL are updated at the same time as the related LFPBs, with the updated estimates used to recalculate the DPL as of contract inception. The remeasurement gain or loss from updating DPLs is recognized in current period net income along with the related change in LFPBs. Deposits related to universal life insurance, deferred annuity contracts and investment contracts are credited to policyholder account balances. Revenues from such contracts consist of asset-based investment management fees, cost of insurance charges, risk charges, policy administration fees and surrender charges. These fees, which are included in universal life and investment-type product policy fees, are recognized when assessed to the contract holder, except for non-level insurance charges which are deferred by the establishment of an unearned revenue liability and amortized over the expected life of the contracts. Premiums and policy fees are presented net of reinsurance. |
Deferred Policy Acquisition Costs, Policy [Policy Text Block] | Deferred Policy Acquisition Costs, Value of Business Acquired and Other Intangibles The Company incurs significant costs in connection with acquiring new and renewal insurance business. Costs that are directly related to the successful acquisition or renewal of insurance contracts are capitalized as deferred policy acquisition costs (“DAC”). These costs mainly consist of commissions and include the portion of employees’ compensation and benefits related to time spent selling, underwriting or processing the issuance of new insurance contracts. All other acquisition-related costs are expensed as incurred. Value of business acquired (“VOBA”) is an intangible asset resulting from a business combination that represents the excess of book value over the estimated fair value of acquired insurance, annuity and investment-type contracts in-force as of the acquisition date. The Company amortizes DAC and VOBA in a manner that approximates a straight-line basis over the expected life of the related contracts. For life insurance contracts, amortization is based on projections of amounts of insurance in-force, while projections of policy counts are used for deferred annuity contracts and expected future benefits payments for income annuities. These assumptions are reviewed at least annually, and if they change significantly, updates are recognized through changes to future amortization. VOBA balances are tested annually to determine if the balance is deemed unrecoverable from expected future profits. All changes in DAC and VOBA balances are recorded to net income. Periodically, the Company modifies product benefits, features, rights or coverages that occur by the exchange of an existing contract for a new contract, or by amendment, endorsement, or rider to a contract, or by election or coverage within a contract. If a modification is considered to have substantially changed the contract, the associated DAC or VOBA is written off immediately through net income and any new acquisition costs associated with the replacement contract are deferred. If the modification does not substantially change the contract, the DAC or VOBA amortization on the original contract will continue and any acquisition costs associated with the related modification are expensed. |
Intangible Assets Arising from Insurance Contracts Acquired in Business Combination, Policy [Policy Text Block] | Deferred Policy Acquisition Costs, Value of Business Acquired and Other Intangibles The Company incurs significant costs in connection with acquiring new and renewal insurance business. Costs that are directly related to the successful acquisition or renewal of insurance contracts are capitalized as deferred policy acquisition costs (“DAC”). These costs mainly consist of commissions and include the portion of employees’ compensation and benefits related to time spent selling, underwriting or processing the issuance of new insurance contracts. All other acquisition-related costs are expensed as incurred. Value of business acquired (“VOBA”) is an intangible asset resulting from a business combination that represents the excess of book value over the estimated fair value of acquired insurance, annuity and investment-type contracts in-force as of the acquisition date. The Company amortizes DAC and VOBA in a manner that approximates a straight-line basis over the expected life of the related contracts. For life insurance contracts, amortization is based on projections of amounts of insurance in-force, while projections of policy counts are used for deferred annuity contracts and expected future benefits payments for income annuities. These assumptions are reviewed at least annually, and if they change significantly, updates are recognized through changes to future amortization. VOBA balances are tested annually to determine if the balance is deemed unrecoverable from expected future profits. All changes in DAC and VOBA balances are recorded to net income. Periodically, the Company modifies product benefits, features, rights or coverages that occur by the exchange of an existing contract for a new contract, or by amendment, endorsement, or rider to a contract, or by election or coverage within a contract. If a modification is considered to have substantially changed the contract, the associated DAC or VOBA is written off immediately through net income and any new acquisition costs associated with the replacement contract are deferred. If the modification does not substantially change the contract, the DAC or VOBA amortization on the original contract will continue and any acquisition costs associated with the related modification are expensed. |
Sales Inducements to Contract Holders, Policy [Policy Text Block] | The Company also has intangible assets representing deferred sales inducements (“DSI”), which are included in other assets, and unearned revenue liabilities, which are included in other policy-related balances. The Company defers sales inducements and unearned revenue and amortizes the balances using the same methodology and assumptions used to amortize DAC and VOBA. |
Reinsurance Accounting Policy [Policy Text Block] | Reinsurance The Company enters into reinsurance arrangements pursuant to which it cedes certain insurance risks to unaffiliated and former related party reinsurers. Cessions under reinsurance agreements do not discharge the Company’s obligations as the primary insurer. The accounting for reinsurance arrangements depends on whether the arrangement provides indemnification against loss or liability relating to insurance risk in accordance with GAAP. For ceded reinsurance of existing in-force blocks of insurance contracts that transfer significant insurance risk, premiums, benefits and the amortization of DAC are reported net of reinsurance ceded. Amounts recoverable from reinsurers related to incurred claims and ceded reserves are included in premiums, reinsurance and other receivables and amounts payable to reinsurers included in other liabilities. If the Company determines that a reinsurance agreement does not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk, the Company records the agreement using the deposit method of accounting. Deposits received are included in other liabilities and deposits made are included in premiums, reinsurance and other receivables. As amounts are paid or received, consistent with the underlying contracts, the deposit assets or liabilities are adjusted. Interest on such deposits is recorded as other revenues or other expenses, as appropriate. The funds withheld liability represents amounts withheld by the Company in accordance with the terms of the reinsurance agreements. Under certain reinsurance agreements, the Company withholds the funds rather than transferring the underlying investments and, as a result, records a funds withheld liability in other liabilities. The Company recognizes interest on funds withheld, included in other expenses, at rates defined by the terms of the agreement which may be contractually specified or directly related to the investment portfolio. Certain funds withheld arrangements may also contain embedded derivatives measured at fair value that are related to the investment return on the assets withheld. Embedded derivatives related to funds withheld arrangements are presented within policyholder account balances on the consolidated balance sheets, with changes in the estimated fair value reported in net derivative gains (losses). Reinsurance arrangements may also contain features classified as MRBs, including reinsurance of guaranteed minimum benefits associated with variable annuity contracts. The Company accounts for assumed reinsurance similar to directly written business. Accounting for reinsurance requires extensive use of assumptions and estimates, particularly related to the future performance of the underlying business and the potential impact of counterparty credit risks. The Company periodically reviews actual and anticipated experience compared to the aforementioned assumptions used to establish assets and liabilities relating to ceded and assumed reinsurance and evaluates the financial strength of counterparties to its reinsurance agreements using criteria similar to that evaluated in the security impairment process discussed in Note 9. |
Investments, Policy [Policy Text Block] | Investments Net Investment Income and Net Investment Gains (Losses) Income from investments is reported in net investment income, unless otherwise stated herein. Gains and losses on sales of investments, impairment losses and changes in valuation allowances are reported in net investment gains (losses), unless otherwise stated herein. Fixed Maturity Securities Available-For-Sale The Company’s fixed maturity securities are classified as available-for-sale and are reported at their estimated fair value. Unrealized investment gains and losses on these securities are recorded as a separate component of OCI, net of policy-related amounts and deferred income taxes. Publicly-traded security transactions are recorded on a trade date basis, while privately-placed and bank loan security transactions are recorded on a settlement date basis. Investment gains and losses on sales are determined on a specific identification basis. Interest income and prepayment fees are recognized when earned. Interest income is recognized using an effective yield method giving effect to amortization of premiums and accretion of discounts and is based on the estimated economic life of the securities, which for residential mortgage-backed securities (“RMBS”), commercial mortgage-backed securities (“CMBS”) and asset-backed securities (“ABS”) (collectively, “Structured Securities”) considers the estimated timing and amount of prepayments of the underlying loans. The amortization of premium and accretion of discount of fixed maturity securities also takes into consideration call and maturity dates. Amortization of premium and accretion of discount on Structured Securities considers the estimated timing and amount of prepayments of the underlying loans. Actual prepayment experience is periodically reviewed, and effective yields are recalculated when differences arise between the originally anticipated and the actual prepayments received and currently anticipated. Prepayment assumptions for Structured Securities are estimated using inputs obtained from third-party specialists and based on management’s knowledge of the current market. For credit-sensitive Structured Securities and certain prepayment-sensitive securities, the effective yield is recalculated on a prospective basis. For all other Structured Securities, the effective yield is recalculated on a retrospective basis. The Company regularly evaluates fixed maturity securities for declines in fair value to determine if a credit loss exists. This evaluation is based on management’s case-by-case evaluation of the underlying reasons for the decline in fair value including, but not limited to an analysis of the gross unrealized losses by severity and financial condition of the issuer. For fixed maturity securities in an unrealized loss position, when the Company has the intent to sell the security, or it is more likely than not that the Company will be required to sell the security before recovery, the amortized cost basis of the security is written down to fair value through net investment gains (losses). For fixed maturity securities that do not meet the aforementioned criteria, management evaluates whether the decline in estimated fair value has resulted from credit losses or other factors. If the Company determines the decline in estimated fair value is due to credit losses, the difference between the amortized cost of the security and the present value of projected future cash flows expected to be collected is recognized as an allowance through net investment gains (losses). If the estimated fair value is less than the present value of projected future cash flows expected to be collected, this portion of the allowance related to other-than-credit factors is recorded in OCI. Once a security specific allowance for credit losses is established, the present value of cash flows expected to be collected from the security continues to be reassessed. Any changes in the security specific allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in net investment gains (losses). Fixed maturity securities are also evaluated to determine whether any amounts have become uncollectible. When all, or a portion, of a security is deemed uncollectible, the uncollectible portion is written-off with an adjustment to amortized cost and a corresponding reduction to the allowance for credit losses. Mortgage Loans Mortgage loans are stated at unpaid principal balance, adjusted for any unamortized premium or discount, and any deferred fees or expenses, and net of an allowance for credit losses. Interest income and prepayment fees are recognized when earned. Interest income is recognized using an effective yield method giving effect to amortization of premiums and accretion of discounts. The allowance for credit losses for mortgage loans represents the Company’s best estimate of expected credit losses over the remaining life of the loans and is determined using relevant available information from internal and external sources, relating to past events, current conditions, and a reasonable and supportable forecast. Policy Loans Policy loans are stated at unpaid principal balances. Interest income is recorded as earned using the contractual interest rate. Generally, accrued interest is capitalized on the policy’s anniversary date. Any unpaid principal and accrued interest is deducted from the cash surrender value or the death benefit prior to settlement of the insurance policy . Limited Partnerships and LLCs The Company uses the equity method of accounting for investments when it has more than a minor ownership interest or more than a minor influence over the investee’s operations; when the Company has virtually no influence over the investee’s operations the investment is carried at estimated fair value. The Company generally recognizes its share of the equity method investee’s earnings on a three-month lag in instances where the investee’s financial information is not sufficiently timely or when the investee’s reporting period differs from the Company’s reporting period; while distributions on investments carried at estimated fair value are recognized as earned or received. Short-term Investments Short-term investments include securities and other investments with remaining maturities of one year or less, but greater than three months, at the time of purchase and are stated at estimated fair value or amortized cost, which approximates estimated fair value. The Company’s short-term investments generally involve large dollar amounts that turn over quickly and have short maturities. For the years ended December 31, 2023, 2022 and 2021, cash proceeds from sales, maturities and repayments of short-term investments were $1.1 billion, $976 million and $3.6 billion, respectively. For the years ended December 31, 2023, 2022 and 2021, cash payments on purchases of short-term investments were $1.4 billion, $611 million and $2.4 billion, respectively. Other Invested Assets Other invested assets consist principally of freestanding derivatives with positive estimated fair values which are described in “— Derivatives” below. Securities Lending Program Securities lending transactions whereby blocks of securities are loaned to third parties, primarily brokerage firms and commercial banks, are treated as financing arrangements and the associated liability is recorded at the amount of cash received. Income and expenses associated with securities lending transactions are reported as investment income and investment expense, respectively, in net investment income. The Company obtains collateral at the inception of the loan, usually cash, in an amount generally equal to 102% of the estimated fair value of the securities loaned and maintains it at a level greater than or equal to 100% for the duration of the loan. The Company monitors the estimated fair value of the securities loaned on a daily basis and additional collateral is obtained as necessary throughout the duration of the loan. Securities loaned under such transactions may be sold or re-pledged by the transferee. The Company is liable to return to the counterparties the cash collateral received. Funding Agreements The Company established liabilities for funding agreements associated with the Company’s institutional spread margin business, which are equal to the unpaid principal balance, adjusted for any unamortized premium or discount. Liabilities related to funding agreements are reported in policyholder account balances. Maturities of Fixed Maturity Securities Actual maturities may differ from contractual maturities due to the exercise of call or prepayment options. Fixed maturity securities not due at a single maturity date have been presented in the year of final contractual maturity. Structured Securities are shown separately, as they are not due at a single maturity. For fixed maturity securities in an unrealized loss position, management first assesses whether the Company intends to sell, or whether it is more likely than not it will be required to sell the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security’s amortized cost basis is written down to estimated fair value through net investment gains (losses). For fixed maturity securities that do not meet the aforementioned criteria, management evaluates whether the decline in estimated fair value has resulted from credit losses or other factors. Inherent in management’s evaluation of the security are assumptions and estimates about the operations of the issuer and its future earnings potential. Considerations used in the allowance for credit loss evaluation process include, but are not limited to: (i) the extent to which estimated fair value is less than amortized cost; (ii) any changes to the rating of the security by a rating agency; (iii) adverse conditions specifically related to the security, industry or geographic area; and (iv) payment structure of the fixed maturity security and the likelihood of the issuer being able to make payments in the future or the issuer’s failure to make scheduled interest and principal payments. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security are compared to the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis, a credit loss is deemed to exist and an allowance for credit losses is recorded, limited by the amount that the estimated fair value is less than the amortized cost basis, with a corresponding charge to net investment gains (losses). Any unrealized losses that have not been recorded through an allowance for credit losses are recognized in OCI. Once a security specific allowance for credit losses is established, the present value of cash flows expected to be collected from the security continues to be reassessed. Any changes in the security specific allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in net investment gains (losses). Fixed maturity securities are also evaluated to determine whether any amounts have become uncollectible. When all, or a portion, of a security is deemed uncollectible, the uncollectible portion is written-off with an adjustment to amortized cost and a corresponding reduction to the allowance for credit losses. Fixed maturity securities are also evaluated to determine if they qualify as purchased financial assets with credit deterioration (“PCD”). To determine if the credit deterioration experienced since origination is more than insignificant, both (i) the extent of the credit deterioration and (ii) any rating agency downgrades are evaluated. For securities categorized as PCD assets, the present value of cash flows expected to be collected from the security are compared to the par value of the security. If the present value of cash flows expected to be collected is less than the par value, credit losses are embedded in the purchase price of the PCD asset. In this situation, both an allowance for credit losses and amortized cost gross-up is recorded, limited by the amount that the estimated fair value is less than the grossed-up amortized cost basis. Any difference between the purchase price and the present value of cash flows is amortized or accreted into net investment income over the life of the PCD asset. Any subsequent PCD asset allowance for credit losses is evaluated in a manner similar to the process described above for fixed maturity securities. The allowance for credit losses is a valuation account that is deducted from the mortgage loan’s amortized cost basis to present the net amount expected to be collected on the mortgage loan. The loan balance, or a portion of the loan balance, is written-off against the allowance when management believes this amount is uncollectible. The allowance for credit losses is estimated using relevant available information, from internal and external sources, relating to past events, current conditions, and a reasonable and supportable forecast. Historical credit loss experience provides the basis for estimating expected credit losses. Adjustments to historical loss information are made for differences in current loan-specific risk characteristics and environmental conditions. A reasonable and supportable forecast period of two-years is used with an input reversion period of one-year. Mortgage loans are evaluated in each of the three portfolio segments to determine the allowance for credit losses. The loan-level loss rates are determined using individual loan terms and characteristics, risk pools/internal ratings, national economic forecasts, prepayment speeds, and estimated default and loss severity. The resulting loss rates are applied to the mortgage loan’s amortized cost to generate an allowance for credit losses. In certain situations, the allowance for credit losses is measured as the difference between the loan’s amortized cost and liquidation value of the collateral. These situations include collateral dependent loans, modifications, foreclosure probable loans, and loans with dissimilar risk characteristics. Mortgage loans are also evaluated to determine if they qualify as PCD assets. To determine if the credit deterioration experienced since origination is more than insignificant, the extent of credit deterioration is evaluated. All re-performing/modified loan (“RPL”) pools purchased after December 31, 2019 are determined to have been acquired with evidence of more than insignificant credit deterioration since origination and are classified as PCD assets. RPLs are pools of residential mortgage loans acquired at a discount or premium which have both credit and non-credit components. For PCD mortgage loans, the allowance for credit losses is determined using a similar methodology described above, except the loss-rate is determined at the pool level instead of the individual loan level. The initial allowance for credit losses, determined on a collective basis, is then allocated to the individual loans. The initial amortized cost of the loan is grossed-up to reflect the sum of the loan’s purchase price and allowance for credit losses. The difference between the grossed-up amortized cost basis and the par value of the loan is a non-credit discount or premium, which is accreted or amortized into net investment income over the remaining life of the loan. Any subsequent PCD mortgage loan allowance for credit losses is evaluated in a manner similar to the process described above for each of the three portfolio segments. Mortgage loans are placed in a nonaccrual status if there are concerns regarding collectability of future payments or the loan is past due, unless the past due loan is well collateralized. |
Derivatives, Policy [Policy Text Block] | Derivatives Freestanding Derivatives Freestanding derivatives are carried at estimated fair value on the Company’s balance sheet either as assets in other invested assets or as liabilities in other liabilities. The Company does not offset the estimated fair value amounts recognized for derivatives executed with the same counterparty under the same master netting agreement. If a derivative is not designated or did not qualify as an accounting hedge, changes in the estimated fair value of the derivative are reported in net derivative gains (losses). The Company generally reports cash received or paid for a derivative in the investing activity section of the statement of cash flows except for cash flows of certain derivative options with deferred premiums, which are reported in the financing activity section of the statement of cash flows. Hedge Accounting The Company primarily designates derivatives as a hedge of a forecasted transaction or a variability of cash flows to be received or paid related to a recognized asset or liability (cash flow hedge). When a derivative is designated as a cash flow hedge and is determined to be highly effective, changes in fair value are recorded in OCI and subsequently reclassified into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item. To qualify for hedge accounting, at the inception of the hedging relationship, the Company formally documents its risk management objective and strategy for undertaking the hedging transaction, as well as its designation of the hedge. In its hedge documentation, the Company sets forth how the hedging instrument is expected to hedge the designated risks related to the hedged item and sets forth the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness is formally assessed at inception and at least quarterly throughout the life of the designated hedging relationship. The Company discontinues hedge accounting prospectively when: (i) it is determined that the derivative is no longer highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item; (ii) the derivative or hedged item expires, is sold, terminated, or exercised; (iii) it is no longer probable that the hedged forecasted transaction will occur; or (iv) the derivative is de-designated as a hedging instrument. When hedge accounting is discontinued the derivative is carried at its estimated fair value on the balance sheet, with changes in its estimated fair value recognized in the current period as net derivative gains (losses). The changes in estimated fair value of derivatives previously recorded in OCI related to discontinued cash flow hedges are released into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item. When the hedged item matures or is sold, or the forecasted transaction is not probable of occurring, the Company immediately reclassifies any remaining balances in OCI to net derivative gains (losses). Embedded Derivatives The Company has index-linked annuities that are directly written or assumed through reinsurance contracts that contain embedded derivatives which are required to be separated from their host contracts and reported as derivatives. Certain funds withheld arrangements associated with reinsurance may also contain embedded derivatives. See “— Insurance Contract Obligations” and “— Reinsurance” for additional information on the accounting policies for embedded derivatives. Accounting for Derivatives See Note 1 for a description of the Company’s accounting policies for derivatives and Note 11 for information about the fair value hierarchy for derivatives. Derivative Strategies Derivatives are financial instruments with values derived from interest rates, foreign currency exchange rates, credit spreads and/or other financial indices. Derivatives may be exchange-traded or contracted in the over-the-counter (“OTC”) market. Certain of the Company’s OTC derivatives are cleared and settled through central clearing counterparties (“OTC-cleared”), while others are bilateral contracts between two counterparties (“OTC-bilateral”). Counterparty Credit Risk |
Fair Value of Financial Instruments, Policy [Policy Text Block] | Fair Value Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. In most cases, the exit price and the transaction (or entry) price will be the same at initial recognition. In determining the estimated fair value of the Company’s investments, fair values are based on unadjusted quoted prices for identical investments in active markets that are readily and regularly obtainable. When such quoted prices are not available, fair values are based on quoted prices in markets that are not active, quoted prices for similar but not identical investments, or other observable inputs. If these inputs are not available, or observable inputs are not determinable, unobservable inputs and/or adjustments to observable inputs requiring management judgment are used to determine the estimated fair value of investments. When developing estimated fair values, the Company considers three broad valuation techniques: (i) the market approach, (ii) the income approach, and (iii) the cost approach. The Company determines the most appropriate valuation technique to use, given what is being measured and the availability of sufficient inputs, giving priority to observable inputs. The Company categorizes its assets and liabilities measured at estimated fair value into a three-level hierarchy, based on the significant input with the lowest level in its valuation. The input levels are as follows: Level 1 Unadjusted quoted prices in active markets for identical assets or liabilities. The Company defines active markets based on average trading volume for equity securities. The size of the bid/ask spread is used as an indicator of market activity for fixed maturity securities. Level 2 Quoted prices in markets that are not active or inputs that are observable either directly or indirectly. These inputs can include quoted prices for similar assets or liabilities other than quoted prices in Level 1, quoted prices in markets that are not active, or other significant inputs that are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 Unobservable inputs that are supported by little or no market activity and are significant to the determination of estimated fair value of the assets or liabilities. Unobservable inputs reflect the reporting entity’s own assumptions about the assumptions that market participants would use in pricing the asset or liability. |
Income Tax, Policy [Policy Text Block] | Income Tax The Company’s income tax provision was prepared following the modified separate return method. The modified separate return method applies the Accounting Standards Codification 740 — Income Taxes (“ASC 740”) to the standalone financial statements of each member of the consolidated group as if the member were a separate taxpayer and a standalone enterprise, after providing benefits for losses. The Company’s accounting for income taxes represents management’s best estimate of various events and transactions. Current and deferred income taxes included herein and attributable to periods up until the Company’s separation from MetLife, Inc. (“Separation”) have been allocated to the Company in a manner that is systematic, rational and consistent with the asset and liability method prescribed by ASC 740. Deferred tax assets and liabilities resulting from temporary differences between the financial reporting and tax bases of assets and liabilities are measured at the balance sheet date using enacted tax rates expected to apply to taxable income in the years the temporary differences are expected to reverse. The realization of deferred tax assets depends upon the existence of sufficient taxable income within the carryback or carryforward periods under the tax law in the applicable tax jurisdiction. Valuation allowances are established when management determines, based on available information, that it is more likely than not that deferred income tax assets will not be realized. Significant judgment is required in determining whether valuation allowances should be established, as well as the amount of such allowances. When making such determination, the Company considers many factors, including the jurisdiction in which the deferred tax asset was generated, the length of time that carryforward can be utilized in the various taxing jurisdictions, future taxable income exclusive of reversing temporary differences and carryforwards, future reversals of existing taxable temporary differences, taxable income in prior carryback years, tax planning strategies and the nature, frequency, and amount of cumulative financial reporting income and losses in recent years. The Inflation Reduction Act, which was enacted in 2022, established a 15% corporate alternative minimum tax (“CAMT”) for corporations whose average annual adjusted financial statement income for any consecutive three–tax year period ending after December 31, 2021, and preceding the tax year exceeds $1.0 billion. The Company elects not to consider any future effects resulting from applicability of the CAMT when assessing the valuation allowance for regular deferred tax assets. The Company may be required to change its provision for income taxes when estimates used in determining valuation allowances on deferred tax assets significantly change or when receipt of new information indicates the need for adjustment in valuation allowances. Additionally, the effect of changes in tax laws, tax regulations, or interpretations of such laws or regulations, is recognized in net income tax expense (benefit) in the period of change. The Company determines whether it is more likely than not that a tax position will be sustained upon examination by the appropriate taxing authorities before any part of the benefit can be recorded on the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50% likely of being realized upon settlement. Unrecognized tax benefits due to tax uncertainties that do not meet the threshold are included in other liabilities and are charged to earnings in the period that such determination is made. The Company classifies interest recognized as interest expense and penalties recognized as a component of income tax expense. |
Commitments and Contingencies, Policy [Policy Text Block] | Litigation and Other Loss Contingencies The Company is a party to or involved in a number of legal disputes, including litigation matters and disputes or other matters involving third parties (e.g., vendors, reinsurers or tax or other authorities), and are subject in the ordinary course to a number of regulatory examinations and investigations. The Company reviews relevant information with respect to litigation and other loss contingencies related to these matters and establishes liabilities when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Legal costs are recognized as incurred. In matters where it is not probable, but it is reasonably possible that a loss will be incurred and the amount of loss can be reasonably estimated, such losses or range of losses are disclosed, and no accrual is made. In the absence of sufficient information to support an assessment of a reasonably possible loss or range of loss, no accrual is made and no loss or range of loss is disclosed. |
Cash and Cash Equivalents, Policy [Policy Text Block] | Cash and Cash Equivalents The Company considers all highly liquid securities and other investments purchased with an original or remaining maturity of three months or less at the date of purchase to be cash equivalents. Cash equivalents are stated at estimated fair value or amortized cost, which approximates estimated fair value. |
Pension and Other Postretirement Plans, Policy [Policy Text Block] | Employee Benefit Plans |
New Accounting Pronouncements, Policy [Policy Text Block] | Adoption of New Accounting Pronouncements Changes to GAAP are established by the Financial Accounting Standards Board (“FASB”) in the form of accounting standards updates (“ASU”) to the FASB Accounting Standards Codification. The Company considers the applicability and impact of all ASUs. Except as noted below, there were no significant ASUs adopted during the year ended December 31, 2023. In March 2022, the FASB issued new guidance on Troubled Debt Restructurings (“TDR”) (ASU 2022-02, Financial Instruments—Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures ). This ASU eliminates TDR recognition and measurement guidance and, instead, requires that an entity evaluate (consistent with the accounting for other loan modifications) whether the modification represents a new loan or a continuation of an existing loan. The amendments also enhance existing disclosure requirements and introduce new requirements related to certain modifications of receivables made to borrowers experiencing financial difficulty. The Company adopted this guidance on January 1, 2023. This ASU was applied prospectively and did not have a material impact on the consolidated financial statements upon adoption but could change the future recognition and measurement of modified loans and other receivables. In August 2018, the FASB issued new guidance on long-duration contracts (ASU 2018-12, Financial Services-Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts ( “LDTI” )). LDTI is effective for fiscal years beginning after January 1, 2023. LDTI resulted in significant changes to the measurement, presentation and disclosure requirements for long-duration insurance contracts. A summary of the most significant changes is provided below: (1) Guaranteed benefits associated with variable annuity and certain fixed annuity contracts have been classified and presented separately on the consolidated balance sheets as MRBs. MRBs are now measured at estimated fair value through net income and reported separately on the consolidated statements of operations, except for nonperformance risk changes, which will be recognized in OCI. (2) Cash flow assumptions used to measure LFPBs on traditional long-duration contracts (including term and non-participating whole life insurance and immediate annuities) have been updated on an annual basis using a retrospective method. The resulting remeasurement gain or loss is now reported separately on the consolidated statements of operations along with the remeasurement gain or loss on universal life-type contract liabilities. (3) The discount rate assumption used to measure the liability for traditional long-duration contracts is now based on an upper-medium grade fixed income yield, updated quarterly, with changes recognized in OCI. (4) DAC for all insurance products are required to be amortized on a constant-level basis over the expected term of the contracts, using amortization methods that are not a function of revenue or profit emergence. Changes in assumptions used to amortize DAC have been recognized as a revision to future amortization amounts. (5) There was a significant increase in required disclosures, including disaggregated rollforwards of insurance contract assets and liabilities supplemented by qualitative and quantitative information regarding the cash flows, assumptions, methods and judgements used to measure those balances. The transition date was January 1, 2021. MRB changes were required to be applied on a retrospective basis, while the changes for insurance liability assumption updates and DAC amortization were applied to existing carrying amounts on the transition date. The cumulative effect, on an after-tax basis, of the adoption of ASU 2018-12 as of the transition date was a $5.2 billion decrease to retained earnings and a $3.9 billion decrease to accumulated other comprehensive income (loss) (“AOCI”). See Note 2 for more detailed information on the impacts of the ASU to the Company’s financial statements. Future Adoption of New Accounting Pronouncements In November 2023, the FASB issued new guidance on Segment Reporting Disclosures (ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures ). This ASU updates reportable segment disclosures primarily through enhanced disclosures about significant segment expenses. This ASU does not change how a company identifies its operating segments, aggregates those operating segments, or applies the quantitative thresholds to determine its reportable segments. This ASU is effective for fiscal years starting January 1, 2024, and for interim periods starting January 1, 2025, and will be applied on a retrospective basis. The Company is currently evaluating the impact of this guidance on its financial statements. In December 2023, the FASB issued new guidance on Income Tax Disclosures (ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures ). This ASU updates the required income tax disclosures to include disclosure of income taxes paid disaggregated by jurisdiction and greater disaggregation of information in the required rate reconciliation. This ASU is effective for fiscal years starting January 1, 2025, and will be applied on a prospective basis. The Company is currently evaluating the impact of this guidance on its financial statements. |
Minimum Guarantees, Policy [Policy Text Block] | Embedded Derivatives Embedded derivatives include crediting rates associated with index-linked annuity contracts. Embedded derivatives are recorded at estimated fair value with changes in estimated fair value reported in net income. The crediting rates associated with these features are embedded derivatives which are measured at estimated fair value separately from the host fixed annuity contract. These embedded derivatives are classified within policyholder account balances on the consolidated balance sheets. The estimated fair value of crediting rates associated with index-linked annuities is determined using a combination of an option-pricing model and an option-budget approach. The valuation of these embedded derivatives also includes the establishment of a risk margin, as well as changes in nonperformance risk. |
Financial Services, Insurance_2
Financial Services, Insurance, ASU 2018-12 Transition (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
ASU 2018-12 Transition [Abstract] | |
Accounting Standards Update and Change in Accounting Principle | The effect of transition adjustments on stockholder’s equity at January 1, 2021 due to the adoption of ASU 2018-12 was as follows: Retained Earnings (Deficit) AOCI (In millions) Liability for future policy benefits $ (434) $ (2,053) Market risk benefits and related adjustments (5,971) (3,452) DAC and VOBA — 494 Reinsurance recoverables (141) 30 Deferred income tax asset 1,375 1,046 Total $ (5,171) $ (3,935) The balances of and changes in LFPBs at January 1, 2021 due to the adoption of ASU 2018-12 were as follows: Term and Whole Life Insurance Income Annuities Structured Settlement and Pension Risk Transfer Annuities (In millions) Balance at December 31, 2020 $ 2,797 $ 4,260 $ 10,115 Removal of related balances in AOCI — (203) (1,784) Change in cash flow assumptions 13 (168) 200 Initial recognition of deferred profit liabilities — 172 217 Change in discount rate assumptions 522 748 2,770 Adjusted balance at January 1, 2021 3,332 4,809 11,518 Less: Reinsurance recoverable 59 29 102 Adjusted balance at January 1, 2021, net of reinsurance $ 3,273 $ 4,780 $ 11,416 The balance of and changes in liabilities classified as MRBs at January 1, 2021 due to the adoption of ASU 2018-12 were as follows: Variable Annuities (In millions) Balance at December 31, 2020 $ 8,622 Adjustment for the difference between carrying amount and estimated fair value, except for the difference due to nonperformance risk 6,347 Adjustment for cumulative effect of changes in nonperformance risk since issuance 3,452 Adjusted balance at January 1, 2021 18,421 Less: Reinsurance recoverable 169 Adjusted balance at January 1, 2021, net of reinsurance $ 18,252 The balances of and changes in DAC and VOBA on January 1, 2021 due to the adoption of ASU 2018-12 were as follows: Variable Annuities Fixed Rate Annuities Index-Linked Annuities Term and Whole Life Insurance Universal Life Insurance (In millions) DAC: Balance at December 31, 2020 $ 2,326 $ 64 $ 886 $ 451 $ 144 Removal of related amounts in AOCI 460 — — — (37) Adjusted balance at January 1, 2021 $ 2,786 $ 64 $ 886 $ 451 $ 107 VOBA: Balance at December 31, 2020 $ 363 $ 76 $ — $ 8 $ 38 Removal of related amounts in AOCI 65 — — — 6 Adjusted balance at January 1, 2021 $ 428 $ 76 $ — $ 8 $ 44 The following tables present amounts previously reported in 2022 and 2021, the effect on those amounts of the change due to the adoption of ASU 2018-12 as described in Note 1, and the currently reported amounts in the Consolidated Balance Sheets and Consolidated Statements of Operations. See Notes 4, 5, 6 and 7 for more information. December 31, 2022 December 31, 2021 As Previously Effect of As Currently As Previously Effect of As Currently (In millions) Total assets $ 216,151 $ (713) $ 215,438 $ 247,255 $ 2,476 $ 249,731 Future policy benefits $ 41,105 $ (9,959) $ 31,146 $ 43,589 $ (3,759) $ 39,830 Policyholder account balances $ 74,112 $ (1,510) $ 72,602 $ 66,195 $ (1,905) $ 64,290 Market risk benefit liabilities $ — $ 10,411 $ 10,411 $ — $ 16,062 $ 16,062 Total liabilities $ 209,287 $ (363) $ 208,924 $ 231,144 $ 10,051 $ 241,195 Retained earnings (deficit) $ (5,717) $ 299 $ (5,418) $ (5,653) $ (3,475) $ (9,128) Accumulated other comprehensive income (loss) $ (5,282) $ (649) $ (5,931) $ 3,901 $ (4,100) $ (199) Total equity $ 6,864 $ (350) $ 6,514 $ 16,111 $ (7,575) $ 8,536 Total liabilities and equity $ 216,151 $ (713) $ 215,438 $ 247,255 $ 2,476 $ 249,731 Year Ended December 31, 2022 Year Ended December 31, 2021 As Previously Effect of As Currently As Previously Effect of As Currently (In millions) Universal life and investment-type product policy fees $ 2,562 $ (686) $ 1,876 $ 2,986 $ (666) $ 2,320 Net derivative gains (losses) $ 402 $ (987) $ (585) $ (2,359) $ (1,627) $ (3,986) Total revenues $ 7,832 $ (1,670) $ 6,162 $ 6,400 $ (2,290) $ 4,110 Policyholder benefits and claims $ 4,143 $ (1,957) $ 2,186 $ 3,213 $ (728) $ 2,485 Change in market risk benefits $ — $ (4,105) $ (4,105) $ — $ (4,142) $ (4,142) Total expenses $ 8,103 $ (6,447) $ 1,656 $ 6,404 $ (4,436) $ 1,968 Net income (loss) $ (63) $ 3,774 $ 3,711 $ 67 $ 1,696 $ 1,763 |
Segment Information (Tables)
Segment Information (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Segment Reporting [Abstract] | |
Segment Reporting Information, by Segment | Operating results by segment, as well as Corporate & Other, were as follows: Year Ended December 31, 2023 Annuities Life Run-off Corporate Total (In millions) Pre-tax adjusted earnings $ 1,380 $ 86 $ (99) $ (91) $ 1,276 Provision for income tax expense (benefit) 257 17 (22) (50) 202 Post-tax adjusted earnings 1,123 69 (77) (41) 1,074 Less: Net income (loss) attributable to noncontrolling interests — — — 1 1 Adjusted earnings $ 1,123 $ 69 $ (77) $ (42) 1,073 Adjustments for: Net investment gains (losses) (242) Net derivative gains (losses), excluding investment hedge adjustments of $105 (4,025) Change in market risk benefits 1,497 Market value adjustments (12) Provision for income tax (expense) benefit 585 Net income (loss) attributable to Brighthouse Life Insurance Company $ (1,124) Interest revenue $ 2,558 $ 391 $ 1,141 $ 575 Interest expense $ — $ — $ — $ 70 Year Ended December 31, 2022 Annuities Life Run-off Corporate Total (In millions) Pre-tax adjusted earnings $ 1,291 $ (32) $ 108 $ (156) $ 1,211 Provision for income tax expense (benefit) 244 (8) 21 (154) 103 Post-tax adjusted earnings 1,047 (24) 87 (2) 1,108 Less: Net income (loss) attributable to noncontrolling interests — — — 1 1 Adjusted earnings $ 1,047 $ (24) $ 87 $ (3) 1,107 Adjustments for: Net investment gains (losses) (240) Net derivative gains (losses), excluding investment hedge adjustments of $71 (656) Change in market risk benefits 4,105 Market value adjustments 86 Provision for income tax (expense) benefit (692) Net income (loss) attributable to Brighthouse Life Insurance Company $ 3,710 Interest revenue $ 2,254 $ 396 $ 1,166 $ 319 Interest expense $ — $ — $ — $ 70 Year Ended December 31, 2021 Annuities Life Run-off Corporate Total (In millions) Pre-tax adjusted earnings $ 1,550 $ 532 $ 264 $ (293) $ 2,053 Provision for income tax expense (benefit) 296 112 58 (108) 358 Post-tax adjusted earnings 1,254 420 206 (185) 1,695 Less: Net income (loss) attributable to noncontrolling interests — — — 1 1 Adjusted earnings $ 1,254 $ 420 $ 206 $ (186) 1,694 Adjustments for: Net investment gains (losses) (63) Net derivative gains (losses), excluding investment hedge adjustments of $21 (4,007) Change in market risk benefits 4,142 Market value adjustments 17 Provision for income tax (expense) benefit (21) Net income (loss) attributable to Brighthouse Life Insurance Company $ 1,762 Interest revenue $ 2,207 $ 643 $ 1,910 $ 76 Interest expense $ — $ — $ — $ 67 Total assets by segment, as well as Corporate & Other, were as follows at: December 31, 2023 2022 (In millions) Annuities $ 157,614 $ 148,228 Life 20,363 17,214 Run-off 26,849 28,466 Corporate & Other 21,378 21,530 Total $ 226,204 $ 215,438 |
Reconciliation of Revenue from Segments to Consolidated | Total revenues by segment, as well as Corporate & Other, were as follows: Years Ended December 31, 2023 2022 2021 (In millions) Annuities $ 4,440 $ 4,048 $ 4,297 Life 1,013 988 1,382 Run-off 1,643 1,703 2,425 Corporate & Other 576 319 76 Adjustments (4,267) (896) (4,070) Total $ 3,405 $ 6,162 $ 4,110 |
Premiums, Universal Life and Investment-Type Product Policy Fees and Other Revenues by Product Groups | Total premiums, universal life and investment-type product policy fees and other revenues by major product group were as follows: Years Ended December 31, 2023 2022 2021 (In millions) Annuity products $ 1,890 $ 1,796 $ 2,093 Life insurance products 1,110 1,119 1,243 Other products 7 8 8 Total $ 3,007 $ 2,923 $ 3,344 |
Insurance Liabilities (Tables)
Insurance Liabilities (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Insurance [Abstract] | |
Schedule of Liability for Future Policy Benefits, by Product Segment | Information regarding LFPBs for non-participating traditional and limited-payment contracts was as follows: Years Ended December 31, 2023 2022 2021 Term and Whole Life Insurance Income Annuities Structured Settlement and Pension Risk Transfer Annuities Term and Whole Life Insurance Income Annuities Structured Settlement and Pension Risk Transfer Annuities Term and Whole Life Insurance Income Annuities Structured Settlement and Pension Risk Transfer Annuities (Dollars in millions) Present value of expected net premiums: Balance, beginning of year $ 2,804 $ — $ — $ 3,212 $ — $ — $ 3,274 $ — $ — Beginning balance at original discount rate 3,146 — — 2,964 — — 2,868 — — Effect of model refinements — — — 121 — — — — — Effect of changes in cash flow assumptions 206 — — 159 — — 100 — — Effect of actual variances from expected experience (17) — — 114 — — 158 — — Adjusted beginning of year balance 3,335 — — 3,358 — — 3,126 — — Issuances 93 — — 93 — — 112 — — Interest accrual 108 — — 112 — — 107 — — Net premiums collected (374) — — (417) — — (381) — — Ending balance at original discount rate 3,162 — — 3,146 — — 2,964 — — Effect of changes in discount rate assumptions (263) — — (342) — — 248 — — Balance, end of year $ 2,899 $ — $ — $ 2,804 $ — $ — $ 3,212 $ — $ — Present value of expected future policy benefits: Balance, beginning of year $ 5,172 $ 3,469 $ 6,793 $ 6,253 $ 4,283 $ 10,171 $ 6,606 $ 4,636 $ 11,301 Beginning balance at original discount rate 5,816 3,848 7,410 5,682 3,817 8,165 5,678 3,889 8,531 Effect of model refinements — — — 134 — (278) — — — Effect of changes in cash flow assumptions 296 — — 179 55 (157) 100 (40) (41) Effect of actual variances from expected experience (15) (21) (47) 150 (21) (23) 158 (6) (16) Adjusted beginning of year balance 6,097 3,827 7,363 6,145 3,851 7,707 5,936 3,843 8,474 Issuances 99 369 — 101 220 — 128 193 — Interest accrual 211 139 314 216 144 327 214 149 359 Benefit payments (502) (342) (592) (646) (367) (624) (596) (368) (668) Ending balance at original discount rate 5,905 3,993 7,085 5,816 3,848 7,410 5,682 3,817 8,165 Effect of changes in discount rate assumptions (520) (274) (388) (644) (379) (617) 571 466 2,006 Balance, end of year $ 5,385 $ 3,719 $ 6,697 $ 5,172 $ 3,469 $ 6,793 $ 6,253 $ 4,283 $ 10,171 Net liability for future policy benefits, end of year $ 2,486 $ 3,719 $ 6,697 $ 2,368 $ 3,469 $ 6,793 $ 3,041 $ 4,283 $ 10,171 Less: Reinsurance recoverable, end of year 24 30 65 32 25 68 42 28 93 Net liability for future policy benefits, after reinsurance recoverable $ 2,462 $ 3,689 $ 6,632 $ 2,336 $ 3,444 $ 6,725 $ 2,999 $ 4,255 $ 10,078 Weighted-average duration of liability 8.8 years 8.2 years 11.6 years 8.5 years 8.5 years 11.6 years 8.5 years 8.5 years 12.7 years Weighted-average interest accretion rate 3.91 % 3.99 % 4.46 % 3.94 % 3.89 % 4.45 % 3.94 % 3.98 % 4.45 % Current discount rate 4.94 % 4.95 % 5.03 % 5.26 % 5.27 % 5.32 % 2.53 % 2.55 % 2.81 % Gross premiums or assessments recognized during period $ 595 $ 472 $ — $ 625 $ 243 $ — $ 648 $ 240 $ — Expected future gross premiums, undiscounted $ 5,999 $ — $ — $ 6,535 $ — $ — $ 6,736 $ — $ — Expected future gross premiums, discounted $ 4,535 $ — $ — $ 4,875 $ — $ — $ 5,014 $ — $ — Expected future benefit payments, undiscounted $ 8,148 $ 5,616 $ 13,767 $ 8,015 $ 5,434 $ 14,418 $ 7,877 $ 5,446 $ 17,241 Expected future benefit payments, discounted $ 5,905 $ 3,993 $ 7,085 $ 5,816 $ 3,848 $ 7,410 $ 5,682 $ 3,817 $ 8,165 Information regarding the additional insurance liabilities for universal life-type contracts with secondary guarantees was as follows: Years Ended December 31, 2023 2022 2021 (Dollars in millions) Balance, beginning of year $ 6,935 $ 7,168 $ 6,743 Beginning balance before the effect of unrealized gains and losses 7,175 6,731 6,203 Effect of changes in cash flow assumptions 52 (37) 153 Effect of actual variances from expected experience 145 179 (124) Adjusted beginning of year balance 7,372 6,873 6,232 Interest accrual 357 333 308 Net assessments collected 414 416 475 Benefit payments (359) (447) (286) Effect of realized capital gains (losses) — — 2 Ending balance before the effect of unrealized gains and losses 7,784 7,175 6,731 Effect of unrealized gains and losses (177) (240) 437 Balance, end of year 7,607 6,935 7,168 Less: Reinsurance recoverable, end of year 1,438 1,384 1,294 Net additional liability, after reinsurance recoverable $ 6,169 $ 5,551 $ 5,874 Weighted-average duration of liability 6.7 years 6.7 years 6.7 years Weighted-average interest accretion rate 4.92 % 4.90 % 4.90 % Gross assessments recognized during period $ 1,064 $ 1,070 $ 1,255 A reconciliation of the net LFPBs for nonparticipating traditional and limited-payment contracts and the additional insurance liabilities for universal life-type contracts with secondary guarantees reported in the preceding rollforward tables to LFPBs on the consolidated balance sheets was as follows at: December 31, 2023 2022 (In millions) Liabilities reported in the preceding rollforward tables $ 20,509 $ 19,565 Long-term care insurance (1) 5,581 5,686 ULSG liabilities, including liability for profits followed by losses 2,427 2,449 Participating whole life insurance (2) 2,849 2,689 Deferred profit liabilities 475 369 Other 308 388 Total liability for future policy benefits $ 32,149 $ 31,146 _______________ (1) Includes liabilities related to fully reinsured individual long-term care insurance. See Note 8. (2) Participating whole life insurance uses an interest assumption based on the non-forfeiture interest rate, ranging from 3.5% to 4.0%, and mortality rates guaranteed in calculating the cash surrender values described in such contracts, and also includes a liability for terminal dividends. Participating whole life insurance represented 3% of the Company’s life insurance in-force at both December 31, 2023 and 2022, and 40% and 41% of gross traditional life insurance premiums for the years ended December 31, 2023 and 2022, respectively. |
Policyholder Account Balance | Information regarding policyholder account balances was as follows: Universal Life Insurance Variable Annuities (1) Index-linked Annuities Fixed Rate Annuities ULSG Company-Owned Life Insurance (1) (Dollars in millions) Year Ended December 31, 2023 Balance, beginning of year $ 2,100 $ 4,664 $ 33,897 $ 14,274 $ 5,307 $ 641 Premiums and deposits 210 75 7,183 2,694 660 — Surrenders and withdrawals (129) (647) (3,732) (2,405) (23) — Benefit payments (59) (101) (240) (377) (85) (8) Net transfers from (to) separate account 18 14 — — — 1 Interest credited 40 129 445 486 208 28 Policy charges (200) (23) (11) — (1,015) (9) Changes related to embedded derivatives — — 4,085 — — — Balance, end of year $ 1,980 $ 4,111 $ 41,627 $ 14,672 $ 5,052 $ 653 Weighted-average crediting rate (2) 2.03 % 2.91 % 1.47 % 3.31 % 4.02 % 4.33 % Year Ended December 31, 2022 Balance, beginning of year $ 2,134 $ 4,475 $ 32,000 $ 11,849 $ 5,569 $ 646 Premiums and deposits 199 145 6,632 3,676 697 — Surrenders and withdrawals (49) (453) (2,220) (904) (32) — Benefit payments (59) (104) (180) (345) (84) (8) Net transfers from (to) separate account 21 131 — — — (13) Interest credited 56 493 392 (2) 197 23 Policy charges (202) (23) (8) — (1,040) (7) Changes related to embedded derivatives — — (2,719) — — — Balance, end of year $ 2,100 $ 4,664 $ 33,897 $ 14,274 $ 5,307 $ 641 Weighted-average crediting rate (2) 2.65 % 10.91 % 1.16 % (0.02) % 3.62 % 3.41 % Year Ended December 31, 2021 Balance, beginning of year $ 2,110 $ 4,605 $ 23,274 $ 12,349 $ 5,823 $ 679 Premiums and deposits 290 194 7,054 114 687 — Surrenders and withdrawals (48) (566) (1,419) (610) (46) — Benefit payments (55) (95) (151) (342) (77) (10) Net transfers from (to) separate account 17 238 — — — (35) Interest credited 84 140 365 338 186 24 Policy charges (264) (41) (6) — (1,004) (12) Changes related to embedded derivatives — — 2,883 — — — Balance, end of year $ 2,134 $ 4,475 $ 32,000 $ 11,849 $ 5,569 $ 646 Weighted-average crediting rate 3.97 % 3.07 % 1.12 % 2.79 % 3.27 % 3.66 % _______________ (1) Includes liabilities related to separate account products where the contract holder elected a general account investment option. (2) Excludes the effects of embedded derivatives related to index-linked crediting rates. A reconciliation of policyholder account balances reported in the preceding rollforward table to the liability for policyholder account balances on the consolidated balance sheets was as follows at: December 31, 2023 2022 (In millions) Policyholder account balances reported in the preceding rollforward table $ 68,095 $ 60,883 Funding agreements classified as investment contracts 11,115 10,689 Other investment contract liabilities 983 1,030 Total policyholder account balances $ 80,193 $ 72,602 |
Policyholder Account Balance, Guaranteed Minimum Crediting Rate | The balance of account values by range of guaranteed minimum crediting rates and the related range of difference, in basis points, between rates being credited to policyholders and the respective guaranteed minimums was as follows at: Range of Guaranteed Minimum Crediting Rate At Guaranteed Minimum 1 to 50 Basis Points Above 51 to 150 Basis Points Above Greater than 150 Basis Points Above Total (In millions) December 31, 2023 Annuities (1): Less than 2.00% $ 645 $ 204 $ 301 $ 7,632 $ 8,782 2.00% to 3.99% 8,125 233 201 307 8,866 Greater than 3.99% 872 — — — 872 Total $ 9,642 $ 437 $ 502 $ 7,939 $ 18,520 Life insurance (2) (3): Less than 2.00% $ — $ — $ — $ 236 $ 236 2.00% to 3.99% — 441 49 132 622 Greater than 3.99% 1,077 — — — 1,077 Total $ 1,077 $ 441 $ 49 $ 368 $ 1,935 ULSG (3): Less than 2.00% $ — $ — $ — $ — $ — 2.00% to 3.99% 1,134 1,485 1,663 254 4,536 Greater than 3.99% 506 — — — 506 Total $ 1,640 $ 1,485 $ 1,663 $ 254 $ 5,042 December 31, 2022 Annuities (1): Less than 2.00% $ 805 $ 293 $ 356 $ 5,805 $ 7,259 2.00% to 3.99% 5,224 4,871 594 8 10,697 Greater than 3.99% 470 — — — 470 Total $ 6,499 $ 5,164 $ 950 $ 5,813 $ 18,426 Life insurance (2) (3): Less than 2.00% $ — $ — $ — $ 172 $ 172 2.00% to 3.99% — 462 87 150 699 Greater than 3.99% 1,148 — — — 1,148 Total $ 1,148 $ 462 $ 87 $ 322 $ 2,019 ULSG (3): Less than 2.00% $ — $ — $ — $ — $ — 2.00% to 3.99% 1,224 1,581 1,729 266 4,800 Greater than 3.99% 527 — — — 527 Total $ 1,751 $ 1,581 $ 1,729 $ 266 $ 5,327 _______________ (1) Includes policyholder account balances for fixed rate annuities and the fixed account portion of variable annuities. (2) Includes policyholder account balances for retained asset accounts, universal life policies and the fixed account portion of universal variable life insurance policies. (3) Amounts are gross of policy loans. |
Market Risk Benefits (Tables)
Market Risk Benefits (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Insurance [Abstract] | |
Market Risk Benefit, Activity | Information regarding MRB assets and liabilities associated with variable annuities was as follows: Years Ended December 31, 2023 2022 2021 (Dollars in millions) Balance, beginning of year $ 9,997 $ 15,726 $ 18,421 Balance, beginning of year, before effect of changes in nonperformance risk 8,253 11,639 14,969 Decrements (176) 16 (70) Effect of changes in future expected assumptions 260 212 41 Effect of actual different from expected experience 186 (48) (86) Effect of changes in interest rates (427) (8,397) (1,831) Effect of changes in fund returns (2,203) 3,806 (2,578) Issuances (7) (47) (96) Effect of changes in risk margin (34) (152) (128) Aging of the block and other 1,496 1,224 1,418 Balance, end of year, before effect of changes in nonperformance risk 7,348 8,253 11,639 Effect of changes in nonperformance risk 2,374 1,744 4,087 Balance, end of year 9,722 9,997 15,726 Less: Reinsurance recoverable, end of year 43 71 118 Balance, end of year, net of reinsurance (1) $ 9,679 $ 9,926 $ 15,608 Weighted-average attained age of contract holder 73.0 years 71.8 years 71.1 years _______________ (1) Amounts represent the sum of MRB assets and MRB liabilities presented on the consolidated balance sheets at December 31, 2023, 2022 and 2021, with the exception of $9 million, $2 million and $5 million, respectively, of index-linked annuities not included in this table. |
Separate Accounts (Tables)
Separate Accounts (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Insurance [Abstract] | |
Separate Account, Liability | Information regarding separate account liabilities was as follows: Years Ended December 31, 2023 2022 2021 Variable Annuities Universal Life Insurance Company-Owned Life Insurance Variable Annuities Universal Life Insurance Company-Owned Life Insurance Variable Annuities Universal Life Insurance Company-Owned Life Insurance (In millions) Balance, beginning of year $ 74,845 $ 1,970 $ 1,919 $ 101,108 $ 2,576 $ 2,367 $ 99,257 $ 2,339 $ 2,253 Premiums and deposits 762 84 — 1,199 91 — 2,081 97 3 Surrenders and withdrawals (6,073) (68) (20) (5,965) (55) (16) (7,971) (69) (68) Benefit payments (1,391) (18) (28) (1,298) (24) (33) (1,575) (24) (38) Investment performance 11,071 405 327 (17,878) (519) (356) 12,054 336 234 Policy charges (2,098) (78) (58) (2,227) (78) (61) (2,481) (85) (47) Net transfers from (to) general account (14) (18) (1) (131) (21) 13 (238) (17) 35 Other (16) (1) 9 37 — 5 (19) (1) (5) Balance, end of year $ 77,086 $ 2,276 $ 2,148 $ 74,845 $ 1,970 $ 1,919 $ 101,108 $ 2,576 $ 2,367 A reconciliation of separate account liabilities reported in the preceding rollforward table to the separate account liabilities balance on the consolidated balance sheets was as follows at: December 31, 2023 2022 (In millions) Separate account liabilities reported in the preceding rollforward table $ 81,510 $ 78,734 Variable income annuities 161 130 Pension risk transfer annuities 19 16 Total separate account liabilities $ 81,690 $ 78,880 |
Fair Value, Separate Account Investment [Table Text Block] | The aggregate estimated fair value of assets, by major investment asset category, supporting separate accounts was as follows at: December 31, 2023 2022 (In millions) Equity securities $ 81,417 $ 78,583 Fixed maturity securities 259 277 Cash and cash equivalents 7 9 Other assets 7 11 Total aggregate estimated fair value of assets $ 81,690 $ 78,880 |
Schedule of Net Amount of Risk by Product and Guarantee [Table Text Block] | Information regarding the net amount at risk and cash surrender value for insurance products was as follows at: Universal Life Insurance Variable Annuities Index-linked Annuities Fixed Rate Annuities ULSG Company-Owned Life Insurance (In millions) December 31, 2023 Account balances reported in the preceding rollforward tables: Policyholder account balances $ 1,980 $ 4,111 $ 41,627 $ 14,672 $ 5,052 $ 653 Separate account liabilities 2,276 77,086 — — — 2,148 Total account balances $ 4,256 $ 81,197 $ 41,627 $ 14,672 $ 5,052 $ 2,801 Net amount at risk $ 22,214 $ 13,156 N/A N/A $ 65,299 $ 2,644 Cash surrender value $ 4,049 $ 80,756 $ 39,270 $ 14,068 $ 4,498 $ 2,579 December 31, 2022 Account balances reported in the preceding rollforward tables: Policyholder account balances $ 2,100 $ 4,664 $ 33,897 $ 14,274 $ 5,307 $ 641 Separate account liabilities 1,970 74,845 — — — 1,919 Total account balances $ 4,070 $ 79,509 $ 33,897 $ 14,274 $ 5,307 $ 2,560 Net amount at risk $ 23,818 $ 16,334 N/A N/A $ 66,926 $ 3,368 Cash surrender value $ 3,789 $ 79,222 $ 31,293 $ 13,723 $ 4,671 $ 2,344 December 31, 2021 Account balances reported in the preceding rollforward tables: Policyholder account balances $ 2,134 $ 4,475 $ 32,000 $ 11,849 $ 5,569 $ 646 Separate account liabilities 2,576 101,108 — — — 2,367 Total account balances $ 4,710 $ 105,583 $ 32,000 $ 11,849 $ 5,569 $ 3,013 Net amount at risk $ 24,995 $ 6,316 N/A N/A $ 68,905 $ 3,665 Cash surrender value $ 4,407 $ 105,574 $ 29,848 $ 11,112 $ 4,821 $ 2,794 |
Deferred Policy Acquisition C_2
Deferred Policy Acquisition Costs, Value of Business Acquired and Other Intangibles (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Net [Abstract] | |
Deferred Policy Acquisition Costs | Information regarding DAC and VOBA was as follows: Variable Annuities Fixed Rate Annuities Index-linked Annuities Term and Whole Life Insurance Universal Life Insurance (In millions) DAC: Adjusted balance at January 1, 2021 (1) $ 2,786 $ 64 $ 886 $ 451 $ 107 Capitalization 90 36 355 (3) 16 Amortization (262) (12) (160) (51) (9) Balance at December 31, 2021 2,614 88 1,081 397 114 Capitalization 54 31 330 (1) 10 Amortization (254) (12) (198) (49) (9) Balance at December 31, 2022 2,414 107 1,213 347 115 Capitalization 36 14 344 2 13 Amortization (233) (11) (225) (43) (9) Balance at December 31, 2023 $ 2,217 $ 110 $ 1,332 $ 306 $ 119 VOBA: Adjusted balance at January 1, 2021 (1) $ 428 $ 76 $ — $ 8 $ 44 Amortization (51) (6) — (2) (5) Balance at December 31, 2021 377 70 — 6 39 Amortization (36) (5) — (1) (4) Balance at December 31, 2022 341 65 — 5 35 Amortization (32) (6) — (1) (4) Balance at December 31, 2023 $ 309 $ 59 $ — $ 4 $ 31 Total DAC and VOBA: Balance at December 31, 2023 $ 2,526 $ 169 $ 1,332 $ 310 $ 150 Balance at December 31, 2022 $ 2,755 $ 172 $ 1,213 $ 352 $ 150 Balance at December 31, 2021 $ 2,991 $ 158 $ 1,081 $ 403 $ 153 _______________ (1) Includes an adjustment to eliminate balances included in AOCI related to the adoption of ASU 2018-12 (see Note 2). |
Present Value of Future Insurance Profits | Information regarding DAC and VOBA was as follows: Variable Annuities Fixed Rate Annuities Index-linked Annuities Term and Whole Life Insurance Universal Life Insurance (In millions) DAC: Adjusted balance at January 1, 2021 (1) $ 2,786 $ 64 $ 886 $ 451 $ 107 Capitalization 90 36 355 (3) 16 Amortization (262) (12) (160) (51) (9) Balance at December 31, 2021 2,614 88 1,081 397 114 Capitalization 54 31 330 (1) 10 Amortization (254) (12) (198) (49) (9) Balance at December 31, 2022 2,414 107 1,213 347 115 Capitalization 36 14 344 2 13 Amortization (233) (11) (225) (43) (9) Balance at December 31, 2023 $ 2,217 $ 110 $ 1,332 $ 306 $ 119 VOBA: Adjusted balance at January 1, 2021 (1) $ 428 $ 76 $ — $ 8 $ 44 Amortization (51) (6) — (2) (5) Balance at December 31, 2021 377 70 — 6 39 Amortization (36) (5) — (1) (4) Balance at December 31, 2022 341 65 — 5 35 Amortization (32) (6) — (1) (4) Balance at December 31, 2023 $ 309 $ 59 $ — $ 4 $ 31 Total DAC and VOBA: Balance at December 31, 2023 $ 2,526 $ 169 $ 1,332 $ 310 $ 150 Balance at December 31, 2022 $ 2,755 $ 172 $ 1,213 $ 352 $ 150 Balance at December 31, 2021 $ 2,991 $ 158 $ 1,081 $ 403 $ 153 _______________ (1) Includes an adjustment to eliminate balances included in AOCI related to the adoption of ASU 2018-12 (see Note 2). |
Deferred Sales Inducement Cost | Information regarding DSI, included in other assets, was as follows: December 31, 2023 2022 2021 Variable Annuities Fixed Rate Annuities Variable Annuities Fixed Rate Annuities Variable Annuities Fixed Rate Annuities (In millions) Balance, beginning of year $ 233 $ 9 $ 259 $ 10 $ 283 $ 12 Capitalization 1 — 1 — 1 — Amortization (25) (1) (27) (1) (25) (2) Balance, end of year $ 209 $ 8 $ 233 $ 9 $ 259 $ 10 |
Unearned Revenue | Information regarding unearned revenue, included in other policy-related balances, was as follows: December 31, 2023 2022 2021 Universal Life Insurance ULSG Variable Annuities Universal Life Insurance ULSG Variable Annuities Universal Life Insurance ULSG Variable Annuities (In millions) Balance, beginning of year $ 143 $ 488 $ 73 $ 118 $ 344 $ 79 $ 80 $ 184 $ 84 Capitalization 35 174 — 35 181 2 46 185 2 Amortization (11) (50) (7) (10) (37) (8) (8) (25) (7) Balance, end of year $ 167 $ 612 $ 66 $ 143 $ 488 $ 73 $ 118 $ 344 $ 79 |
Reinsurance (Tables)
Reinsurance (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Effects of Reinsurance [Line Items] | |
Effect of reinsurance | The amounts on the consolidated statements of operations include the impact of reinsurance. Information regarding the significant effects of reinsurance was as follows: Years Ended December 31, 2023 2022 2021 (In millions) Premiums Direct premiums $ 1,458 $ 1,321 $ 1,398 Reinsurance assumed 20 8 (10) Reinsurance ceded (667) (688) (701) Net premiums $ 811 $ 641 $ 687 Universal life and investment-type product policy fees Direct universal life and investment-type product policy fees $ 2,402 $ 2,525 $ 2,871 Reinsurance assumed 48 44 41 Reinsurance ceded (672) (693) (592) Net universal life and investment-type product policy fees $ 1,778 $ 1,876 $ 2,320 Other revenues Direct other revenues $ 202 $ 220 $ 262 Reinsurance assumed 3 3 6 Reinsurance ceded 213 183 69 Net other revenues $ 418 $ 406 $ 337 Policyholder benefits and claims Direct policyholder benefits and claims $ 3,608 $ 3,788 $ 3,867 Reinsurance assumed 123 134 101 Reinsurance ceded (1,313) (1,736) (1,483) Net policyholder benefits and claims $ 2,418 $ 2,186 $ 2,485 Change in market risk benefits Direct change in market risk benefits $ (1,436) $ (3,942) $ (3,956) Reinsurance assumed (92) (214) (243) Reinsurance ceded 31 51 57 Net change in market risk benefits $ (1,497) $ (4,105) $ (4,142) Other expenses Direct other expenses $ 1,625 $ 1,758 $ 1,815 Reinsurance assumed 25 — 20 Reinsurance ceded (25) (64) (11) Net other expenses $ 1,625 $ 1,694 $ 1,824 The amounts on the consolidated balance sheets include the impact of reinsurance. Information regarding the significant effects of reinsurance was as follows at: December 31, 2023 2022 Direct Assumed Ceded Total Direct Assumed Ceded Total (In millions) Assets Premiums, reinsurance and other receivables (net of allowance for credit losses) $ 289 $ 33 $ 19,067 $ 19,389 $ 245 $ 30 $ 17,870 $ 18,145 Market risk benefit assets $ 613 $ — $ 43 $ 656 $ 412 $ — $ 71 $ 483 Liabilities Future policy benefits $ 31,989 $ 160 $ — $ 32,149 $ 31,020 $ 126 $ — $ 31,146 Policyholder account balances $ 75,893 $ 4,300 $ — $ 80,193 $ 68,409 $ 4,193 $ — $ 72,602 Market risk benefit liabilities $ 9,972 $ 372 $ — $ 10,344 $ 9,980 $ 431 $ — $ 10,411 Other policy-related balances $ 2,023 $ 1,596 $ — $ 3,619 $ 2,228 $ 1,632 $ — $ 3,860 Other liabilities $ 6,526 $ 11 $ 1,235 $ 7,772 $ 5,059 $ 22 $ 1,434 $ 6,515 |
Affiliated Entity | |
Effects of Reinsurance [Line Items] | |
Effect of reinsurance | Information regarding the significant effects of assumed reinsurance with NELICO included on the consolidated statements of operations was as follows: Years Ended December 31, 2023 2022 2021 (In millions) Premiums $ 6 $ 2 $ 2 Universal life and investment-type product policy fees $ (1) $ (1) $ 1 Other revenues $ 1 $ 2 $ 2 Policyholder benefits and claims $ 39 $ 22 $ 16 Change in market risk benefits $ (92) $ (214) $ (243) Other expenses $ — $ (6) $ (3) Information regarding the significant effects of assumed reinsurance with NELICO included on the consolidated balance sheets was as follows at: December 31, 2023 2022 (In millions) Assets Premiums, reinsurance and other receivables (net of allowance for credit losses) $ 28 $ 29 Liabilities Future policy benefits $ 47 $ 31 Market risk benefit liabilities $ 367 $ 428 Other policy-related balances $ 13 $ 11 Other liabilities $ (4) $ 11 |
Investments (Tables)
Investments (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Investments, Debt and Equity Securities [Abstract] | |
Fixed Maturity Securities by Sector | Fixed maturity securities by sector were as follows at: December 31, 2023 December 31, 2022 Amortized Allowance for Credit Losses Gross Unrealized Estimated Amortized Allowance for Credit Losses Gross Unrealized Estimated Gains Losses Gains Losses (In millions) U.S. corporate $ 38,303 $ 15 $ 383 $ 3,332 $ 35,339 $ 36,399 $ 1 $ 200 $ 4,436 $ 32,162 Foreign corporate 12,769 — 89 1,276 11,582 12,368 1 37 1,912 10,492 U.S. government and agency 8,446 — 285 517 8,214 8,195 — 299 596 7,898 RMBS 8,127 4 48 805 7,366 8,384 1 44 936 7,491 ABS 6,509 — 23 131 6,401 5,647 — 3 295 5,355 CMBS 6,940 2 2 601 6,339 7,239 3 — 699 6,537 State and political subdivision 3,958 — 153 298 3,813 4,015 — 120 394 3,741 Foreign government 1,077 — 41 87 1,031 1,148 — 39 106 1,081 Total fixed maturity securities $ 86,129 $ 21 $ 1,024 $ 7,047 $ 80,085 $ 83,395 $ 6 $ 742 $ 9,374 $ 74,757 |
Maturities of Fixed Maturity Securities | The amortized cost and estimated fair value of fixed maturity securities, by contractual maturity date, were as follows at December 31, 2023: Due in One Due After One Due After Five Due After Ten Structured Total Fixed (In millions) Amortized cost $ 2,725 $ 17,064 $ 15,000 $ 29,764 $ 21,576 $ 86,129 Estimated fair value $ 2,691 $ 16,611 $ 13,764 $ 26,913 $ 20,106 $ 80,085 |
Continuous Gross Unrealized Losses for Fixed Maturity Securities by Sector | The estimated fair value and gross unrealized losses of fixed maturity securities in an unrealized loss position, by sector and by length of time that the securities have been in a continuous unrealized loss position, were as follows at: December 31, 2023 December 31, 2022 Less than 12 Months 12 Months or Greater Less than 12 Months 12 Months or Greater Estimated Gross Estimated Gross Estimated Gross Estimated Gross (Dollars in millions) U.S. corporate $ 4,549 $ 409 $ 22,435 $ 2,923 $ 24,163 $ 3,279 $ 3,915 $ 1,157 Foreign corporate 1,010 74 8,229 1,202 8,219 1,407 1,560 505 U.S. government and agency 445 8 3,453 509 3,037 259 1,146 337 RMBS 413 21 5,749 784 4,693 489 2,245 447 ABS 572 3 3,355 128 3,347 159 1,728 136 CMBS 411 33 5,713 568 5,524 534 961 165 State and political subdivision 460 31 1,636 267 2,026 313 239 81 Foreign government 113 6 620 81 779 98 21 8 Total fixed maturity securities $ 7,973 $ 585 $ 51,190 $ 6,462 $ 51,788 $ 6,538 $ 11,815 $ 2,836 Total number of securities in an unrealized loss position 1,339 6,958 7,261 2,018 |
Rollforward of the Allowance for Credit Losses for Fixed Maturity Securities by Sector | The changes in the allowance for credit losses by sector were as follows: U.S. Corporate RMBS CMBS Foreign Corporate Total (In millions) Balance at December 31, 2021 $ 2 $ — $ 2 $ 7 $ 11 Allowance on securities where credit losses were not previously recorded — 1 — — 1 Reductions for securities sold (1) — — — (1) Change in allowance on securities with an allowance recorded in a previous period — — 1 — 1 Write-offs charged against allowance (1) — — — (6) (6) Balance at December 31, 2022 1 1 3 1 6 Allowance on securities where credit losses were not previously recorded 15 3 — — 18 Reductions for securities sold (1) — — — (1) Change in allowance on securities with an allowance recorded in a previous period — — (1) — (1) Write-offs charged against allowance (1) — — — (1) (1) Balance at December 31, 2023 $ 15 $ 4 $ 2 $ — $ 21 _______________ (1) The Company recorded total write-offs of $8 million and $10 million for the years ended December 31, 2023 and 2022, respectively. |
Mortgage Loans by Portfolio Segment | Mortgage loans are summarized as follows at: December 31, 2023 2022 Carrying % of Carrying % of (Dollars in millions) Commercial $ 13,189 58.7 % $ 13,547 59.2 % Agricultural 4,416 19.6 4,333 18.9 Residential 5,007 22.3 5,116 22.4 Total mortgage loans (1) 22,612 100.6 22,996 100.5 Allowance for credit losses (137) (0.6) (119) (0.5) Total mortgage loans, net $ 22,475 100.0 % $ 22,877 100.0 % _______________ (1) Purchases of mortgage loans from third parties were $311 million and $2.2 billion for the years ended December 31, 2023 and 2022, respectively, and were primarily comprised of residential mortgage loans. |
Rollforward of the Allowance for Credit Losses for Mortgage Loans by Portfolio Segment | The changes in the allowance for credit losses by portfolio segment were as follows: Commercial Agricultural Residential Total (In millions) Balance at December 31, 2021 $ 67 $ 12 $ 44 $ 123 Current period provision 5 3 11 19 Charge-offs, net of recoveries (23) — — (23) Balance at December 31, 2022 49 15 55 119 Current period provision 24 5 (6) 23 Charge-offs, net of recoveries (4) (1) — (5) Balance at December 31, 2023 $ 69 $ 19 $ 49 $ 137 |
Credit Quality of Mortgage Loans by Portfolio Segment | The amortized cost of mortgage loans by year of origination and credit quality indicator was as follows at: 2023 2022 2021 2020 2019 Prior Total (In millions) December 31, 2023 Commercial mortgage loans Loan-to-value ratios: Less than 65% $ 206 $ 655 $ 1,823 $ 177 $ 1,239 $ 2,628 $ 6,728 65% to 75% — 935 1,079 222 261 1,157 3,654 76% to 80% — 427 76 39 209 563 1,314 Greater than 80% — 400 227 — 150 716 1,493 Total commercial mortgage loans 206 2,417 3,205 438 1,859 5,064 13,189 Agricultural mortgage loans Loan-to-value ratios: Less than 65% 202 571 1,132 452 505 1,265 4,127 65% to 75% 1 127 108 6 30 17 289 Total agricultural mortgage loans 203 698 1,240 458 535 1,282 4,416 Residential mortgage loans Performing 105 1,286 1,669 145 204 1,508 4,917 Nonperforming — 22 22 1 2 43 90 Total residential mortgage loans 105 1,308 1,691 146 206 1,551 5,007 Total $ 514 $ 4,423 $ 6,136 $ 1,042 $ 2,600 $ 7,897 $ 22,612 2022 2021 2020 2019 2018 Prior Total (In millions) December 31, 2022 Commercial mortgage loans Loan-to-value ratios: Less than 65% $ 1,916 $ 2,819 $ 405 $ 1,493 $ 888 $ 3,624 $ 11,145 65% to 75% 503 354 — 271 367 402 1,897 76% to 80% — 18 40 90 65 48 261 Greater than 80% — — — 25 57 162 244 Total commercial mortgage loans 2,419 3,191 445 1,879 1,377 4,236 13,547 Agricultural mortgage loans Loan-to-value ratios: Less than 65% 532 1,163 418 496 643 710 3,962 65% to 75% 148 90 59 56 1 16 370 Greater than 80% — — — — 1 — 1 Total agricultural mortgage loans 680 1,253 477 552 645 726 4,333 Residential mortgage loans Performing 1,266 1,745 167 215 168 1,491 5,052 Nonperforming 4 8 — 2 1 49 64 Total residential mortgage loans 1,270 1,753 167 217 169 1,540 5,116 Total $ 4,369 $ 6,197 $ 1,089 $ 2,648 $ 2,191 $ 6,502 $ 22,996 The amortized cost of commercial mortgage loans by debt-service coverage ratio was as follows at: December 31, 2023 2022 Amortized Cost % of Amortized Cost % of (Dollars in millions) Debt-service coverage ratios: Greater than 1.20x $ 12,082 91.6 % $ 12,132 89.6 % 1.00x - 1.20x 702 5.3 589 4.3 Less than 1.00x 405 3.1 826 6.1 Total $ 13,189 100.0 % $ 13,547 100.0 % |
Past Due Mortgage Loans by Portfolio Segment | The aging of the amortized cost of past due mortgage loans by portfolio segment was as follows at: December 31, 2023 2022 Commercial Agricultural Residential Total Commercial Agricultural Residential Total (In millions) Current $ 13,172 $ 4,400 $ 4,915 $ 22,487 $ 13,547 $ 4,314 $ 5,041 $ 22,902 30-59 days past due — — 2 2 — — 11 11 60-89 days past due — — 30 30 — — 16 16 90-179 days past due — — 23 23 — 3 31 34 180+ days past due 17 16 37 70 — 16 17 33 Total $ 13,189 $ 4,416 $ 5,007 $ 22,612 $ 13,547 $ 4,333 $ 5,116 $ 22,996 |
Mortgage Loans in Nonaccrual Status by Portfolio Segment | The amortized cost of mortgage loans in a nonaccrual status by portfolio segment was as follows at: Commercial Agricultural Residential (1) Total (In millions) December 31, 2023 $ 17 $ — $ 90 $ 107 December 31, 2022 $ 11 $ 3 $ 64 $ 78 _______________ (1) The Company had no mortgage loans in nonaccrual status for which there was no related allowance for credit losses at both December 31, 2023 and 2022. |
Net Unrealized Investment Gains (Losses) | The components of net unrealized investment gains (losses), included in AOCI, were as follows: Years Ended December 31, 2023 2022 2021 (In millions) Fixed maturity securities $ (6,023) $ (8,632) $ 8,251 Derivatives 344 628 320 Other (7) (7) (27) Subtotal (5,686) (8,011) 8,544 Amounts allocated from: Future policy benefits 696 992 (1,925) Deferred income tax benefit (expense) 1,048 1,474 (1,390) Net unrealized investment gains (losses) $ (3,942) $ (5,545) $ 5,229 The changes in net unrealized investment gains (losses) were as follows: Years Ended December 31, 2023 2022 2021 (In millions) Balance at December 31, $ (5,545) $ 5,229 $ 5,429 Unrealized investment gains (losses) change due to cumulative effect, net of income tax — — 1,959 Balance at January 1, $ (5,545) $ 5,229 $ 7,388 Unrealized investment gains (losses) during the year 2,325 (16,555) (3,420) Unrealized investment gains (losses) relating to: Future policy benefits (296) 2,917 687 Deferred income tax benefit (expense) (426) 2,864 574 Balance at December 31, $ (3,942) $ (5,545) $ 5,229 Change in net unrealized investment gains (losses) $ 1,603 $ (10,774) $ (2,159) |
Securities Lending | Elements of the securities lending program are presented below at: December 31, 2023 2022 (In millions) Securities on loan: (1) Amortized cost $ 3,420 $ 3,995 Estimated fair value $ 3,194 $ 3,638 Cash collateral received from counterparties (2) $ 3,277 $ 3,731 Reinvestment portfolio — estimated fair value $ 3,246 $ 3,603 _______________ (1) Included in fixed maturity securities. (2) Included in payables for collateral under securities loaned and other transactions. The cash collateral liability by loaned security type and remaining tenor of the agreements were as follows at: December 31, 2023 December 31, 2022 Open (1) 1 Month 1 to 6 Total Open (1) 1 Month 1 to 6 Total (In millions) U.S. government and agency $ 647 $ 655 $ 1,584 $ 2,886 $ 640 $ 1,527 $ 984 $ 3,151 U.S. corporate — 252 — 252 2 410 — 412 Foreign corporate — 130 — 130 — 152 — 152 Foreign government — 9 — 9 — 16 — 16 Total $ 647 $ 1,046 $ 1,584 $ 3,277 $ 642 $ 2,105 $ 984 $ 3,731 _______________ (1) The related loaned security could be returned to the Company on the next business day which would require the Company to immediately return the cash collateral. |
Invested Assets on Deposit, Held in Trust and Pledged as Collateral | Invested assets on deposit, held in trust and pledged as collateral at estimated fair value were as follows at: December 31, 2023 2022 (In millions) Invested assets on deposit (regulatory deposits) (1) $ 8,590 $ 7,996 Invested assets held in trust (reinsurance agreements) (2) 7,103 5,592 Invested assets pledged as collateral (3) 13,979 13,920 Total invested assets on deposit, held in trust and pledged as collateral $ 29,672 $ 27,508 _______________ (1) The Company has assets, primarily fixed maturity securities, on deposit with governmental authorities relating to certain policyholder liabilities, of which $102 million and $21 million of the assets on deposit represents restricted cash and cash equivalents at December 31, 2023 and 2022, respectively. (2) The Company has assets, primarily fixed maturity securities, held in trust relating to certain reinsurance transactions, of which $117 million and $233 million of the assets held in trust balance represents restricted cash and cash equivalents at December 31, 2023 and 2022, respectively. (3) The Company has pledged invested assets in connection with various agreements and transactions, including funding agreements (see Note 4) and derivative transactions (see Note 10). |
Variable Interest Entities | The carrying amount and maximum exposure to loss related to the VIEs for which the Company has concluded that it holds a variable interest, but is not the primary beneficiary, were as follows at: December 31, 2023 2022 Carrying Maximum Carrying Maximum (In millions) Fixed maturity securities $ 15,386 $ 16,611 $ 15,781 $ 17,334 Limited partnerships and LLCs 4,220 5,242 4,123 5,478 Total $ 19,606 $ 21,853 $ 19,904 $ 22,812 |
Components of Net Investment Income | The components of net investment income were as follows: Years Ended December 31, 2023 2022 2021 (In millions) Investment income: Fixed maturity securities $ 3,481 $ 3,044 $ 2,794 Equity securities 2 2 5 Mortgage loans 957 840 686 Policy loans 45 42 41 Limited partnerships and LLCs (1) 167 263 1,391 Cash, cash equivalents and short-term investments 181 56 3 Other 84 66 42 Total investment income 4,917 4,313 4,962 Less: Investment expenses 357 249 147 Net investment income $ 4,560 $ 4,064 $ 4,815 _______________ (1) Includes net investment income pertaining to other limited partnership interests of $186 million, $170 million and $1.3 billion for the years ended December 31, 2023, 2022 and 2021, respectively. |
Components of Net Investment Gains (Losses) | Components of Net Investment Gains (Losses) The components of net investment gains (losses) were as follows: Years Ended December 31, 2023 2022 2021 (In millions) Fixed maturity securities $ (214) $ (188) $ (22) Equity securities (1) (12) — Mortgage loans (24) (20) (29) Limited partnerships and LLCs (1) (20) — Other (2) — (12) Total net investment gains (losses) $ (242) $ (240) $ (63) Gains (losses) from foreign currency transactions included within net investment gains (losses) were ($1) million, ($18) million and $0 for the years ended December 31, 2023, 2022 and 2021, respectively. |
Sales or Disposals of Fixed Maturity Securities | Sales or Disposals of Fixed Maturity Securities Investment gains and losses on sales of securities are determined on a specific identification basis. Proceeds from sales or disposals of fixed maturity securities and the components of fixed maturity securities net investment gains (losses) were as follows: Years Ended December 31, 2023 2022 2021 (In millions) Proceeds $ 2,223 $ 6,557 $ 6,201 Gross investment gains $ 15 $ 55 $ 96 Gross investment losses (206) (236) (100) Net investment gains (losses) $ (191) $ (181) $ (4) |
Derivatives (Tables)
Derivatives (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position | The primary underlying risk exposure, gross notional amount and estimated fair value of derivatives, excluding embedded derivatives, held were as follows at: December 31, 2023 2022 Gross Notional Amount Estimated Fair Value Gross Notional Amount Estimated Fair Value Primary Underlying Risk Exposure Assets Liabilities Assets Liabilities (In millions) Derivatives Designated as Hedging Instruments: Cash flow hedges: Interest rate forwards Interest rate $ — $ — $ — $ 60 $ — $ 12 Foreign currency swaps Foreign currency exchange rate 3,895 339 45 3,981 584 8 Total qualifying hedges 3,895 339 45 4,041 584 20 Derivatives Not Designated or Not Qualifying as Hedging Instruments: Interest rate swaps Interest rate 31,252 140 103 3,145 98 46 Interest rate floors Interest rate 3,500 7 1 3,250 12 3 Interest rate caps Interest rate 7,050 19 1 6,350 137 43 Interest rate options Interest rate 33,680 47 167 28,688 22 232 Interest rate forwards Interest rate 17,017 32 1,937 18,168 35 2,466 Foreign currency swaps Foreign currency exchange rate 735 99 1 810 147 — Foreign currency forwards Foreign currency exchange rate 384 — 1 295 1 1 Credit default swaps — written Credit 1,405 27 — 1,757 18 2 Credit default swaptions Credit — — — 100 — — Equity index options Equity market 20,099 757 687 17,229 697 351 Equity total return swaps Equity market 53,742 2,236 2,137 32,909 520 747 Hybrid options Equity market 270 — — — — — Total non-designated or non-qualifying derivatives 169,134 3,364 5,035 112,701 1,687 3,891 Total $ 173,029 $ 3,703 $ 5,080 $ 116,742 $ 2,271 $ 3,911 |
Derivative Instruments, Gain (Loss) | The amount and location of gains (losses), including earned income, recognized for derivatives and gains (losses) pertaining to hedged items reported in net derivative gains (losses) were as follows: Year Ended December 31, 2023 Net Net Net Amount of Gains (Losses) Deferred in AOCI (In millions) Derivatives Designated as Hedging Instruments: Cash flow hedges: Interest rate $ 1 $ — $ 3 $ (1) Foreign currency exchange rate 7 (8) 51 (272) Total cash flow hedges 8 (8) 54 (273) Derivatives Not Designated or Not Qualifying as Hedging Instruments: Interest rate (384) — — — Foreign currency exchange rate (40) 2 — — Credit 32 — — — Equity market 570 — — — Embedded (4,100) — — — Total non-qualifying hedges (3,922) 2 — — Total $ (3,914) $ (6) $ 54 $ (273) Year Ended December 31, 2022 Net Net Net Amount of Gains (Losses) Deferred in AOCI (In millions) Derivatives Designated as Hedging Instruments: Cash flow hedges: Interest rate $ 5 $ — $ 4 $ (50) Foreign currency exchange rate 12 (11) 52 379 Total cash flow hedges 17 (11) 56 329 Derivatives Not Designated or Not Qualifying as Hedging Instruments: Interest rate (4,001) — — — Foreign currency exchange rate 95 (16) — — Credit (2) — — — Equity market 590 — — — Embedded 2,743 — — — Total non-qualifying hedges (575) (16) — — Total $ (558) $ (27) $ 56 $ 329 Year Ended December 31, 2021 Net Net Net Amount of Gains (Losses) Deferred in AOCI (In millions) Derivatives Designated as Hedging Instruments: Cash flow hedges: Interest rate $ 2 $ — $ 3 $ (20) Foreign currency exchange rate 7 (3) 34 190 Total cash flow hedges 9 (3) 37 170 Derivatives Not Designated or Not Qualifying as Hedging Instruments: Interest rate (717) — — — Foreign currency exchange rate 48 2 — — Credit 17 — — — Equity market (486) — — — Embedded (2,856) — — — Total non-qualifying hedges (3,994) 2 — — Total $ (3,985) $ (1) $ 37 $ 170 |
Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) | The amount and location of gains (losses), including earned income, recognized for derivatives and gains (losses) pertaining to hedged items reported in net derivative gains (losses) were as follows: Year Ended December 31, 2023 Net Net Net Amount of Gains (Losses) Deferred in AOCI (In millions) Derivatives Designated as Hedging Instruments: Cash flow hedges: Interest rate $ 1 $ — $ 3 $ (1) Foreign currency exchange rate 7 (8) 51 (272) Total cash flow hedges 8 (8) 54 (273) Derivatives Not Designated or Not Qualifying as Hedging Instruments: Interest rate (384) — — — Foreign currency exchange rate (40) 2 — — Credit 32 — — — Equity market 570 — — — Embedded (4,100) — — — Total non-qualifying hedges (3,922) 2 — — Total $ (3,914) $ (6) $ 54 $ (273) Year Ended December 31, 2022 Net Net Net Amount of Gains (Losses) Deferred in AOCI (In millions) Derivatives Designated as Hedging Instruments: Cash flow hedges: Interest rate $ 5 $ — $ 4 $ (50) Foreign currency exchange rate 12 (11) 52 379 Total cash flow hedges 17 (11) 56 329 Derivatives Not Designated or Not Qualifying as Hedging Instruments: Interest rate (4,001) — — — Foreign currency exchange rate 95 (16) — — Credit (2) — — — Equity market 590 — — — Embedded 2,743 — — — Total non-qualifying hedges (575) (16) — — Total $ (558) $ (27) $ 56 $ 329 Year Ended December 31, 2021 Net Net Net Amount of Gains (Losses) Deferred in AOCI (In millions) Derivatives Designated as Hedging Instruments: Cash flow hedges: Interest rate $ 2 $ — $ 3 $ (20) Foreign currency exchange rate 7 (3) 34 190 Total cash flow hedges 9 (3) 37 170 Derivatives Not Designated or Not Qualifying as Hedging Instruments: Interest rate (717) — — — Foreign currency exchange rate 48 2 — — Credit 17 — — — Equity market (486) — — — Embedded (2,856) — — — Total non-qualifying hedges (3,994) 2 — — Total $ (3,985) $ (1) $ 37 $ 170 |
Schedule of estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps | The estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps were as follows at: December 31, 2023 2022 Rating Agency Designation of Referenced Estimated Fair Value of Credit Default Swaps Maximum Amount of Future Payments under Credit Default Swaps Weighted Average Years to Maturity (2) Estimated Fair Value of Credit Default Swaps Maximum Amount of Future Payments under Credit Default Swaps Weighted Average Years to Maturity (2) (Dollars in millions) Aaa/Aa/A $ 6 $ 419 1.6 $ 7 $ 544 2.2 Baa 19 958 4.9 8 1,185 5.0 Ba 2 24 3.0 2 24 4.0 Caa and Lower — 4 2.0 (1) 4 3.0 Total $ 27 $ 1,405 3.9 $ 16 $ 1,757 4.1 _______________ (1) The Company has written credit protection on both single name and index references. The rating agency designations are based on availability and the midpoint of the applicable ratings among Moody’s, S&P and Fitch. If no rating is available from a rating agency, then an internally developed rating is used. (2) The weighted average years to maturity of the credit default swaps is calculated based on weighted average gross notional amounts. |
Estimated Fair Value of Derivative Assets after Master Netting Agreements and Cash Collateral | The estimated fair values of net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at: Gross Amounts Not Offset on the Consolidated Balance Sheets Gross Amount Recognized Financial Instruments (1) Collateral Received/Pledged (2) Net Amount Securities Collateral Received/Pledged (3) Net Amount After Securities Collateral (In millions) December 31, 2023 Derivative assets $ 3,495 $ (3,112) $ (154) $ 229 $ (194) $ 35 Derivative liabilities $ 4,917 $ (3,112) $ — $ 1,805 $ (1,805) $ — December 31, 2022 Derivative assets $ 2,295 $ (1,659) $ (629) $ 7 $ (5) $ 2 Derivative liabilities $ 3,910 $ (1,659) $ — $ 2,251 $ (2,251) $ — _______________ (1) Represents amounts subject to an enforceable master netting agreement or similar agreement. (2) The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreement. (3) Securities collateral received from counterparties is not reported on the consolidated balance sheets and may not be sold or re-pledged unless the counterparty is in default. Amounts do not include excess of collateral pledged or received. |
Estimated Fair Value of Derivative Liabilities after Master Netting Agreements and Cash Collateral | The estimated fair values of net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at: Gross Amounts Not Offset on the Consolidated Balance Sheets Gross Amount Recognized Financial Instruments (1) Collateral Received/Pledged (2) Net Amount Securities Collateral Received/Pledged (3) Net Amount After Securities Collateral (In millions) December 31, 2023 Derivative assets $ 3,495 $ (3,112) $ (154) $ 229 $ (194) $ 35 Derivative liabilities $ 4,917 $ (3,112) $ — $ 1,805 $ (1,805) $ — December 31, 2022 Derivative assets $ 2,295 $ (1,659) $ (629) $ 7 $ (5) $ 2 Derivative liabilities $ 3,910 $ (1,659) $ — $ 2,251 $ (2,251) $ — _______________ (1) Represents amounts subject to an enforceable master netting agreement or similar agreement. (2) The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreement. (3) Securities collateral received from counterparties is not reported on the consolidated balance sheets and may not be sold or re-pledged unless the counterparty is in default. Amounts do not include excess of collateral pledged or received. |
Schedule of Derivative Instruments | The aggregate estimated fair values of derivatives in a net liability position containing such credit-contingent provisions and the aggregate estimated fair value of assets posted as collateral for such instruments were as follows at: December 31, 2023 2022 (In millions) Estimated fair value of derivatives in a net liability position (1) $ 1,805 $ 2,251 Estimated fair value of collateral provided (2): Fixed maturity securities $ 4,811 $ 4,894 _______________ (1) After taking into consideration the existence of netting agreements. (2) Substantially all of the Company’s collateral arrangements provide for daily posting of collateral for the full value of the derivative contract. As a result, if the credit-contingent provisions of derivative contracts in a net liability position were triggered, minimal additional assets would be required to be posted as collateral or needed to settle the instruments immediately. Additionally, the Company is required to pledge initial margin for certain new OTC-bilateral derivative transactions to third-party custodians. |
Fair Value (Tables)
Fair Value (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Recurring Fair Value Measurements | The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy are presented in the tables below. Investments that do not have a readily determinable fair value and are measured at net asset value (or equivalent) as a practical expedient to estimated fair value are excluded from the fair value hierarchy. December 31, 2023 Fair Value Hierarchy Level 1 Level 2 Level 3 Total Estimated (In millions) Assets Fixed maturity securities: U.S. corporate $ — $ 34,344 $ 995 $ 35,339 Foreign corporate — 11,257 325 11,582 U.S. government and agency 3,680 4,534 — 8,214 RMBS — 7,351 15 7,366 ABS — 6,075 326 6,401 CMBS — 6,300 39 6,339 State and political subdivision — 3,813 — 3,813 Foreign government — 995 36 1,031 Total fixed maturity securities 3,680 74,669 1,736 80,085 Equity securities 18 23 25 66 Short-term investments 214 360 — 574 Derivative assets: (1) Interest rate — 245 — 245 Foreign currency exchange rate — 426 12 438 Credit — 21 6 27 Equity market — 2,993 — 2,993 Total derivative assets — 3,685 18 3,703 Market risk benefit assets — — 656 656 Separate account assets 20 81,670 — 81,690 Total assets $ 3,932 $ 160,407 $ 2,435 $ 166,774 Liabilities Market risk benefit liabilities $ — $ — $ 10,344 $ 10,344 Derivative liabilities: (1) Interest rate — 2,209 — 2,209 Foreign currency exchange rate — 47 — 47 Credit — — — — Equity market — 2,824 — 2,824 Total derivative liabilities — 5,080 — 5,080 Embedded derivatives on index-linked annuities (2) — — 8,186 8,186 Total liabilities $ — $ 5,080 $ 18,530 $ 23,610 December 31, 2022 Fair Value Hierarchy Level 1 Level 2 Level 3 Total Estimated (In millions) Assets Fixed maturity securities: U.S. corporate $ — $ 30,973 $ 1,189 $ 32,162 Foreign corporate — 9,894 598 10,492 U.S. government and agency 3,507 4,391 — 7,898 RMBS — 7,477 14 7,491 ABS — 5,037 318 5,355 CMBS — 6,504 33 6,537 State and political subdivision — 3,741 — 3,741 Foreign government — 1,043 38 1,081 Total fixed maturity securities 3,507 69,060 2,190 74,757 Equity securities 12 27 27 66 Short-term investments 206 93 — 299 Derivative assets: (1) Interest rate — 304 — 304 Foreign currency exchange rate — 703 29 732 Credit — 10 8 18 Equity market — 1,217 — 1,217 Total derivative assets — 2,234 37 2,271 Market risk benefit assets — — 483 483 Separate account assets 29 78,851 — 78,880 Total assets $ 3,754 $ 150,265 $ 2,737 $ 156,756 Liabilities Market risk benefit liabilities $ — $ — $ 10,411 $ 10,411 Derivative liabilities: (1) Interest rate — 2,802 — 2,802 Foreign currency exchange rate — 9 — 9 Credit — — 2 2 Equity market — 1,098 — 1,098 Total derivative liabilities — 3,909 2 3,911 Embedded derivatives on index-linked annuities (2) — — 3,932 3,932 Total liabilities $ — $ 3,909 $ 14,345 $ 18,254 _______________ (1) Derivative assets are reported in other invested assets and derivative liabilities are reported in other liabilities. The amounts are presented gross in the tables above to reflect the presentation on the consolidated balance sheets. (2) Embedded derivative liabilities on index-linked annuities are reported in policyholder account balances. |
Fair Value Measurement Inputs and Valuation Techniques | Certain quantitative information about the significant unobservable inputs used in the fair value measurement, and the sensitivity of the estimated fair value to changes in those inputs, for the more significant asset and liability classes measured at fair value on a recurring basis using significant unobservable inputs (Level 3) were as follows at: December 31, 2023 December 31, 2022 Impact of Valuation Techniques Significant Range Range Market Risk Benefits Variable annuity guaranteed minimum benefits Option pricing techniques • Mortality rates 0.04 % - 12.90 % 0.04 % - 12.90 % Decrease (1) • Lapse rates 1.00 % - 22.80 % 1.00 % - 24.11 % Decrease (2) • Utilization rates 0.00 % - 25.00 % 0.00 % - 25.00 % Increase (3) • Withdrawal rates 0.00 % - 10.00 % 0.00 % - 10.00 % (4) • Long-term equity volatilities 12.59 % - 22.50 % 19.99 % - 28.45 % Increase (5) • Nonperformance risk spread 0.76 % - 1.63 % (2.73) % - 4.52 % Decrease (6) Embedded Derivatives Index-linked annuity crediting rates • Option pricing techniques • Mortality rates 0.03 % - 9.24 % 0.03 % - 9.24 % Decrease (1) • Lapse rates 1.00 % - 62.30 % 1.00 % - 62.30 % Decrease (2) • Withdrawal rates 0.50 % - 9.00 % 0.50 % - 9.00 % (4) • Nonperformance risk spread 0.45 % - 1.74 % 0.00 % - 1.98 % Decrease (6) _______________ (1) Mortality rates vary by age and by demographic characteristics such as gender. The range shown reflects the mortality rate for policyholders between 35 and 90 years old. Mortality rate assumptions are set based on company experience and include an assumption for mortality improvement. (2) The lapse rate range reflects base lapse rates for major product categories for duration 1-20. Base lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, as well as other factors, such as the applicability of any surrender charges. For variable annuity guarantees, a dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in-the-money contracts are less likely to lapse. Lapse rates are also generally assumed to be lower in periods when a surrender charge applies. (3) The utilization rate assumption for variable annuity guarantees estimates the percentage of contract holders with a GMIB or lifetime withdrawal benefit who will elect to utilize the benefit upon becoming eligible in a given year. The range shown represents the floor and cap of the GMIB dynamic election rates across varying levels of in-the-money. For lifetime withdrawal guarantee riders, the assumption is that everyone will begin withdrawals once account value reaches zero which is equivalent to a 100% utilization rate. Utilization rates may vary by the type of guarantee, the amount by which the guaranteed amount is greater than the account value, the contract’s withdrawal history and by the age of the policyholder. (4) The withdrawal rate represents the percentage of account balance that any given policyholder will elect to withdraw from the contract each year. The withdrawal rate assumption varies by age and duration of the contract, and also by other factors such as benefit type. For any given contract, withdrawal rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. For variable annuity GMWBs, any increase (decrease) in withdrawal rates results in an increase (decrease) in the estimated fair value of the guarantees. For variable annuity GMABs and GMIBs, any increase (decrease) in withdrawal rates results in a decrease (increase) in the estimated fair value. (5) Long-term equity volatilities represent equity volatility beyond the period for which observable equity volatilities are available. For any given contract, long-term equity volatility rates vary throughout the period over which cash flows are projected for purposes of valuing MRBs. (6) Nonperformance risk spread varies by duration. For any given contract, multiple nonperformance risk spreads will apply, depending on the duration of the cash flow being discounted for purposes of valuing the MRB or embedded derivative. |
Fair Value, Measured on Recurring Basis, Unobservable Input Reconciliation | The changes in assets and (liabilities) measured at estimated fair value on a recurring basis using significant unobservable inputs (excluding MRBs disclosed in Note 5) were summarized as follows: Fair Value Measurements Using Significant Unobservable Inputs (Level 3) Fixed Maturity Securities Corporate (1) Structured Securities Foreign Equity Short-term Net Embedded Derivatives on Index-Linked Annuities (In millions) Balance, January 1, 2022 $ 1,399 $ 220 $ 26 $ 13 $ 2 $ 36 $ (6,641) Total realized/unrealized gains (losses) included in net income (loss) (3) (4) (5) 1 — — — (9) 2,743 Total realized/unrealized gains (losses) included in AOCI (266) (23) (10) — — 17 — Purchases (5) 933 251 5 14 — 1 — Sales (5) (184) (16) (2) — (2) (9) — Issuances (5) — — — — — — — Settlements (5) — — — — — — (34) Transfers into Level 3 (6) 94 33 19 — — — — Transfers out of Level 3 (6) (184) (101) — — — (1) — Balance, December 31, 2022 1,787 365 38 27 — 35 (3,932) Total realized/unrealized gains (losses) included in net income (loss) (3) (4) (11) — — (3) — (6) (4,097) Total realized/unrealized gains (losses) included in AOCI 28 5 3 — — (3) — Purchases (5) 162 85 — 2 — 4 — Sales (5) (116) (22) (2) (1) — — — Issuances (5) — — — — — — — Settlements (5) — — — — — — (157) Transfers into Level 3 (6) 188 3 — — — — — Transfers out of Level 3 (6) (718) (56) (3) — — (12) — Balance, December 31, 2023 $ 1,320 $ 380 $ 36 $ 25 $ — $ 18 $ (8,186) Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at December 31, 2021 (7) $ (2) $ — $ — $ — $ — $ (11) $ (2,929) Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at December 31, 2022 (7) $ 3 $ — $ — $ 1 $ — $ (1) $ 2,485 Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at December 31, 2023 (7) $ (11) $ — $ — $ (2) $ — $ (5) $ (4,513) Changes in unrealized gains (losses) included in OCI for the instruments still held as of December 31, 2021 (7) $ (6) $ — $ — $ — $ — $ 12 $ — Changes in unrealized gains (losses) included in OCI for the instruments still held as of December 31, 2022 (7) $ (268) $ (23) $ (10) $ — $ — $ 17 $ — Changes in unrealized gains (losses) included in OCI for the instruments still held as of December 31, 2023 (7) $ 11 $ 4 $ 3 $ — $ — $ (3) $ — Gains (Losses) Data for the year ended December 31, 2021: Total realized/unrealized gains (losses) included in net income (loss) (3) (4) $ (1) $ — $ — $ — $ — $ 1 $ (2,856) Total realized/unrealized gains (losses) included in AOCI $ (7) $ — $ — $ — $ — $ 12 $ — _______________ (1) Comprised of U.S. and foreign corporate securities. (2) Freestanding derivative assets and liabilities are reported net for purposes of the rollforward. (3) Amortization of premium/accretion of discount is included in net investment income. Changes in the allowance for credit losses and direct write-offs are charged to net income (loss) on securities are included in net investment gains (losses). Lapses associated with net embedded derivatives are included in net derivative gains (losses). Substantially all realized/unrealized gains (losses) included in net income (loss) for net derivatives and net embedded derivatives are reported in net derivative gains (losses). (4) Interest and dividend accruals, as well as cash interest coupons and dividends received, are excluded from the rollforward. (5) Items purchased/issued and then sold/settled in the same period are excluded from the rollforward. Fees attributed to embedded derivatives are included in settlements. (6) Gains and losses, in net income (loss) and OCI, are calculated assuming transfers into and/or out of Level 3 occurred at the beginning of the period. Items transferred into and out of Level 3 in the same period are excluded from the rollforward. (7) Changes in unrealized gains (losses) included in net income (loss) for fixed maturities are reported in either net investment income or net investment gains (losses). Substantially all changes in unrealized gains (losses) included in net income (loss) for net derivatives and net embedded derivatives are reported in net derivative gains (losses). |
Fair Value of Financial Instruments Carried at Other Than Fair Value | The carrying values and estimated fair values for such financial instruments, and their corresponding placement in the fair value hierarchy, are summarized as follows at: December 31, 2023 Fair Value Hierarchy Carrying Level 1 Level 2 Level 3 Total (In millions) Assets Mortgage loans $ 22,475 $ — $ — $ 20,578 $ 20,578 Policy loans $ 938 $ — $ 479 $ 494 $ 973 Other invested assets $ 260 $ — $ 245 $ 15 $ 260 Premiums, reinsurance and other receivables $ 7,431 $ — $ 80 $ 7,498 $ 7,578 Liabilities Policyholder account balances $ 31,362 $ — $ — $ 30,501 $ 30,501 Long-term debt $ 836 $ — $ 26 $ 755 $ 781 Other liabilities $ 1,191 $ — $ 438 $ 753 $ 1,191 Separate account liabilities $ 1,148 $ — $ 1,148 $ — $ 1,148 December 31, 2022 Fair Value Hierarchy Carrying Level 1 Level 2 Level 3 Total (In millions) Assets Mortgage loans $ 22,877 $ — $ — $ 20,760 $ 20,760 Policy loans $ 898 $ — $ 477 $ 453 $ 930 Other invested assets $ 341 $ — $ 201 $ 140 $ 341 Premiums, reinsurance and other receivables $ 5,915 $ — $ 77 $ 5,988 $ 6,065 Liabilities Policyholder account balances $ 31,223 $ — $ — $ 30,303 $ 30,303 Short-term debt $ 125 $ — $ — $ 125 $ 125 Long-term debt $ 838 $ — $ 28 $ 714 $ 742 Other liabilities $ 1,009 $ — $ 212 $ 797 $ 1,009 Separate account liabilities $ 1,022 $ — $ 1,022 $ — $ 1,022 |
Long-term and Short-term Debt (
Long-term and Short-term Debt (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Debt Disclosure [Abstract] | |
Schedule of Long-term Debt | Long-term debt outstanding was as follows at: December 31, Stated Interest Rate Maturity 2023 2022 (In millions) Surplus note — affiliated (1) 8.070% 2059 $ 412 $ 412 Surplus note — affiliated (1) 8.150% 2058 200 200 Surplus note — affiliated (1) 7.800% 2058 200 200 Other long-term debt — unaffiliated (2) 7.028% 2030 24 26 Total long-term debt $ 836 $ 838 _______________ (1) Interest on affiliated surplus notes is payable annually. Payments of interest and principal may be made only with the prior approval of the Delaware Department of Insurance. (2) Represents non-recourse debt of a subsidiary for which creditors have no access, subject to customary exceptions, to the general assets of the Company other than recourse to certain investment companies. |
Equity (Tables)
Equity (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Equity [Abstract] | |
Schedules of statutory net income, capital and surplus and reserve strengthening by subsidiary including dividend restrictions | Statutory net income (loss) was as follows: Years Ended December 31, Company State of Domicile 2023 2022 2021 (In millions) Brighthouse Life Insurance Company Delaware $ (3,131) $ 1,373 $ (156) Brighthouse Life Insurance Company of NY New York $ 539 $ (152) $ (52) Statutory capital and surplus was as follows at: December 31, Company 2023 2022 (In millions) Brighthouse Life Insurance Company $ 4,623 $ 6,349 Brighthouse Life Insurance Company of NY $ 819 $ 223 The table below sets forth the dividends permitted to be paid by certain of the Company’s insurance companies without insurance regulatory approval and dividends paid: 2024 2023 2022 2021 Company Permitted Without Approval (1) Paid (2) Paid (2) Paid (2) (In millions) Brighthouse Life Insurance Company (3) $ — $ 266 $ — $ 550 Brighthouse Life Insurance Company of NY $ 81 $ — $ — $ — _______________ (1) Reflects dividend amounts that may be paid during 2024 without prior regulatory approval. However, because dividend tests may be based on dividends previously paid over rolling 12-month periods, if paid before a specified date during 2024, some or all of such dividends may require regulatory approval to the extent dividends were paid in 2023. (2) Reflects all amounts paid, including those requiring regulatory approval. (3) Any payment of dividends in 2024 would be considered an extraordinary dividend subject to regulatory approval due to negative unassigned funds (surplus). |
Components of Accumulated Other Comprehensive Income (Loss) [Table Text Block] | Information regarding changes in the balances of each component of AOCI was as follows: Unrealized Unrealized Gains (Losses) on Derivatives Changes in Nonperformance Risk on Market Risk Benefits Changes in Discount Rates on the Liability for Future Policy Benefits Foreign Currency Translation Adjustments Total (In millions) Balance at December 31, 2020 $ 5,321 $ 108 $ — $ — $ (8) $ 5,421 Cumulative effect to change in accounting principle, net of income tax (2) 1,959 — (2,727) (3,167) — (3,935) Balance at January 1, 2021 7,280 108 (2,727) (3,167) (8) 1,486 OCI before reclassifications (2,898) 170 (636) 1,234 1 (2,129) Deferred income tax benefit (expense) (3) 608 (36) 134 (259) — 447 AOCI before reclassifications, net of income tax 4,990 242 (3,229) (2,192) (7) (196) Amounts reclassified from AOCI 7 (12) — — — (5) Deferred income tax benefit (expense) (3) (1) 3 — — — 2 Amounts reclassified from AOCI, net of income tax 6 (9) — — — (3) Balance at December 31, 2021 4,996 233 (3,229) (2,192) (7) (199) OCI before reclassifications (14,148) 329 2,344 4,060 (22) (7,437) Deferred income tax benefit (expense) (3) 2,951 (50) (492) (852) 4 1,561 AOCI before reclassifications, net of income tax (6,201) 512 (1,377) 1,016 (25) (6,075) Amounts reclassified from AOCI 202 (21) — — — 181 Deferred income tax benefit (expense) (3) (42) 5 — — — (37) Amounts reclassified from AOCI, net of income tax 160 (16) — — — 144 Balance at December 31, 2022 (6,041) 496 (1,377) 1,016 (25) (5,931) OCI before reclassifications 2,109 (273) (637) (376) 18 841 Deferred income tax benefit (expense) (3) (443) 58 134 79 (4) (176) AOCI before reclassifications, net of income tax (4,375) 281 (1,880) 719 (11) (5,266) Amounts reclassified from AOCI 204 (11) — — — 193 Deferred income tax benefit (expense) (3) (43) 2 — — — (41) Amounts reclassified from AOCI, net of income tax 161 (9) — — — 152 Balance at December 31, 2023 $ (4,214) $ 272 $ (1,880) $ 719 $ (11) $ (5,114) _______________ (1) See Note 9 for information on offsets to investments related to future policy benefits. (2) See Notes 1 and 2 for information on the adoption of ASU 2018-12. (3) The effects of income taxes on amounts recorded to AOCI are also recognized in AOCI. These income tax effects are released from AOCI when the related activity is reclassified into results from operations. |
Reclassification out of Accumulated Other Comprehensive Income (Loss) [Table Text Block] | Information regarding amounts reclassified out of each component of AOCI was as follows: AOCI Components Amounts Reclassified from AOCI Consolidated Statements of Operations Locations Years Ended December 31, 2023 2022 2021 (In millions) Net unrealized investment gains (losses): Net unrealized investment gains(losses) $ (192) $ (182) $ (4) Net investment gains (losses) Net unrealized investment gains (losses) (12) (20) (3) Net derivative gains (losses) Net unrealized investment gains (losses), before income tax (204) (202) (7) Income tax (expense) benefit 43 42 1 Net unrealized investment gains (losses), net of income tax (161) (160) (6) Unrealized gains (losses) on derivatives - cash flow hedges: Interest rate swaps 1 5 2 Net derivative gains (losses) Interest rate swaps 3 4 3 Net investment income Foreign currency swaps 7 12 7 Net derivative gains (losses) Gains (losses) on cash flow hedges, before income tax 11 21 12 Income tax (expense) benefit (2) (5) (3) Gains (losses) on cash flow hedges, net of income tax 9 16 9 Total reclassifications, net of income tax $ (152) $ (144) $ 3 |
Other Revenues and Other Expe_2
Other Revenues and Other Expenses (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Other Income and Expenses [Abstract] | |
Other Expenses | Information on other expenses was as follows: Years Ended December 31, 2023 2022 2021 (In millions) Compensation $ 383 $ 336 $ 360 Contracted services and other labor costs 282 266 249 Transition services agreements 30 55 119 Establishment costs — 63 93 Premium and other taxes, licenses and fees 55 49 47 Volume related costs, excluding compensation, net of DAC capitalization 536 496 666 Interest expense on debt 70 70 67 Other 269 359 223 Total other expenses $ 1,625 $ 1,694 $ 1,824 |
Income Tax (Tables)
Income Tax (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Provision for income tax from continuing operations | The provision for income tax was as follows: Years Ended December 31, 2023 2022 2021 (In millions) Current: Federal $ (5) $ (88) $ 5 Deferred: Federal (378) 883 374 Provision for income tax expense (benefit) $ (383) $ 795 $ 379 |
Income tax for continuing operations effective rate reconciliation | The reconciliation of the income tax provision at the statutory tax rate to the provision for income tax as reported was as follows: Years Ended December 31, 2023 2022 2021 (Dollars in millions) Tax provision at statutory rate $ (316) $ 946 $ 449 Tax effect of: Resolution of prior years — (71) (3) Dividends received deduction (31) (32) (34) Change in uncertain tax benefits — (20) — Tax credits (8) (19) (15) Change in valuation allowance (18) — 18 Return to provision (5) (5) 12 Adjustments to deferred tax — (2) (48) Other, net (5) (2) — Provision for income tax expense (benefit) $ (383) $ 795 $ 379 Effective tax rate 25 % 18 % 18 % |
Components of deferred tax assets and liabilities | Net deferred income tax assets and liabilities consisted of the following at: December 31, 2023 2022 (In millions) Deferred income tax assets: Net unrealized investment losses $ 1,048 $ 1,473 Net operating loss carryforwards 1,826 1,246 Investments, including derivatives 210 285 Tax credit carryforwards 189 183 Employee benefits 3 3 Intangibles 48 55 Other — 28 Total deferred income tax assets 3,324 3,273 Less: Valuation allowance — 18 Total net deferred income tax assets 3,324 3,255 Deferred income tax liabilities: Policyholder liabilities and receivables 910 985 DAC 580 597 Other 1 — Total deferred income tax liabilities 1,491 1,582 Net deferred income tax asset (liability) $ 1,833 $ 1,673 |
Summary of Operating Loss Carryforwards | The following table sets forth the net operating loss carryforwards for tax purposes at December 31, 2023. Net Operating Loss Carryforwards (In millions) Expiration 2032 $ 2,006 Indefinite 6,691 $ 8,697 |
Summary of Tax Credit Carryforwards | The following table sets forth the general business credits and foreign tax credits available for carryforward for tax purposes at December 31, 2023. Tax Credit Carryforwards General Business Credits Foreign Tax Credits (In millions) Expiration 2024-2028 $ — $ 44 2029-2033 — 120 2034-2038 20 — 2039-2043 5 — Indefinite — — $ 25 $ 164 |
Reconciliation of unrecognized tax benefits | A reconciliation of the beginning and ending amount of unrecognized tax benefits was as follows: Years Ended December 31, 2023 2022 2021 (In millions) Balance at January 1, $ 14 $ 34 $ 34 Additions for tax positions of prior years — — — Reductions for tax positions of prior years — — — Additions for tax positions of current year — — — Reductions for tax positions of current year — — — Settlements with tax authorities — — — Lapses of statutes of limitations — (20) — Balance at December 31, $ 14 $ 14 $ 34 Unrecognized tax benefits that, if recognized would impact the effective rate $ 14 $ 14 $ 34 |
Business, Basis of Presentati_3
Business, Basis of Presentation and Summary of Significant Accounting Policies (Narrative) (Details) $ in Millions | 12 Months Ended | |||
Dec. 31, 2023 USD ($) Segment | Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) | Dec. 31, 2020 USD ($) | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||||
Number of Reportable Segments | Segment | 3 | |||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||
Stockholder's Equity, Including Portion Attributable to Noncontrolling Interest | $ 5,941 | $ 6,514 | $ 8,536 | $ 18,115 |
Proceeds from Sale of Short-Term Investments | 1,100 | 976 | 3,600 | |
Payments to Acquire Short-Term Investments | $ 1,400 | $ 611 | $ 2,400 | |
Retained Earnings (Deficit) | ||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||
Stockholder's Equity, Including Portion Attributable to Noncontrolling Interest | (5,200) | |||
AOCI Attributable to Parent | ||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||
Stockholder's Equity, Including Portion Attributable to Noncontrolling Interest | $ (3,900) |
Effect of Transition Adjustment
Effect of Transition Adjustments on Stockholders’ Equity, ASU 2018-12 Transition (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Jan. 01, 2021 | Dec. 31, 2020 |
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||||
Liability for Future Policy Benefit, before Reinsurance | $ 32,149 | $ 31,146 | |||
Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Net | 4,487 | 4,642 | |||
Stockholder's Equity, Including Portion Attributable to Noncontrolling Interest | $ 5,941 | $ 6,514 | $ 8,536 | $ 18,115 | |
Retained Earnings (Deficit) | |||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||||
Stockholder's Equity, Including Portion Attributable to Noncontrolling Interest | (5,200) | ||||
Retained Earnings (Deficit) | Accounting Standards Update 2018-12 | |||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||||
Liability for Future Policy Benefit, before Reinsurance | $ (434) | ||||
Market risk benefits and related adjustments | (5,971) | ||||
Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Net | 0 | ||||
Reinsurance Recoverables, Including Reinsurance Premium Paid | (141) | ||||
Deferred income tax liability | 1,375 | ||||
Stockholder's Equity, Including Portion Attributable to Noncontrolling Interest | (5,171) | ||||
AOCI Attributable to Parent | |||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||||
Stockholder's Equity, Including Portion Attributable to Noncontrolling Interest | $ (3,900) | ||||
AOCI Attributable to Parent | Accounting Standards Update 2018-12 | |||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||||
Liability for Future Policy Benefit, before Reinsurance | (2,053) | ||||
Market risk benefits and related adjustments | (3,452) | ||||
Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Net | 494 | ||||
Reinsurance Recoverables, Including Reinsurance Premium Paid | 30 | ||||
Deferred income tax liability | 1,046 | ||||
Stockholder's Equity, Including Portion Attributable to Noncontrolling Interest | $ (3,935) |
Changes in LFPBs, ASU 2018-12 T
Changes in LFPBs, ASU 2018-12 Transition (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Jan. 01, 2021 | Dec. 31, 2020 |
Liability for Future Policy Benefit, Activity | |||||
Accumulated other comprehensive income (loss) | $ (5,114) | $ (5,931) | $ (199) | $ 5,421 | |
Future policy benefits | 32,149 | 31,146 | 39,830 | ||
Previously Reported | |||||
Liability for Future Policy Benefit, Activity | |||||
Accumulated other comprehensive income (loss) | (5,282) | 3,901 | |||
Future policy benefits | 41,105 | 43,589 | |||
Accounting Standards Update 2018-12 | Revision of Prior Period, Accounting Standards Update, Adjustment | |||||
Liability for Future Policy Benefit, Activity | |||||
Accumulated other comprehensive income (loss) | (649) | (4,100) | |||
Future policy benefits | (9,959) | (3,759) | |||
Term and Whole Life Insurance | |||||
Liability for Future Policy Benefit, Activity | |||||
Liability for Future Policy Benefit, Expected Future Policy Benefit, Undiscounted, before Reinsurance | 8,148 | 8,015 | 7,877 | ||
Liability for Future Policy Benefit, Expected Future Policy Benefit, Cumulative Increase (Decrease) from Cash Flow Change | 296 | 179 | 100 | ||
Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change | 5,385 | 5,172 | 6,253 | 6,606 | |
Liability for Future Policy Benefit, Reinsurance Recoverable, after Allowance | 24 | 32 | 42 | ||
Future policy benefits | $ 2,462 | $ 2,336 | $ 2,999 | ||
Term and Whole Life Insurance | Accounting Standards Update 2018-12 | |||||
Liability for Future Policy Benefit, Activity | |||||
Liability for Future Policy Benefit, Expected Future Policy Benefit, Undiscounted, before Reinsurance | $ 3,332 | ||||
Liability for Future Policy Benefit, Reinsurance Recoverable, after Allowance | 59 | ||||
Future policy benefits | 3,273 | ||||
Term and Whole Life Insurance | Accounting Standards Update 2018-12 | Previously Reported | |||||
Liability for Future Policy Benefit, Activity | |||||
Liability for Future Policy Benefit, Expected Future Policy Benefit, Undiscounted, before Reinsurance | 2,797 | ||||
Term and Whole Life Insurance | Accounting Standards Update 2018-12 | Revision of Prior Period, Accounting Standards Update, Adjustment | |||||
Liability for Future Policy Benefit, Activity | |||||
Accumulated other comprehensive income (loss) | 0 | ||||
Liability for Future Policy Benefit, Expected Future Policy Benefit, Cumulative Increase (Decrease) from Cash Flow Change | 13 | ||||
Deferred Profit Liabilities | 0 | ||||
Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change | 522 | ||||
Income Annuity [Domain] | Accounting Standards Update 2018-12 | |||||
Liability for Future Policy Benefit, Activity | |||||
Liability for Future Policy Benefit, Expected Future Policy Benefit, Undiscounted, before Reinsurance | 4,809 | ||||
Liability for Future Policy Benefit, Reinsurance Recoverable, after Allowance | 29 | ||||
Future policy benefits | 4,780 | ||||
Income Annuity [Domain] | Accounting Standards Update 2018-12 | Previously Reported | |||||
Liability for Future Policy Benefit, Activity | |||||
Liability for Future Policy Benefit, Expected Future Policy Benefit, Undiscounted, before Reinsurance | 4,260 | ||||
Income Annuity [Domain] | Accounting Standards Update 2018-12 | Revision of Prior Period, Accounting Standards Update, Adjustment | |||||
Liability for Future Policy Benefit, Activity | |||||
Accumulated other comprehensive income (loss) | (203) | ||||
Liability for Future Policy Benefit, Expected Future Policy Benefit, Cumulative Increase (Decrease) from Cash Flow Change | (168) | ||||
Deferred Profit Liabilities | 172 | ||||
Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change | 748 | ||||
Structured Settlement and Pension Risk Transfer Annuities [Domain] | Accounting Standards Update 2018-12 | |||||
Liability for Future Policy Benefit, Activity | |||||
Liability for Future Policy Benefit, Expected Future Policy Benefit, Undiscounted, before Reinsurance | 11,518 | ||||
Liability for Future Policy Benefit, Reinsurance Recoverable, after Allowance | 102 | ||||
Future policy benefits | 11,416 | ||||
Structured Settlement and Pension Risk Transfer Annuities [Domain] | Accounting Standards Update 2018-12 | Previously Reported | |||||
Liability for Future Policy Benefit, Activity | |||||
Liability for Future Policy Benefit, Expected Future Policy Benefit, Undiscounted, before Reinsurance | $ 10,115 | ||||
Structured Settlement and Pension Risk Transfer Annuities [Domain] | Accounting Standards Update 2018-12 | Revision of Prior Period, Accounting Standards Update, Adjustment | |||||
Liability for Future Policy Benefit, Activity | |||||
Accumulated other comprehensive income (loss) | (1,784) | ||||
Liability for Future Policy Benefit, Expected Future Policy Benefit, Cumulative Increase (Decrease) from Cash Flow Change | 200 | ||||
Deferred Profit Liabilities | 217 | ||||
Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change | $ 2,770 |
Changes in liabilities classifi
Changes in liabilities classified as MRBs, ASU 2018-12 Transition (Details) - USD ($) $ in Millions | 12 Months Ended | ||||
Jan. 01, 2021 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Market Risk Benefit [Line Items] | |||||
Market risk benefit liabilities | $ 10,344 | $ 10,411 | $ 16,062 | ||
Change in market risk benefits | 1,497 | 4,105 | 4,142 | ||
Previously Reported | |||||
Market Risk Benefit [Line Items] | |||||
Market risk benefit liabilities | 0 | 0 | |||
Change in market risk benefits | 0 | 0 | |||
Variable Annuities | |||||
Market Risk Benefit [Line Items] | |||||
Market risk benefit liabilities | $ 18,421 | ||||
Market Risk Benefit, before Reinsurance and Cumulative Increase (Decrease) from Instrument-Specific Credit Risk Change | 7,348 | 8,253 | 11,639 | $ 14,969 | |
Market Risk Benefit, Reinsurance Recoverable, after Allowance | 169 | 43 | 71 | 118 | |
Market Risk Benefit, after Reinsurance and Cumulative Increase (Decrease) from Instrument-Specific Credit Risk Change | 18,252 | $ 9,679 | $ 9,926 | $ 15,608 | |
Variable Annuities | Previously Reported | |||||
Market Risk Benefit [Line Items] | |||||
Market risk benefit liabilities | $ 8,622 | ||||
Variable Annuities | Revision of Prior Period, Accounting Standards Update, Adjustment | |||||
Market Risk Benefit [Line Items] | |||||
Change in market risk benefits | 6,347 | ||||
Market Risk Benefit, before Reinsurance and Cumulative Increase (Decrease) from Instrument-Specific Credit Risk Change | $ 3,452 |
Changes in DAC and VOBA, ASU 20
Changes in DAC and VOBA, ASU 2018-12 Transition (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Jan. 01, 2021 | Dec. 31, 2020 |
Variable Annuities | |||||
Deferred Policy Acquisition Cost and Present Value of Future Profit [Line Items] | |||||
Deferred Policy Acquisition Cost | $ 2,217 | $ 2,414 | $ 2,614 | $ 2,786 | |
Present Value of Future Insurance Profits, Net | 309 | 341 | 377 | 428 | |
Variable Annuities | Accounting Standards Update 2018-12 | |||||
Deferred Policy Acquisition Cost and Present Value of Future Profit [Line Items] | |||||
Deferred Policy Acquisition Cost | $ 2,786 | ||||
Present Value of Future Insurance Profits, Net | 428 | ||||
Variable Annuities | Accounting Standards Update 2018-12 | Previously Reported | |||||
Deferred Policy Acquisition Cost and Present Value of Future Profit [Line Items] | |||||
Deferred Policy Acquisition Cost | 2,326 | ||||
Present Value of Future Insurance Profits, Net | 363 | ||||
Variable Annuities | AOCI Attributable to Parent | Accounting Standards Update 2018-12 | Revision of Prior Period, Accounting Standards Update, Adjustment | |||||
Deferred Policy Acquisition Cost and Present Value of Future Profit [Line Items] | |||||
Deferred Policy Acquisition Cost | 460 | ||||
Present Value of Future Insurance Profits, Net | 65 | ||||
Fixed Rate Annuities | |||||
Deferred Policy Acquisition Cost and Present Value of Future Profit [Line Items] | |||||
Deferred Policy Acquisition Cost | 110 | 107 | 88 | 64 | |
Present Value of Future Insurance Profits, Net | 59 | 65 | 70 | 76 | |
Fixed Rate Annuities | Accounting Standards Update 2018-12 | |||||
Deferred Policy Acquisition Cost and Present Value of Future Profit [Line Items] | |||||
Deferred Policy Acquisition Cost | 64 | ||||
Present Value of Future Insurance Profits, Net | 76 | ||||
Fixed Rate Annuities | Accounting Standards Update 2018-12 | Previously Reported | |||||
Deferred Policy Acquisition Cost and Present Value of Future Profit [Line Items] | |||||
Deferred Policy Acquisition Cost | 64 | ||||
Present Value of Future Insurance Profits, Net | 76 | ||||
Fixed Rate Annuities | AOCI Attributable to Parent | Accounting Standards Update 2018-12 | Revision of Prior Period, Accounting Standards Update, Adjustment | |||||
Deferred Policy Acquisition Cost and Present Value of Future Profit [Line Items] | |||||
Deferred Policy Acquisition Cost | 0 | ||||
Present Value of Future Insurance Profits, Net | 0 | ||||
Index-linked Annuities | |||||
Deferred Policy Acquisition Cost and Present Value of Future Profit [Line Items] | |||||
Deferred Policy Acquisition Cost | 1,332 | 1,213 | 1,081 | 886 | |
Present Value of Future Insurance Profits, Net | 0 | 0 | 0 | 0 | |
Index-linked Annuities | Accounting Standards Update 2018-12 | |||||
Deferred Policy Acquisition Cost and Present Value of Future Profit [Line Items] | |||||
Deferred Policy Acquisition Cost | 886 | ||||
Present Value of Future Insurance Profits, Net | 0 | ||||
Index-linked Annuities | Accounting Standards Update 2018-12 | Previously Reported | |||||
Deferred Policy Acquisition Cost and Present Value of Future Profit [Line Items] | |||||
Deferred Policy Acquisition Cost | 886 | ||||
Present Value of Future Insurance Profits, Net | 0 | ||||
Index-linked Annuities | AOCI Attributable to Parent | Accounting Standards Update 2018-12 | Revision of Prior Period, Accounting Standards Update, Adjustment | |||||
Deferred Policy Acquisition Cost and Present Value of Future Profit [Line Items] | |||||
Deferred Policy Acquisition Cost | 0 | ||||
Present Value of Future Insurance Profits, Net | 0 | ||||
Term and Whole Life Insurance | |||||
Deferred Policy Acquisition Cost and Present Value of Future Profit [Line Items] | |||||
Deferred Policy Acquisition Cost | 306 | 347 | 397 | 451 | |
Present Value of Future Insurance Profits, Net | 4 | 5 | 6 | 8 | |
Term and Whole Life Insurance | Accounting Standards Update 2018-12 | |||||
Deferred Policy Acquisition Cost and Present Value of Future Profit [Line Items] | |||||
Deferred Policy Acquisition Cost | 451 | ||||
Present Value of Future Insurance Profits, Net | 8 | ||||
Term and Whole Life Insurance | Accounting Standards Update 2018-12 | Previously Reported | |||||
Deferred Policy Acquisition Cost and Present Value of Future Profit [Line Items] | |||||
Deferred Policy Acquisition Cost | 451 | ||||
Present Value of Future Insurance Profits, Net | 8 | ||||
Term and Whole Life Insurance | AOCI Attributable to Parent | Accounting Standards Update 2018-12 | Revision of Prior Period, Accounting Standards Update, Adjustment | |||||
Deferred Policy Acquisition Cost and Present Value of Future Profit [Line Items] | |||||
Deferred Policy Acquisition Cost | 0 | ||||
Present Value of Future Insurance Profits, Net | 0 | ||||
Universal Life Insurance | |||||
Deferred Policy Acquisition Cost and Present Value of Future Profit [Line Items] | |||||
Deferred Policy Acquisition Cost | 119 | 115 | 114 | 107 | |
Present Value of Future Insurance Profits, Net | $ 31 | $ 35 | $ 39 | 44 | |
Universal Life Insurance | Accounting Standards Update 2018-12 | |||||
Deferred Policy Acquisition Cost and Present Value of Future Profit [Line Items] | |||||
Deferred Policy Acquisition Cost | 107 | ||||
Present Value of Future Insurance Profits, Net | 44 | ||||
Universal Life Insurance | Accounting Standards Update 2018-12 | Previously Reported | |||||
Deferred Policy Acquisition Cost and Present Value of Future Profit [Line Items] | |||||
Deferred Policy Acquisition Cost | 144 | ||||
Present Value of Future Insurance Profits, Net | $ 38 | ||||
Universal Life Insurance | AOCI Attributable to Parent | Accounting Standards Update 2018-12 | Revision of Prior Period, Accounting Standards Update, Adjustment | |||||
Deferred Policy Acquisition Cost and Present Value of Future Profit [Line Items] | |||||
Deferred Policy Acquisition Cost | (37) | ||||
Present Value of Future Insurance Profits, Net | $ 6 |
ASU 2018-12 Transition BS (Deta
ASU 2018-12 Transition BS (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 |
Condensed Balance Sheet Statements, Captions [Line Items] | ||||
Total assets | $ 226,204 | $ 215,438 | $ 249,731 | |
Future policy benefits | 32,149 | 31,146 | 39,830 | |
Policyholder Contract Deposit | 80,193 | 72,602 | 64,290 | |
Market risk benefit liabilities | 10,344 | 10,411 | 16,062 | |
Total liabilities | 220,263 | 208,924 | 241,195 | |
Retained earnings (deficit) | (6,542) | (5,418) | (9,128) | |
Accumulated other comprehensive income (loss) | (5,114) | (5,931) | (199) | $ 5,421 |
Stockholder's Equity, Including Portion Attributable to Noncontrolling Interest | 5,941 | 6,514 | 8,536 | $ 18,115 |
Liabilities and Equity | $ 226,204 | 215,438 | 249,731 | |
Previously Reported | ||||
Condensed Balance Sheet Statements, Captions [Line Items] | ||||
Total assets | 216,151 | 247,255 | ||
Future policy benefits | 41,105 | 43,589 | ||
Policyholder Contract Deposit | 74,112 | 66,195 | ||
Market risk benefit liabilities | 0 | 0 | ||
Total liabilities | 209,287 | 231,144 | ||
Retained earnings (deficit) | (5,717) | (5,653) | ||
Accumulated other comprehensive income (loss) | (5,282) | 3,901 | ||
Stockholder's Equity, Including Portion Attributable to Noncontrolling Interest | 6,864 | 16,111 | ||
Liabilities and Equity | 216,151 | 247,255 | ||
Revision of Prior Period, Accounting Standards Update, Adjustment | Accounting Standards Update 2018-12 | ||||
Condensed Balance Sheet Statements, Captions [Line Items] | ||||
Total assets | (713) | 2,476 | ||
Future policy benefits | (9,959) | (3,759) | ||
Policyholder Contract Deposit | (1,510) | (1,905) | ||
Market risk benefit liabilities | 10,411 | 16,062 | ||
Total liabilities | (363) | 10,051 | ||
Retained earnings (deficit) | 299 | (3,475) | ||
Accumulated other comprehensive income (loss) | (649) | (4,100) | ||
Stockholder's Equity, Including Portion Attributable to Noncontrolling Interest | (350) | (7,575) | ||
Liabilities and Equity | $ (713) | $ 2,476 |
ASU 2018-12 Transition IS (Deta
ASU 2018-12 Transition IS (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Condensed Income Statements, Captions [Line Items] | |||
Insurance Commissions and Fees | $ 1,778 | $ 1,876 | $ 2,320 |
Net derivative gains (losses) | (3,920) | (585) | (3,986) |
Total revenues | 3,405 | 6,162 | 4,110 |
Policyholder Benefits and Claims Incurred, Net | 2,418 | 2,186 | 2,485 |
Change in market risk benefits | (1,497) | (4,105) | (4,142) |
Total expenses | 4,911 | 1,656 | 1,968 |
Post-tax adjusted earnings | $ (1,123) | 3,711 | 1,763 |
Previously Reported | |||
Condensed Income Statements, Captions [Line Items] | |||
Insurance Commissions and Fees | 2,562 | 2,986 | |
Net derivative gains (losses) | 402 | (2,359) | |
Total revenues | 7,832 | 6,400 | |
Policyholder Benefits and Claims Incurred, Net | 4,143 | 3,213 | |
Change in market risk benefits | 0 | 0 | |
Total expenses | 8,103 | 6,404 | |
Post-tax adjusted earnings | (63) | 67 | |
Revision of Prior Period, Accounting Standards Update, Adjustment | Accounting Standards Update 2018-12 | |||
Condensed Income Statements, Captions [Line Items] | |||
Insurance Commissions and Fees | (686) | (666) | |
Net derivative gains (losses) | (987) | (1,627) | |
Total revenues | (1,670) | (2,290) | |
Policyholder Benefits and Claims Incurred, Net | (1,957) | (728) | |
Change in market risk benefits | (4,105) | (4,142) | |
Total expenses | (6,447) | (4,436) | |
Post-tax adjusted earnings | $ 3,774 | $ 1,696 |
Segment Information (Operating
Segment Information (Operating Results) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Segment Reporting Information [Line Items] | |||
Pre-tax adjusted earnings | $ (1,506) | $ 4,506 | $ 2,142 |
Provision for income tax expense (benefit) | (383) | 795 | 379 |
Post-tax adjusted earnings | (1,123) | 3,711 | 1,763 |
Less: Net income (loss) attributable to noncontrolling interests | 1 | 1 | 1 |
Net investment gains (losses) | (242) | (240) | (63) |
Investment Hedge Adjustment | 4,560 | 4,064 | 4,815 |
Change in market risk benefits | 1,497 | 4,105 | 4,142 |
Market value adjustments | 1,801 | 1,313 | 1,243 |
Net income (loss) attributable to Brighthouse Life Insurance Company | (1,124) | 3,710 | 1,762 |
Annuities | |||
Segment Reporting Information [Line Items] | |||
Interest revenue | 2,558 | 2,254 | 2,207 |
Interest expense | 0 | 0 | 0 |
Life | |||
Segment Reporting Information [Line Items] | |||
Interest revenue | 391 | 396 | 643 |
Interest expense | 0 | 0 | 0 |
Run-off | |||
Segment Reporting Information [Line Items] | |||
Interest revenue | 1,141 | 1,166 | 1,910 |
Interest expense | 0 | 0 | 0 |
Corporate & Other | |||
Segment Reporting Information [Line Items] | |||
Interest revenue | 575 | 319 | 76 |
Interest expense | 70 | 70 | 67 |
Operating Segments | |||
Segment Reporting Information [Line Items] | |||
Pre-tax adjusted earnings | 1,276 | 1,211 | 2,053 |
Provision for income tax expense (benefit) | 202 | 103 | 358 |
Post-tax adjusted earnings | 1,074 | 1,108 | 1,695 |
Less: Net income (loss) attributable to noncontrolling interests | 1 | 1 | 1 |
Adjusted earnings | 1,073 | 1,107 | 1,694 |
Operating Segments | Annuities | |||
Segment Reporting Information [Line Items] | |||
Pre-tax adjusted earnings | 1,380 | 1,291 | 1,550 |
Provision for income tax expense (benefit) | 257 | 244 | 296 |
Post-tax adjusted earnings | 1,123 | 1,047 | 1,254 |
Less: Net income (loss) attributable to noncontrolling interests | 0 | 0 | 0 |
Adjusted earnings | 1,123 | 1,047 | 1,254 |
Operating Segments | Life | |||
Segment Reporting Information [Line Items] | |||
Pre-tax adjusted earnings | 86 | (32) | 532 |
Provision for income tax expense (benefit) | 17 | (8) | 112 |
Post-tax adjusted earnings | 69 | (24) | 420 |
Less: Net income (loss) attributable to noncontrolling interests | 0 | 0 | 0 |
Adjusted earnings | 69 | (24) | 420 |
Operating Segments | Run-off | |||
Segment Reporting Information [Line Items] | |||
Pre-tax adjusted earnings | (99) | 108 | 264 |
Provision for income tax expense (benefit) | (22) | 21 | 58 |
Post-tax adjusted earnings | (77) | 87 | 206 |
Less: Net income (loss) attributable to noncontrolling interests | 0 | 0 | 0 |
Adjusted earnings | (77) | 87 | 206 |
Operating Segments | Corporate & Other | |||
Segment Reporting Information [Line Items] | |||
Pre-tax adjusted earnings | (91) | (156) | (293) |
Provision for income tax expense (benefit) | (50) | (154) | (108) |
Post-tax adjusted earnings | (41) | (2) | (185) |
Less: Net income (loss) attributable to noncontrolling interests | 1 | 1 | 1 |
Adjusted earnings | (42) | (3) | (186) |
Segment Reconciling Items | |||
Segment Reporting Information [Line Items] | |||
Provision for income tax expense (benefit) | 585 | (692) | (21) |
Net investment gains (losses) | (242) | (240) | (63) |
Net derivative gains (losses), excluding investment hedge adjustments | (4,025) | (656) | (4,007) |
Investment Hedge Adjustment | (105) | (71) | (21) |
Change in market risk benefits | 1,497 | 4,105 | 4,142 |
Market value adjustments | $ (12) | $ 86 | $ 17 |
Segment Information (Reconcilia
Segment Information (Reconciliation of Operating Revenues to Total Revenues) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Segment Reporting Information [Line Items] | |||
Total revenues | $ 3,405 | $ 6,162 | $ 4,110 |
Segment Reconciling Items | |||
Segment Reporting Information [Line Items] | |||
Total revenues | (4,267) | (896) | (4,070) |
Operating Segments | Annuities | |||
Segment Reporting Information [Line Items] | |||
Total revenues | 4,440 | 4,048 | 4,297 |
Operating Segments | Life | |||
Segment Reporting Information [Line Items] | |||
Total revenues | 1,013 | 988 | 1,382 |
Operating Segments | Run-off | |||
Segment Reporting Information [Line Items] | |||
Total revenues | 1,643 | 1,703 | 2,425 |
Operating Segments | Corporate & Other | |||
Segment Reporting Information [Line Items] | |||
Total revenues | $ 576 | $ 319 | $ 76 |
Segment Information (Total Asse
Segment Information (Total Assets by Segment) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 |
Segment Reporting Information [Line Items] | |||
Total assets | $ 226,204 | $ 215,438 | $ 249,731 |
Annuities | |||
Segment Reporting Information [Line Items] | |||
Total assets | 157,614 | 148,228 | |
Life | |||
Segment Reporting Information [Line Items] | |||
Total assets | 20,363 | 17,214 | |
Run-off | |||
Segment Reporting Information [Line Items] | |||
Total assets | 26,849 | 28,466 | |
Corporate & Other | |||
Segment Reporting Information [Line Items] | |||
Total assets | $ 21,378 | $ 21,530 |
Segment Information (Premiums,
Segment Information (Premiums, Universal Life and Investment-Type Product Policy Fees and Other Revenues by Major Product Group) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Segment Reporting Information [Line Items] | |||
Total premiums, universal life and investment-type product policy fees and other revenues | $ 3,007 | $ 2,923 | $ 3,344 |
Annuity products | |||
Segment Reporting Information [Line Items] | |||
Total premiums, universal life and investment-type product policy fees and other revenues | 1,890 | 1,796 | 2,093 |
Life insurance products | |||
Segment Reporting Information [Line Items] | |||
Total premiums, universal life and investment-type product policy fees and other revenues | 1,110 | 1,119 | 1,243 |
Accident & health insurance | |||
Segment Reporting Information [Line Items] | |||
Total premiums, universal life and investment-type product policy fees and other revenues | $ 7 | $ 8 | $ 8 |
Segment Information (Narrative)
Segment Information (Narrative) (Details) | 12 Months Ended |
Dec. 31, 2023 Segment | |
Segment Reporting [Abstract] | |
Number of segments | 3 |
Insurance Liabilities (Future P
Insurance Liabilities (Future Policy Benefits Information by Product) (Details) - USD ($) $ in Millions | 12 Months Ended | |||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||
Liability for Future Policy Benefit, before Reinsurance | $ 32,149 | $ 31,146 | ||
Future policy benefits | 32,149 | 31,146 | $ 39,830 | |
Term and Whole Life Insurance | ||||
Liability for Future Policy Benefit, Expected Net Premium [Roll Forward] | ||||
Liability for Future Policy Benefit, Expected Net Premium, before Reinsurance, after Discount Rate Change | 2,899 | 2,804 | 3,212 | $ 3,274 |
Liability for Future Policy Benefit, Expected Net Premium, Original Discount Rate, before Cash Flow and Reinsurance | 3,162 | 3,146 | 2,964 | 2,868 |
Liability for Future Policy Benefit, Expected Net Premium, Cumulative Increase (Decrease) from Model Refinements | 0 | 121 | 0 | |
Liability for Future Policy Benefit, Expected Net Premium, Cumulative Increase (Decrease) from Cash Flow Change | 206 | 159 | 100 | |
Liability for Future Policy Benefit, Expected Net Premium, Cumulative Increase (Decrease) of Actual Variance from Expected Experience | (17) | 114 | 158 | |
Liability for Future Policy Benefit, Expected Net Premium, Original Discount Rate, before Reinsurance, after Cash Flow Change | 3,335 | 3,358 | 3,126 | |
Liability for Future Policy Benefit, Expected Net Premium, Issuance | 93 | 93 | 112 | |
Liability for Future Policy Benefit, Expected Net Premium, Interest Income | 108 | 112 | 107 | |
Liability for Future Policy Benefit, Expected Net Premium, Net Premium Collected | (374) | (417) | (381) | |
AOCI, Liability for Future Policy Benefit, Expected Net Premium, before Tax | (263) | (342) | 248 | |
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||
Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change | 5,385 | 5,172 | 6,253 | 6,606 |
Liability for Future Policy Benefit, Expected Future Policy Benefit, Original Discount Rate, before Cash Flow and Reinsurance | 5,905 | 5,816 | 5,682 | 5,678 |
Liability for Future Policy Benefit, Expected Future Policy Benefit, Cumulative Increase (Decrease) from Model Refinements | 0 | 134 | 0 | |
Liability for Future Policy Benefit, Expected Future Policy Benefit, Cumulative Increase (Decrease) from Cash Flow Change | 296 | 179 | 100 | |
Liability for Future Policy Benefit, Expected Future Policy Benefit, Cumulative Increase (Decrease) of Actual Variance from Expected Experience | (15) | 150 | 158 | |
Liability for Future Policy Benefit, Expected Future Benefit, Original Discount Rate, before Reinsurance, after Cash Flow Change | 6,097 | 6,145 | 5,936 | |
Liability for Future Policy Benefit, Expected Future Policy Benefit, Issuance | 99 | 101 | 128 | |
Liability for Future Policy Benefit, Expected Future Policy Benefit, Interest Expense | 211 | 216 | 214 | |
Liability for Future Policy Benefit, Expected Future Policy Benefit, Benefit Payment | (502) | (646) | (596) | |
AOCI, Liability for Future Policy Benefit, Expected Future Policy Benefit, before Tax | (520) | (644) | 571 | |
Liability for Future Policy Benefit, before Reinsurance | 2,486 | 2,368 | 3,041 | |
Liability for Future Policy Benefit, Reinsurance Recoverable, after Allowance | 24 | 32 | 42 | |
Future policy benefits | $ 2,462 | $ 2,336 | $ 2,999 | |
Liability for Future Policy Benefit, Weighted-Average Duration | 8 years 9 months 18 days | 8 years 6 months | 8 years 6 months | |
Liability for Future Policy Benefit, Weighted-Average Interest Accretion Rate | 3.91% | 3.94% | 3.94% | |
Liability for Future Policy Benefit, Current Weighted-Average Discount Rate | 4.94% | 5.26% | 2.53% | |
Liability for Future Policy Benefit, Gross Premium Income | $ 595 | $ 625 | $ 648 | |
Liability for Future Policy Benefit, Expected Future Gross Premium, Undiscounted, before Reinsurance | 5,999 | 6,535 | 6,736 | |
Liability for Future Policy Benefit, Expected Future Gross Premium, Discounted, before Reinsurance | 4,535 | 4,875 | 5,014 | |
Liability for Future Policy Benefit, Expected Future Policy Benefit, Undiscounted, before Reinsurance | 8,148 | 8,015 | 7,877 | |
Liability for Future Policy Benefit, Expected Future Policy Benefit, Discounted, before Reinsurance | 5,905 | 5,816 | 5,682 | |
Income Annuities | ||||
Liability for Future Policy Benefit, Expected Net Premium [Roll Forward] | ||||
Liability for Future Policy Benefit, Expected Net Premium, before Reinsurance, after Discount Rate Change | 0 | 0 | 0 | 0 |
Liability for Future Policy Benefit, Expected Net Premium, Original Discount Rate, before Cash Flow and Reinsurance | 0 | 0 | 0 | 0 |
Liability for Future Policy Benefit, Expected Net Premium, Cumulative Increase (Decrease) from Model Refinements | 0 | 0 | 0 | |
Liability for Future Policy Benefit, Expected Net Premium, Cumulative Increase (Decrease) from Cash Flow Change | 0 | 0 | 0 | |
Liability for Future Policy Benefit, Expected Net Premium, Cumulative Increase (Decrease) of Actual Variance from Expected Experience | 0 | 0 | 0 | |
Liability for Future Policy Benefit, Expected Net Premium, Original Discount Rate, before Reinsurance, after Cash Flow Change | 0 | 0 | 0 | |
Liability for Future Policy Benefit, Expected Net Premium, Issuance | 0 | 0 | 0 | |
Liability for Future Policy Benefit, Expected Net Premium, Interest Income | 0 | 0 | 0 | |
Liability for Future Policy Benefit, Expected Net Premium, Net Premium Collected | 0 | 0 | 0 | |
AOCI, Liability for Future Policy Benefit, Expected Net Premium, before Tax | 0 | 0 | 0 | |
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||
Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change | 3,719 | 3,469 | 4,283 | 4,636 |
Liability for Future Policy Benefit, Expected Future Policy Benefit, Original Discount Rate, before Cash Flow and Reinsurance | 3,993 | 3,848 | 3,817 | 3,889 |
Liability for Future Policy Benefit, Expected Future Policy Benefit, Cumulative Increase (Decrease) from Model Refinements | 0 | 0 | 0 | |
Liability for Future Policy Benefit, Expected Future Policy Benefit, Cumulative Increase (Decrease) from Cash Flow Change | 0 | 55 | (40) | |
Liability for Future Policy Benefit, Expected Future Policy Benefit, Cumulative Increase (Decrease) of Actual Variance from Expected Experience | (21) | (21) | (6) | |
Liability for Future Policy Benefit, Expected Future Benefit, Original Discount Rate, before Reinsurance, after Cash Flow Change | 3,827 | 3,851 | 3,843 | |
Liability for Future Policy Benefit, Expected Future Policy Benefit, Issuance | 369 | 220 | 193 | |
Liability for Future Policy Benefit, Expected Future Policy Benefit, Interest Expense | 139 | 144 | 149 | |
Liability for Future Policy Benefit, Expected Future Policy Benefit, Benefit Payment | (342) | (367) | (368) | |
AOCI, Liability for Future Policy Benefit, Expected Future Policy Benefit, before Tax | (274) | (379) | 466 | |
Liability for Future Policy Benefit, before Reinsurance | 3,719 | 3,469 | 4,283 | |
Liability for Future Policy Benefit, Reinsurance Recoverable, after Allowance | 30 | 25 | 28 | |
Future policy benefits | $ 3,689 | $ 3,444 | $ 4,255 | |
Liability for Future Policy Benefit, Weighted-Average Duration | 8 years 2 months 12 days | 8 years 6 months | 8 years 6 months | |
Liability for Future Policy Benefit, Weighted-Average Interest Accretion Rate | 3.99% | 3.89% | 3.98% | |
Liability for Future Policy Benefit, Current Weighted-Average Discount Rate | 4.95% | 5.27% | 2.55% | |
Liability for Future Policy Benefit, Gross Premium Income | $ 472 | $ 243 | $ 240 | |
Liability for Future Policy Benefit, Expected Future Gross Premium, Undiscounted, before Reinsurance | 0 | 0 | 0 | |
Liability for Future Policy Benefit, Expected Future Gross Premium, Discounted, before Reinsurance | 0 | 0 | 0 | |
Liability for Future Policy Benefit, Expected Future Policy Benefit, Undiscounted, before Reinsurance | 5,616 | 5,434 | 5,446 | |
Liability for Future Policy Benefit, Expected Future Policy Benefit, Discounted, before Reinsurance | 3,993 | 3,848 | 3,817 | |
Structured Settlement and Pension Risk Transfer Annuities | ||||
Liability for Future Policy Benefit, Expected Net Premium [Roll Forward] | ||||
Liability for Future Policy Benefit, Expected Net Premium, before Reinsurance, after Discount Rate Change | 0 | 0 | 0 | 0 |
Liability for Future Policy Benefit, Expected Net Premium, Original Discount Rate, before Cash Flow and Reinsurance | 0 | 0 | 0 | 0 |
Liability for Future Policy Benefit, Expected Net Premium, Cumulative Increase (Decrease) from Model Refinements | 0 | 0 | 0 | |
Liability for Future Policy Benefit, Expected Net Premium, Cumulative Increase (Decrease) from Cash Flow Change | 0 | 0 | 0 | |
Liability for Future Policy Benefit, Expected Net Premium, Cumulative Increase (Decrease) of Actual Variance from Expected Experience | 0 | 0 | 0 | |
Liability for Future Policy Benefit, Expected Net Premium, Original Discount Rate, before Reinsurance, after Cash Flow Change | 0 | 0 | 0 | |
Liability for Future Policy Benefit, Expected Net Premium, Issuance | 0 | 0 | 0 | |
Liability for Future Policy Benefit, Expected Net Premium, Interest Income | 0 | 0 | 0 | |
Liability for Future Policy Benefit, Expected Net Premium, Net Premium Collected | 0 | 0 | 0 | |
AOCI, Liability for Future Policy Benefit, Expected Net Premium, before Tax | 0 | 0 | 0 | |
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||
Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change | 6,697 | 6,793 | 10,171 | 11,301 |
Liability for Future Policy Benefit, Expected Future Policy Benefit, Original Discount Rate, before Cash Flow and Reinsurance | 7,085 | 7,410 | 8,165 | 8,531 |
Liability for Future Policy Benefit, Expected Future Policy Benefit, Cumulative Increase (Decrease) from Model Refinements | 0 | (278) | 0 | |
Liability for Future Policy Benefit, Expected Future Policy Benefit, Cumulative Increase (Decrease) from Cash Flow Change | 0 | (157) | (41) | |
Liability for Future Policy Benefit, Expected Future Policy Benefit, Cumulative Increase (Decrease) of Actual Variance from Expected Experience | (47) | (23) | (16) | |
Liability for Future Policy Benefit, Expected Future Benefit, Original Discount Rate, before Reinsurance, after Cash Flow Change | 7,363 | 7,707 | $ 8,474 | |
Liability for Future Policy Benefit, Expected Future Policy Benefit, Issuance | 0 | 0 | 0 | |
Liability for Future Policy Benefit, Expected Future Policy Benefit, Interest Expense | 314 | 327 | 359 | |
Liability for Future Policy Benefit, Expected Future Policy Benefit, Benefit Payment | (592) | (624) | (668) | |
AOCI, Liability for Future Policy Benefit, Expected Future Policy Benefit, before Tax | (388) | (617) | 2,006 | |
Liability for Future Policy Benefit, before Reinsurance | 6,697 | 6,793 | 10,171 | |
Liability for Future Policy Benefit, Reinsurance Recoverable, after Allowance | 65 | 68 | 93 | |
Future policy benefits | $ 6,632 | $ 6,725 | $ 10,078 | |
Liability for Future Policy Benefit, Weighted-Average Duration | 11 years 7 months 6 days | 11 years 7 months 6 days | 12 years 8 months 12 days | |
Liability for Future Policy Benefit, Weighted-Average Interest Accretion Rate | 4.46% | 4.45% | 4.45% | |
Liability for Future Policy Benefit, Current Weighted-Average Discount Rate | 5.03% | 5.32% | 2.81% | |
Liability for Future Policy Benefit, Gross Premium Income | $ 0 | $ 0 | $ 0 | |
Liability for Future Policy Benefit, Expected Future Gross Premium, Undiscounted, before Reinsurance | 0 | 0 | 0 | |
Liability for Future Policy Benefit, Expected Future Gross Premium, Discounted, before Reinsurance | 0 | 0 | 0 | |
Liability for Future Policy Benefit, Expected Future Policy Benefit, Undiscounted, before Reinsurance | 13,767 | 14,418 | 17,241 | |
Liability for Future Policy Benefit, Expected Future Policy Benefit, Discounted, before Reinsurance | $ 7,085 | $ 7,410 | $ 8,165 |
Insurance Liabilities (Future_2
Insurance Liabilities (Future Policy Benefits - SOP) (Details) - ULSG - USD ($) $ in Millions | 12 Months Ended | |||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Additional Liability, Long-Duration Insurance [Line Items] | ||||
Additional Liability, Long-Duration Insurance, before Reinsurance, after Discount Rate Change | $ 7,607 | $ 6,935 | $ 7,168 | $ 6,743 |
Additional Liability, Long-Duration Insurance, Original Discount Rate, before Cash Flow and Reinsurance | 7,784 | 7,175 | 6,731 | 6,203 |
Additional Liability, Long-Duration Insurance, Cumulative Increase (Decrease) from Cash Flow Change | 52 | (37) | 153 | |
Additional Liability, Long-Duration Insurance, Cumulative Increase (Decrease) of Actual Variance from Expected Experience | 145 | 179 | (124) | |
Additional Liability, Long-Duration Insurance, Original Discount Rate, before Reinsurance, after Cash Flow Change | 7,372 | 6,873 | $ 6,232 | |
Additional Liability, Long-Duration Insurance, Interest Income (Expense) | 357 | 333 | 308 | |
Additional Liability, Long-Duration Insurance, Net Premium Collected | 414 | 416 | 475 | |
Additional Liability, Long-Duration Insurance, Benefit Payment | (359) | (447) | (286) | |
Additional Liability, Long-Duration Insurance, Remeasurement Gain (Loss) | 0 | 0 | 2 | |
AOCI, Liability for Future Policy Benefit, before Tax | (177) | (240) | 437 | |
Additional Liability, Long-Duration Insurance, Reinsurance Recoverable, after Allowance | 1,438 | 1,384 | 1,294 | |
Additional Liability, Long-Duration Insurance, after Reinsurance | $ 6,169 | $ 5,551 | $ 5,874 | |
Additional Liability, Long-Duration Insurance, Weighted-Average Duration | 6 years 8 months 12 days | 6 years 8 months 12 days | 6 years 8 months 12 days | |
Additional Liability, Long-Duration Insurance, Weighted-Average Interest Accretion Rate | 4.92% | 4.90% | 4.90% | |
Additional Liability, Long-Duration Insurance, Gross Premium Income | $ 1,064 | $ 1,070 | $ 1,255 |
Insurance Liabilities (Future_3
Insurance Liabilities (Future Policy Benefits - Reconciliation) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Liability for Future Policy Benefit, by Product Segment [Line Items] | ||
Liability for Future Policy Benefit, before Reinsurance | $ 32,149 | $ 31,146 |
Liabilities reported in the preceding rollforward tables | ||
Liability for Future Policy Benefit, by Product Segment [Line Items] | ||
Liability for Future Policy Benefit, before Reinsurance | 20,509 | 19,565 |
Long-term care insurance (1) | ||
Liability for Future Policy Benefit, by Product Segment [Line Items] | ||
Liability for Future Policy Benefit, before Reinsurance | 5,581 | 5,686 |
ULSG liabilities, including liability for profits followed by losses | ||
Liability for Future Policy Benefit, by Product Segment [Line Items] | ||
Liability for Future Policy Benefit, before Reinsurance | 2,427 | 2,449 |
Participating whole life insurance (2) | ||
Liability for Future Policy Benefit, by Product Segment [Line Items] | ||
Liability for Future Policy Benefit, before Reinsurance | 2,849 | 2,689 |
Deferred profit liabilities | ||
Liability for Future Policy Benefit, by Product Segment [Line Items] | ||
Liability for Future Policy Benefit, before Reinsurance | 475 | 369 |
Other | ||
Liability for Future Policy Benefit, by Product Segment [Line Items] | ||
Liability for Future Policy Benefit, before Reinsurance | $ 308 | $ 388 |
Insurance Liabilities (Policyho
Insurance Liabilities (Policyholder Account Balances) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Policyholder Account Balance [Line Items] | |||
Policyholder Account Balance, Beginning Balance | $ 72,602 | ||
Interest credited to policyholder account balances | 1,801 | $ 1,313 | $ 1,243 |
Policyholder Account Balance, Ending Balance | 80,193 | 72,602 | |
Universal Life Insurance | |||
Policyholder Account Balance [Line Items] | |||
Policyholder Account Balance, Beginning Balance | 2,100 | 2,134 | 2,110 |
Premiums and deposits | 210 | 199 | 290 |
Surrenders and withdrawals | (129) | (49) | (48) |
Benefit payments | (59) | (59) | (55) |
Net transfers from (to) separate account | 18 | 21 | 17 |
Interest credited to policyholder account balances | 40 | 56 | 84 |
Policy charges | (200) | (202) | (264) |
Changes related to embedded derivatives | 0 | 0 | 0 |
Policyholder Account Balance, Ending Balance | $ 1,980 | $ 2,100 | $ 2,134 |
Weighted-average crediting rate (2) | 2.03% | 2.65% | 3.97% |
Variable Annuities | |||
Policyholder Account Balance [Line Items] | |||
Policyholder Account Balance, Beginning Balance | $ 4,664 | $ 4,475 | $ 4,605 |
Premiums and deposits | 75 | 145 | 194 |
Surrenders and withdrawals | (647) | (453) | (566) |
Benefit payments | (101) | (104) | (95) |
Net transfers from (to) separate account | 14 | 131 | 238 |
Interest credited to policyholder account balances | 129 | 493 | 140 |
Policy charges | (23) | (23) | (41) |
Changes related to embedded derivatives | 0 | 0 | 0 |
Policyholder Account Balance, Ending Balance | $ 4,111 | $ 4,664 | $ 4,475 |
Weighted-average crediting rate (2) | 2.91% | 10.91% | 3.07% |
Index-linked Annuities | |||
Policyholder Account Balance [Line Items] | |||
Policyholder Account Balance, Beginning Balance | $ 33,897 | $ 32,000 | $ 23,274 |
Premiums and deposits | 7,183 | 6,632 | 7,054 |
Surrenders and withdrawals | (3,732) | (2,220) | (1,419) |
Benefit payments | (240) | (180) | (151) |
Net transfers from (to) separate account | 0 | 0 | 0 |
Interest credited to policyholder account balances | 445 | 392 | 365 |
Policy charges | (11) | (8) | (6) |
Changes related to embedded derivatives | 4,085 | (2,719) | 2,883 |
Policyholder Account Balance, Ending Balance | $ 41,627 | $ 33,897 | $ 32,000 |
Weighted-average crediting rate (2) | 1.47% | 1.16% | 1.12% |
Fixed Rate Annuities | |||
Policyholder Account Balance [Line Items] | |||
Policyholder Account Balance, Beginning Balance | $ 14,274 | $ 11,849 | $ 12,349 |
Premiums and deposits | 2,694 | 3,676 | 114 |
Surrenders and withdrawals | (2,405) | (904) | (610) |
Benefit payments | (377) | (345) | (342) |
Net transfers from (to) separate account | 0 | 0 | 0 |
Interest credited to policyholder account balances | 486 | (2) | 338 |
Policy charges | 0 | 0 | 0 |
Changes related to embedded derivatives | 0 | 0 | 0 |
Policyholder Account Balance, Ending Balance | $ 14,672 | $ 14,274 | $ 11,849 |
Weighted-average crediting rate (2) | 3.31% | (0.02%) | 2.79% |
ULSG | |||
Policyholder Account Balance [Line Items] | |||
Policyholder Account Balance, Beginning Balance | $ 5,307 | $ 5,569 | $ 5,823 |
Premiums and deposits | 660 | 697 | 687 |
Surrenders and withdrawals | (23) | (32) | (46) |
Benefit payments | (85) | (84) | (77) |
Net transfers from (to) separate account | 0 | 0 | 0 |
Interest credited to policyholder account balances | 208 | 197 | 186 |
Policy charges | (1,015) | (1,040) | (1,004) |
Changes related to embedded derivatives | 0 | 0 | 0 |
Policyholder Account Balance, Ending Balance | $ 5,052 | $ 5,307 | $ 5,569 |
Weighted-average crediting rate (2) | 4.02% | 3.62% | 3.27% |
Company-Owned Life Insurance | |||
Policyholder Account Balance [Line Items] | |||
Policyholder Account Balance, Beginning Balance | $ 641 | $ 646 | $ 679 |
Premiums and deposits | 0 | 0 | 0 |
Surrenders and withdrawals | 0 | 0 | 0 |
Benefit payments | (8) | (8) | (10) |
Net transfers from (to) separate account | 1 | (13) | (35) |
Interest credited to policyholder account balances | 28 | 23 | 24 |
Policy charges | (9) | (7) | (12) |
Changes related to embedded derivatives | 0 | 0 | 0 |
Policyholder Account Balance, Ending Balance | $ 653 | $ 641 | $ 646 |
Weighted-average crediting rate (2) | 4.33% | 3.41% | 3.66% |
Insurance Liabilities (Reconcil
Insurance Liabilities (Reconciliation of Policyholder Account Balances) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Policyholder Account Balance [Line Items] | ||
Policyholder Account Balance | $ 80,193 | $ 72,602 |
Rollforwards Total | ||
Policyholder Account Balance [Line Items] | ||
Policyholder Account Balance | 68,095 | 60,883 |
Funding agreements classified as investment contracts | ||
Policyholder Account Balance [Line Items] | ||
Policyholder Account Balance | 11,115 | 10,689 |
Other investment contract liabilities | ||
Policyholder Account Balance [Line Items] | ||
Policyholder Account Balance | $ 983 | $ 1,030 |
Insurance Liabilities (Balance
Insurance Liabilities (Balance of Account Values by range of guaranteed minimum crediting rates) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Variable Annuities | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | $ 18,520 | $ 18,426 |
Life | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 1,935 | 2,019 |
ULSG | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 5,042 | 5,327 |
Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range Less Than 0200 | Variable Annuities | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 8,782 | 7,259 |
Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range Less Than 0200 | Life | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 236 | 172 |
Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range Less Than 0200 | ULSG | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 0 | 0 |
Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range From 0200 to 0399 | Variable Annuities | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 8,866 | 10,697 |
Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range From 0200 to 0399 | Life | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 622 | 699 |
Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range From 0200 to 0399 | ULSG | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 4,536 | 4,800 |
Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater | Variable Annuities | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 872 | 470 |
Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater | Life | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 1,077 | 1,148 |
Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater | ULSG | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 506 | 527 |
Policyholder Account Balance, at Guaranteed Minimum Crediting Rate | Variable Annuities | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 9,642 | 6,499 |
Policyholder Account Balance, at Guaranteed Minimum Crediting Rate | Life | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 1,077 | 1,148 |
Policyholder Account Balance, at Guaranteed Minimum Crediting Rate | ULSG | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 1,640 | 1,751 |
Policyholder Account Balance, at Guaranteed Minimum Crediting Rate | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range Less Than 0200 | Variable Annuities | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 645 | 805 |
Policyholder Account Balance, at Guaranteed Minimum Crediting Rate | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range Less Than 0200 | Life | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 0 | 0 |
Policyholder Account Balance, at Guaranteed Minimum Crediting Rate | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range Less Than 0200 | ULSG | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 0 | 0 |
Policyholder Account Balance, at Guaranteed Minimum Crediting Rate | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range From 0200 to 0399 | Variable Annuities | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 8,125 | 5,224 |
Policyholder Account Balance, at Guaranteed Minimum Crediting Rate | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range From 0200 to 0399 | Life | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 0 | 0 |
Policyholder Account Balance, at Guaranteed Minimum Crediting Rate | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range From 0200 to 0399 | ULSG | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 1,134 | 1,224 |
Policyholder Account Balance, at Guaranteed Minimum Crediting Rate | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater | Variable Annuities | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 872 | 470 |
Policyholder Account Balance, at Guaranteed Minimum Crediting Rate | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater | Life | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 1,077 | 1,148 |
Policyholder Account Balance, at Guaranteed Minimum Crediting Rate | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater | ULSG | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 506 | 527 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0001 to 0050 | Variable Annuities | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 437 | 5,164 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0001 to 0050 | Life | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 441 | 462 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0001 to 0050 | ULSG | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 1,485 | 1,581 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0001 to 0050 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range Less Than 0200 | Variable Annuities | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 204 | 293 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0001 to 0050 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range Less Than 0200 | Life | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 0 | 0 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0001 to 0050 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range Less Than 0200 | ULSG | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 0 | 0 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0001 to 0050 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range From 0200 to 0399 | Variable Annuities | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 233 | 4,871 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0001 to 0050 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range From 0200 to 0399 | Life | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 441 | 462 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0001 to 0050 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range From 0200 to 0399 | ULSG | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 1,485 | 1,581 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0001 to 0050 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater | Variable Annuities | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 0 | 0 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0001 to 0050 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater | Life | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 0 | 0 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0001 to 0050 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater | ULSG | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 0 | 0 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0150 | Variable Annuities | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 502 | 950 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0150 | Life | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 49 | 87 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0150 | ULSG | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 1,663 | 1,729 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0150 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range Less Than 0200 | Variable Annuities | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 301 | 356 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0150 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range Less Than 0200 | Life | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 0 | 0 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0150 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range Less Than 0200 | ULSG | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 0 | 0 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0150 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range From 0200 to 0399 | Variable Annuities | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 201 | 594 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0150 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range From 0200 to 0399 | Life | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 49 | 87 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0150 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range From 0200 to 0399 | ULSG | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 1,663 | 1,729 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0150 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater | Variable Annuities | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 0 | 0 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0150 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater | Life | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 0 | 0 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0150 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater | ULSG | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 0 | 0 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0151 and Greater | Variable Annuities | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 7,939 | 5,813 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0151 and Greater | Life | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 368 | 322 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0151 and Greater | ULSG | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 254 | 266 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0151 and Greater | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range Less Than 0200 | Variable Annuities | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 7,632 | 5,805 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0151 and Greater | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range Less Than 0200 | Life | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 236 | 172 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0151 and Greater | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range Less Than 0200 | ULSG | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 0 | 0 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0151 and Greater | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range From 0200 to 0399 | Variable Annuities | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 307 | 8 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0151 and Greater | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range From 0200 to 0399 | Life | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 132 | 150 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0151 and Greater | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range From 0200 to 0399 | ULSG | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 254 | 266 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0151 and Greater | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater | Variable Annuities | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 0 | 0 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0151 and Greater | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater | Life | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | 0 | 0 |
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0151 and Greater | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater | ULSG | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||
Policyholder Account Balances gross of policy loans and excludes excessing interest reserves | $ 0 | $ 0 |
Insurance Liabilities (Liabilit
Insurance Liabilities (Liability for Future Policy Benefits - Narrative) (Details) | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Mean Reversion Rate | 0.0375 | 0.0350 | 0.0300 |
Participating whole life insurance (2) | |||
Participating Insurance, Percentage of Gross Insurance in Force | 3% | ||
Participating Insurance, Percentage of Premium Income | 40% | 41% | |
Participating whole life insurance (2) | Minimum | |||
Liability for Future Policy Benefits, Interest Rate | 3.50% | ||
Participating whole life insurance (2) | Maximum | |||
Liability for Future Policy Benefits, Interest Rate | 4% |
Insurance Liabilities (Obligati
Insurance Liabilities (Obligations Under Funding Agreements - Narrative) (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Line of Credit Facility [Line Items] | ||
Outstanding funding agreements to certain SPEs | $ 5,500 | $ 5,500 |
Outstanding funding agreements to certain SPEs - Inactive | 525 | 525 |
Federal Home Loan Bank of Atlanta | ||
Line of Credit Facility [Line Items] | ||
Federal Home Loan Bank, Advances, Branch of FHLB Bank, Amount of Advances | 4,400 | 3,900 |
Farmer Mac Funding Agreements [Member] | ||
Line of Credit Facility [Line Items] | ||
Line of Credit Facility, Maximum Amount Outstanding During Period | $ 700 | $ 700 |
Market Risk Benefits (Details)
Market Risk Benefits (Details) - USD ($) $ in Millions | 12 Months Ended | ||||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Jan. 01, 2021 | Dec. 31, 2020 | |
Variable Annuities | |||||
Market Risk Benefit [Line Items] | |||||
Market Risk Benefit, after Increase (Decrease) from Instrument-Specific Credit Risk | $ 9,722 | $ 9,997 | $ 15,726 | $ 18,421 | |
Market Risk Benefit, before Reinsurance and Cumulative Increase (Decrease) from Instrument-Specific Credit Risk Change | 7,348 | 8,253 | 11,639 | $ 14,969 | |
Market Risk Benefit, Decrements | (176) | 16 | (70) | ||
Market Risk Benefit, Increase (Decrease) from Future Expected Policyholder Behavior Assumption | 260 | 212 | 41 | ||
Market Risk Benefit, Increase (Decrease) from Actual Policyholder Behavior Different from Expected | 186 | (48) | (86) | ||
Market Risk Benefit, Increase (Decrease) from Interest Rate Change | (427) | (8,397) | (1,831) | ||
Market Risk Benefit, Increase (Decrease) from Equity Market Change | (2,203) | 3,806 | (2,578) | ||
Market Risk Benefit, Issuance | (7) | (47) | (96) | ||
Market Risk Benefit, Effect of changes in risk margin | (34) | (152) | (128) | ||
Market Risk Benefit, Aging of the Block and Other | 1,496 | 1,224 | 1,418 | ||
AOCI, Market Risk Benefit, Instrument-Specific Credit Risk, before Tax | 2,374 | 1,744 | 4,087 | ||
Market Risk Benefit, Reinsurance Recoverable, after Allowance | 43 | 71 | 118 | $ 169 | |
Market Risk Benefit, after Reinsurance and Cumulative Increase (Decrease) from Instrument-Specific Credit Risk Change | $ 9,679 | $ 9,926 | $ 15,608 | $ 18,252 | |
Market Risk Benefit, Weighted-Average Attained Age of Contract holder | 73 years | 71 years 9 months 18 days | 71 years 1 month 6 days | ||
Index-linked Annuities | |||||
Market Risk Benefit [Line Items] | |||||
Market Risk Benefit, after Increase (Decrease) from Instrument-Specific Credit Risk | $ 9 | $ 2 | $ 5 |
Separate Accounts (Separate Acc
Separate Accounts (Separate Account Liability) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Separate Account, Liability [Line Items] | |||
Separate Account, Liability, Beginning Balance | $ 78,880 | ||
Separate Account, Liability, Ending Balance | 81,690 | $ 78,880 | |
Variable Annuities | |||
Separate Account, Liability [Line Items] | |||
Separate Account, Liability, Beginning Balance | 74,845 | 101,108 | $ 99,257 |
Premiums and deposits | 762 | 1,199 | 2,081 |
Surrenders and withdrawals | (6,073) | (5,965) | (7,971) |
Benefit payments | (1,391) | (1,298) | (1,575) |
Investment performance | 11,071 | (17,878) | 12,054 |
Policy charges | (2,098) | (2,227) | (2,481) |
Net transfers from (to) general account | (14) | (131) | (238) |
Other | (16) | 37 | (19) |
Separate Account, Liability, Ending Balance | 77,086 | 74,845 | 101,108 |
Universal Life Insurance | |||
Separate Account, Liability [Line Items] | |||
Separate Account, Liability, Beginning Balance | 1,970 | 2,576 | 2,339 |
Premiums and deposits | 84 | 91 | 97 |
Surrenders and withdrawals | (68) | (55) | (69) |
Benefit payments | (18) | (24) | (24) |
Investment performance | 405 | (519) | 336 |
Policy charges | (78) | (78) | (85) |
Net transfers from (to) general account | (18) | (21) | (17) |
Other | (1) | 0 | (1) |
Separate Account, Liability, Ending Balance | 2,276 | 1,970 | 2,576 |
Company-Owned Life Insurance | |||
Separate Account, Liability [Line Items] | |||
Separate Account, Liability, Beginning Balance | 1,919 | 2,367 | 2,253 |
Premiums and deposits | 0 | 0 | 3 |
Surrenders and withdrawals | (20) | (16) | (68) |
Benefit payments | (28) | (33) | (38) |
Investment performance | 327 | (356) | 234 |
Policy charges | (58) | (61) | (47) |
Net transfers from (to) general account | (1) | 13 | 35 |
Other | 9 | 5 | (5) |
Separate Account, Liability, Ending Balance | $ 2,148 | $ 1,919 | $ 2,367 |
Separate Accounts (Reconciliati
Separate Accounts (Reconciliation of Separate Account Liability) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Separate Account, Liability [Line Items] | ||
Separate account liabilities | $ 81,690 | $ 78,880 |
Variable income annuities | 161 | 130 |
Pension risk transfer annuities | 19 | 16 |
Rollforwards Total | ||
Separate Account, Liability [Line Items] | ||
Separate account liabilities | $ 81,510 | $ 78,734 |
Separate Accounts (Aggregate FV
Separate Accounts (Aggregate FV of Assets Supporting Separate Accounts) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Separate Account, Liability [Line Items] | ||
Separate account assets | $ 81,690 | $ 78,880 |
Equity securities | ||
Separate Account, Liability [Line Items] | ||
Separate account assets | 81,417 | 78,583 |
Fixed maturity securities | ||
Separate Account, Liability [Line Items] | ||
Separate account assets | 259 | 277 |
Cash and cash equivalents | ||
Separate Account, Liability [Line Items] | ||
Separate account assets | 7 | 9 |
Other assets | ||
Separate Account, Liability [Line Items] | ||
Separate account assets | $ 7 | $ 11 |
Separate Accounts (Net Amount a
Separate Accounts (Net Amount at Risk and Cash Surrender Value) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 |
Net Amount at Risk by Product and Guarantee [Line Items] | ||||
Policyholder Account Balance | $ 80,193 | $ 72,602 | ||
Separate account liabilities | 81,690 | 78,880 | ||
Universal Life Insurance | ||||
Net Amount at Risk by Product and Guarantee [Line Items] | ||||
Policyholder Account Balance | 1,980 | 2,100 | $ 2,134 | $ 2,110 |
Separate account liabilities | 2,276 | 1,970 | 2,576 | |
Total account balances | 4,256 | 4,070 | 4,710 | |
Net amount at risk | 22,214 | 23,818 | 24,995 | |
Cash surrender value | 4,049 | 3,789 | 4,407 | |
Variable Annuities | ||||
Net Amount at Risk by Product and Guarantee [Line Items] | ||||
Policyholder Account Balance | 4,111 | 4,664 | 4,475 | 4,605 |
Separate account liabilities | 77,086 | 74,845 | 101,108 | 99,257 |
Total account balances | 81,197 | 79,509 | 105,583 | |
Net amount at risk | 13,156 | 16,334 | 6,316 | |
Cash surrender value | 80,756 | 79,222 | 105,574 | |
Index-linked Annuities | ||||
Net Amount at Risk by Product and Guarantee [Line Items] | ||||
Policyholder Account Balance | 41,627 | 33,897 | 32,000 | 23,274 |
Separate account liabilities | 0 | 0 | 0 | |
Total account balances | 41,627 | 33,897 | 32,000 | |
Cash surrender value | 39,270 | 31,293 | 29,848 | |
Fixed Rate Annuities | ||||
Net Amount at Risk by Product and Guarantee [Line Items] | ||||
Policyholder Account Balance | 14,672 | 14,274 | 11,849 | 12,349 |
Separate account liabilities | 0 | 0 | 0 | |
Total account balances | 14,672 | 14,274 | 11,849 | |
Cash surrender value | 14,068 | 13,723 | 11,112 | |
ULSG | ||||
Net Amount at Risk by Product and Guarantee [Line Items] | ||||
Policyholder Account Balance | 5,052 | 5,307 | 5,569 | 5,823 |
Separate account liabilities | 0 | 0 | 0 | |
Total account balances | 5,052 | 5,307 | 5,569 | |
Net amount at risk | 65,299 | 66,926 | 68,905 | |
Cash surrender value | 4,498 | 4,671 | 4,821 | |
Company-Owned Life Insurance | ||||
Net Amount at Risk by Product and Guarantee [Line Items] | ||||
Policyholder Account Balance | 653 | 641 | 646 | 679 |
Separate account liabilities | 2,148 | 1,919 | 2,367 | $ 2,253 |
Total account balances | 2,801 | 2,560 | 3,013 | |
Net amount at risk | 2,644 | 3,368 | 3,665 | |
Cash surrender value | $ 2,579 | $ 2,344 | $ 2,794 |
Deferred Policy Acquisition C_3
Deferred Policy Acquisition Costs, Value of Business Acquired and Other Intangibles (Information Regarding DAC and VOBA) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Deferred Policy Acquisition Cost and Present Value of Future Profit [Line Items] | |||
Balance, end of period, Total DAC and VOBA | $ 4,487 | $ 4,642 | |
Variable Annuities | |||
Deferred Policy Acquisition Cost and Present Value of Future Profit [Line Items] | |||
Balance, beginning of period, DAC | 2,414 | 2,614 | $ 2,786 |
Capitalization | 36 | 54 | 90 |
Amortization | (233) | (254) | (262) |
Balance, end of period, DAC | 2,217 | 2,414 | 2,614 |
Balance, beginning of period, VOBA | 341 | 377 | 428 |
Amortization | (32) | (36) | (51) |
Balance, end of period, VOBA | 309 | 341 | 377 |
Balance, end of period, Total DAC and VOBA | 2,526 | 2,755 | 2,991 |
Fixed Rate Annuities | |||
Deferred Policy Acquisition Cost and Present Value of Future Profit [Line Items] | |||
Balance, beginning of period, DAC | 107 | 88 | 64 |
Capitalization | 14 | 31 | 36 |
Amortization | (11) | (12) | (12) |
Balance, end of period, DAC | 110 | 107 | 88 |
Balance, beginning of period, VOBA | 65 | 70 | 76 |
Amortization | (6) | (5) | (6) |
Balance, end of period, VOBA | 59 | 65 | 70 |
Balance, end of period, Total DAC and VOBA | 169 | 172 | 158 |
Index-linked Annuities | |||
Deferred Policy Acquisition Cost and Present Value of Future Profit [Line Items] | |||
Balance, beginning of period, DAC | 1,213 | 1,081 | 886 |
Capitalization | 344 | 330 | 355 |
Amortization | (225) | (198) | (160) |
Balance, end of period, DAC | 1,332 | 1,213 | 1,081 |
Balance, beginning of period, VOBA | 0 | 0 | 0 |
Amortization | 0 | 0 | 0 |
Balance, end of period, VOBA | 0 | 0 | 0 |
Balance, end of period, Total DAC and VOBA | 1,332 | 1,213 | 1,081 |
Term and Whole Life Insurance | |||
Deferred Policy Acquisition Cost and Present Value of Future Profit [Line Items] | |||
Balance, beginning of period, DAC | 347 | 397 | 451 |
Capitalization | 2 | (1) | (3) |
Amortization | (43) | (49) | (51) |
Balance, end of period, DAC | 306 | 347 | 397 |
Balance, beginning of period, VOBA | 5 | 6 | 8 |
Amortization | (1) | (1) | (2) |
Balance, end of period, VOBA | 4 | 5 | 6 |
Balance, end of period, Total DAC and VOBA | 310 | 352 | 403 |
Universal Life Insurance | |||
Deferred Policy Acquisition Cost and Present Value of Future Profit [Line Items] | |||
Balance, beginning of period, DAC | 115 | 114 | 107 |
Capitalization | 13 | 10 | 16 |
Amortization | (9) | (9) | (9) |
Balance, end of period, DAC | 119 | 115 | 114 |
Balance, beginning of period, VOBA | 35 | 39 | 44 |
Amortization | (4) | (4) | (5) |
Balance, end of period, VOBA | 31 | 35 | 39 |
Balance, end of period, Total DAC and VOBA | $ 150 | $ 150 | $ 153 |
Deferred Policy Acquisition C_4
Deferred Policy Acquisition Costs, Value of Business Acquired and Other Intangibles (Information Regarding DSI) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Variable Annuities | |||
Deferred Sale Inducement Cost [Line Items] | |||
Balance, beginning of year | $ 233 | $ 259 | $ 283 |
Capitalization | 1 | 1 | 1 |
Amortization | (25) | (27) | (25) |
Balance, end of year | 209 | 233 | 259 |
Fixed Rate Annuities | |||
Deferred Sale Inducement Cost [Line Items] | |||
Balance, beginning of year | 9 | 10 | 12 |
Capitalization | 0 | 0 | 0 |
Amortization | (1) | (1) | (2) |
Balance, end of year | $ 8 | $ 9 | $ 10 |
Deferred Policy Acquisition C_5
Deferred Policy Acquisition Costs, Value of Business Acquired and Other Intangibles (Unearned Revenue) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Universal Life Insurance | |||
Deferred Revenue Arrangement [Line Items] | |||
Balance, beginning of year | $ 143 | $ 118 | $ 80 |
Capitalization | 35 | 35 | 46 |
Amortization | (11) | (10) | (8) |
Balance, end of year | 167 | 143 | 118 |
ULSG | |||
Deferred Revenue Arrangement [Line Items] | |||
Balance, beginning of year | 488 | 344 | 184 |
Capitalization | 174 | 181 | 185 |
Amortization | (50) | (37) | (25) |
Balance, end of year | 612 | 488 | 344 |
Variable Annuities | |||
Deferred Revenue Arrangement [Line Items] | |||
Balance, beginning of year | 73 | 79 | 84 |
Capitalization | 0 | 2 | 2 |
Amortization | (7) | (8) | (7) |
Balance, end of year | $ 66 | $ 73 | $ 79 |
Reinsurance (Effects of Reinsur
Reinsurance (Effects of Reinsurance on Earnings) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Premiums | |||
Direct premiums | $ 1,458 | $ 1,321 | $ 1,398 |
Reinsurance assumed | 20 | 8 | (10) |
Reinsurance ceded | (667) | (688) | (701) |
Net premiums | 811 | 641 | 687 |
Universal life and investment-type product policy fees | |||
Direct universal life and investment-type product policy fees | 2,402 | 2,525 | 2,871 |
Reinsurance assumed | 48 | 44 | 41 |
Reinsurance ceded | (672) | (693) | (592) |
Net universal life and investment-type product policy fees | 1,778 | 1,876 | 2,320 |
Other revenues | |||
Direct other revenues | 202 | 220 | 262 |
Reinsurance assumed | 3 | 3 | 6 |
Reinsurance ceded | 213 | 183 | 69 |
Net other revenues | 418 | 406 | 337 |
Policyholder benefits and claims | |||
Direct policyholder benefits and claims | 3,608 | 3,788 | 3,867 |
Reinsurance assumed | 123 | 134 | 101 |
Reinsurance ceded | (1,313) | (1,736) | (1,483) |
Net policyholder benefits and claims | 2,418 | 2,186 | 2,485 |
Change in market risk benefits | |||
Direct change in market risk benefits | (1,436) | (3,942) | (3,956) |
Reinsurance assumed | (92) | (214) | (243) |
Reinsurance ceded | 31 | 51 | 57 |
Net change in market risk benefits | (1,497) | (4,105) | (4,142) |
Other expenses | |||
Direct other expenses | 1,625 | 1,758 | 1,815 |
Reinsurance assumed | 25 | 0 | 20 |
Reinsurance ceded | (25) | (64) | (11) |
Total other expenses | $ 1,625 | $ 1,694 | $ 1,824 |
Reinsurance (Effects of Reins_2
Reinsurance (Effects of Reinsurance on Balance Sheet) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 |
Assets | |||
Premiums and Other Receivables, Net | $ 19,389 | $ 18,145 | |
Market risk benefit assets | 656 | 483 | |
Liabilities | |||
Future policy benefits | 32,149 | 31,146 | $ 39,830 |
Policyholder account balances | 80,193 | 72,602 | 64,290 |
Market risk benefit liabilities | 10,344 | 10,411 | $ 16,062 |
Other policy-related balances | 3,619 | 3,860 | |
Other liabilities | 7,772 | 6,515 | |
Direct Reinsurance | |||
Assets | |||
Premiums and Other Receivables, Net | 289 | 245 | |
Market risk benefit assets | 613 | 412 | |
Liabilities | |||
Future policy benefits | 31,989 | 31,020 | |
Policyholder account balances | 75,893 | 68,409 | |
Market risk benefit liabilities | 9,972 | 9,980 | |
Other policy-related balances | 2,023 | 2,228 | |
Other liabilities | 6,526 | 5,059 | |
Assumed Reinsurance | |||
Assets | |||
Premiums and Other Receivables, Net | 33 | 30 | |
Market risk benefit assets | 0 | 0 | |
Liabilities | |||
Future policy benefits | 160 | 126 | |
Policyholder account balances | 4,300 | 4,193 | |
Market risk benefit liabilities | 372 | 431 | |
Other policy-related balances | 1,596 | 1,632 | |
Other liabilities | 11 | 22 | |
Ceded Reinsurance | |||
Assets | |||
Premiums and Other Receivables, Net | 19,067 | 17,870 | |
Market risk benefit assets | 43 | 71 | |
Liabilities | |||
Future policy benefits | 0 | 0 | |
Policyholder account balances | 0 | 0 | |
Market risk benefit liabilities | 0 | 0 | |
Other policy-related balances | 0 | 0 | |
Other liabilities | $ 1,235 | $ 1,434 |
Reinsurance (Effects of Affilia
Reinsurance (Effects of Affiliated Reinsurance on Statements of Operations) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Premiums | |||
Reinsurance assumed | $ 20 | $ 8 | $ (10) |
Universal life and investment-type product policy fees | |||
Reinsurance assumed | 48 | 44 | 41 |
Other revenues | |||
Reinsurance assumed | 3 | 3 | 6 |
Policyholder benefits and claims | |||
Reinsurance assumed | 123 | 134 | 101 |
Change in market risk benefits | |||
Reinsurance assumed | 92 | 214 | 243 |
Other expenses | |||
Reinsurance assumed | 25 | 0 | 20 |
Affiliated Entity | Assumed Reinsurance | |||
Premiums | |||
Reinsurance assumed | 6 | 2 | 2 |
Universal life and investment-type product policy fees | |||
Reinsurance assumed | (1) | (1) | 1 |
Other revenues | |||
Reinsurance assumed | 1 | 2 | 2 |
Policyholder benefits and claims | |||
Reinsurance assumed | 39 | 22 | 16 |
Change in market risk benefits | |||
Reinsurance assumed | (92) | (214) | (243) |
Other expenses | |||
Reinsurance assumed | $ 0 | $ (6) | $ (3) |
Reinsurance (Effects of Affil_2
Reinsurance (Effects of Affiliated Reinsurance on Balance Sheets) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 |
Assets | |||
Premiums and Other Receivables, Net | $ 19,389 | $ 18,145 | |
Market risk benefit assets | 656 | 483 | |
Liabilities | |||
Policyholder account balances | 80,193 | 72,602 | $ 64,290 |
Market risk benefit liabilities | 10,344 | 10,411 | $ 16,062 |
Other policy-related balances | 3,619 | 3,860 | |
Other liabilities | 7,772 | 6,515 | |
Assumed Reinsurance | |||
Assets | |||
Premiums and Other Receivables, Net | 33 | 30 | |
Market risk benefit assets | 0 | 0 | |
Liabilities | |||
Policyholder account balances | 4,300 | 4,193 | |
Market risk benefit liabilities | 372 | 431 | |
Other policy-related balances | 1,596 | 1,632 | |
Other liabilities | 11 | 22 | |
Assumed Reinsurance | Affiliated Entity | |||
Assets | |||
Premiums and Other Receivables, Net | 28 | 29 | |
Liabilities | |||
Future policy benefits | 47 | 31 | |
Market risk benefit liabilities | 367 | 428 | |
Other policy-related balances | 13 | 11 | |
Other liabilities | $ (4) | $ 11 |
Reinsurance (Reinsurance Introd
Reinsurance (Reinsurance Introduction - Narrative) (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Effects of Reinsurance [Line Items] | ||
Reinsurance Retention Policy, Reinsured Risk, Percentage | 100% | |
Reinsurance Retention Policy, Excess Retention, Percentage | 100% | |
Reinsurance Recoverables, Ceded | $ 18,700 | $ 17,300 |
Maximum | ||
Effects of Reinsurance [Line Items] | ||
Reinsurance, Amount Retained, Per Life | $ 20 | |
Participating whole life insurance | ||
Effects of Reinsurance [Line Items] | ||
Reinsurance Retention Policy, Reinsured Risk, Percentage | 90% | |
Accident & health insurance | ||
Effects of Reinsurance [Line Items] | ||
Reinsurance Retention Policy, Reinsured Risk, Percentage | 100% | |
Ceded Credit Risk, Secured [Member] | Accident & health insurance | ||
Effects of Reinsurance [Line Items] | ||
Reinsurance Recoverables, Ceded | $ 5,800 | |
Ceded Credit Risk, Unsecured [Member] | ||
Effects of Reinsurance [Line Items] | ||
Reinsurance Recoverables, Ceded | $ 6,000 | $ 6,000 |
Reinsurance (Reinsurance Recove
Reinsurance (Reinsurance Recoverables - Narrative) (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Ceded Credit Risk [Line Items] | ||
Reinsurance Recoverables, Ceded | $ 18,700 | $ 17,300 |
Premiums, reinsurance and other, allowance for credit losses | 3 | 10 |
Reinsurance Recoverables on Unpaid Losses, Allowance | 3 | |
Reinsurance, Loss on Uncollectible Accounts in Period, Amount | 10 | |
Five Largest Ceded Reinsurers [Member] | ||
Ceded Credit Risk [Line Items] | ||
Ceded Credit Risk, Reinsurance Recoverables, Net | $ 16,700 | $ 15,300 |
Ceded Credit Risk, Reinsurance Recoverables, Percentage | 89% | 88% |
Ceded Credit Risk, Unsecured [Member] | ||
Ceded Credit Risk [Line Items] | ||
Reinsurance Recoverables, Ceded | $ 6,000 | $ 6,000 |
Ceded Credit Risk, Unsecured [Member] | Five Largest Ceded Reinsurers [Member] | ||
Ceded Credit Risk [Line Items] | ||
Ceded Credit Risk, Reinsurance Recoverables, Net | $ 4,200 | $ 4,100 |
Reinsurance (Reinsurance Deposi
Reinsurance (Reinsurance Deposit Part B - Narrative) (Details) - USD ($) $ in Billions | Dec. 31, 2023 | Dec. 31, 2022 |
Reinsurance Disclosures [Abstract] | ||
Deposit Contracts, Assets | $ 7.4 | $ 5.8 |
Deposit Contracts, Liabilities | $ 4 | $ 4 |
Reinsurance (Related Party Rein
Reinsurance (Related Party Reinsurance - Narrative) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Effects of Reinsurance [Line Items] | ||
Deposit Contracts, Assets | $ 7,400 | $ 5,800 |
Deposit Contracts, Liabilities | 4,000 | 4,000 |
Affiliated Entity | ||
Effects of Reinsurance [Line Items] | ||
Deposit Contracts, Assets | 0 | 0 |
Deposit Contracts, Liabilities | $ 112 | $ 142 |
Investments (Fixed Maturity Sec
Investments (Fixed Maturity Securities by Sector) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 |
Debt Securities, Available-for-sale [Line Items] | |||
Fixed maturity securities, amortized cost | $ 86,129 | $ 83,395 | |
Fixed maturity securities, allowance for credit losses | 21 | 6 | $ 11 |
Fixed maturity securities, gross unrealized gains | 1,024 | 742 | |
Fixed maturity securities, gross unrealized losses | 7,047 | 9,374 | |
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 80,085 | 74,757 | |
U.S. corporate | |||
Debt Securities, Available-for-sale [Line Items] | |||
Fixed maturity securities, amortized cost | 38,303 | 36,399 | |
Fixed maturity securities, allowance for credit losses | 15 | 1 | 2 |
Fixed maturity securities, gross unrealized gains | 383 | 200 | |
Fixed maturity securities, gross unrealized losses | 3,332 | 4,436 | |
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 35,339 | 32,162 | |
Foreign corporate | |||
Debt Securities, Available-for-sale [Line Items] | |||
Fixed maturity securities, amortized cost | 12,769 | 12,368 | |
Fixed maturity securities, allowance for credit losses | 0 | 1 | 7 |
Fixed maturity securities, gross unrealized gains | 89 | 37 | |
Fixed maturity securities, gross unrealized losses | 1,276 | 1,912 | |
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 11,582 | 10,492 | |
U.S. government and agency | |||
Debt Securities, Available-for-sale [Line Items] | |||
Fixed maturity securities, amortized cost | 8,446 | 8,195 | |
Fixed maturity securities, allowance for credit losses | 0 | 0 | |
Fixed maturity securities, gross unrealized gains | 285 | 299 | |
Fixed maturity securities, gross unrealized losses | 517 | 596 | |
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 8,214 | 7,898 | |
RMBS | |||
Debt Securities, Available-for-sale [Line Items] | |||
Fixed maturity securities, amortized cost | 8,127 | 8,384 | |
Fixed maturity securities, allowance for credit losses | 4 | 1 | 0 |
Fixed maturity securities, gross unrealized gains | 48 | 44 | |
Fixed maturity securities, gross unrealized losses | 805 | 936 | |
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 7,366 | 7,491 | |
ABS | |||
Debt Securities, Available-for-sale [Line Items] | |||
Fixed maturity securities, amortized cost | 6,509 | 5,647 | |
Fixed maturity securities, allowance for credit losses | 0 | 0 | |
Fixed maturity securities, gross unrealized gains | 23 | 3 | |
Fixed maturity securities, gross unrealized losses | 131 | 295 | |
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 6,401 | 5,355 | |
CMBS | |||
Debt Securities, Available-for-sale [Line Items] | |||
Fixed maturity securities, amortized cost | 6,940 | 7,239 | |
Fixed maturity securities, allowance for credit losses | 2 | 3 | $ 2 |
Fixed maturity securities, gross unrealized gains | 2 | 0 | |
Fixed maturity securities, gross unrealized losses | 601 | 699 | |
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 6,339 | 6,537 | |
State and political subdivision | |||
Debt Securities, Available-for-sale [Line Items] | |||
Fixed maturity securities, amortized cost | 3,958 | 4,015 | |
Fixed maturity securities, allowance for credit losses | 0 | 0 | |
Fixed maturity securities, gross unrealized gains | 153 | 120 | |
Fixed maturity securities, gross unrealized losses | 298 | 394 | |
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 3,813 | 3,741 | |
Foreign government | |||
Debt Securities, Available-for-sale [Line Items] | |||
Fixed maturity securities, amortized cost | 1,077 | 1,148 | |
Fixed maturity securities, allowance for credit losses | 0 | 0 | |
Fixed maturity securities, gross unrealized gains | 41 | 39 | |
Fixed maturity securities, gross unrealized losses | 87 | 106 | |
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | $ 1,031 | $ 1,081 |
Investments (Maturities of Fixe
Investments (Maturities of Fixed Maturity Securities) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Investments, Debt and Equity Securities [Abstract] | ||
Amortized cost, due in one year or less | $ 2,725 | |
Amortized cost, due after one year through five years | 17,064 | |
Amortized cost, due after five years through ten years | 15,000 | |
Amortized cost, due after ten years | 29,764 | |
Amortized cost, Structured Securities | 21,576 | |
Fixed maturity securities, amortized cost | 86,129 | $ 83,395 |
Estimated fair value, due in one year or less | 2,691 | |
Estimated fair value, due after one year through five years | 16,611 | |
Estimated fair value, due after five years through ten years | 13,764 | |
Estimated fair value, due after ten years | 26,913 | |
Estimated fair value, Structured Securities | 20,106 | |
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | $ 80,085 | $ 74,757 |
Investments (Continuous Gross U
Investments (Continuous Gross Unrealized Losses for Fixed Maturity Securities by Sector) (Details) $ in Millions | Dec. 31, 2023 USD ($) | Dec. 31, 2022 USD ($) |
Debt Securities, Available-for-sale [Line Items] | ||
Fixed maturity securities in continuous unrealized loss position, less than 12 months, estimated fair value | $ 7,973 | $ 51,788 |
Fixed maturity securities in continuous unrealized loss position, less than 12 months, gross unrealized losses | $ 585 | $ 6,538 |
Fixed maturity securities in continuous unrealized loss position, less than 12 months, number of securities | 1,339 | 7,261 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, estimated fair value | $ 51,190 | $ 11,815 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, gross unrealized losses | $ 6,462 | $ 2,836 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, number of securities | 6,958 | 2,018 |
U.S. corporate | ||
Debt Securities, Available-for-sale [Line Items] | ||
Fixed maturity securities in continuous unrealized loss position, less than 12 months, estimated fair value | $ 4,549 | $ 24,163 |
Fixed maturity securities in continuous unrealized loss position, less than 12 months, gross unrealized losses | 409 | 3,279 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, estimated fair value | 22,435 | 3,915 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, gross unrealized losses | 2,923 | 1,157 |
Foreign corporate | ||
Debt Securities, Available-for-sale [Line Items] | ||
Fixed maturity securities in continuous unrealized loss position, less than 12 months, estimated fair value | 1,010 | 8,219 |
Fixed maturity securities in continuous unrealized loss position, less than 12 months, gross unrealized losses | 74 | 1,407 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, estimated fair value | 8,229 | 1,560 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, gross unrealized losses | 1,202 | 505 |
U.S. government and agency | ||
Debt Securities, Available-for-sale [Line Items] | ||
Fixed maturity securities in continuous unrealized loss position, less than 12 months, estimated fair value | 445 | 3,037 |
Fixed maturity securities in continuous unrealized loss position, less than 12 months, gross unrealized losses | 8 | 259 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, estimated fair value | 3,453 | 1,146 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, gross unrealized losses | 509 | 337 |
RMBS | ||
Debt Securities, Available-for-sale [Line Items] | ||
Fixed maturity securities in continuous unrealized loss position, less than 12 months, estimated fair value | 413 | 4,693 |
Fixed maturity securities in continuous unrealized loss position, less than 12 months, gross unrealized losses | 21 | 489 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, estimated fair value | 5,749 | 2,245 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, gross unrealized losses | 784 | 447 |
ABS | ||
Debt Securities, Available-for-sale [Line Items] | ||
Fixed maturity securities in continuous unrealized loss position, less than 12 months, estimated fair value | 572 | 3,347 |
Fixed maturity securities in continuous unrealized loss position, less than 12 months, gross unrealized losses | 3 | 159 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, estimated fair value | 3,355 | 1,728 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, gross unrealized losses | 128 | 136 |
CMBS | ||
Debt Securities, Available-for-sale [Line Items] | ||
Fixed maturity securities in continuous unrealized loss position, less than 12 months, estimated fair value | 411 | 5,524 |
Fixed maturity securities in continuous unrealized loss position, less than 12 months, gross unrealized losses | 33 | 534 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, estimated fair value | 5,713 | 961 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, gross unrealized losses | 568 | 165 |
State and political subdivision | ||
Debt Securities, Available-for-sale [Line Items] | ||
Fixed maturity securities in continuous unrealized loss position, less than 12 months, estimated fair value | 460 | 2,026 |
Fixed maturity securities in continuous unrealized loss position, less than 12 months, gross unrealized losses | 31 | 313 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, estimated fair value | 1,636 | 239 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, gross unrealized losses | 267 | 81 |
Foreign government | ||
Debt Securities, Available-for-sale [Line Items] | ||
Fixed maturity securities in continuous unrealized loss position, less than 12 months, estimated fair value | 113 | 779 |
Fixed maturity securities in continuous unrealized loss position, less than 12 months, gross unrealized losses | 6 | 98 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, estimated fair value | 620 | 21 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, gross unrealized losses | $ 81 | $ 8 |
Investments (Rollforward of the
Investments (Rollforward of the Allowance for Credit Losses for Fixed Maturity Securities by Sector (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward] | ||
Fixed maturity securities, allowance for credit losses, beginning of year | $ 6 | $ 11 |
Allowance on securities where credit losses were not previously recorded | 18 | 1 |
Reductions for securities sold | (1) | (1) |
Change in allowance on securities with an allowance recorded in a previous period | (1) | 1 |
Write-offs charged against allowance | (1) | (6) |
Fixed maturity securities, allowance for credit losses, end of year | 21 | 6 |
U.S. corporate | ||
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward] | ||
Fixed maturity securities, allowance for credit losses, beginning of year | 1 | 2 |
Allowance on securities where credit losses were not previously recorded | 15 | 0 |
Reductions for securities sold | (1) | (1) |
Change in allowance on securities with an allowance recorded in a previous period | 0 | 0 |
Write-offs charged against allowance | 0 | 0 |
Fixed maturity securities, allowance for credit losses, end of year | 15 | 1 |
RMBS | ||
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward] | ||
Fixed maturity securities, allowance for credit losses, beginning of year | 1 | 0 |
Allowance on securities where credit losses were not previously recorded | 3 | 1 |
Reductions for securities sold | 0 | 0 |
Change in allowance on securities with an allowance recorded in a previous period | 0 | 0 |
Write-offs charged against allowance | 0 | 0 |
Fixed maturity securities, allowance for credit losses, end of year | 4 | 1 |
CMBS | ||
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward] | ||
Fixed maturity securities, allowance for credit losses, beginning of year | 3 | 2 |
Allowance on securities where credit losses were not previously recorded | 0 | 0 |
Reductions for securities sold | 0 | 0 |
Change in allowance on securities with an allowance recorded in a previous period | (1) | 1 |
Write-offs charged against allowance | 0 | 0 |
Fixed maturity securities, allowance for credit losses, end of year | 2 | 3 |
Foreign corporate | ||
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward] | ||
Fixed maturity securities, allowance for credit losses, beginning of year | 1 | 7 |
Allowance on securities where credit losses were not previously recorded | 0 | 0 |
Reductions for securities sold | 0 | 0 |
Change in allowance on securities with an allowance recorded in a previous period | 0 | 0 |
Write-offs charged against allowance | (1) | (6) |
Fixed maturity securities, allowance for credit losses, end of year | $ 0 | $ 1 |
Investments (Mortgage Loans by
Investments (Mortgage Loans by Portfolio Segment) (Details) - Mortgage Loans - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Financing receivable, before allowance for credit losses | $ 22,612 | $ 22,996 | |
Financing receivable, allowance for credit losses | (137) | (119) | $ (123) |
Financing receivable, net of allowance for credit losses | $ 22,475 | $ 22,877 | |
Financing receivable, before allowance for credit losses as a percentage of financing receivable, net of allowance for credit losses | 100.60% | 100.50% | |
Financing receivable, allowance for credit losses as a percentage of financing receivable, net of allowance for credit losses | (0.60%) | (0.50%) | |
Financing receivable, after allowance for credit losses as a percentage of financing receivable, net of allowance for credit losses | 100% | 100% | |
Commercial | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Financing receivable, before allowance for credit losses | $ 13,189 | $ 13,547 | |
Financing receivable, allowance for credit losses | $ (69) | $ (49) | (67) |
Financing receivable, before allowance for credit losses as a percentage of financing receivable, net of allowance for credit losses | 58.70% | 59.20% | |
Agricultural | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Financing receivable, before allowance for credit losses | $ 4,416 | $ 4,333 | |
Financing receivable, allowance for credit losses | $ (19) | $ (15) | (12) |
Financing receivable, before allowance for credit losses as a percentage of financing receivable, net of allowance for credit losses | 19.60% | 18.90% | |
Residential | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Financing receivable, before allowance for credit losses | $ 5,007 | $ 5,116 | |
Financing receivable, allowance for credit losses | $ (49) | $ (55) | $ (44) |
Financing receivable, before allowance for credit losses as a percentage of financing receivable, net of allowance for credit losses | 22.30% | 22.40% |
Investments (Rollforward of t_2
Investments (Rollforward of the Allowance for Credit Losses for Mortgage Loans by Portfolio Segment) (Details) - Mortgage Loans - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Financing Receivable, Allowance for Credit Loss [Roll Forward] | ||
Financing receivable, allowance for credit losses, beginning of year | $ 119 | $ 123 |
Current period provision | 23 | 19 |
Financing Receivable, Allowance for Credit Loss, Writeoff, after Recovery | (5) | (23) |
Financing receivable, allowance for credit losses, end of year | 137 | 119 |
Commercial | ||
Financing Receivable, Allowance for Credit Loss [Roll Forward] | ||
Financing receivable, allowance for credit losses, beginning of year | 49 | 67 |
Current period provision | 24 | 5 |
Financing Receivable, Allowance for Credit Loss, Writeoff, after Recovery | (4) | (23) |
Financing receivable, allowance for credit losses, end of year | 69 | 49 |
Agricultural | ||
Financing Receivable, Allowance for Credit Loss [Roll Forward] | ||
Financing receivable, allowance for credit losses, beginning of year | 15 | 12 |
Current period provision | 5 | 3 |
Financing Receivable, Allowance for Credit Loss, Writeoff, after Recovery | (1) | 0 |
Financing receivable, allowance for credit losses, end of year | 19 | 15 |
Residential | ||
Financing Receivable, Allowance for Credit Loss [Roll Forward] | ||
Financing receivable, allowance for credit losses, beginning of year | 55 | 44 |
Current period provision | (6) | 11 |
Financing Receivable, Allowance for Credit Loss, Writeoff, after Recovery | 0 | 0 |
Financing receivable, allowance for credit losses, end of year | $ 49 | $ 55 |
Investments (PCD Mortgage Loans
Investments (PCD Mortgage Loans) (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Mortgage Loans | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Financing receivables purchased with credit deterioration, par value | $ 0 | $ 69 |
Investments (Credit Quality of
Investments (Credit Quality of Mortgage Loans by Portfolio Segment) (Details) - Mortgage Loans - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated in current FY | $ 514 | $ 4,369 |
Financing receivable, originated in FY before latest FY | 4,423 | 6,197 |
Financing receivable, originated two years before latest FY | 6,136 | 1,089 |
Financing receivable, originated three years before latest FY | 1,042 | 2,648 |
Financing receivable, originated four years before latest FY | 2,600 | 2,191 |
Financing receivable, originated five or more years before latest FY | 7,897 | 6,502 |
Financing receivable, before allowance for credit losses | 22,612 | 22,996 |
Commercial | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated in current FY | 206 | 2,419 |
Financing receivable, originated in FY before latest FY | 2,417 | 3,191 |
Financing receivable, originated two years before latest FY | 3,205 | 445 |
Financing receivable, originated three years before latest FY | 438 | 1,879 |
Financing receivable, originated four years before latest FY | 1,859 | 1,377 |
Financing receivable, originated five or more years before latest FY | 5,064 | 4,236 |
Financing receivable, before allowance for credit losses | $ 13,189 | $ 13,547 |
Financing receivable, before allowance for credit losses by debt service coverage ratio as a percentage of financing receivable, before allowance for credit losses | 100% | 100% |
Commercial | Debt Service Coverage Ratio, Greater than 1.20x | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, before allowance for credit losses | $ 12,082 | $ 12,132 |
Financing receivable, before allowance for credit losses by debt service coverage ratio as a percentage of financing receivable, before allowance for credit losses | 91.60% | 89.60% |
Commercial | Debt Service Coverage Ratio, 1.00x to 1.20x | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, before allowance for credit losses | $ 702 | $ 589 |
Financing receivable, before allowance for credit losses by debt service coverage ratio as a percentage of financing receivable, before allowance for credit losses | 5.30% | 4.30% |
Commercial | Debt Service Coverage Ratio, Less than 1.00x | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, before allowance for credit losses | $ 405 | $ 826 |
Financing receivable, before allowance for credit losses by debt service coverage ratio as a percentage of financing receivable, before allowance for credit losses | 3.10% | 6.10% |
Commercial | Loan-to-Value Ratio, Less than 65% | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated in current FY | $ 206 | $ 1,916 |
Financing receivable, originated in FY before latest FY | 655 | 2,819 |
Financing receivable, originated two years before latest FY | 1,823 | 405 |
Financing receivable, originated three years before latest FY | 177 | 1,493 |
Financing receivable, originated four years before latest FY | 1,239 | 888 |
Financing receivable, originated five or more years before latest FY | 2,628 | 3,624 |
Financing receivable, before allowance for credit losses | 6,728 | 11,145 |
Commercial | Loan-to-Value Ratio, 65% to 75% | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated in current FY | 0 | 503 |
Financing receivable, originated in FY before latest FY | 935 | 354 |
Financing receivable, originated two years before latest FY | 1,079 | 0 |
Financing receivable, originated three years before latest FY | 222 | 271 |
Financing receivable, originated four years before latest FY | 261 | 367 |
Financing receivable, originated five or more years before latest FY | 1,157 | 402 |
Financing receivable, before allowance for credit losses | 3,654 | 1,897 |
Commercial | Loan-to-Value Ratio, 76% to 80% | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated in current FY | 0 | 0 |
Financing receivable, originated in FY before latest FY | 427 | 18 |
Financing receivable, originated two years before latest FY | 76 | 40 |
Financing receivable, originated three years before latest FY | 39 | 90 |
Financing receivable, originated four years before latest FY | 209 | 65 |
Financing receivable, originated five or more years before latest FY | 563 | 48 |
Financing receivable, before allowance for credit losses | 1,314 | 261 |
Commercial | Loan-to-Value Ratio, Greater than 80% | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated in current FY | 0 | 0 |
Financing receivable, originated in FY before latest FY | 400 | 0 |
Financing receivable, originated two years before latest FY | 227 | 0 |
Financing receivable, originated three years before latest FY | 0 | 25 |
Financing receivable, originated four years before latest FY | 150 | 57 |
Financing receivable, originated five or more years before latest FY | 716 | 162 |
Financing receivable, before allowance for credit losses | 1,493 | 244 |
Agricultural | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated in current FY | 203 | 680 |
Financing receivable, originated in FY before latest FY | 698 | 1,253 |
Financing receivable, originated two years before latest FY | 1,240 | 477 |
Financing receivable, originated three years before latest FY | 458 | 552 |
Financing receivable, originated four years before latest FY | 535 | 645 |
Financing receivable, originated five or more years before latest FY | 1,282 | 726 |
Financing receivable, before allowance for credit losses | 4,416 | 4,333 |
Agricultural | Loan-to-Value Ratio, Less than 65% | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated in current FY | 202 | 532 |
Financing receivable, originated in FY before latest FY | 571 | 1,163 |
Financing receivable, originated two years before latest FY | 1,132 | 418 |
Financing receivable, originated three years before latest FY | 452 | 496 |
Financing receivable, originated four years before latest FY | 505 | 643 |
Financing receivable, originated five or more years before latest FY | 1,265 | 710 |
Financing receivable, before allowance for credit losses | 4,127 | 3,962 |
Agricultural | Loan-to-Value Ratio, 65% to 75% | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated in current FY | 1 | 148 |
Financing receivable, originated in FY before latest FY | 127 | 90 |
Financing receivable, originated two years before latest FY | 108 | 59 |
Financing receivable, originated three years before latest FY | 6 | 56 |
Financing receivable, originated four years before latest FY | 30 | 1 |
Financing receivable, originated five or more years before latest FY | 17 | 16 |
Financing receivable, before allowance for credit losses | 289 | 370 |
Agricultural | Loan-to-Value Ratio, Greater than 80% | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated in current FY | 0 | |
Financing receivable, originated in FY before latest FY | 0 | |
Financing receivable, originated two years before latest FY | 0 | |
Financing receivable, originated three years before latest FY | 0 | |
Financing receivable, originated four years before latest FY | 1 | |
Financing receivable, originated five or more years before latest FY | 0 | |
Financing receivable, before allowance for credit losses | 1 | |
Residential | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated in current FY | 105 | 1,270 |
Financing receivable, originated in FY before latest FY | 1,308 | 1,753 |
Financing receivable, originated two years before latest FY | 1,691 | 167 |
Financing receivable, originated three years before latest FY | 146 | 217 |
Financing receivable, originated four years before latest FY | 206 | 169 |
Financing receivable, originated five or more years before latest FY | 1,551 | 1,540 |
Financing receivable, before allowance for credit losses | 5,007 | 5,116 |
Residential | Performing | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated in current FY | 105 | 1,266 |
Financing receivable, originated in FY before latest FY | 1,286 | 1,745 |
Financing receivable, originated two years before latest FY | 1,669 | 167 |
Financing receivable, originated three years before latest FY | 145 | 215 |
Financing receivable, originated four years before latest FY | 204 | 168 |
Financing receivable, originated five or more years before latest FY | 1,508 | 1,491 |
Financing receivable, before allowance for credit losses | 4,917 | 5,052 |
Residential | Nonperforming | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated in current FY | 0 | 4 |
Financing receivable, originated in FY before latest FY | 22 | 8 |
Financing receivable, originated two years before latest FY | 22 | 0 |
Financing receivable, originated three years before latest FY | 1 | 2 |
Financing receivable, originated four years before latest FY | 2 | 1 |
Financing receivable, originated five or more years before latest FY | 43 | 49 |
Financing receivable, before allowance for credit losses | $ 90 | $ 64 |
Investments (Past Due Mortgage
Investments (Past Due Mortgage Loans by Portfolio Segment) (Details) - Mortgage Loans - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | $ 22,612 | $ 22,996 |
Current | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 22,487 | 22,902 |
30 to 59 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 2 | 11 |
60 to 89 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 30 | 16 |
90 to 179 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 23 | 34 |
180 Days and Greater Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 70 | 33 |
Commercial | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 13,189 | 13,547 |
Commercial | Current | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 13,172 | 13,547 |
Commercial | 30 to 59 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 0 | 0 |
Commercial | 60 to 89 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 0 | 0 |
Commercial | 90 to 179 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 0 | 0 |
Commercial | 180 Days and Greater Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 17 | 0 |
Agricultural | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 4,416 | 4,333 |
Agricultural | Current | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 4,400 | 4,314 |
Agricultural | 30 to 59 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 0 | 0 |
Agricultural | 60 to 89 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 0 | 0 |
Agricultural | 90 to 179 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 0 | 3 |
Agricultural | 180 Days and Greater Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 16 | 16 |
Residential | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 5,007 | 5,116 |
Residential | Current | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 4,915 | 5,041 |
Residential | 30 to 59 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 2 | 11 |
Residential | 60 to 89 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 30 | 16 |
Residential | 90 to 179 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 23 | 31 |
Residential | 180 Days and Greater Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | $ 37 | $ 17 |
Investments (Mortgage Loans in
Investments (Mortgage Loans in Nonaccrual Status by Portfolio Segment) (Details) - Mortgage Loans - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Financing Receivable, Nonaccrual [Line Items] | ||
Financing receivable in nonaccrual status | $ 107 | $ 78 |
Commercial | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Financing receivable in nonaccrual status | 17 | 11 |
Agricultural | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Financing receivable in nonaccrual status | 0 | 3 |
Residential | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Financing receivable in nonaccrual status | $ 90 | $ 64 |
Investments (Net Unrealized Inv
Investments (Net Unrealized Investment Gains (Losses)) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 |
Components of net unrealized investment gains (losses) included in accumulated other comprehensive loss | |||
Fixed maturity securities | $ (6,023) | $ (8,632) | $ 8,251 |
Derivatives | 344 | 628 | 320 |
Other | (7) | (7) | (27) |
Subtotal | (5,686) | (8,011) | 8,544 |
Amounts allocated from: Future policy benefits | 696 | 992 | (1,925) |
Deferred income tax benefit (expense) | 1,048 | 1,474 | (1,390) |
Net unrealized investment gains (losses) | $ (3,942) | $ (5,545) | $ 5,229 |
Investments (Changes in Net Unr
Investments (Changes in Net Unrealized Investment Gains (Losses)) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Gain (Loss) on Securities [Line Items] | |||
Unrealized investment gains (losses), beginning of year | $ (5,545) | $ 5,229 | $ 5,429 |
Unrealized investment gains (losses) during the year | 2,325 | (16,555) | (3,420) |
Unrealized investment gains (losses) relating to: Future policy benefits | (296) | 2,917 | 687 |
Unrealized investment gains (losses) relating to: Deferred income tax benefit (expense) | (426) | 2,864 | 574 |
Unrealized investment gains (losses), end of year | (3,942) | (5,545) | 5,229 |
Change in net unrealized investment gains (losses) | 1,603 | (10,774) | (2,159) |
Cumulative effect of change in accounting principle, net of income tax | |||
Gain (Loss) on Securities [Line Items] | |||
Unrealized investment gains (losses), beginning of year | 0 | 0 | 1,959 |
Unrealized investment gains (losses), end of year | 0 | 0 | |
Cumulative Effect, Adjusted Balance | |||
Gain (Loss) on Securities [Line Items] | |||
Unrealized investment gains (losses), beginning of year | $ (5,545) | 5,229 | 7,388 |
Unrealized investment gains (losses), end of year | $ (5,545) | $ 5,229 |
Investments (Securities Lending
Investments (Securities Lending) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Securities Financing Transaction [Line Items] | ||
Cash collateral received from counterparties | $ 3,277 | $ 3,731 |
Reinvestment portfolio — estimated fair value | 3,246 | 3,603 |
Amortized cost | ||
Securities Financing Transaction [Line Items] | ||
Securities on loan | 3,420 | 3,995 |
Estimated fair value | ||
Securities Financing Transaction [Line Items] | ||
Securities on loan | $ 3,194 | $ 3,638 |
Investments (Securities Lendi_2
Investments (Securities Lending Remaining Tenor) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Securities Financing Transaction [Line Items] | ||
Cash collateral received from counterparties | $ 3,277 | $ 3,731 |
Remaining Tenor of Securities Lending Agreements: Open | ||
Securities Financing Transaction [Line Items] | ||
Cash collateral received from counterparties | 647 | 642 |
Remaining Tenor of Securities Lending Agreements: 1 Month or Less | ||
Securities Financing Transaction [Line Items] | ||
Cash collateral received from counterparties | 1,046 | 2,105 |
Remaining Tenor of Securities Lending Agreements: 1 to 6 Months | ||
Securities Financing Transaction [Line Items] | ||
Cash collateral received from counterparties | 1,584 | 984 |
U.S. government and agency | ||
Securities Financing Transaction [Line Items] | ||
Cash collateral received from counterparties | 2,886 | 3,151 |
U.S. government and agency | Remaining Tenor of Securities Lending Agreements: Open | ||
Securities Financing Transaction [Line Items] | ||
Cash collateral received from counterparties | 647 | 640 |
U.S. government and agency | Remaining Tenor of Securities Lending Agreements: 1 Month or Less | ||
Securities Financing Transaction [Line Items] | ||
Cash collateral received from counterparties | 655 | 1,527 |
U.S. government and agency | Remaining Tenor of Securities Lending Agreements: 1 to 6 Months | ||
Securities Financing Transaction [Line Items] | ||
Cash collateral received from counterparties | 1,584 | 984 |
U.S. corporate | ||
Securities Financing Transaction [Line Items] | ||
Cash collateral received from counterparties | 252 | 412 |
U.S. corporate | Remaining Tenor of Securities Lending Agreements: Open | ||
Securities Financing Transaction [Line Items] | ||
Cash collateral received from counterparties | 0 | 2 |
U.S. corporate | Remaining Tenor of Securities Lending Agreements: 1 Month or Less | ||
Securities Financing Transaction [Line Items] | ||
Cash collateral received from counterparties | 252 | 410 |
U.S. corporate | Remaining Tenor of Securities Lending Agreements: 1 to 6 Months | ||
Securities Financing Transaction [Line Items] | ||
Cash collateral received from counterparties | 0 | 0 |
Foreign corporate | ||
Securities Financing Transaction [Line Items] | ||
Cash collateral received from counterparties | 130 | 152 |
Foreign corporate | Remaining Tenor of Securities Lending Agreements: Open | ||
Securities Financing Transaction [Line Items] | ||
Cash collateral received from counterparties | 0 | 0 |
Foreign corporate | Remaining Tenor of Securities Lending Agreements: 1 Month or Less | ||
Securities Financing Transaction [Line Items] | ||
Cash collateral received from counterparties | 130 | 152 |
Foreign corporate | Remaining Tenor of Securities Lending Agreements: 1 to 6 Months | ||
Securities Financing Transaction [Line Items] | ||
Cash collateral received from counterparties | 0 | 0 |
Foreign Government | ||
Securities Financing Transaction [Line Items] | ||
Cash collateral received from counterparties | 9 | 16 |
Foreign Government | Remaining Tenor of Securities Lending Agreements: Open | ||
Securities Financing Transaction [Line Items] | ||
Cash collateral received from counterparties | 0 | 0 |
Foreign Government | Remaining Tenor of Securities Lending Agreements: 1 Month or Less | ||
Securities Financing Transaction [Line Items] | ||
Cash collateral received from counterparties | 9 | 16 |
Foreign Government | Remaining Tenor of Securities Lending Agreements: 1 to 6 Months | ||
Securities Financing Transaction [Line Items] | ||
Cash collateral received from counterparties | $ 0 | $ 0 |
Investments (Invested Assets on
Investments (Invested Assets on Deposit, Held In Trust and Pledged as Collateral) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Investments, Debt and Equity Securities [Abstract] | ||
Invested assets on deposit (regulatory deposits) | $ 8,590 | $ 7,996 |
Invested assets held in trust (reinsurance agreements) | 7,103 | 5,592 |
Invested assets pledged as collateral | 13,979 | 13,920 |
Total invested assets on deposit, held in trust and pledged as collateral | $ 29,672 | $ 27,508 |
Investments (Variable Interest
Investments (Variable Interest Entities) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 |
Variable Interest Entity [Line Items] | |||
Carrying amount | $ 226,204 | $ 215,438 | $ 249,731 |
VIE, Not Primary Beneficiary | |||
Variable Interest Entity [Line Items] | |||
Carrying amount | 19,606 | 19,904 | |
Maximum exposure to loss | 21,853 | 22,812 | |
VIE, Not Primary Beneficiary | Fixed maturity securities | |||
Variable Interest Entity [Line Items] | |||
Carrying amount | 15,386 | 15,781 | |
Maximum exposure to loss | 16,611 | 17,334 | |
VIE, Not Primary Beneficiary | Limited partnerships and LLCs | |||
Variable Interest Entity [Line Items] | |||
Carrying amount | 4,220 | 4,123 | |
Maximum exposure to loss | $ 5,242 | $ 5,478 |
Investments (Net Investment Inc
Investments (Net Investment Income) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Net Investment Income [Line Items] | |||
Gross investment income | $ 4,917 | $ 4,313 | $ 4,962 |
Less: Investment expenses | 357 | 249 | 147 |
Net investment income | 4,560 | 4,064 | 4,815 |
Fixed maturity securities | |||
Net Investment Income [Line Items] | |||
Gross investment income | 3,481 | 3,044 | 2,794 |
Equity securities | |||
Net Investment Income [Line Items] | |||
Gross investment income | 2 | 2 | 5 |
Mortgage loans | |||
Net Investment Income [Line Items] | |||
Gross investment income | 957 | 840 | 686 |
Policy loans | |||
Net Investment Income [Line Items] | |||
Gross investment income | 45 | 42 | 41 |
Limited partnerships and LLCs | |||
Net Investment Income [Line Items] | |||
Gross investment income | 167 | 263 | 1,391 |
Cash, cash equivalents and short-term investments | |||
Net Investment Income [Line Items] | |||
Gross investment income | 181 | 56 | 3 |
Other | |||
Net Investment Income [Line Items] | |||
Gross investment income | $ 84 | $ 66 | $ 42 |
Investments (Components of Net
Investments (Components of Net Investment Gains (Losses)) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Net Investment Gains (Losses) [Line Items] | |||
Net investment gains (losses) | $ (242) | $ (240) | $ (63) |
Fixed maturity securities | |||
Net Investment Gains (Losses) [Line Items] | |||
Net investment gains (losses) | (214) | (188) | (22) |
Equity securities | |||
Net Investment Gains (Losses) [Line Items] | |||
Net investment gains (losses) | (1) | (12) | 0 |
Mortgage loans | |||
Net Investment Gains (Losses) [Line Items] | |||
Net investment gains (losses) | (24) | (20) | (29) |
Limited partnerships and LLCs | |||
Net Investment Gains (Losses) [Line Items] | |||
Net investment gains (losses) | (1) | (20) | 0 |
Other | |||
Net Investment Gains (Losses) [Line Items] | |||
Net investment gains (losses) | $ (2) | $ 0 | $ (12) |
Investments (Sales or Disposals
Investments (Sales or Disposals of Fixed Maturity Securities) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Investments, Debt and Equity Securities [Abstract] | |||
Proceeds from sales or disposals of fixed maturity securities | $ 2,223 | $ 6,557 | $ 6,201 |
Fixed maturity securities, gross investment gains | 15 | 55 | 96 |
Fixed maturity securities, gross investment losses | (206) | (236) | (100) |
Fixed maturity securities, net investment gains (losses) | $ (191) | $ (181) | $ (4) |
Investments (Fixed Maturity S_2
Investments (Fixed Maturity Securities by Sector) - Narrative (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Debt Securities, Available-for-sale [Line Items] | ||
Fixed maturity securities, non-income producing | $ 80,085 | $ 74,757 |
Non-Income Producing | ||
Debt Securities, Available-for-sale [Line Items] | ||
Fixed maturity securities, non-income producing | $ 52 | $ 0 |
Investments (Fixed Maturity S_3
Investments (Fixed Maturity Securities - Narrative) (Details) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 USD ($) | Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) | |
Debt Securities, Available-for-sale [Line Items] | |||
Fixed maturity securities, allowance for credit losses | $ 21 | $ 6 | $ 11 |
Fixed maturity securities with allowance for credit losses, number of securities | 15 | ||
Fixed maturity securities, total write-offs | $ 8 | 10 | |
Fixed maturity securities | |||
Debt Securities, Available-for-sale [Line Items] | |||
Accrued interest receivable | $ 648 | $ 595 |
Investments (Mortgage Loans - N
Investments (Mortgage Loans - Narrative) (Details) - Mortgage Loans - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Financing receivables purchased from third parties | $ 311 | $ 2,200 |
Accrued interest receivable | 122 | 115 |
Financing receivables purchased with credit deterioration, par value | 0 | 69 |
Financing receivables in nonaccrual status, investment income | 2 | 2 |
Financing Receivable, Troubled Debt Restructuring | $ 0 | $ 0 |
Minimum | Performing | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Financing receivable, before allowance for credit losses by performance status as a percentage of financing receivables, before allowance for credit losses | 99% | 99% |
Investments (Other Invested Ass
Investments (Other Invested Assets And Leveraged Leases - Narrative) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Derivative [Line Items] | ||
Leveraged leases by performance status as a percentage of leveraged leases | 100% | 100% |
Leveraged leases, net of allowance for credit losses | $ 47 | $ 48 |
Leveraged leases, allowance for credit losses | $ 13 | $ 13 |
Minimum | ||
Derivative [Line Items] | ||
Percentage of other invested assets comprised of freestanding derivatives with positive estimated fair values | 75% |
Investments (Securities Lendi_3
Investments (Securities Lending - Narrative) (Details) $ in Millions | Dec. 31, 2023 USD ($) |
Investments, Debt and Equity Securities [Abstract] | |
Cash collateral on deposit from counterparties | $ 631 |
Percentage of reinvestment portfolio invested in liquid assets | 56% |
Investments (Invested Assets _2
Investments (Invested Assets on Deposit, Held in Trust and Pledged as Collateral - Narrative) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Restricted Cash and Cash Equivalents Items [Line Items] | ||
Invested assets on deposit (regulatory deposits) | $ 8,590 | $ 7,996 |
Invested assets held in trust (reinsurance agreements) | 7,103 | 5,592 |
Restricted Cash and Cash Equivalents | ||
Restricted Cash and Cash Equivalents Items [Line Items] | ||
Invested assets on deposit (regulatory deposits) | 102 | 21 |
Invested assets held in trust (reinsurance agreements) | 117 | 233 |
FHLB common stock | $ 245 | $ 201 |
Investments (Collectively Signi
Investments (Collectively Significant Equity Method Investments - Narrative) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Schedule of Equity Method Investments [Line Items] | |||
Carrying value of investments accounted for under the equity method | $ 4,900 | ||
Total assets | 226,204 | $ 215,438 | $ 249,731 |
Total liabilities | 220,263 | 208,924 | 241,195 |
Net income (loss) | (1,124) | 3,710 | 1,762 |
Nonconsolidated Equity Method Investment | |||
Schedule of Equity Method Investments [Line Items] | |||
Unfunded commitments | 1,200 | ||
Total assets | 799,000 | 879,800 | |
Total liabilities | 56,700 | 109,200 | |
Net income (loss) | $ 24,800 | $ (12,800) | $ 22,600 |
Investments (Net Investment I_2
Investments (Net Investment Income - Narrative) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Net Investment Income [Line Items] | |||
Net investment income | $ 4,560 | $ 4,064 | $ 4,815 |
Other limited partnership interests | |||
Net Investment Income [Line Items] | |||
Net investment income | $ 186 | $ 170 | $ 1,300 |
Investments (Components of Ne_2
Investments (Components of Net Investment Gains (Losses) - Narrative) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Gain (Loss) on Securities [Line Items] | |||
Net investment gains (losses) | $ (242) | $ (240) | $ (63) |
Foreign Exchange | |||
Gain (Loss) on Securities [Line Items] | |||
Net investment gains (losses) | $ (1) | $ (18) | $ 0 |
Derivatives (Primary Risks Mana
Derivatives (Primary Risks Managed by Derivatives) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | $ 173,029 | $ 116,742 |
Derivative assets | 3,703 | 2,271 |
Derivative liabilities | 5,080 | 3,911 |
Derivatives Designated as Hedging Instruments: | ||
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | 3,895 | 4,041 |
Derivative assets | 339 | 584 |
Derivative liabilities | 45 | 20 |
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | ||
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | 169,134 | 112,701 |
Derivative assets | 3,364 | 1,687 |
Derivative liabilities | 5,035 | 3,891 |
Interest rate swaps | Derivatives Not Designated or Not Qualifying as Hedging Instruments: | ||
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | 31,252 | 3,145 |
Derivative assets | 140 | 98 |
Derivative liabilities | 103 | 46 |
Interest rate floors | Derivatives Not Designated or Not Qualifying as Hedging Instruments: | ||
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | 3,500 | 3,250 |
Derivative assets | 7 | 12 |
Derivative liabilities | 1 | 3 |
Interest rate caps | Derivatives Not Designated or Not Qualifying as Hedging Instruments: | ||
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | 7,050 | 6,350 |
Derivative assets | 19 | 137 |
Derivative liabilities | 1 | 43 |
Interest rate options | Derivatives Not Designated or Not Qualifying as Hedging Instruments: | ||
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | 33,680 | 28,688 |
Derivative assets | 47 | 22 |
Derivative liabilities | 167 | 232 |
Interest rate forwards | Derivatives Not Designated or Not Qualifying as Hedging Instruments: | ||
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | 17,017 | 18,168 |
Derivative assets | 32 | 35 |
Derivative liabilities | 1,937 | 2,466 |
Interest rate forwards | Cash flow hedges: | Derivatives Designated as Hedging Instruments: | ||
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | 0 | 60 |
Derivative assets | 0 | 0 |
Derivative liabilities | 0 | 12 |
Foreign currency swaps | Derivatives Not Designated or Not Qualifying as Hedging Instruments: | ||
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | 735 | 810 |
Derivative assets | 99 | 147 |
Derivative liabilities | 1 | 0 |
Foreign currency swaps | Cash flow hedges: | Derivatives Designated as Hedging Instruments: | ||
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | 3,895 | 3,981 |
Derivative assets | 339 | 584 |
Derivative liabilities | 45 | 8 |
Foreign currency forwards | Derivatives Not Designated or Not Qualifying as Hedging Instruments: | ||
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | 384 | 295 |
Derivative assets | 0 | 1 |
Derivative liabilities | 1 | 1 |
Credit default swaps — written | Derivatives Not Designated or Not Qualifying as Hedging Instruments: | ||
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | 1,405 | 1,757 |
Derivative assets | 27 | 18 |
Derivative liabilities | 0 | 2 |
Credit default swaptions | Derivatives Not Designated or Not Qualifying as Hedging Instruments: | ||
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | 0 | 100 |
Derivative assets | 0 | 0 |
Derivative liabilities | 0 | 0 |
Equity index options | Derivatives Not Designated or Not Qualifying as Hedging Instruments: | ||
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | 20,099 | 17,229 |
Derivative assets | 757 | 697 |
Derivative liabilities | 687 | 351 |
Equity total return swaps | Derivatives Not Designated or Not Qualifying as Hedging Instruments: | ||
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | 53,742 | 32,909 |
Derivative assets | 2,236 | 520 |
Derivative liabilities | 2,137 | 747 |
Hybrid options | Derivatives Not Designated or Not Qualifying as Hedging Instruments: | ||
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | 270 | 0 |
Derivative assets | 0 | 0 |
Derivative liabilities | $ 0 | $ 0 |
Derivatives (Derivatives Pertai
Derivatives (Derivatives Pertaining to Hedged Items) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net derivative gains (losses) | $ (3,920) | $ (585) | $ (3,986) |
Net Derivative Gains (Losses) Recognized for Hedged Items | (6) | (27) | (1) |
Net investment income | 4,560 | 4,064 | 4,815 |
Amount of Gains (Losses) Deferred in AOCI | (273) | 329 | 170 |
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net Derivative Gains (Losses) Recognized for Hedged Items | 2 | (16) | 2 |
Amount of Gains (Losses) Deferred in AOCI | 0 | 0 | 0 |
Cash flow hedges: | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net Derivative Gains (Losses) Recognized for Hedged Items | (8) | (11) | (3) |
Amount of Gains (Losses) Deferred in AOCI | (273) | 329 | 170 |
Net Derivative Gains (Losses) Recognized for Derivatives | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net derivative gains (losses) | (3,914) | (558) | (3,985) |
Net Derivative Gains (Losses) Recognized for Derivatives | Derivatives Not Designated or Not Qualifying as Hedging Instruments: | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net derivative gains (losses) | (3,922) | (575) | (3,994) |
Net Derivative Gains (Losses) Recognized for Derivatives | Cash flow hedges: | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net derivative gains (losses) | 8 | 17 | 9 |
Net Investment Income | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net investment income | 54 | 56 | 37 |
Net Investment Income | Derivatives Not Designated or Not Qualifying as Hedging Instruments: | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net investment income | 0 | 0 | 0 |
Net Investment Income | Cash flow hedges: | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net investment income | 54 | 56 | 37 |
Interest rate | Derivatives Not Designated or Not Qualifying as Hedging Instruments: | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net Derivative Gains (Losses) Recognized for Hedged Items | 0 | 0 | 0 |
Amount of Gains (Losses) Deferred in AOCI | 0 | 0 | 0 |
Interest rate | Cash flow hedges: | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net Derivative Gains (Losses) Recognized for Hedged Items | 0 | 0 | 0 |
Amount of Gains (Losses) Deferred in AOCI | (1) | (50) | (20) |
Interest rate | Net Derivative Gains (Losses) Recognized for Derivatives | Derivatives Not Designated or Not Qualifying as Hedging Instruments: | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net derivative gains (losses) | (384) | (4,001) | (717) |
Interest rate | Net Derivative Gains (Losses) Recognized for Derivatives | Cash flow hedges: | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net derivative gains (losses) | 1 | 5 | 2 |
Interest rate | Net Investment Income | Derivatives Not Designated or Not Qualifying as Hedging Instruments: | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net investment income | 0 | 0 | 0 |
Interest rate | Net Investment Income | Cash flow hedges: | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net investment income | 3 | 4 | 3 |
Foreign currency exchange rate | Derivatives Not Designated or Not Qualifying as Hedging Instruments: | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net Derivative Gains (Losses) Recognized for Hedged Items | 2 | (16) | 2 |
Amount of Gains (Losses) Deferred in AOCI | 0 | 0 | 0 |
Foreign currency exchange rate | Cash flow hedges: | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net Derivative Gains (Losses) Recognized for Hedged Items | (8) | (11) | (3) |
Amount of Gains (Losses) Deferred in AOCI | (272) | 379 | 190 |
Foreign currency exchange rate | Net Derivative Gains (Losses) Recognized for Derivatives | Derivatives Not Designated or Not Qualifying as Hedging Instruments: | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net derivative gains (losses) | (40) | 95 | 48 |
Foreign currency exchange rate | Net Derivative Gains (Losses) Recognized for Derivatives | Cash flow hedges: | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net derivative gains (losses) | 7 | 12 | 7 |
Foreign currency exchange rate | Net Investment Income | Derivatives Not Designated or Not Qualifying as Hedging Instruments: | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net investment income | 0 | 0 | 0 |
Foreign currency exchange rate | Net Investment Income | Cash flow hedges: | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net investment income | 51 | 52 | 34 |
Credit | Derivatives Not Designated or Not Qualifying as Hedging Instruments: | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net Derivative Gains (Losses) Recognized for Hedged Items | 0 | 0 | 0 |
Amount of Gains (Losses) Deferred in AOCI | 0 | 0 | 0 |
Credit | Net Derivative Gains (Losses) Recognized for Derivatives | Derivatives Not Designated or Not Qualifying as Hedging Instruments: | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net derivative gains (losses) | 32 | (2) | 17 |
Credit | Net Investment Income | Derivatives Not Designated or Not Qualifying as Hedging Instruments: | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net investment income | 0 | 0 | 0 |
Equity market | Derivatives Not Designated or Not Qualifying as Hedging Instruments: | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net Derivative Gains (Losses) Recognized for Hedged Items | 0 | 0 | 0 |
Amount of Gains (Losses) Deferred in AOCI | 0 | 0 | 0 |
Equity market | Net Derivative Gains (Losses) Recognized for Derivatives | Derivatives Not Designated or Not Qualifying as Hedging Instruments: | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net derivative gains (losses) | 570 | 590 | (486) |
Equity market | Net Investment Income | Derivatives Not Designated or Not Qualifying as Hedging Instruments: | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net investment income | 0 | 0 | 0 |
Embedded | Derivatives Not Designated or Not Qualifying as Hedging Instruments: | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net Derivative Gains (Losses) Recognized for Hedged Items | 0 | 0 | 0 |
Amount of Gains (Losses) Deferred in AOCI | 0 | 0 | 0 |
Embedded | Net Derivative Gains (Losses) Recognized for Derivatives | Derivatives Not Designated or Not Qualifying as Hedging Instruments: | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net derivative gains (losses) | (4,100) | 2,743 | (2,856) |
Embedded | Net Investment Income | Derivatives Not Designated or Not Qualifying as Hedging Instruments: | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net investment income | $ 0 | $ 0 | $ 0 |
Derivatives (Credit Derivatives
Derivatives (Credit Derivatives) (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Credit Derivatives [Line Items] | ||
Estimated Fair Value of Credit Default Swaps | $ 27 | $ 16 |
Maximum Amount of Future Payments under Credit Default Swaps | $ 1,405 | $ 1,757 |
Weighted Average Years to Maturity (2) | 3 years 10 months 24 days | 4 years 1 month 6 days |
Credit default swaps | Aaa/Aa/A | ||
Credit Derivatives [Line Items] | ||
Estimated Fair Value of Credit Default Swaps | $ 6 | $ 7 |
Maximum Amount of Future Payments under Credit Default Swaps | $ 419 | $ 544 |
Weighted Average Years to Maturity (2) | 1 year 7 months 6 days | 2 years 2 months 12 days |
Credit default swaps | Baa | ||
Credit Derivatives [Line Items] | ||
Estimated Fair Value of Credit Default Swaps | $ 19 | $ 8 |
Maximum Amount of Future Payments under Credit Default Swaps | $ 958 | $ 1,185 |
Weighted Average Years to Maturity (2) | 4 years 10 months 24 days | 5 years |
Credit default swaps | Ba | ||
Credit Derivatives [Line Items] | ||
Estimated Fair Value of Credit Default Swaps | $ 2 | $ 2 |
Maximum Amount of Future Payments under Credit Default Swaps | $ 24 | $ 24 |
Weighted Average Years to Maturity (2) | 3 years | 4 years |
Credit default swaps | Caa and Lower | ||
Credit Derivatives [Line Items] | ||
Estimated Fair Value of Credit Default Swaps | $ 0 | $ (1) |
Maximum Amount of Future Payments under Credit Default Swaps | $ 4 | $ 4 |
Weighted Average Years to Maturity (2) | 2 years | 3 years |
Derivatives (Estimated Fair Val
Derivatives (Estimated Fair Value of Derivatives Assets and Liabilities after Master Netting Agreements and Cash Collateral) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Offsetting Derivative Assets [Abstract] | ||
Derivative Asset, Fair Value, Amount Not Offset Against Collateral | $ 3,495 | $ 2,295 |
Derivative Asset, Not Offset, Policy Election Deduction | (3,112) | (1,659) |
Derivative Asset, Collateral, Obligation to Return Cash, Offset | (154) | (629) |
Derivative Asset, Fair Value, Amount Offset Against Collateral | 229 | 7 |
Derivative Asset, Collateral, Obligation to Return Securities, Offset | (194) | (5) |
Derivative Asset, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election | 35 | 2 |
Offsetting Derivative Liabilities [Abstract] | ||
Derivative Liability, Fair Value, Amount Not Offset Against Collateral | 4,917 | 3,910 |
Derivative Liability, Not Offset, Policy Election Deduction | (3,112) | (1,659) |
Derivative Liability, Collateral, Right to Reclaim Cash, Offset | 0 | 0 |
Derivative Liability, Fair Value, Amount Offset Against Collateral | 1,805 | 2,251 |
Derivative Liability, Collateral, Right to Reclaim Securities, Offset | (1,805) | (2,251) |
Derivative Liability, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election | $ 0 | $ 0 |
Derivatives (Credit Risk on Fre
Derivatives (Credit Risk on Freestanding Derivatives) (Details) - Derivatives Subject To Credit-Contingent Provisions - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Credit Derivatives [Line Items] | ||
Estimated fair value of derivatives in a net liability position (1) | $ 1,805 | $ 2,251 |
Fixed maturity securities | ||
Credit Derivatives [Line Items] | ||
Estimated fair value of collateral provided (2): | $ 4,811 | $ 4,894 |
Derivatives (Derivatives - Narr
Derivatives (Derivatives - Narrative) (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2023 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ||
Maximum Length of Time Hedged in Cash Flow Hedge | 1 year | |
Derivative AOCI associated with Cash Flow Hedges Pre Tax | $ 628 | $ 344 |
Fair Value (Recurring Fair Valu
Fair Value (Recurring Fair Value Measurements) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 |
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | $ 80,085 | $ 74,757 | |
Equity securities | 66 | 66 | |
Short-term investments | 574 | 299 | |
Derivative assets: | 3,703 | 2,271 | |
Market risk benefit assets | 656 | 483 | |
Separate account assets | 81,690 | 78,880 | |
Liabilities [Abstract] | |||
Market risk benefit liabilities | 10,344 | 10,411 | $ 16,062 |
Derivative liabilities: | 5,080 | 3,911 | |
Recurring | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 80,085 | 74,757 | |
Equity securities | 66 | 66 | |
Short-term investments | 574 | 299 | |
Derivative assets: | 3,703 | 2,271 | |
Market risk benefit assets | 656 | 483 | |
Separate account assets | 81,690 | 78,880 | |
Total assets | 166,774 | 156,756 | |
Liabilities [Abstract] | |||
Market risk benefit liabilities | 10,344 | 10,411 | |
Derivative liabilities: | 5,080 | 3,911 | |
Embedded derivatives on index-linked annuities | 8,186 | 3,932 | |
Total liabilities | 23,610 | 18,254 | |
Recurring | Interest rate | |||
Assets [Abstract] | |||
Derivative assets: | 245 | 304 | |
Liabilities [Abstract] | |||
Derivative liabilities: | 2,209 | 2,802 | |
Recurring | Foreign currency exchange rate | |||
Assets [Abstract] | |||
Derivative assets: | 438 | 732 | |
Liabilities [Abstract] | |||
Derivative liabilities: | 47 | 9 | |
Recurring | Credit | |||
Assets [Abstract] | |||
Derivative assets: | 27 | 18 | |
Liabilities [Abstract] | |||
Derivative liabilities: | 0 | 2 | |
Recurring | Equity market | |||
Assets [Abstract] | |||
Derivative assets: | 2,993 | 1,217 | |
Liabilities [Abstract] | |||
Derivative liabilities: | 2,824 | 1,098 | |
Recurring | U.S. corporate | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 35,339 | 32,162 | |
Recurring | Foreign corporate | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 11,582 | 10,492 | |
Recurring | U.S. government and agency | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 8,214 | 7,898 | |
Recurring | RMBS | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 7,366 | 7,491 | |
Recurring | ABS | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 6,401 | 5,355 | |
Recurring | CMBS | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 6,339 | 6,537 | |
Recurring | State and political subdivision | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 3,813 | 3,741 | |
Recurring | Foreign government | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 1,031 | 1,081 | |
Recurring | Level 1 | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 3,680 | 3,507 | |
Equity securities | 18 | 12 | |
Short-term investments | 214 | 206 | |
Derivative assets: | 0 | 0 | |
Market risk benefit assets | 0 | 0 | |
Separate account assets | 20 | 29 | |
Total assets | 3,932 | 3,754 | |
Liabilities [Abstract] | |||
Market risk benefit liabilities | 0 | 0 | |
Derivative liabilities: | 0 | 0 | |
Embedded derivatives on index-linked annuities | 0 | 0 | |
Total liabilities | 0 | 0 | |
Recurring | Level 1 | Interest rate | |||
Assets [Abstract] | |||
Derivative assets: | 0 | 0 | |
Liabilities [Abstract] | |||
Derivative liabilities: | 0 | 0 | |
Recurring | Level 1 | Foreign currency exchange rate | |||
Assets [Abstract] | |||
Derivative assets: | 0 | 0 | |
Liabilities [Abstract] | |||
Derivative liabilities: | 0 | 0 | |
Recurring | Level 1 | Credit | |||
Assets [Abstract] | |||
Derivative assets: | 0 | 0 | |
Liabilities [Abstract] | |||
Derivative liabilities: | 0 | 0 | |
Recurring | Level 1 | Equity market | |||
Assets [Abstract] | |||
Derivative assets: | 0 | 0 | |
Liabilities [Abstract] | |||
Derivative liabilities: | 0 | 0 | |
Recurring | Level 1 | U.S. corporate | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 0 | 0 | |
Recurring | Level 1 | Foreign corporate | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 0 | 0 | |
Recurring | Level 1 | U.S. government and agency | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 3,680 | 3,507 | |
Recurring | Level 1 | RMBS | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 0 | 0 | |
Recurring | Level 1 | ABS | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 0 | 0 | |
Recurring | Level 1 | CMBS | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 0 | 0 | |
Recurring | Level 1 | State and political subdivision | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 0 | 0 | |
Recurring | Level 1 | Foreign government | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 0 | 0 | |
Recurring | Level 2 | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 74,669 | 69,060 | |
Equity securities | 23 | 27 | |
Short-term investments | 360 | 93 | |
Derivative assets: | 3,685 | 2,234 | |
Market risk benefit assets | 0 | 0 | |
Separate account assets | 81,670 | 78,851 | |
Total assets | 160,407 | 150,265 | |
Liabilities [Abstract] | |||
Market risk benefit liabilities | 0 | 0 | |
Derivative liabilities: | 5,080 | 3,909 | |
Embedded derivatives on index-linked annuities | 0 | 0 | |
Total liabilities | 5,080 | 3,909 | |
Recurring | Level 2 | Interest rate | |||
Assets [Abstract] | |||
Derivative assets: | 245 | 304 | |
Liabilities [Abstract] | |||
Derivative liabilities: | 2,209 | 2,802 | |
Recurring | Level 2 | Foreign currency exchange rate | |||
Assets [Abstract] | |||
Derivative assets: | 426 | 703 | |
Liabilities [Abstract] | |||
Derivative liabilities: | 47 | 9 | |
Recurring | Level 2 | Credit | |||
Assets [Abstract] | |||
Derivative assets: | 21 | 10 | |
Liabilities [Abstract] | |||
Derivative liabilities: | 0 | 0 | |
Recurring | Level 2 | Equity market | |||
Assets [Abstract] | |||
Derivative assets: | 2,993 | 1,217 | |
Liabilities [Abstract] | |||
Derivative liabilities: | 2,824 | 1,098 | |
Recurring | Level 2 | U.S. corporate | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 34,344 | 30,973 | |
Recurring | Level 2 | Foreign corporate | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 11,257 | 9,894 | |
Recurring | Level 2 | U.S. government and agency | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 4,534 | 4,391 | |
Recurring | Level 2 | RMBS | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 7,351 | 7,477 | |
Recurring | Level 2 | ABS | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 6,075 | 5,037 | |
Recurring | Level 2 | CMBS | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 6,300 | 6,504 | |
Recurring | Level 2 | State and political subdivision | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 3,813 | 3,741 | |
Recurring | Level 2 | Foreign government | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 995 | 1,043 | |
Recurring | Level 3 | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 1,736 | 2,190 | |
Equity securities | 25 | 27 | |
Short-term investments | 0 | 0 | |
Derivative assets: | 18 | 37 | |
Market risk benefit assets | 656 | 483 | |
Separate account assets | 0 | 0 | |
Total assets | 2,435 | 2,737 | |
Liabilities [Abstract] | |||
Market risk benefit liabilities | 10,344 | 10,411 | |
Derivative liabilities: | 0 | 2 | |
Embedded derivatives on index-linked annuities | 8,186 | 3,932 | |
Total liabilities | 18,530 | 14,345 | |
Recurring | Level 3 | Interest rate | |||
Assets [Abstract] | |||
Derivative assets: | 0 | 0 | |
Liabilities [Abstract] | |||
Derivative liabilities: | 0 | 0 | |
Recurring | Level 3 | Foreign currency exchange rate | |||
Assets [Abstract] | |||
Derivative assets: | 12 | 29 | |
Liabilities [Abstract] | |||
Derivative liabilities: | 0 | 0 | |
Recurring | Level 3 | Credit | |||
Assets [Abstract] | |||
Derivative assets: | 6 | 8 | |
Liabilities [Abstract] | |||
Derivative liabilities: | 0 | 2 | |
Recurring | Level 3 | Equity market | |||
Assets [Abstract] | |||
Derivative assets: | 0 | 0 | |
Liabilities [Abstract] | |||
Derivative liabilities: | 0 | 0 | |
Recurring | Level 3 | U.S. corporate | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 995 | 1,189 | |
Recurring | Level 3 | Foreign corporate | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 325 | 598 | |
Recurring | Level 3 | U.S. government and agency | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 0 | 0 | |
Recurring | Level 3 | RMBS | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 15 | 14 | |
Recurring | Level 3 | ABS | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 326 | 318 | |
Recurring | Level 3 | CMBS | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 39 | 33 | |
Recurring | Level 3 | State and political subdivision | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 0 | 0 | |
Recurring | Level 3 | Foreign government | |||
Assets [Abstract] | |||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | $ 36 | $ 38 |
Fair Value (Assets and Liabilit
Fair Value (Assets and Liabilities Measured - Quantitative Information) (Details) - Level 3 | Dec. 31, 2023 | Dec. 31, 2022 |
Measurement Input, Mortality Rate | Minimum | ||
Fair Value, Option, Quantitative Disclosures | ||
Market Risk Benefit, Measurement Input | 0.0004 | 0.0004 |
Embedded Derivative Liability, Measurement Input | 0.0003 | 0.0003 |
Measurement Input, Mortality Rate | Maximum | ||
Fair Value, Option, Quantitative Disclosures | ||
Market Risk Benefit, Measurement Input | 0.1290 | 0.1290 |
Embedded Derivative Liability, Measurement Input | 0.0924 | 0.0924 |
Measurement Input, Lapse Rate | Minimum | ||
Fair Value, Option, Quantitative Disclosures | ||
Market Risk Benefit, Measurement Input | 0.0100 | 0.0100 |
Embedded Derivative Liability, Measurement Input | 0.0100 | 0.0100 |
Measurement Input, Lapse Rate | Maximum | ||
Fair Value, Option, Quantitative Disclosures | ||
Market Risk Benefit, Measurement Input | 0.2280 | 0.2411 |
Embedded Derivative Liability, Measurement Input | 0.6230 | 0.6230 |
Measurement Input, Utilization Rate | Minimum | ||
Fair Value, Option, Quantitative Disclosures | ||
Market Risk Benefit, Measurement Input | 0 | 0 |
Measurement Input, Utilization Rate | Maximum | ||
Fair Value, Option, Quantitative Disclosures | ||
Market Risk Benefit, Measurement Input | 0.2500 | 0.2500 |
Measurement Input, Withdrawal Rate | Minimum | ||
Fair Value, Option, Quantitative Disclosures | ||
Market Risk Benefit, Measurement Input | 0 | 0 |
Embedded Derivative Liability, Measurement Input | 0.0050 | 0.0050 |
Measurement Input, Withdrawal Rate | Maximum | ||
Fair Value, Option, Quantitative Disclosures | ||
Market Risk Benefit, Measurement Input | 0.1000 | 0.1000 |
Embedded Derivative Liability, Measurement Input | 0.0900 | 0.0900 |
Measurement Input, Long Term Equity Volatilities | Minimum | ||
Fair Value, Option, Quantitative Disclosures | ||
Market Risk Benefit, Measurement Input | 0.1259 | 0.1999 |
Measurement Input, Long Term Equity Volatilities | Maximum | ||
Fair Value, Option, Quantitative Disclosures | ||
Market Risk Benefit, Measurement Input | 0.2250 | 0.2845 |
Measurement Input, Entity Credit Risk | Minimum | ||
Fair Value, Option, Quantitative Disclosures | ||
Market Risk Benefit, Measurement Input | 0.0076 | (0.0273) |
Embedded Derivative Liability, Measurement Input | 0.0045 | 0 |
Measurement Input, Entity Credit Risk | Maximum | ||
Fair Value, Option, Quantitative Disclosures | ||
Market Risk Benefit, Measurement Input | 0.0163 | 0.0452 |
Embedded Derivative Liability, Measurement Input | 0.0174 | 0.0198 |
Fair Value (Unobservable Input
Fair Value (Unobservable Input Reconciliation) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Net Derivatives (2) | |||
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward] | |||
Balance, beginning of period | $ 35 | $ 36 | |
Total realized/unrealized gains (losses) included in net income (loss) (3) (4) | (6) | (9) | $ 1 |
Total realized/unrealized gains (losses) included in AOCI | (3) | 17 | 12 |
Purchases (5) | 4 | 1 | |
Sales (5) | 0 | (9) | |
Issuances (5) | 0 | 0 | |
Settlements (5) | 0 | 0 | |
Transfers into Level 3 (6) | 0 | 0 | |
Transfers out of Level 3 (6) | (12) | (1) | |
Balance, end of period | 18 | 35 | 36 |
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period | (5) | (1) | (11) |
Changes in unrealized gains (losses) included in OCI | (3) | 17 | 12 |
Embedded Derivatives on Index-Linked Annuities | |||
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward] | |||
Balance, beginning of period | (3,932) | (6,641) | |
Total realized/unrealized gains (losses) included in net income (loss) (3) (4) | (4,097) | 2,743 | (2,856) |
Total realized/unrealized gains (losses) included in AOCI | 0 | 0 | 0 |
Purchases (5) | 0 | 0 | |
Sales (5) | 0 | 0 | |
Issuances (5) | 0 | 0 | |
Settlements (5) | (157) | (34) | |
Transfers into Level 3 (6) | 0 | 0 | |
Transfers out of Level 3 (6) | 0 | 0 | |
Balance, end of period | (8,186) | (3,932) | (6,641) |
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period | (4,513) | 2,485 | (2,929) |
Changes in unrealized gains (losses) included in OCI | 0 | 0 | 0 |
Corporate (1) | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Balance, beginning of period | 1,787 | 1,399 | |
Total realized/unrealized gains (losses) included in net income (loss) (3) (4) | (11) | (5) | (1) |
Total realized/unrealized gains (losses) included in AOCI | 28 | (266) | (7) |
Purchases (5) | 162 | 933 | |
Sales (5) | (116) | (184) | |
Issuances (5) | 0 | 0 | |
Settlements (5) | 0 | 0 | |
Transfers into Level 3 (6) | 188 | 94 | |
Transfers out of Level 3 (6) | (718) | (184) | |
Balance, end of period | 1,320 | 1,787 | 1,399 |
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period | (11) | 3 | (2) |
Changes in unrealized gains (losses) included in OCI | 11 | (268) | (6) |
Structured Securities | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Balance, beginning of period | 365 | 220 | |
Total realized/unrealized gains (losses) included in net income (loss) (3) (4) | 0 | 1 | 0 |
Total realized/unrealized gains (losses) included in AOCI | 5 | (23) | 0 |
Purchases (5) | 85 | 251 | |
Sales (5) | (22) | (16) | |
Issuances (5) | 0 | 0 | |
Settlements (5) | 0 | 0 | |
Transfers into Level 3 (6) | 3 | 33 | |
Transfers out of Level 3 (6) | (56) | (101) | |
Balance, end of period | 380 | 365 | 220 |
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period | 0 | 0 | 0 |
Changes in unrealized gains (losses) included in OCI | 4 | (23) | 0 |
Foreign Government | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Balance, beginning of period | 38 | 26 | |
Total realized/unrealized gains (losses) included in net income (loss) (3) (4) | 0 | 0 | 0 |
Total realized/unrealized gains (losses) included in AOCI | 3 | (10) | 0 |
Purchases (5) | 0 | 5 | |
Sales (5) | (2) | (2) | |
Issuances (5) | 0 | 0 | |
Settlements (5) | 0 | 0 | |
Transfers into Level 3 (6) | 0 | 19 | |
Transfers out of Level 3 (6) | (3) | 0 | |
Balance, end of period | 36 | 38 | 26 |
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period | 0 | 0 | 0 |
Changes in unrealized gains (losses) included in OCI | 3 | (10) | 0 |
Equity Securities | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Balance, beginning of period | 27 | 13 | |
Total realized/unrealized gains (losses) included in net income (loss) (3) (4) | (3) | 0 | 0 |
Total realized/unrealized gains (losses) included in AOCI | 0 | 0 | 0 |
Purchases (5) | 2 | 14 | |
Sales (5) | (1) | 0 | |
Issuances (5) | 0 | 0 | |
Settlements (5) | 0 | 0 | |
Transfers into Level 3 (6) | 0 | 0 | |
Transfers out of Level 3 (6) | 0 | 0 | |
Balance, end of period | 25 | 27 | 13 |
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period | (2) | 1 | 0 |
Changes in unrealized gains (losses) included in OCI | 0 | 0 | 0 |
Short-term Investments | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Balance, beginning of period | 0 | 2 | |
Total realized/unrealized gains (losses) included in net income (loss) (3) (4) | 0 | 0 | 0 |
Total realized/unrealized gains (losses) included in AOCI | 0 | 0 | 0 |
Purchases (5) | 0 | 0 | |
Sales (5) | 0 | (2) | |
Issuances (5) | 0 | 0 | |
Settlements (5) | 0 | 0 | |
Transfers into Level 3 (6) | 0 | 0 | |
Transfers out of Level 3 (6) | 0 | 0 | |
Balance, end of period | 0 | 0 | 2 |
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period | 0 | 0 | 0 |
Changes in unrealized gains (losses) included in OCI | $ 0 | $ 0 | $ 0 |
Fair Value (Financial Instrumen
Fair Value (Financial Instruments Carried at Other Than Fair Value) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Assets | ||
Policy loans | $ 938 | $ 898 |
Liabilities | ||
Separate account liabilities | 81,690 | 78,880 |
Carrying Value | ||
Assets | ||
Mortgage loans | 22,475 | 22,877 |
Policy loans | 938 | 898 |
Other invested assets | 260 | 341 |
Premiums, reinsurance and other receivables | 7,431 | 5,915 |
Liabilities | ||
Policyholder account balances | 31,362 | 31,223 |
Short-term debt | 125 | |
Long-term debt | 836 | 838 |
Other liabilities | 1,191 | 1,009 |
Separate account liabilities | 1,148 | 1,022 |
Estimated Fair Value | ||
Assets | ||
Mortgage loans | 20,578 | 20,760 |
Policy loans | 973 | 930 |
Other invested assets | 260 | 341 |
Premiums, reinsurance and other receivables | 7,578 | 6,065 |
Liabilities | ||
Policyholder account balances | 30,501 | 30,303 |
Short-term debt | 125 | |
Long-term debt | 781 | 742 |
Other liabilities | 1,191 | 1,009 |
Separate account liabilities | 1,148 | 1,022 |
Estimated Fair Value | Level 1 | ||
Assets | ||
Mortgage loans | 0 | 0 |
Policy loans | 0 | 0 |
Other invested assets | 0 | 0 |
Premiums, reinsurance and other receivables | 0 | 0 |
Liabilities | ||
Policyholder account balances | 0 | 0 |
Short-term debt | 0 | |
Long-term debt | 0 | 0 |
Other liabilities | 0 | 0 |
Separate account liabilities | 0 | 0 |
Estimated Fair Value | Level 2 | ||
Assets | ||
Mortgage loans | 0 | 0 |
Policy loans | 479 | 477 |
Other invested assets | 245 | 201 |
Premiums, reinsurance and other receivables | 80 | 77 |
Liabilities | ||
Policyholder account balances | 0 | 0 |
Short-term debt | 0 | |
Long-term debt | 26 | 28 |
Other liabilities | 438 | 212 |
Separate account liabilities | 1,148 | 1,022 |
Estimated Fair Value | Level 3 | ||
Assets | ||
Mortgage loans | 20,578 | 20,760 |
Policy loans | 494 | 453 |
Other invested assets | 15 | 140 |
Premiums, reinsurance and other receivables | 7,498 | 5,988 |
Liabilities | ||
Policyholder account balances | 30,501 | 30,303 |
Short-term debt | 125 | |
Long-term debt | 755 | 714 |
Other liabilities | 753 | 797 |
Separate account liabilities | $ 0 | $ 0 |
Long-term and Short-term Debt_2
Long-term and Short-term Debt (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Debt Instrument [Line Items] | ||
Debt instrument, carrying value | $ 836 | $ 838 |
Surplus Note Due 2059 | ||
Debt Instrument [Line Items] | ||
Debt instrument, stated interest rate | 8.07% | 8.07% |
Debt instrument, carrying value | $ 412 | $ 412 |
Surplus Note Due Dec 2058 | ||
Debt Instrument [Line Items] | ||
Debt instrument, stated interest rate | 8.15% | 8.15% |
Debt instrument, carrying value | $ 200 | $ 200 |
Surplus Note Due Sep 2058 | ||
Debt Instrument [Line Items] | ||
Debt instrument, stated interest rate | 7.80% | 7.80% |
Debt instrument, carrying value | $ 200 | $ 200 |
Non-recourse Debt Due 2030 | ||
Debt Instrument [Line Items] | ||
Debt instrument, stated interest rate | 7.028% | 7.028% |
Debt instrument, carrying value | $ 24 | $ 26 |
Long-term and Short-term Debt_3
Long-term and Short-term Debt (Narrative) (Details) - USD ($) $ in Millions | 12 Months Ended | |||||||||
Jun. 30, 2023 | Mar. 28, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | May 16, 2023 | Feb. 16, 2023 | Nov. 16, 2022 | Aug. 16, 2022 | May 16, 2022 | |
Debt Instrument [Line Items] | ||||||||||
Long-term debt maturities, year one | $ 2 | |||||||||
Long-term debt maturities, year two | 3 | |||||||||
Long-term debt maturities, year three | 3 | |||||||||
Long-term debt maturities, year four | 3 | |||||||||
Long-term debt maturities, year five | 3 | |||||||||
Long-term debt maturities, after year five | 822 | |||||||||
Interest expense on long-term debt | 70 | $ 70 | $ 67 | |||||||
Intercompany Liquidity Facilities | Brighthouse Life Insurance Company as Lender | ||||||||||
Debt Instrument [Line Items] | ||||||||||
Debt instrument, face amount | $ 75 | $ 125 | $ 125 | $ 125 | $ 125 | |||||
Debt instrument, stated interest rate | 6.4433% | 5.9966% | 5.7689% | 4.0466% | 2.5363% | |||||
Repayments of Short-Term Debt | $ 75 | $ 50 | ||||||||
Intercompany Liquidity Facilities | BH Holdings as Lender | ||||||||||
Debt Instrument [Line Items] | ||||||||||
Debt instrument, face amount | $ 75 | $ 125 | $ 125 | $ 125 | $ 125 | |||||
Debt instrument, stated interest rate | 6.2918% | 5.9937% | 5.4504% | 4.0466% | 2.5363% | |||||
Repayments of Short-Term Debt | $ 75 | $ 50 | ||||||||
BRCD Reinsurance Financing Arrangement | ||||||||||
Debt Instrument [Line Items] | ||||||||||
Credit facilities, maximum borrowing capacity | 15,000 | |||||||||
Credit facilities, outstanding balance | 0 | |||||||||
Credit facilities, remaining borrowing capacity | 15,000 | |||||||||
Credit facilities, commitment fee amount | 21 | 26 | 34 | |||||||
BLIC Repurchase Facility | ||||||||||
Debt Instrument [Line Items] | ||||||||||
Credit facilities, maximum borrowing capacity | 2,500 | |||||||||
Credit facilities, outstanding balance | 0 | |||||||||
Affiliated Entity | ||||||||||
Debt Instrument [Line Items] | ||||||||||
Interest expense on long-term debt | $ 68 | $ 68 | $ 65 | |||||||
Surplus Note Due 2059 | ||||||||||
Debt Instrument [Line Items] | ||||||||||
Debt instrument, stated interest rate | 8.07% | 8.07% |
Equity (Statutory Net Income_Lo
Equity (Statutory Net Income/Loss) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Parent Company | |||
Statutory Accounting Practices [Line Items] | |||
Statutory Accounting Practices, Statutory Net Income Amount | $ (3,131) | $ 1,373 | $ (156) |
Brighthouse Life Insurance Co of NY | |||
Statutory Accounting Practices [Line Items] | |||
Statutory Accounting Practices, Statutory Net Income Amount | $ 539 | $ (152) | $ (52) |
Equity (Statutory Capital and S
Equity (Statutory Capital and Surplus) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Parent Company | ||
Statutory Accounting Practices [Line Items] | ||
Statutory Accounting Practices, Statutory Capital and Surplus, Balance | $ 4,623 | $ 6,349 |
Brighthouse Life Insurance Co of NY | ||
Statutory Accounting Practices [Line Items] | ||
Statutory Accounting Practices, Statutory Capital and Surplus, Balance | $ 819 | $ 223 |
Equity (Dividend Restrictions)
Equity (Dividend Restrictions) (Details) - USD ($) $ in Millions | 12 Months Ended | |||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2024 | |
Parent Company | ||||
Statutory Accounting Practices [Line Items] | ||||
Payments of Dividends | $ 266 | $ 0 | $ 550 | |
Parent Company | Scenario, Forecast | ||||
Statutory Accounting Practices [Line Items] | ||||
Permitted w/o Approval | $ 0 | |||
Brighthouse Life Insurance Co of NY | ||||
Statutory Accounting Practices [Line Items] | ||||
Payments of Dividends | $ 0 | $ 0 | $ 0 | |
Brighthouse Life Insurance Co of NY | Scenario, Forecast | ||||
Statutory Accounting Practices [Line Items] | ||||
Permitted w/o Approval | $ 81 |
Equity (Components of Accumulat
Equity (Components of Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | $ (5,931) | $ (199) | $ 5,421 |
OCI before reclassifications | 841 | (7,437) | (2,129) |
Deferred income tax benefit (expense) (3) | (176) | 1,561 | 447 |
AOCI before reclassifications, net of income tax | (5,266) | (6,075) | (196) |
Amounts reclassified from AOCI | 193 | 181 | (5) |
Deferred income tax benefit (expense) (3) | (41) | (37) | 2 |
Amounts reclassified from AOCI, net of income tax | 152 | 144 | (3) |
Balance end of period | (5,114) | (5,931) | (199) |
Cumulative effect of change in accounting principle, net of income tax | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | (3,935) | ||
Cumulative Effect, Adjusted Balance | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | 1,486 | ||
Unrealized Investment Gains (Losses), Net of Related Offsets (1) | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | (6,041) | 4,996 | 5,321 |
OCI before reclassifications | 2,109 | (14,148) | (2,898) |
Deferred income tax benefit (expense) (3) | (443) | 2,951 | 608 |
AOCI before reclassifications, net of income tax | (4,375) | (6,201) | 4,990 |
Amounts reclassified from AOCI | 204 | 202 | 7 |
Deferred income tax benefit (expense) (3) | (43) | (42) | (1) |
Amounts reclassified from AOCI, net of income tax | 161 | 160 | 6 |
Balance end of period | (4,214) | (6,041) | 4,996 |
Unrealized Investment Gains (Losses), Net of Related Offsets (1) | Cumulative effect of change in accounting principle, net of income tax | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | 1,959 | ||
Unrealized Investment Gains (Losses), Net of Related Offsets (1) | Cumulative Effect, Adjusted Balance | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | 7,280 | ||
Unrealized Gains (Losses) on Derivatives | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | 496 | 233 | 108 |
OCI before reclassifications | (273) | 329 | 170 |
Deferred income tax benefit (expense) (3) | 58 | (50) | (36) |
AOCI before reclassifications, net of income tax | 281 | 512 | 242 |
Amounts reclassified from AOCI | (11) | (21) | (12) |
Deferred income tax benefit (expense) (3) | 2 | 5 | 3 |
Amounts reclassified from AOCI, net of income tax | (9) | (16) | (9) |
Balance end of period | 272 | 496 | 233 |
Unrealized Gains (Losses) on Derivatives | Cumulative effect of change in accounting principle, net of income tax | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | 0 | ||
Unrealized Gains (Losses) on Derivatives | Cumulative Effect, Adjusted Balance | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | 108 | ||
Changes in Nonperformance Risk on Market Risk Benefits | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | (1,377) | (3,229) | 0 |
OCI before reclassifications | (637) | 2,344 | (636) |
Deferred income tax benefit (expense) (3) | 134 | (492) | 134 |
AOCI before reclassifications, net of income tax | (1,880) | (1,377) | (3,229) |
Amounts reclassified from AOCI | 0 | 0 | 0 |
Deferred income tax benefit (expense) (3) | 0 | 0 | 0 |
Amounts reclassified from AOCI, net of income tax | 0 | 0 | 0 |
Balance end of period | (1,880) | (1,377) | (3,229) |
Changes in Nonperformance Risk on Market Risk Benefits | Cumulative effect of change in accounting principle, net of income tax | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | (2,727) | ||
Changes in Nonperformance Risk on Market Risk Benefits | Cumulative Effect, Adjusted Balance | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | (2,727) | ||
Changes in Discount Rates on the Liability for Future Policy Benefits | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | 1,016 | (2,192) | 0 |
OCI before reclassifications | (376) | 4,060 | 1,234 |
Deferred income tax benefit (expense) (3) | 79 | (852) | (259) |
AOCI before reclassifications, net of income tax | 719 | 1,016 | (2,192) |
Amounts reclassified from AOCI | 0 | 0 | 0 |
Deferred income tax benefit (expense) (3) | 0 | 0 | 0 |
Amounts reclassified from AOCI, net of income tax | 0 | 0 | 0 |
Balance end of period | 719 | 1,016 | (2,192) |
Changes in Discount Rates on the Liability for Future Policy Benefits | Cumulative effect of change in accounting principle, net of income tax | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | (3,167) | ||
Changes in Discount Rates on the Liability for Future Policy Benefits | Cumulative Effect, Adjusted Balance | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | (3,167) | ||
Foreign Currency Translation Adjustments | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | (25) | (7) | (8) |
OCI before reclassifications | 18 | (22) | 1 |
Deferred income tax benefit (expense) (3) | (4) | 4 | 0 |
AOCI before reclassifications, net of income tax | (11) | (25) | (7) |
Amounts reclassified from AOCI | 0 | 0 | 0 |
Deferred income tax benefit (expense) (3) | 0 | 0 | 0 |
Amounts reclassified from AOCI, net of income tax | 0 | 0 | 0 |
Balance end of period | $ (11) | $ (25) | (7) |
Foreign Currency Translation Adjustments | Cumulative effect of change in accounting principle, net of income tax | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | 0 | ||
Foreign Currency Translation Adjustments | Cumulative Effect, Adjusted Balance | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | $ (8) |
Equity (Reclassifications Out o
Equity (Reclassifications Out of Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Net investment gains (losses) | $ (242) | $ (240) | $ (63) |
Net investment income | 4,560 | 4,064 | 4,815 |
Net derivative gains (losses) | (3,920) | (585) | (3,986) |
Income (loss) before provision for income tax | (1,506) | 4,506 | 2,142 |
Income tax (expense) benefit | 383 | (795) | (379) |
Net income (loss) | (1,123) | 3,711 | 1,763 |
Reclassification out of Accumulated Other Comprehensive Income | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Net income (loss) | (152) | (144) | 3 |
Reclassification out of Accumulated Other Comprehensive Income | Net unrealized investment gains (losses): | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Net investment gains (losses) | (192) | (182) | (4) |
Net derivative gains (losses) | (12) | (20) | (3) |
Income (loss) before provision for income tax | (204) | (202) | (7) |
Income tax (expense) benefit | 43 | 42 | 1 |
Net income (loss) | (161) | (160) | (6) |
Reclassification out of Accumulated Other Comprehensive Income | Unrealized Gains (Losses) on Derivatives | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Income (loss) before provision for income tax | 11 | 21 | 12 |
Income tax (expense) benefit | (2) | (5) | (3) |
Net income (loss) | 9 | 16 | 9 |
Reclassification out of Accumulated Other Comprehensive Income | Unrealized Gains (Losses) on Derivatives | Interest rate swaps | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Net investment income | 3 | 4 | 3 |
Net derivative gains (losses) | 1 | 5 | 2 |
Reclassification out of Accumulated Other Comprehensive Income | Unrealized Gains (Losses) on Derivatives | Foreign currency swaps | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Net derivative gains (losses) | $ 7 | $ 12 | $ 7 |
Equity (Statutory Equity and In
Equity (Statutory Equity and Income - Narrative) (Details) - Minimum | 12 Months Ended |
Dec. 31, 2023 | |
Parent Company | |
Statutory Accounting Practices [Line Items] | |
Description of Regulatory Capital Requirements under Insurance Regulations | 400 |
Brighthouse Life Insurance Co of NY | |
Statutory Accounting Practices [Line Items] | |
Description of Regulatory Capital Requirements under Insurance Regulations | 400 |
Equity (Captive Equity and Inco
Equity (Captive Equity and Income - Narrative) (Details) - Brighthouse Reinsurance Company of Delaware - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Statutory Accounting Practices [Line Items] | |||
Statutory Accounting Practices, Statutory Capital and Surplus, Balance | $ 11,000 | $ 10,700 | |
Statutory Accounting Practices, Statutory Net Income Amount | (300) | (208) | $ 543 |
Statutory Accounting Practices, Prescribed Practice, Amount | $ 661 | $ 696 |
Equity (Captive Dividend Restri
Equity (Captive Dividend Restriction - Narrative) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Accounts Receivable | |||
Statutory Accounting Practices [Line Items] | |||
Payments of Dividends | $ 400 | ||
Investments | |||
Statutory Accounting Practices [Line Items] | |||
Payments of Dividends | 197 | ||
Cash | |||
Statutory Accounting Practices [Line Items] | |||
Payments of Dividends | 3 | ||
Preferred Stock | Brighthouse Reinsurance Company of Delaware | |||
Statutory Accounting Practices [Line Items] | |||
Payments of Dividends | $ 1 | $ 1 | $ 1 |
Other Revenues and Other Expe_3
Other Revenues and Other Expenses (Other Expenses) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Other Income and Expenses [Abstract] | |||
Compensation | $ 383 | $ 336 | $ 360 |
Contracted services and other labor costs | 282 | 266 | 249 |
Transition services agreements | 30 | 55 | 119 |
Establishment costs | 0 | 63 | 93 |
Premium and other taxes, licenses and fees | 55 | 49 | 47 |
Volume related costs, excluding compensation, net of DAC capitalization | 536 | 496 | 666 |
Interest expense on debt | 70 | 70 | 67 |
Other General and Administrative Expense | 269 | 359 | 223 |
Total other expenses | $ 1,625 | $ 1,694 | $ 1,824 |
Other Revenues and Other Expe_4
Other Revenues and Other Expenses (Other Revenues-Narrative) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Distribution service | |||
Revenue from Contract with Customer, Including Assessed Tax | $ 199 | $ 217 | $ 264 |
Income Tax (Provision for Incom
Income Tax (Provision for Income Tax) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Current: | |||
Federal | $ (5) | $ (88) | $ 5 |
Deferred: | |||
Federal | (378) | 883 | 374 |
Current and Deferred: | |||
Provision for income tax expense (benefit) | $ (383) | $ 795 | $ 379 |
Income Tax (Rate Reconciliation
Income Tax (Rate Reconciliation) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income tax expense benefit continuing operations income tax reconciliation | |||
Tax provision at statutory rate | $ (316) | $ 946 | $ 449 |
Resolution of prior years | 0 | (71) | (3) |
Dividends received deduction | (31) | (32) | (34) |
Change in uncertain tax benefits | 0 | (20) | 0 |
Tax credits | (8) | (19) | (15) |
Change in valuation allowance | (18) | 0 | 18 |
Return to provision | (5) | (5) | 12 |
Adjustments to deferred tax | 0 | (2) | (48) |
Other, net | (5) | (2) | 0 |
Provision for income tax expense (benefit) | $ (383) | $ 795 | $ 379 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | 25% | 18% | 18% |
Income Tax (Net Deferred Income
Income Tax (Net Deferred Income Tax Assets and Liabilities) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Deferred income tax assets: | ||
Net unrealized investment losses | $ 1,048 | $ 1,473 |
Net operating loss carryforwards | 1,826 | 1,246 |
Investments, including derivatives | 210 | 285 |
Tax credit carryforwards | 189 | 183 |
Employee benefits | 3 | 3 |
Intangibles | 48 | 55 |
Other | 0 | 28 |
Total deferred income tax assets | 3,324 | 3,273 |
Less: Valuation allowance | 0 | 18 |
Total net deferred income tax assets | 3,324 | 3,255 |
Deferred income tax liabilities: | ||
Policyholder liabilities and receivables | 910 | 985 |
DAC | 580 | 597 |
Other | 1 | 0 |
Total deferred income tax liabilities | 1,491 | 1,582 |
Net deferred income tax asset (liability) | $ 1,833 | $ 1,673 |
Income Tax (Net Operating Loss
Income Tax (Net Operating Loss Carryforwards) (Details) $ in Millions | Dec. 31, 2023 USD ($) |
Operating Loss Carryforwards [Line Items] | |
Operating Loss Carryforwards | $ 8,697 |
Expiration Period Fourth Four Years By Deferred Tax Asset [Member] | |
Operating Loss Carryforwards [Line Items] | |
Operating Loss Carryforwards | 2,006 |
Expiration Period For Indefinite Number Of Years By Deferred Tax Asset [Member] | |
Operating Loss Carryforwards [Line Items] | |
Operating Loss Carryforwards | $ 6,691 |
Income Tax (Tax Credit Carryfor
Income Tax (Tax Credit Carryforwards) (Details) $ in Millions | Dec. 31, 2023 USD ($) |
Foreign Tax Authority | |
Tax Credit Carryforward [Line Items] | |
Tax credit carryforwards | $ 164 |
Foreign Tax Authority | 2024-2028 | |
Tax Credit Carryforward [Line Items] | |
Tax credit carryforwards | 44 |
Foreign Tax Authority | 2029-2033 | |
Tax Credit Carryforward [Line Items] | |
Tax credit carryforwards | 120 |
Foreign Tax Authority | 2034-2038 | |
Tax Credit Carryforward [Line Items] | |
Tax credit carryforwards | 0 |
Foreign Tax Authority | 2039-2043 | |
Tax Credit Carryforward [Line Items] | |
Tax credit carryforwards | 0 |
Foreign Tax Authority | Indefinite | |
Tax Credit Carryforward [Line Items] | |
Tax credit carryforwards | 0 |
General business tax credit carryforward | |
Tax Credit Carryforward [Line Items] | |
Tax credit carryforwards | 25 |
General business tax credit carryforward | 2024-2028 | |
Tax Credit Carryforward [Line Items] | |
Tax credit carryforwards | 0 |
General business tax credit carryforward | 2029-2033 | |
Tax Credit Carryforward [Line Items] | |
Tax credit carryforwards | 0 |
General business tax credit carryforward | 2034-2038 | |
Tax Credit Carryforward [Line Items] | |
Tax credit carryforwards | 20 |
General business tax credit carryforward | 2039-2043 | |
Tax Credit Carryforward [Line Items] | |
Tax credit carryforwards | 5 |
General business tax credit carryforward | Indefinite | |
Tax Credit Carryforward [Line Items] | |
Tax credit carryforwards | $ 0 |
Income Tax (Reconciliation of U
Income Tax (Reconciliation of Unrecognized Tax Benefits) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Reconciliation of Unrecognized Tax Benefits | |||
Balance at January 1, | $ 14 | $ 34 | $ 34 |
Additions for tax positions of prior years | 0 | 0 | 0 |
Reductions for tax positions of prior years | 0 | 0 | 0 |
Additions for tax positions of current year | 0 | 0 | 0 |
Reductions for tax positions of current year | 0 | 0 | 0 |
Settlements with tax authorities | 0 | 0 | 0 |
Lapses of statutes of limitations | 0 | (20) | 0 |
Balance at December 31, | 14 | 14 | 34 |
Unrecognized tax benefits that, if recognized would impact the effective rate | $ 14 | $ 14 | $ 34 |
Income Tax (Narrative) (Details
Income Tax (Narrative) (Details) - USD ($) | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Tax Examination, Penalties Expense | $ 0 | $ 0 | $ 0 |
Net cash paid (received) for income tax | 0 | 12,000,000 | (53,000,000) |
Current income tax recoverable | 24,000,000 | 18,000,000 | |
MetLife, Inc. | |||
Net cash paid (received) for income tax | 0 | 14,000,000 | |
Income taxes paid | $ 73,000,000 | ||
Current income tax recoverable | $ 15,000,000 | $ 14,000,000 |
Contingencies, Commitments an_2
Contingencies, Commitments and Guarantees (Contingencies, Commitments and Guarantees - Narrative) (Details) - USD ($) $ in Millions | 3 Months Ended | 12 Months Ended | ||
Sep. 30, 2022 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items] | ||||
Settlement for reinsurance-related matter | $ 269 | $ 359 | $ 223 | |
Cumulative maximum indemnities and guarantees contractual limitation | 98 | |||
Liabilities for indemnities, guarantees and commitments | 1 | 1 | ||
Non-litigation loss | ||||
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items] | ||||
Settlement for reinsurance-related matter | $ 140 | |||
Minimum | ||||
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items] | ||||
Indemnities and guarantees contractual limitation range | 6 | |||
Minimum | Non-litigation loss | ||||
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items] | ||||
Loss contingency, range of possible loss, portion not accrued | 0 | |||
Maximum | ||||
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items] | ||||
Loss contingency, range of possible loss, portion not accrued | 10 | |||
Indemnities and guarantees contractual limitation range | 92 | |||
Maximum | Non-litigation loss | ||||
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items] | ||||
Loss contingency, range of possible loss, portion not accrued | 125 | |||
Mortgage Loan Commitments | ||||
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items] | ||||
Fair value disclosure, off-balance sheet risks, face amount, liability | 374 | 247 | ||
Commitments to Fund Partnership Investments and Private Corporate Bond Investments | ||||
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items] | ||||
Fair value disclosure, off-balance sheet risks, face amount, liability | $ 1,400 | $ 1,900 |
Related Party Transaction (Rela
Related Party Transaction (Related Party Transaction - Narrative) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Related Party Transaction [Line Items] | |||
Insurance Commissions and Fees | $ 1,778 | $ 1,876 | $ 2,320 |
Total revenues | 3,405 | 6,162 | 4,110 |
Broker Dealer Activities [Member] | |||
Related Party Transaction [Line Items] | |||
Total revenues | 169 | 186 | 224 |
Operating Costs and Expenses | 887 | 920 | 1,000 |
Other Receivables | 14 | 14 | |
All Services and Transactions Except Broker Dealer Activities | |||
Related Party Transaction [Line Items] | |||
Accounts Payable, Other | (110) | (188) | |
Affiliated Entity | |||
Related Party Transaction [Line Items] | |||
Insurance Commissions and Fees | 175 | 193 | 235 |
Selling, General and Administrative Expense | $ 935 | $ 946 | $ 1,000 |
Consolidated Summary of Inves_2
Consolidated Summary of Investments - Other Than Investments in Related Parties (Details) $ in Millions | Dec. 31, 2023 USD ($) |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | $ 119,537 |
Amount at Which Shown on Balance Sheet | 113,495 |
U.S. government and agency | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 8,446 |
Estimated Fair Value | 8,214 |
Amount at Which Shown on Balance Sheet | 8,214 |
State and political subdivision | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 3,958 |
Estimated Fair Value | 3,813 |
Amount at Which Shown on Balance Sheet | 3,813 |
Public utilities | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 3,745 |
Estimated Fair Value | 3,430 |
Amount at Which Shown on Balance Sheet | 3,430 |
Foreign government | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 1,077 |
Estimated Fair Value | 1,031 |
Amount at Which Shown on Balance Sheet | 1,031 |
All other corporate bonds | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 46,909 |
Estimated Fair Value | 43,115 |
Amount at Which Shown on Balance Sheet | 43,115 |
Total bonds | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 64,135 |
Estimated Fair Value | 59,603 |
Amount at Which Shown on Balance Sheet | 59,603 |
Mortgage-backed and asset-backed securities | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 21,576 |
Estimated Fair Value | 20,106 |
Amount at Which Shown on Balance Sheet | 20,106 |
Redeemable preferred stock | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 418 |
Estimated Fair Value | 376 |
Amount at Which Shown on Balance Sheet | 376 |
Total fixed maturity securities | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 86,129 |
Estimated Fair Value | 80,085 |
Amount at Which Shown on Balance Sheet | 80,085 |
Non-redeemable preferred stock | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 33 |
Estimated Fair Value | 34 |
Amount at Which Shown on Balance Sheet | 34 |
Industrial, miscellaneous and all other | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 31 |
Estimated Fair Value | 31 |
Amount at Which Shown on Balance Sheet | 31 |
Public utilities | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 0 |
Estimated Fair Value | 1 |
Amount at Which Shown on Balance Sheet | 1 |
Total equity securities | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 64 |
Estimated Fair Value | 66 |
Amount at Which Shown on Balance Sheet | 66 |
Mortgage loans | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 22,475 |
Amount at Which Shown on Balance Sheet | 22,475 |
Policy loans | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 938 |
Amount at Which Shown on Balance Sheet | 938 |
Limited partnerships and LLCs | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 4,946 |
Amount at Which Shown on Balance Sheet | 4,946 |
Short-term investments | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 574 |
Amount at Which Shown on Balance Sheet | 574 |
Other invested assets | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 4,411 |
Amount at Which Shown on Balance Sheet | $ 4,411 |
Condensed Financial Informati_2
Condensed Financial Information (Parent Company) (Condensed Balance Sheets) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 |
Investments: | ||||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | $ 80,085 | $ 74,757 | ||
Equity securities | 66 | 66 | ||
Mortgage loans (net of allowance for credit losses of $129 and $114, respectively) | 22,475 | 22,877 | ||
Policy loans | 938 | 898 | ||
Limited partnerships and limited liability companies | 4,946 | 4,774 | ||
Short-term investments | 574 | 299 | ||
Other invested assets, at estimated fair value | 4,411 | 2,984 | ||
Total investments | 113,495 | 106,655 | ||
Cash and cash equivalents | 3,165 | 3,752 | $ 3,904 | $ 3,684 |
Accrued Investment Income Receivable | 1,163 | 868 | ||
Premiums, reinsurance and other receivables (net of allowance for credit losses of $3 and $10, respectively) | 19,389 | 18,145 | ||
Deferred policy acquisition costs and value of business acquired | 4,487 | 4,642 | ||
Current income tax recoverable | 24 | 18 | ||
Deferred income tax asset | 1,833 | 1,673 | ||
Market risk benefit assets | 656 | 483 | ||
Other Assets | 302 | 322 | ||
Separate account assets | 81,690 | 78,880 | ||
Total assets | 226,204 | 215,438 | 249,731 | |
Liabilities | ||||
Future policy benefits | 32,149 | 31,146 | ||
Policyholder account balances | 80,193 | 72,602 | 64,290 | |
Market risk benefit liabilities | 10,344 | 10,411 | 16,062 | |
Other policy-related balances | 3,619 | 3,860 | ||
Payables for collateral under securities loaned and other transactions | 3,660 | 4,547 | ||
Long-term and short-term debt | 836 | 838 | ||
Other liabilities | 7,772 | 6,515 | ||
Separate account liabilities | 81,690 | 78,880 | ||
Total liabilities | 220,263 | 208,924 | 241,195 | |
Brighthouse Life Insurance Company’s stockholder’s equity: | ||||
Common stock, par value $25,000 per share; 4,000 shares authorized; 3,000 shares issued and outstanding | 75 | 75 | ||
Additional paid-in capital | 17,507 | 17,773 | ||
Retained earnings (deficit) | (6,542) | (5,418) | (9,128) | |
Accumulated other comprehensive income (loss) | (5,114) | (5,931) | (199) | 5,421 |
Total Brighthouse Life Insurance Company's stockholder's equity | 5,926 | 6,499 | ||
Total liabilities and equity | 226,204 | 215,438 | 249,731 | |
Parent Company | ||||
Investments: | ||||
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $73,144 and $71,285, respectively; allowance for credit losses of $20 and $4, respectively) | 68,317 | 64,250 | ||
Equity securities | 48 | 55 | ||
Mortgage loans (net of allowance for credit losses of $129 and $114, respectively) | 21,249 | 21,658 | ||
Policy loans | 938 | 898 | ||
Limited partnerships and limited liability companies | 4,384 | 4,191 | ||
Short-term investments | 574 | 299 | ||
Investment in subsidiaries | 2,347 | 2,604 | ||
Other invested assets, at estimated fair value | 8,697 | 2,600 | ||
Total investments | 106,554 | 96,555 | ||
Cash and cash equivalents | 2,682 | 3,102 | $ 3,309 | $ 3,384 |
Accrued Investment Income Receivable | 1,049 | 765 | ||
Premiums, reinsurance and other receivables (net of allowance for credit losses of $3 and $10, respectively) | 18,869 | 17,591 | ||
Due from Affiliates | 15,830 | 11,091 | ||
Deferred policy acquisition costs and value of business acquired | 4,047 | 4,184 | ||
Current income tax recoverable | 23 | 27 | ||
Deferred income tax asset | 3,380 | 3,321 | ||
Market risk benefit assets | 588 | 438 | ||
Other Assets | 279 | 299 | ||
Separate account assets | 77,563 | 74,958 | ||
Total assets | 230,864 | 212,331 | ||
Liabilities | ||||
Future policy benefits | 32,066 | 31,693 | ||
Policyholder account balances | 79,017 | 67,753 | ||
Market risk benefit liabilities | 10,183 | 10,303 | ||
Other policy-related balances | 3,902 | 4,296 | ||
Payables for collateral under securities loaned and other transactions | 3,616 | 4,353 | ||
Long-term and short-term debt | 812 | 812 | ||
Other liabilities | 17,779 | 11,664 | ||
Separate account liabilities | 77,563 | 74,958 | ||
Total liabilities | 224,938 | 205,832 | ||
Brighthouse Life Insurance Company’s stockholder’s equity: | ||||
Common stock, par value $25,000 per share; 4,000 shares authorized; 3,000 shares issued and outstanding | 75 | 75 | ||
Additional paid-in capital | 17,507 | 17,773 | ||
Retained earnings (deficit) | (6,542) | (5,418) | ||
Accumulated other comprehensive income (loss) | (5,114) | (5,931) | ||
Total Brighthouse Life Insurance Company's stockholder's equity | 5,926 | 6,499 | ||
Total liabilities and equity | $ 230,864 | $ 212,331 |
Condensed Financial Informati_3
Condensed Financial Information (Parent Company) (Condensed Balance Sheets - Insets) (Details) - USD ($) $ / shares in Units, $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 |
Condensed Balance Sheet Statements, Captions [Line Items] | |||
Amortized cost of fixed maturity securities available-for-sale | $ 86,129 | $ 83,395 | |
Fixed maturity securities, allowance for credit losses | 21 | 6 | $ 11 |
Mortgage loans valuation allowances | 137 | 119 | |
Premiums, reinsurance and other, allowance for credit losses | $ 3 | $ 10 | |
Common stock, par value | $ 25,000 | $ 25,000 | |
Common stock, shares authorized | 4,000 | 4,000 | |
Common stock, shares, issued | 3,000 | 3,000 | |
Common stock, shares, outstanding | 3,000 | 3,000 | |
Parent Company | |||
Condensed Balance Sheet Statements, Captions [Line Items] | |||
Amortized cost of fixed maturity securities available-for-sale | $ 73,144 | $ 71,285 | |
Fixed maturity securities, allowance for credit losses | 20 | 4 | |
Mortgage loans valuation allowances | 129 | 114 | |
Premiums, reinsurance and other, allowance for credit losses | $ 3 | $ 10 | |
Common stock, par value | $ 25,000 | $ 25,000 | |
Common stock, shares authorized | 4,000 | 4,000 | |
Common stock, shares, issued | 3,000 | 3,000 | |
Common stock, shares, outstanding | 3,000 | 3,000 |
Condensed Financial Informati_4
Condensed Financial Information (Parent Company) (Condensed Statements of Operations) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Condensed Income Statements, Captions [Line Items] | |||
Premiums | $ 811 | $ 641 | $ 687 |
Universal life and investment-type product policy fees | 1,778 | 1,876 | 2,320 |
Net investment income | 4,560 | 4,064 | 4,815 |
Other revenues | 418 | 406 | 337 |
Net investment gains (losses) | (242) | (240) | (63) |
Net derivative gains (losses) | (3,920) | (585) | (3,986) |
Total revenues | 3,405 | 6,162 | 4,110 |
Expenses | |||
Policyholder benefits and claims (including remeasurement gains (losses) of ($137), $79, $47, respectively) | 2,418 | 2,186 | 2,485 |
Interest credited to policyholder account balances | 1,801 | 1,313 | 1,243 |
Amortization of deferred policy acquisition costs and value of business acquired | 564 | 568 | 558 |
Change in market risk benefits | (18) | 286 | (14) |
Other expenses | 1,625 | 1,694 | 1,824 |
Total expenses | 4,911 | 1,656 | 1,968 |
Income (loss) before provision for income tax | (1,506) | 4,506 | 2,142 |
Provision for income tax expense (benefit) | (383) | 795 | 379 |
Net income (loss) attributable to Brighthouse Life Insurance Company | (1,124) | 3,710 | 1,762 |
Comprehensive income (loss) | (307) | (2,022) | 77 |
Parent Company | |||
Condensed Income Statements, Captions [Line Items] | |||
Premiums | 599 | 423 | 423 |
Universal life and investment-type product policy fees | 1,527 | 1,607 | 2,025 |
Net investment income | 3,992 | 3,620 | 4,340 |
Other revenues | 519 | 480 | 394 |
Net investment gains (losses) | (234) | (233) | 12 |
Net derivative gains (losses) | (3,616) | 1,800 | (3,488) |
Total revenues | 2,787 | 7,697 | 3,706 |
Expenses | |||
Policyholder benefits and claims (including remeasurement gains (losses) of ($137), $79, $47, respectively) | 1,692 | 1,420 | 1,534 |
Interest credited to policyholder account balances | 1,641 | 1,152 | 1,079 |
Amortization of deferred policy acquisition costs and value of business acquired | 499 | 504 | 503 |
Change in market risk benefits | (1,494) | (4,107) | (4,153) |
Other expenses | 1,817 | 1,926 | 2,815 |
Total expenses | 4,155 | 895 | 1,778 |
Income (loss) before provision for income tax | (1,368) | 6,802 | 1,928 |
Provision for income tax expense (benefit) | (347) | 1,292 | 340 |
Income (loss) before equity in earnings (losses) of subsidiaries | (1,021) | 5,510 | 1,588 |
Income (Loss) from Subsidiaries, Net of Tax | (103) | (1,800) | 174 |
Net income (loss) attributable to Brighthouse Life Insurance Company | (1,124) | 3,710 | 1,762 |
Comprehensive income (loss) | $ (307) | $ (2,022) | $ 77 |
Condensed Financial Informati_5
Condensed Financial Information (Parent Company) (Condensed Statements of Operations - Insets) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Condensed Income Statements, Captions [Line Items] | |||
Liability for Future Policy Benefit, Remeasurement Gain (Loss) | $ (233) | $ 137 | $ (51) |
Parent Company | |||
Condensed Income Statements, Captions [Line Items] | |||
Liability for Future Policy Benefit, Remeasurement Gain (Loss) | $ (137) | $ 79 | $ 47 |
Condensed Financial Informati_6
Condensed Financial Information (Parent Company) (Condensed Statements of Cash Flows) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Condensed Statements of Cash Flows | |||
Net cash provided by (used in) operating activities | $ (7) | $ (782) | $ 1,249 |
Cash flows from investing activities | |||
Sales, maturities and repayments of fixed maturity securities | 5,922 | 10,647 | 12,406 |
Sales, maturities and repayments of equity securities | 30 | 50 | 128 |
Sales, maturities and repayments of mortgage loans | 1,206 | 2,075 | 2,891 |
Sales, maturities and repayments of limited partnerships and limited liability companies | 205 | 252 | 271 |
Purchases of fixed maturity securities | (8,699) | (15,720) | (21,036) |
Purchases of equity securities | (4) | (14) | (18) |
Purchases of mortgage loans | (813) | (5,321) | (6,929) |
Purchases of limited partnerships and limited liability companies | (453) | (814) | (837) |
Cash received in connection with freestanding derivatives | 5,048 | 4,439 | 3,956 |
Cash paid in connection with freestanding derivatives | (5,422) | (4,270) | (4,590) |
Receipts on loans to affiliate | 125 | 0 | 0 |
Issuances of loans to affiliate | 0 | (125) | (1) |
Net change in policy loans | (40) | (29) | 15 |
Net change in short-term investments | (259) | 365 | 1,223 |
Net change in other invested assets | (109) | (372) | (24) |
Net cash provided by (used in) investing activities | (3,263) | (8,837) | (12,545) |
Cash flows from financing activities | |||
Policyholder account balances: Deposits | 21,514 | 31,190 | 15,520 |
Policyholder account balances: Withdrawals | (17,641) | (19,960) | (4,100) |
Net change in payables for collateral under securities loaned and other transactions | (887) | (1,706) | 1,016 |
Dividends paid to parent | (266) | 0 | (550) |
Financing element on certain derivative instruments and other derivative related transactions, net | 91 | (178) | (368) |
Net cash provided by (used in) financing activities | 2,683 | 9,467 | 11,516 |
Change in cash, cash equivalents and restricted cash | (587) | (152) | 220 |
Cash, cash equivalents and restricted cash, beginning of year | 3,752 | 3,904 | 3,684 |
Cash, cash equivalents and restricted cash, end of year | 3,165 | 3,752 | 3,904 |
Supplemental disclosures of cash flow information | |||
Net cash paid (received) for interest | 71 | 69 | 67 |
Net cash paid (received) for income tax | 0 | (12) | 53 |
Non-cash transactions: | |||
Transfer of fixed maturity securities from affiliates | 0 | 99 | 0 |
Transfer from investments to affiliates | 0 | 95 | 0 |
Parent Company | |||
Condensed Statements of Cash Flows | |||
Net cash provided by (used in) operating activities | 238 | (938) | 1,285 |
Cash flows from investing activities | |||
Sales, maturities and repayments of fixed maturity securities | 5,561 | 9,701 | 11,647 |
Sales, maturities and repayments of equity securities | 18 | 48 | 107 |
Sales, maturities and repayments of mortgage loans | 1,180 | 2,036 | 2,814 |
Sales, maturities and repayments of limited partnerships and limited liability companies | 197 | 249 | 271 |
Purchases of fixed maturity securities | (7,587) | (14,364) | (18,942) |
Purchases of equity securities | (3) | (14) | (8) |
Purchases of mortgage loans | (775) | (4,864) | (6,680) |
Purchases of limited partnerships and limited liability companies | (449) | (807) | (837) |
Cash received in connection with freestanding derivatives | 4,505 | 4,327 | 3,489 |
Cash paid in connection with freestanding derivatives | (5,207) | (3,833) | (4,471) |
Receipts on loans to affiliate | 125 | 0 | 0 |
Issuances of loans to affiliate | 0 | (125) | 0 |
Returns of capital and dividends from subsidiaries | 25 | 30 | 24 |
Capital contributions to subsidiaries | 0 | (100) | 0 |
Net change in policy loans | (40) | (29) | 15 |
Net change in short-term investments | (261) | 351 | 1,021 |
Net change in other invested assets | (4,530) | (381) | (33) |
Net cash provided by (used in) investing activities | (7,241) | (7,775) | (11,583) |
Cash flows from financing activities | |||
Policyholder account balances: Deposits | 24,917 | 29,938 | 14,210 |
Policyholder account balances: Withdrawals | (17,305) | (19,680) | (3,890) |
Net change in payables for collateral under securities loaned and other transactions | (737) | (1,569) | 821 |
Dividends paid to parent | (266) | 0 | (550) |
Financing element on certain derivative instruments and other derivative related transactions, net | (26) | (183) | (368) |
Net cash provided by (used in) financing activities | 6,583 | 8,506 | 10,223 |
Change in cash, cash equivalents and restricted cash | (420) | (207) | (75) |
Cash, cash equivalents and restricted cash, beginning of year | 3,102 | 3,309 | 3,384 |
Cash, cash equivalents and restricted cash, end of year | 2,682 | 3,102 | 3,309 |
Supplemental disclosures of cash flow information | |||
Net cash paid (received) for interest | 65 | 65 | 65 |
Net cash paid (received) for income tax | (20) | (56) | 45 |
Parent Company | Fixed maturity securities | |||
Non-cash transactions: | |||
Transfer of fixed maturity securities from affiliates | 103 | 589 | 240 |
Transfer from investments to affiliates | 234 | 296 | 722 |
Parent Company | Limited partnerships and limited liability companies | |||
Non-cash transactions: | |||
Transfer from investments to affiliates | 0 | 587 | 0 |
Parent Company | Mortgage loans | |||
Non-cash transactions: | |||
Transfer from investments to affiliates | $ 0 | $ 89 | $ 0 |
Condensed Financial Informati_7
Condensed Financial Information (Parent Company) (Investment in Subsidiaries Footnote) (Details) - Parent Company - Brighthouse Life Insurance Co of NY - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Condensed Financial Statements, Captions [Line Items] | ||
Cash Capital Contributions To Subsidiaries | $ 100 | |
Non-Cash Capital Contributions To Subsidiaries | $ 100 |
Consolidated Supplementary In_2
Consolidated Supplementary Insurance Information (Balance Sheet Items) (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 |
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
DAC and VOBA | $ 4,487 | $ 4,642 | |
Supplementary Insurance Information Future Policy Benefits Other Policy Related Balances And Policyholder Dividend Obligation | 35,768 | 35,006 | |
Policyholder account balances | 80,193 | 72,602 | $ 64,290 |
Unearned Premiums | 16 | 15 | |
Unearned Revenue | 844 | 704 | |
Annuities | |||
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
DAC and VOBA | 4,027 | 4,140 | |
Supplementary Insurance Information Future Policy Benefits Other Policy Related Balances And Policyholder Dividend Obligation | 3,995 | 3,742 | |
Policyholder account balances | 60,723 | 53,156 | |
Unearned Premiums | 0 | 0 | |
Unearned Revenue | 65 | 73 | |
Life | |||
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
DAC and VOBA | 456 | 498 | |
Supplementary Insurance Information Future Policy Benefits Other Policy Related Balances And Policyholder Dividend Obligation | 5,942 | 5,714 | |
Policyholder account balances | 2,187 | 2,349 | |
Unearned Premiums | 11 | 10 | |
Unearned Revenue | 167 | 143 | |
Run-off | |||
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
DAC and VOBA | 4 | 4 | |
Supplementary Insurance Information Future Policy Benefits Other Policy Related Balances And Policyholder Dividend Obligation | 19,420 | 18,688 | |
Policyholder account balances | 6,694 | 6,933 | |
Unearned Premiums | 0 | 0 | |
Unearned Revenue | 612 | 488 | |
Corporate & Other | |||
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
DAC and VOBA | 0 | 0 | |
Supplementary Insurance Information Future Policy Benefits Other Policy Related Balances And Policyholder Dividend Obligation | 6,411 | 6,862 | |
Policyholder account balances | 10,589 | 10,164 | |
Unearned Premiums | 5 | 5 | |
Unearned Revenue | $ 0 | $ 0 |
Consolidated Supplementary In_3
Consolidated Supplementary Insurance Information (Income Statement Items) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
Premiums and Universal Life and Investment-Type Product Policy Fees | $ 2,589 | $ 2,517 | $ 3,007 |
Net Investment Income (1) | 4,560 | 4,064 | 4,815 |
Policyholder Benefits and Claims, and Interest Credited to Policyholder Account Balances | 4,219 | 3,499 | 3,728 |
Amortization of deferred policy acquisition costs and value of business acquired | 564 | 568 | 558 |
Other Expenses | 1,625 | 1,694 | 1,824 |
Annuities | |||
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
Premiums and Universal Life and Investment-Type Product Policy Fees | 1,499 | 1,418 | 1,785 |
Net Investment Income (1) | 2,536 | 2,233 | 2,196 |
Policyholder Benefits and Claims, and Interest Credited to Policyholder Account Balances | 1,556 | 1,271 | 1,144 |
Amortization of deferred policy acquisition costs and value of business acquired | 507 | 505 | 491 |
Other Expenses | 997 | 980 | 1,112 |
Life | |||
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
Premiums and Universal Life and Investment-Type Product Policy Fees | 615 | 588 | 733 |
Net Investment Income (1) | 385 | 391 | 642 |
Policyholder Benefits and Claims, and Interest Credited to Policyholder Account Balances | 688 | 847 | 610 |
Amortization of deferred policy acquisition costs and value of business acquired | 57 | 63 | 67 |
Other Expenses | 182 | 110 | 173 |
Run-off | |||
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
Premiums and Universal Life and Investment-Type Product Policy Fees | 475 | 511 | 489 |
Net Investment Income (1) | 1,115 | 1,146 | 1,900 |
Policyholder Benefits and Claims, and Interest Credited to Policyholder Account Balances | 1,587 | 1,216 | 1,953 |
Amortization of deferred policy acquisition costs and value of business acquired | 0 | 0 | 0 |
Other Expenses | 167 | 292 | 191 |
Corporate & Other | |||
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
Premiums and Universal Life and Investment-Type Product Policy Fees | 0 | 0 | 0 |
Net Investment Income (1) | 524 | 294 | 77 |
Policyholder Benefits and Claims, and Interest Credited to Policyholder Account Balances | 388 | 165 | 21 |
Amortization of deferred policy acquisition costs and value of business acquired | 0 | 0 | 0 |
Other Expenses | $ 279 | $ 312 | $ 348 |
Consolidated Reinsurance (Detai
Consolidated Reinsurance (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |||
Gross Amount | $ 463,582 | $ 475,382 | $ 494,317 |
Ceded | 129,016 | 138,063 | 145,618 |
Assumed | 7,479 | 8,034 | 8,966 |
Net Amount | $ 342,045 | $ 345,353 | $ 357,665 |
% Amount Assumed to Net | 2.20% | 2.30% | 2.50% |
Consolidated Reinsurance | |||
Direct premiums | $ 1,458 | $ 1,321 | $ 1,398 |
Ceded | 667 | 688 | 701 |
Assumed | 20 | 8 | (10) |
Net Amount | $ 811 | $ 641 | $ 687 |
% Amount Assumed to Net | 2.50% | 1.20% | (1.50%) |
Affiliated Entity | |||
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |||
Assumed | $ 1,400 | $ 1,500 | $ 1,600 |
Life | |||
Consolidated Reinsurance | |||
Direct premiums | 1,257 | 1,123 | 1,193 |
Ceded | 475 | 493 | 500 |
Assumed | 20 | 8 | (10) |
Net Amount | $ 802 | $ 638 | $ 683 |
% Amount Assumed to Net | 2.50% | 1.30% | (1.50%) |
Life | Affiliated Entity | |||
Consolidated Reinsurance | |||
Assumed | $ 6 | $ 2 | $ 2 |
Other products | |||
Consolidated Reinsurance | |||
Direct premiums | 201 | 198 | 205 |
Ceded | 192 | 195 | 201 |
Assumed | 0 | 0 | 0 |
Net Amount | $ 9 | $ 3 | $ 4 |
% Amount Assumed to Net | 0% | 0% | 0% |